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ABSTRACT
This thesis reports a psychophysiological examination of the effects of distractors on 
pain in the cold-pressor test (immersion of a limb in ice-cold water). Visual distractor 
stimuli at two levels of novelty were compared with no distraction in a between-group 
design. Study 1 investigated effects in behavioural and autonomic nervous system measures 
(skin conductance level, respiration rate, heart rate, systolic and diastolic blood pressure). 
The two distractor groups reported less pain than the control group, with subjects receiving 
the highly-novel distractor rating their pain as least overall. Skin conductance level, 
respiration rate and heart rate responses in the cold pressor were also modified by a novel 
distractor, with the high-novelty group showing the smallest responses overall. Study 2 
extended the measures of Study 1 to include EEG changes in the cold-pressor test. The 
behavioural and autonomic nervous system results were similar to those of Study 1, with 
the novel distractor groups showing smaller pain responses than the control. The EEG 
results showed changes in all frequency bands during the cold-pressor test. Response 
patterns and a cluster analysis of the variables suggested that increases in skin conductance 
level and heart rate, and decreases in alpha-2 and beta-1 activity, reflect increased pain and 
are modified by novelty. The response patterns suggested that increased respiratory rate is a 
response to novelty rather than pain, with increases in systolic and diastolic blood pressure 
reflecting the additive effects of pain and thermoregulation. Results also suggested that 
increases in delta-1, beta-2 and beta-3 reflect increased arousal during the cold-pressor test, 
with changes in delta-2, theta and alpha-1 related to the onset of the stimulus complex. 
These results are discussed in terms of the Orienting Response (OR), which provides a
IV
physiological explanation as to why distractor stimuli may reduce the perception of pain 
and attenuate pain responses.
v
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CHAPTER 1
PAIN AND NOCICEPTION
CHAPTER 1: PAIN AND NOCICEPTION
1,1. Introduction to Pain
Pain is defined as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage or described in terms of such damage” (International 
Association for the Study of Pain, 1979, p. 250). It has been estimated that one in every six 
adults in the United States and other comparably-developed nations suffers from clinical 
pain at any given moment (Wall & Jones, 1991), highlighting the importance of pain in 
medicine and biology today. Research and recall of pain has historically separated pain by 
its temporal qualities into two categories: acute and chronic (Smith, Gracely & Safer, 
1998). Typically, acute pain research relies on normal healthy volunteers undergoing 
experimentally-induced pain. These subjects have some knowledge and expectation about 
the experimental pain, and the pain is usually of limited intensity and duration, with 
subjects being able to stop their pain at any time. Subjects typically proceed from a pain- 
free state, through an increase in pain and return to a pain-free state, where subjects then 
attempt to recall their pain (Smith et al., 1998). Research in the rating and recall of chronic 
pain focuses on patients with naturally-occurring pain. Chronic-pain patients have limited 
knowledge about the course of their pain, inability to stop their pain at any time, and 
experience pain, which impacts their daily living. In contrast to acute-pain studies, studies 
involving chronic-pain patients involve reducing pain by a treatment intervention and the 
quality of the experience is recalled after this attempted reduction in pain (Smith et al., 
1998).
12
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The classic unidimensional view of pain explained it as a purely-physiological response, 
arising from the stimulation of pain receptors and virtually proportional to the number of 
receptors being stimulated (Melzack & Wall, 1988). Today, pain is viewed as being a 
multidimensional phenomenon, where an individual’s perception of and response to pain is 
influenced by a variety of subjective experiences (Melzack & Wall, 1988; Melzack, 1993, 
1996). It is now widely recognised that there are three major dimensions of pain, a sensory- 
discriminative component referring to the location, intensity and spatiotemporal properties 
of noxious stimuli, a motivational-affective component describing the unpleasant affective 
quality of pain, and a cognitive-evaluative component involved in the subjective overall 
experience of pain (Melzack, 1975; Melzack & Casey, 1968; Melzack & Torgenson, 1971). 
The distinction between the components of pain has been shown statistically through pain 
ratings (Fernandez & Turk, 1992) and experimentally, where Gracely and Dubner (1987) 
found that the opioid drug fentanyl reduced the intensity of pain and diazepam reduced the 
unpleasantness of pain during electrical tooth stimulation.
The McGill Pain Questionnaire (MPQ) (Melzack, 1975) is a pain questionnaire widely 
used in clinical and experimental populations to assess the major dimensions of pain. The 
MPQ consists of 78 pain descriptors classified into three major categories. These 
categories, as well as a miscellaneous category, are designed to assess the sensory- 
discriminative, motivational-affective and cognitive-evaluative aspects of pain. Each 
subclass of words consists of qualitatively-similar words that increase in intensity from 
least pain to most pain. Scores on the MPQ are based on the rank value of the pain 
descriptors in each subclass. The descriptor indicating the least pain is given a rank of 1 and 
the descriptor indicating the most pain is given the highest rank value. The rank values are 
summed to provide a score for the sensory (subclasses 1-10), affective (subclasses 11-15),
13
evaluative (subclass 16) and miscellaneous (subclasses 17-20) categories, as well as 
providing an overall total score (subclasses 1-20). In addition to the pain descriptors, the 
MPQ contains words that describe the overall present pain intensity (PPI), which is 
recorded as a number from 1 to 5 and provides a foundation for the overall pain intensity 
for each individual subject. This questionnaire has been found to be a reliable, valid and 
consistent measurement tool (Turk, Rudy & Salovey, 1985) and it has been widely used in 
clinical and experimental populations. The MPQ has also been used cross-culturally and 
has led to the development of similar questionnaires in a variety of languages (Melzack & 
Katz, 1992).
Multidimensional views of pain differentiate nociception from pain. Nociception 
involves the generation of neural information from peripheral sensory fibres to the spinal 
cord and higher levels of the central nervous system (CNS) (Rang, Bevan & Dray, 1995), 
whereas pain has a number of psychological aspects associated with it (Melzack & Wall, 
1988; Melzack, 1993, 1996). The following sections review the major theories of pain from 
simple unidimensional models to more-complex multidimensional models and explain the 
concept of nociception in more detail.
1.2. Models of Pain
Traditionally, since at least the time of the ancient Greeks, pain was conceptualised as 
having one dimension. This unidimensional model of pain, known as the specificity model, 
proposed that pain is a specific sensation and that pain intensity is directly proportional to 
the amount of peripheral nociceptive input related to tissue damage (Melzack & Wall, 
1988). The specificity model proposed that a mosaic of specific pain receptors in the body
14
tissue project to a pain centre in the brain. The model maintains that free nerve endings act 
as pain receptors and generate pain impulses that are carried by A-delta and C-fibre 
nociceptors via the spinothalamic tract to a pain centre in the thalamus. The specificity 
model implies that specific receptors relay information about cold, heat and pain to the 
brain, where the experience of pain is felt. Melzack and Wall (1965) criticised this attempt 
to link specific somatic sensations to specific types of receptors on the basis that it assumed 
a fixed direct-line communication system from the skin to the brain. Melzack and Wall 
(1965) argued that there are a number of psychological aspects of pain that are associated 
with the outcome of the brain processes involved in pain. Melzack and Wall (1965) also 
argued that there are only a small number of specialised fibres that respond only to intense 
stimulation. Although these fibres relay messages that are interpreted as pain, not every 
neural impulse initiated in these fibres will receive this interpretation, therefore they argued 
against labelling any one of these as an exclusive pain fibre.
Traditional unidimensional models of pain, such as the specificity model, fail to link the 
variability of pain with the physiology of the somatosensory system. The failure of surgical 
treatments to alleviate pain by blockage of sensory input from nociceptors or its 
transmission along the spinal cord (Flor, Birbaumer & Turk, 1990), failure to find specific 
receptors exclusive to relaying pain (Melzack & Wall, 1965, 1982), an inability to account 
for findings such as phantom limb pain, and the low correspondence between physical 
stimulation and pain reports have demonstrated the inadequacies of this model (Melzack, 
1988).
Newer models of pain have identified different components that represent the pain 
experience and better explain situational and individual differences in pain responses 
(McCaul & Malott, 1984). The multidimensional conceptualisation of pain into three major
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dimensions (sensory-discriminative, motivational-affective and cognitive-evaluative) yvas 
first described in the gate-control model of pain (Melzack & Wall, 1965, 1982, 1988). This 
is the most widely-cited theory of pain in the literature and is often described as the leading 
pain model (Brannon & Feist, 1997). The gate-control model proposes that the perception 
of pain is modulated in the dorsal horns of the spinal cord. According to this model, 
laminae I and II of the dorsal horns (the substantia gelatinosa) act like a ‘gate’ that opens or 
closes. Both the small A-delta and C fibres and the large A-beta fibres travel through the 
substantia gelatinosa, which also receives projections from other laminae. This arrangement 
of neurons in the substantia gelatinosa provides the physiological basis for the modulation 
of sensory information.
The gate control model hypothesises that primary afferent neurons enter the dorsal horns 
of the spinal cord and pass through the substantia gelatinosa. The activity and structure of 
the substantia gelatinosa modulates sensory information affecting the transmission of neural 
information to the brain. Melzack and Wall (1982) proposed that prolonged activity in the 
spinal cord is caused by activity in the small A-delta and C fibres. This type of activity 
promotes sensitivity and produces pain. Activity of these small fibres thus opens the ‘gate’. 
In contrast, activity of the large A-beta fibres produces an initial burst of activity in the 
spinal cord, followed by inhibition. Activity of these fibres closes the ‘gate’. With the 
‘gate’ open, neural impulses from peripheral nociceptors flow through the spinal cord to the 
brain and the person experiences pain. With the ‘gate’ closed, nociceptive information is 
inhibited in the spinal cord and the perception of pain is reduced.
Melzack and Wall (1988) propose that central nervous system activities subserving
attention, emotion and memories or prior experience associated with pain exert control over
sensory input via a ‘central control trigger’. The ‘central control trigger’ consists of nerve
16
impulses that activate descending efferent fibres and influence the gating mechanism. The 
descending control systems involved in the modulation of pain include the effect of 
endogenous opiates. Brainstem inhibitory fibres descend through a distinct pathway in the 
dorsolateral spinal cord and lead to the release of endorphins in the substantia gelatinosa, 
producing an analgesic effect during pain (Melzack & Wall, 1988). Melzack and Wall 
(1988) maintain, however, that while there is no doubt that these opiate systems exist, the 
mechanisms by which they come into action and elicit analgesia during processes such as 
distraction, remain poorly understood.
Melzack (1993) extended the gate-control model with a ‘neuromatrix theory’, which 
emphasises the perception of pain at the cortical level of the brain. The neuromatrix theory 
proposes that a widespread network of neurons consisting of loops between the thalamus 
and the cortex, as well as between the cortex and the limbic system (neuromatrix) 
“generates patterns, processes information that flows through it and ultimately produces a 
pattern that is felt by the whole body” (Melzack, 1993, p. 623). In this theory, Melzack 
(1993) suggests that a ‘neurosignature’ is produced by patterns of synaptic connections in 
the entire neuromatrix. The neuromatrix and neurosignature act together to process 
incoming sensory information, sometimes in the absence of sensory input such, as with the 
occurrence of phantom limb pain. Phantom limb pain is the experience of chronic pain in 
an absent body part, such as in the case where amputation removes the nerves that produce 
the impulses leading to the experience of pain. Despite removal of the physical basis for 
pain, limb pain still may be felt by amputees.
The gate control model has had much success in generating research, particularly in 
regard to the psychological processes involved in the modulation of pain, however the
physiological details of the model have received much criticism (e.g., Nathan, 1976).
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Nathan (1976) argues that the details surrounding the stimulus-specificity of nerve fibres in 
the gate control model are incorrect, as the pain fibres do not form functionally- 
homogenous groups. Drawing upon previous research (Nathan & Rudge, 1974), Nathan 
(1976) also argues that, while the idea of presynaptic inhibition of the pain fibres in the gate 
control model is accurate, the mechanism and location of this process is wrong.
Flor et al. (1990) have criticised component models of pain, such as the gate control 
model, for neglecting the role of reinforcement and learning factors involved in the 
perception of pain. Flor et al. (1990) developed a psychobiological model of pain that 
incorporates subjective-psychological, motor-behavioural and physical-organic 
components. The physiological level incorporates ascending and descending neuronal 
processes, supraspinal and cortical mechanisms, as well as neurochemical processes. The 
verbal-subjective modality includes thoughts, feelings and images. The behavioural-motor 
level includes pain behaviours ranging from medication intake to use of the health care 
system. Flor et al. (1990) proposed that the development and maintenance of chronic pain is 
a function of several interacting components: a) a predisposition to respond with a specific 
bodily system, b) external or internal aversive stimulation, c) maladaptive information­
processing of, and coping with, pain-related social and/or physiological stimuli, and d) 
operant, respondent and observational learning processes. The psychobiological model of 
pain focuses on the development and aetiology of chronic pain syndromes. While it is 
useful in explaining the development of chronic pain and the interaction of psychological 
and biomedical variables in chronic pain states, this model does not sufficiently explain 
psychophysiological mechanisms involved in acute pain syndromes.
The parallel-processing model of pain (Levanthal & Everhart, 1980) also describes pain
as multidimensional, and has been used to explain the cognitive processing of pain in acute-
18
pain studies (Ahles, Blanchard & Levanthal, 1983; Dar & Leventhal, 1993; Leventhal & 
Everhart, 1980). According to this model, the affective and sensory aspects of the noxious 
stimulus are encoded simultaneously and contribute independently to the overall pain 
experience. The parallel-processing model suggests that through experience with different 
noxious stimuli, individuals form a schema that represents the sensory and affective aspects 
of the pain experience. Further encounters with the noxious stimuli modify the existing 
schema, with the pain schema determining whether aspects of the pain experience will be 
brought into focal awareness. The parallel-processing model assumes that the pain schema 
incorporates the distress schema, representing the distressing and upsetting aspects of pain. 
The model assumes that the pain schema contains both sensory information from the 
noxious stimulus and emotions or distress associated with the actual experience of pain 
(Dar & Leventhal, 1993). Therefore, when an individual experiences pain, the sensory and 
emotional aspects of the situation are processed simultaneously (Dar & Leventhal, 1993; 
Leventhal & Everhart, 1980). When individuals are instructed to attend only to the sensory 
aspects of the stimulus, these instructions over-ride the existing schema, and pain is 
processed mainly in terms of its sensory features. As a result, the emotional-distressful 
component of pain is reduced. The parallel-processing model of pain is a cognitive model, 
explaining the experience of pain in terms of information processing. Although the model 
explains the modulation of pain through psychological factors, it does not explain the 
physiological aspects of pain and pain modulation.
In summary, the gate control model provides a physiological basis for the role of
psychological influences in pain and explains how the subjective experience of pain can be
related through physiological principles and events. The psychobiological model of pain
also attempts to explain pain in terms of an interaction between subjective-psychological
19
(thoughts, feelings and images), motor-behavioural (pain behaviours) and physical-organic 
(neuronal processes) components. Despite providing an overview of such components, the 
psychobiological model fails to adequately explain the connection between them and 
focuses primarily on the aetiology of chronic rather than acute pain. The parallel-processing 
model conceptualises pain in terms of cognitive information processing. This model fails to 
mention the physiology of pain nor incorporate physiological aspects of pain into its 
processes.
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1.3. Nociception and Neural Activation
The sensation of pain depends on the activation of a set of neurons that includes primary 
afferent fibres, intemeurons in the spinal cord (or in the case of the trigeminal system, 
intemeurons in the brain stem), cells of the ascending tracts, thalamic neurons and neurons 
of the cerebral cortex (Willis, 1995).
Primary afferent fibres that respond essentially to noxious stimuli are classified as 
nociceptors (Sherrington, 1906, cited in Willis, 1995). The threshold for activation for 
nociceptors is often well below the threshold for pain (Handwerker, Adriansen, Gybels & 
Van Hees. 1984) and therefore, nociceptors can have a moderate level of activity before the 
perception of pain becomes conscious (Willis, 1995). A wide variety of noxious stimuli 
(chemical, thermal and mechanical) can activate the nociceptor terminal (Reichling & 
Levine. 1999). Chemical stimuli include endogenous inflammatory mediators (e.g., 
hydrogen ions, bradykinin, prostaglandin, leukotrienes, histamine and serotonin) as well as 
exogenous agents such as capsaicin (Dubner & Hargreaves, 1989). Depending on the nature 
of the chemical stimuli, multiple transducing mechanisms activate sensory neurons at the 
periphery (Reichling & Levine, 1999). Thermal stimuli include heat and cold. Heat- 
activated ion channels mediate the transduction of heat stimuli, whereas cutaneous cold 
transduction arises from the temperature-sensitivity of calcium- and voltage-dependent 
oscillations in membrane potential that occur in cold-sensitive afferents (Reichling & 
Levine, 1999). Mechanical transduction arises from a wide variety of mechanical stimuli, 
and similar to heat transduction, is mediated by mechanically-activated ion channels 
(Reichling & Levine, 1999).
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Nociceptors are located in the skin, joints, muscles and viscera (Willis, 1985) and are 
traditionally divided into three groups; A-beta or large myelinated (5-15 pm), A-delta or 
small myelinated (1-5 pm) and C or unmyelinated (0.25-1.5 pm). Experiments using 
microneurography have identified A-delta and C-fibre nociceptors in the skin, with the 
activation of A-delta nociceptors causing pricking pain and the activation of C-nociceptors 
causing burning or dull pain (Konietzny, Perl, Trevino, Light & Hensel, 1981; Ochoa & 
Torebjork, 1989). Primary afferent nociceptors tend to respond to more than one modality 
and are thus polymodal (Morin & Bushnell, 1998; Reichling & Levine, 1999). Because of 
their polymodal responsiveness, nociceptors have been described as ‘integrators’ (Reichling 
& Levine, 1999), receiving a pattern of inputs and producing a single output (a train of 
patterned action potentials).
Morin and Bushnell (1998) have recently demonstrated that heat pain, and warm and 
cool sensations, are mediated by receptors in the skin, but those responsible for noxious 
cold sensations are located below the skin. Using hot and cold cutaneous stimuli, Morin 
and Bushnell (1998) asked subjects to rate perceived temperature and pain intensity on an 
electronic visual analogue scale (VAS). Results showed that heat pain, and warm and cool 
sensations, all diminished shortly after the skin surface temperature returned toward 
baseline, whereas cold pain sensation persisted well after the skin surface and 
intracutaneous temperatures began to rewarm. This is consistent with other studies that 
have shown that noxious cold sensation is mediated primarily by C-fibre nociceptors 
located in the walls of cutaneous veins rather than on the surface of the skin (Arndt & 
Klement, 1991; Klement & Arndt 1992; Menger, Steifenhofer, Jyvasjarvi, & Kniffi, 1993).
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A special type of nociceptor has been identified in the joints, skin and viscera 
(Handwerker, Kilo & Reeh, 1991). This type of nociceptor, often called the ‘sleeping 
nociceptor’, is difficult to activate under normal circumstances, but when stimulated by 
inflammation, becomes very easy to activate (Willis, 1995). It is thought that this 
nociceptor is different from the A or C-fibre nociceptors, since the sleeping nociceptor acts 
as a type of chemoreceptor that develops mechanical sensitivity as a result of the activation 
of chemical agents such as bradykinin. prostaglandins, serotonin, histamine and other 
substances released in tissue damage (Willis, 1995).
The pain system involves ascending pathways that transfer neural information from 
peripheral nociceptors to higher levels of the CNS (Willis. 1995). Nociceptive information 
is conveyed synaptically to intemeurons in the spinal cord and medullary dorsal horn 
(Willis, 1985). evoking responses in neurons in laminae 1, 11, IV-VI and X of the dorsal 
horn (Willis. 1995).
There are two general classes of neurons that receive input from intemeurons in the 
spinal and medullary dorsal horns (Dubner & Bennett. 1983). One class, consisting of the 
nociceptive-specific (NS) neurons, responds only to intense forms of mechanical, thermal 
and other noxious stimuli and receives input exclusively from nociceptors. The other class, 
consisting of the wide-dynamic range (WDR) neurons, is activated by hair movement and 
weak mechanical stimuli, responding maximally to intense stimulation such as a pinch or a 
pinprick (Price & Dubner. 1977). The endogenous opioid peptides enkephalin and 
dynorphin are found in the dorsal horn. During inflammation and response to pain, there is 
an increase in the synthesis and content of endogenous opioids in the dorsal horn, with the 
opioid neural activity in the dorsal hom related to the analgesic action of morphine (Dubner 
& Hargreaves, 1989).
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From the spinal cord, neural information is transmitted to the brain via a number of 
ascending pathways such as the spinothalamic tract (STT). Willis (1995) has suggested that 
activation of STT cells is likely to signal the sensation of pain. Nociceptors also activate a 
number of other ascending pathways including the spinoreticular, spinomesencephalic and 
spinocervical tracts (Willis, 1995). Activation of these pathways contributes to pain either 
by activating attentional mechanisms and arousal or by producing emotional and autonomic 
reactions. It is thought that neurons in the somatosensory areas of the cortex are involved in 
the perception of pain, while diencephalic and telencephalic structures, including the 
medial thalamus, hypothalamus, limbic cortex and anterior cingulate cortex, play a role in 
affective and motivational pain reactions (Willis, 1995).
While ascending neural pathways convey nociceptive information up the spinal cord to 
the brain, a number of descending systems have been identified which involve the 
modulation of pain. When stimulated, these areas produce analgesia or antinociception 
(Willis, 1982) and include pathways descending from the periaqueductal grey (PAG), 
nucleus raphe magnus and the medullary formation (Melzack & Wall, 1988; Willis, 1982, 
1995). Although other pathways are thought to be involved in the control of pain (such as 
those descending from nuclei in the parabrachial region of the rostral pons), pathways 
descending from the PAG, nucleus raphe magnus and medullary reticular formation contain 
multiple receptors for endogenous opioid peptides (endorphins, dynorphins and 
enkephalins) and thus play a fundamental role in the endogenous modulation of pain.
In addition to the opioid peptides, other descending neurochemical systems play a role
in the modulation of pain (Dubner & Hargreaves, 1989). Descending serotonin or
norepinephrine pathways affect the output of WDR and NS neurons and alter the
responsiveness to noxious inputs (Dubner & Hargreaves, 1989). These descending control
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systems play a major role in pain modulation and are a major component of the gate-control 
model of pain (Melzack & Wall, 1965, 1988). Despite the importance of these systems, it is 
still not fully understood under what conditions these pathways are stimulated and 
contribute to analgesia during pain.
1.4. Summary
In summary, pain is a subjective experience comprising sensory-discriminative, 
motivational-affective and cognitive-evaluative dimensions, while nociception refers to 
altered neuronal activity in the pain-mediated nervous system. Several pathways involved 
in pain and nociception have been identified, with ascending pathways including the dorsal 
horns, several spinal tracts, the thalamus and reticular formation. Descending pathways 
have also been identified that contain multiple receptors for endogenous opioids and are 
thought to be involved in the modulation of pain. Pathways descending from the PAG, 
nucleus raphe magnus and medullary formation contain multiple receptors for endogenous 
opioids, although the exact mechanisms as to how these endogenous opioids are activated 
and result in pain attenuation remain poorly understood.
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CHAPTER 2: THE PSYCHOPHYSIOLOGY OF EXPERIMENTAL PAIN
2.1. Experimental Pain Stimuli and the Cold-Pressor Test
The cold-pressor test (immersion of a limb in ice-cold water) is a standardised model of 
experimental pain (Chen, Dworkin, Haug & Gehrig, 1989a). The test was first introduced 
by Hines and Brown (1932) in studying blood pressure aspects of hypertension, but after 
years of research, the psychophysiology of the cold-pressor test remain poorly understood 
(Peckerman, Hurwitz, Saab, Llabre, McCabe & Schneiderman, 1994).
Cold pressor pain peaks in approximately one minute following immersion of a limb 
(Wolf & Hardy, 1941), after which adaptation occurs, although individual differences in 
response to this stimulus have been identified (Chen, Dworkin, Haug & Gehrig, 1989b). 
The cold-pressor test is regarded as a physical stressor (as the task invokes stress on the 
body) with a passive coping component (Pickering & Gerin, 1990; Gregg, James, Matyas 
& Thorsteinsson, 1999). Active coping is generally defined in terms of the ability to 
influence the outcome of a task, such as in mental arithmetic or physical activity 
(Sherwood, Dolan & Light, 1990). Passive coping occurs when an individual cannot 
influence the outcome of an event, such as in experimental tasks including exposure to 
unavoidable shock and the cold-pressor test (Sherwood et al., 1990). It can be argued that 
the ability of subjects to remove their immersed limb from the cold-pressor test introduces 
an element of active coping, however as subjects are usually instructed to immerse their 
limb for as long as they possibly can, the task is usually considered a passive coping task.
During immersion, a diffuse dull aching is perceived, which led Chen et al. (1989a) to 
describe the pain produced by the cold-pressor test as an analogue of acute clinical pain.
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This differentiates the cold-pressor test from the sharp shooting pain that is elicited by more 
widely-used phasic experimental pain stimuli such as electric shock, CO2 laser heat and 
thermal heat impulses (Chen et al., 1989a).
Cold pain is mediated primarily by the activation of C-fibre nociceptors (Konietzny et 
al., 1981; Melzack & Wall, 1988; Ochoa & Torebjork, 1989). As cold stimulation excites 
both pain and temperature fibres, both the somatosensory (pain) and thermoregulatory 
(cold) systems are activated (Lovallo, 1975), resulting in an overlap in responses to this 
stimulus. This overlap is primarily seen in the autonomic nervous system where cold and 
pain increase responses in the cardiovascular system. This overlap therefore makes it 
difficult to separate the relative contributions of cold responses from pain responses 
(Peckerman et al., 1994).
Eccleston (1995) identified several parameters that vary considerably across different 
cold-pressor paradigms, making it difficult to compare results. These differences include 
the immersion of different limbs, varying water temperatures and maximum immersion 
times. Although immersion of the hand or arm is the most-common method of inducing 
pain (e.g. al’Absi, Buchanan, Marrero & Lovallo, 1999; Chen et al., 1989a, 1989b; 
Dowling, 1992, 1983; S. Maltzman, 1992; Maltzman-Greenstein, 1984; Steptoe & Vogel, 
1992; Gregg et al., 1999), the foot cold-pressor test (Allen, Sherwood, Obrist, Crowell & 
Grange, 1987; Peckerman et al., 1994) and forehead cold-pressor test (Anderson, Lane, 
Murunaka, Williams & Houseworth, 1988; Peckerman, Saab, McCabe, Skyler, Winters, 
Llabre & Schneiderman, 1991) have also been used. Water temperature also differs 
significantly across studies, with the temperature of the cold pressor ranging from 0°C (i.e. 
Avia & Kanfer, 1980) to as high as 7°C (i.e. Ahles et al., 1983; Steptoe & Vogele, 1992).
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Similarly, the maximum time of cold immersion varies across different experimental 
investigations, ranging from 40 seconds (Dowling, 1982, 1993) to a maximum exposure of 
as long as 10 minutes (Rosenbaum, 1980; Scott & Barber, 1977). Eccleston (1995) has 
argued that these and a number of other methodological differences across studies make it 
difficult to compare the effects of the cold-pressor test, as different qualities and intensities 
of pain are produced. These discrepancies also include the differential effects of gender on 
pain report (Levine & De Simone, 1991), the different instructions given to subjects across 
studies and the choice of distraction strategy for pain attenuation. Eccleston (1995) suggests 
that each study employing the cold-pressor test as an experimental pain stimulus should 
report all procedural and instructional details in full.
2.2. Psychophysiology of Pain
2.2.1. Autonomic nervous system responses
The cold-pressor test affects the sympathetic division of the ANS (Lovallo, 1975) in a 
manner that is considered to be part of a general defence reaction to threatening or noxious 
stimuli (Janig, 1985). The defence reaction is an integrated response consisting of 
autonomic, endocrine and motor components in which typical autonomic responses include 
an increase in blood flow through skeletal muscle, sweat secretion, and a decrease in blood 
flow through the skin and viscera (Janig, 1985). Various hormones involved in the response 
include the release of adrenocorticotropin from the anterior pituitary gland, vasopressin 
from the posterior pituitary and catecholamines from the adrenal medulla (Janig, 1985).
The cold-pressor test is commonly used as test of autonomic function in cardiovascular 
psychophysiology (De Quattro & De Ping Lee, 1989). Using a “traditional” experimental
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cold-pressor paradigm of hand or foot immersion in ice water, the cardiovascular response 
has been well documented, with significant increases in heart rate, and systolic and 
diastolic blood pressure occurring (Allen & Crowell, 1989; Allen, Shelly & Boquet, 1992; 
Gregg et al., 1999; Hatch, Klatt, Porges, Schroeder-Jasheway & Supik, 1986; Heiden, 
Larkin & Knowlton, 1990; Peckerman et al., 1994; Saab, Llabre, Hurwitz, Schneiderman, 
Wohlgemuth, Durel, Massie & Nagel, 1993; Allen et al., 1987; Steptoe & Vogele, 1992). 
These responses are modulated by emotional states, where fear inhibits cardiovascular 
reactivity and anxiety increases sympathetic output, inducing hyperalgesia (Rhudy & 
Meagher, 2000). The forehead cold-pressor test (application of an ice bag to the forehead) 
also affects the sympathetic nervous system (Anderson et al., 1998; Peckerman et al., 1991) 
but these effects are mediated by the trigeminal neural pathway. Cold stimulation of the 
opthalamic trigeminal nerve evokes significant parasympathetic as well as sympathetic 
activation (Saab et al., 1993). The parasympathetic activation during the forehead cold- 
pressor test decelerates heart rate via vagal restraint, whereas cold stimulation of the foot or 
hand increases sympathetic output via the cardiac nerve, resulting in an increase in heart 
rate.
The hemodynamic profile of the cold-pressor test differs from that of more active
stressors such as exercise and cognitive challenge. While active tasks elicit a myocardial
response (cardiovascular reactivity produces large increases in cardiac output with little
effect on total peripheral resistance), passive tasks such as the cold pressor produce a
vascular response (significant increases in total peripheral resistance with little effect on
cardiac output). Alpha-adrenergic processes mediate passive tasks like the cold-pressor test.
This means that enhancement in the cardiovascular system occurs through alpha-receptor
activation, rather than beta-adrenergic processes (Allen and Crowell, 1989; Allen, et al.,
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1987; Gregg et al., 1999; Obrist, Light, Hastrup & Langer, 1981; Saab et al, 1993). This 
pattern has been observed in a number of studies (Allen & Crowell, 1989; Allen et al., 
1987; Allen et al., 1992; Gregg et al., 1999; Peckerman et al., 1994; Saab et al., 1993; 
Sherwood, Allen, Obrist & Langer, 1986) and involves an increase in heart rate and total 
peripheral resistance accompanied by a corresponding decrease in stroke volume (off­
setting the increase in cardiac output). This profile remains relatively unaffected by beta- 
adrenegeric blockade and is stable over as much as a ten year time period (Sherwood, 
Girdler, Bragdon, West, Brownley, Hinderliter & Light, 1997).
Peckerman et al. (1994) have specifically examined the hemodynamics of the cold- 
pressor test in order to determine its pain and non-pain stimulus components. Pain and non­
pain related increases in blood pressure were examined by analysing residual effects of 
changes in total peripheral resistance and cardiac output during the foot and forehead cold- 
pressor tests. The data suggested that non-painful (cold) stimulation increases blood 
pressure through vascular constriction, whereas pain-related increases occur via vasomotor 
(total peripheral resistance) and cardiac mechanisms. Peckerman et al. (1994) concluded 
that arterial vasoconstriction and elevated blood pressure are stimulated jointly from cold 
and pain, and increased HR and venous return are stimulated by pain.
Increases in respiratory rate (RR) (Allen, Sherwood & Obrist, 1986; Steptoe & Vogele, 
1992) have also been shown to occur during cold pressor stimulation, but a study by Allen 
and Crowell (1989) failed to find any overall effect on RR during the cold-pressor test 
compared with baseline measurements. Allen and colleagues (Allen & Crowell, 1990; 
Allen et al., 1992) have also shown that when RR is paced during the cold pressor, no effect 
on RR is seen, indicating that RR is under some voluntary control.
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In addition to blood pressure, HR and RR increases, the cold-pressor test also evokes 
increases in skin conductance level (SCL). Dowling (1982) examined HR and SCL 
measures during a 40 second cold-pressor test and found increases in both measures. The 
change in SCL was correlated with the evaluative component of pain on the McGill Pain 
Questionnaire (MPQ). This correlation was in the negative direction, but Dowling (1982) 
did not explain the cause of this inverse relationship. In a follow up study, Dowling (1983) 
used the Autonomic Perception Questionnaire (APQ) (Mandler, Mandler & Uviller, 1958) 
to examine subjective awareness of autonomic arousal. Following his earlier study, 
Dowling (1983) examined HR and SCL during the cold-pressor test. Even though a 
maximum immersion time of 5 minutes was employed, Dowling only examined 
physiological reactions during the first 40 seconds as the major physiological reactions take 
place in this stage. Dowling (1983) found changes in HR and SCL, and reported SCL to be 
positively correlated to the experience of pain as indicated on the Autonomic Perception 
Questionnaire (APQ), which examines the relationship between subjective awareness of 
autonomic arousal and reactivity to pain as shown by behavioural responses. Dowling 
concluded that pain sensitivity is not mediated by an awareness of autonomic arousal. 
During both experiments, the cold-pressor test was preceded by a warning signal one 
minute before immersion and another to signal immersion of the hand in the ice cold water. 
Dowling excluded the first 10 seconds of data from analysis to account for any effects due 
to orienting to the warning stimulus, but it is possible that the first warning stimulus 
interfered with analysis of the resting phase and that physiological responses to the second 
warning stimulus lasted longer than 10 seconds. Therefore, there is no way of determining 
whether the HR and SCL responses were due to an orienting or startle response to the
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warning stimuli, or were the result of the cold-pressor test, or an interaction between the 
two.
Steptoe and Vogele (1992) examined HR, Systolic Blood Pressure (SBP), Diastolic 
Blood Pressure (DBP), RR, SCL, and palmar sweat index during mental arithmetic, mirror 
drawing and the cold-pressor test. The accuracy of bodily sensations was estimated using 
within-subject correlations between four bodily sensations (racing heart, high blood 
pressure, shortness of breath and sweaty hands). Heart rate, systolic and diastolic blood 
pressure were recorded continuously from the middle finger of the left-hand using a 
Finapres blood pressure monitor. Respiration rate was monitored using a volumetric 
transducer fixed around the trunk and skin resistance was measured from the hypothenar 
eminence of the left-hand using silver/silver-chloride electrodes. Palmar sweat-gland 
activity was measured using a plastic impression technique, with fingerprints from the left 
index finger obtained at 2-minute intervals. Results showed elevated cardiovascular, 
electrodermal and respiratory activity in the task phases, with the cold-pressor test 
producing increases in HR, SBP, SCL, palmar sweat and RR. The accuracy of HR 
perception was highest, followed by blood pressure, RR and SCL, indicating that subjects 
are aware of physiological responses during experimental stressors.
Cioffi and Holloway (1993) examined SCL and HR during the cold-pressor test in three
different conditions in a between-subjects design. In one condition, subjects were instructed
to concentrate on their room at home (distraction). In a second condition, subjects
monitored their hand sensations during the cold-pressor test (monitoring) and in a third
condition, subjects were instructed to suppress the sensations produced from the cold-
pressor test (suppression). There were no significant differences in tolerance time (the
maximum time tolerated in the cold-pressor test) between the groups, however subjects in
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the suppression condition showed a greater increase in SCL during the cold-pressor test 
than subjects in the monitoring and distraction tasks. Although there was an overall 
increase in heart rate during the cold-pressor test, there were no group differences. Post­
pressor pain ratings also showed that suppression produced the slowest recovery from pain, 
with subjects who suppressed their cold-pressor sensations recovering from their 
discomfort more slowly than subjects who used distraction and monitoring tasks. 
Additionally, subjects who suppressed their cold-pressor pain showed greater increases in 
skin conductance level and pain ratings during a subsequent vibration task than subjects in 
the distraction and monitoring groups. Cioffi and Holloway (1993) concluded that trying to 
avoid pain through suppression actually enhances it, and that attentional avoidance without 
the aid of a focused distractor can result in later pain stimuli being experienced as more 
unpleasant.
Overall, ANS responses to the cold-pressor test have been well documented, with 
increases in heart rate, arterial blood pressure, respiration rate and electrodermal activity 
occurring. Increments in blood pressure are thought to be a result of activation in both the 
somatosensory and thermoregulatory systems, while increases in heart rate are thought to 
primarily reflect pain. The effects on skin conductance level during the cold-pressor test 
have not been as extensively examined as cardiovascular responses, but increases in SCL 
are thought to reflect the aversive nature of pain.
2.2.2. Central nervous system responses
The following sections will review central nervous system responses to the cold-pressor 
test, using EEG, ERP and functional neuroimaging techniques to quantify results.
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2.2.2.1. Electroencephalography
Quantitative-electroencephalogram (Q-EEG) analysis has been used over the past 
decade to investigate EEG changes during the cold-pressor test. Chen et al. (1989b) 
reported heightened delta (1-3 Hz) cortical power spectral (CPS) densities at all 
topographic loci, consistent with subjective differences in the pain state. These responses 
were examined in pain tolerant (PT) subjects (defined as those who kept their hands 
immersed in the cold pressor for a three minute maximum duration) and pain sensitive (PS) 
subjects (defined as those who withdrew their hand from the cold pressor prior to the expiry 
of the three minute maximum period). While mean tolerance time for PT subjects was the 
maximum immersion time of three minutes, mean tolerance time for the PS group was 50.3 
seconds. Of the forty-two male subjects, twenty-nine were pain tolerant and thirteen were 
pain sensitive. The PS subjects had greater subjective pain ratings than the PT subjects, but 
there were no reported differences in anxiety.
In addition to the behavioural data, PS subjects showed heightened delta activity, 
particularly at parietal and occipital loci. Chen et al. (1989b) concluded that PS subjects are 
more reactive to pain than PT subjects and suggested that PT individuals may exert higher 
cognitive self-regulation on pain and discomfort. Gotliebsen and Arendt-Nielson (1990) 
also reported increased delta activity at central sites (C3, Cz and C4) during a five minute 
maximum cold-pressor test, while a study by Ferracuti, Seri, Mattia and Crucca (1994) 
reported a longer-lasting increase in delta activity (2-4 Hz) that was more pronounced 
frontally. Ferracuti et al. (1994) examined Q-EEG changes in fifteen male subjects during a 
cold water (0°C) and a warm water (25°C) condition. The cold-water condition consisted of 
immersion of the hand in the cold pressor for at least two minutes. There were no Q-EEG
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changes observed in the warm water condition. Ferracuti et al. (1994) related the increase in 
delta to cortical inhibition, identifying the slow wave activity as indicating an attempt to 
inhibit sensorial perception of the nociceptive input.
Q-EEG studies have also reported a reduction in alpha activity (8-13 Hz) (alpha 
desynchronisation) during the cold-pressor test. Gotliebsen and Arendt-Nielson (1990) 
reported a decrease in broadband alpha activity from all recorded sites (Fz, C3, Cz, C4, Pz) 
and Chen et al. (1989b) also found a non-specific reduction from a pre-test baseline of the 
8-13 Hz alpha rhythm during both the cold-pressor test and a post-test baseline stage. 
Ferracuti et al. (1994) examined Q-EEG pattern modifications in alpha-1 (8-10 Hz) and 
alpha-2 (10-12 Hz) and reported a widespread arrest in alpha-1 that recovered quickly to 
pre-test levels. Unlike alpha-1, alpha-2 showed longer-lasting desynchronisation that was 
evident in parietal electrodes contralateral to the stimulated hand. Ferracuti et al. (1994) 
interpreted this alpha-2 response to be a result of the painful aspect of the cold-pressor test, 
while alpha-1 was interpreted to reflect an arrest reaction to the ice-cold water.
In contrast to a reduction in alpha activity, a study by Backonja, Howland, Wang, 
Smith, Salinsky and Cleelend (1991) has reported an increase in alpha activity during the 
cold-pressor test. Backonja et al. (1991) examined event related desynchronisation (ERD) 
of alpha activity during the cold-pressor test (0-2°C) and a cold-water condition (20 C) in 
four female and ten male subjects. Alpha-1 was defined as 8-10 Hz and alpha-2 as 10-12 
Hz. Both the cold pressor and cold-water conditions were of five-minute maximum 
durations and Q-EEG was examined from epochs in the 60-240 sec period of the immersion 
in the water. Backonja et al. (1991) reported alpha augmentation during the cold-pressor 
test in frontal and posterior regions, created primarily by an increase in alpha-1. In the cold-
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water condition, alpha activity did not differ from levels at baseline. Backonja et al. (1991) 
suggested that the elevation in regional alpha power may be due to inhibitory processes. 
Differences in results between the Backonja et al. (1991) study and other studies (Chen et 
al., 1989b; Ferracuti et al., 1994; Gotliebsen and Arendt-Nielson; 1990) may be because 
Backonja et al. (1991) examined alpha activity 60 seconds after immersion compared with 
examining alpha activity immediately, as other studies have done. Given the results of 
Chen et al. (1989b), who showed a dichotomy of PS and PT subjects in cold pressor pain 
responses, the subjects in the Backonja et al (1991) study would have been predominantly 
PT. The difference in pain responsivity between PT and PS subjects indicates physiological 
and cognitive differences between the groups (Chen et al., 1989b), which may account for 
the different results. As males and females respond differently to pain (Fillingim & 
Maixner, 1995) and also respond differently to an experimenter of the opposite sex (Levine 
& De Simone, 1991), the inclusion of both sexes in the Backonja et al. (1991) study also 
may have contributed to the different results.
Backonja et al. (1991) and Ferracuti et al. (1994) have also reported increased theta 
activity (4-8 Hz) during the cold-pressor test. Backonja et al. (1991) reported increased 
theta activity in the ipsilateral frontal electrodes during painful stimulation, while Ferracuti 
reported increases at central and posterior sites. The functional significance of this increase 
in theta has not been discussed. In a wider context, a study by Larbig, Elbert, Lutzenberger, 
Rockstroh, Schnerr and Birbaumer (1982) examined EEG changes during the anticipation 
of painful phasic electrical stimulation and found elevated levels of theta activity during the 
anticipation phase. Larbig et al. (1982) suggested that such increases in theta activity 
represent inhibitory processes in an attempt to control pain during noxious stimulation.
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In addition to changes in delta, theta and alpha activity, heightened beta activity has also 
been reported during the cold-pressor test. Backonja et al. (1991) found increases in beta-1 
(12-26 Hz) and beta-2 (26-30 Hz) bilaterally in frontal and posterior regions during 
painfully-cold stimulation. Chen et al. (1989b) reported increased beta-1 (13-20 Hz) and 
beta-2 (21-32 Hz) activity at all topographic loci during the cold-pressor test. Beta activity 
increased for both PT and PS subjects in the cold-pressor test and did not differentiate 
between the groups. Chen et al. (1989b) considered that the increased beta activity reflected 
heightened vigilance or scanning processes involved in pain and discomfort
The traditional view of the relationship between beta activity and arousal suggests that it 
is positive in nature, where increases in beta reflect increases in levels of arousal 
(Andreassi. 1995: Cobb. 1963). However, a study by Lim, Barry, Gordon, Sawant, Rennie 
and Yiannikas (1995) has contradicted this traditional view, and reported increases in beta 
and alpha concomitant with decreases in skin conductance level (SCL) in a habituation 
study where subjects were able to ignore a series of repeated tones. Lim et al. (1995) 
suggested that there is a quantitative link between central and autonomic measures, with a 
decrease in arousal detected by both EEG and SCL.
Backonja et al. (1991) and Veerasam and Stohler (1992) have also suggested that 
increased EMG activity from clenching of the facial and jaw muscles contaminates high 
frequency beta bands. Backonja et al. (1991) observed large increases in central and 
posterior regions in the high beta band (26-30 Hz) during the cold-pressor test. Because this 
increase was not reflected in the lower beta band (12-26 Hz), Backonja et al. (1991) 
attributed this primarily to EMG activity. Veerasam and Stohler (1992) induced pain by 
injecting hypertonic saline into the jaw muscle and examined high frequency activity (13­
100 Hz) during the pain state. Following this. Veerasam and Stohler (1992) found
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significant increases in higher EEG frequencies at temporal recording sites and concluded 
that the increase in higher beta frequencies may be due to contamination by muscle activity 
during head and body movement.
A number of studies during the cold-pressor test have identified changes in different 
EEG frequency bands using Q-EEG analysis. Studies have shown a global increase in delta 
activity during the cold-pressor test and have interpreted this as reflecting the aversive 
nature of pain. Increased theta activity has also been reported, although the functional 
significance of this has not been extensively examined. Alpha desynchronisation has also 
been reported (with one study showing alpha augmentation), with alpha-1 interpreted as 
reflecting a reaction to the stimulus and alpha-2 being dependent on painful stimulation. 
Heightened beta activity during the cold-pressor test has been interpreted as reflecting the 
heightened vigilance or scanning processes involved in pain and discomfort, however it has 
also been suggested that increased beta activity, particularly in the higher beta bands, is due 
to the contamination by muscle activity from clenching of the facial and jaw muscles. The 
next section reviews EEG responses evoked by more phasic experimental pain stimuli 
(event-related potentials) and examines the effect of attentional manipulation on these 
responses.
2.1.2.2. Somatosensory event-related potentials
Studies investigating somatosensory event-related brain potentials (SERPs) to phasic 
stimuli by far out-number those studies examining EEG changes to more tonic pain stimuli. 
SERP pain studies have also shown that certain components of the SERP response correlate 
with the subjective report of pain and are modified with attention. Results of the SERP
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studies reviewed in this section therefore suggest that EEG power changes within bands 
during more tonic pain stimuli (such as the cold-pressor test) may also be modified by 
attention, distraction and emotions.
SERPs elicited by phasic noxious stimuli have been investigated for over twenty years 
(Becker, Haley, Urena & Yingling, 2000). Different types of painful phasic stimuli 
(electrical stimulation of the skin or teeth, mechanical or laser stimulation of the skin, and 
chemical stimulation of the nasal mucosa) produce morphologically-similar SERPs at the 
vertex (Becker, Yingling & Fein, 1993; Bromm, 1985; Chen, 1993).
A number of early studies (Chapman & Jacobson, 1984; Chatrian, Canfield, Knauss & 
Lettich, 1974; Chatrian, Farrell, Canfield & Lettich, 1975; Chen, Chapman & Harkins, 
1979) found high correlations between components in the SERPs to a variety of noxious 
stimuli and the subjective report of pain. Specifically, Chen et al. (1979) found the N175- 
P260 component to be closely related to the sensation of pain, while the early N65-P120 
was interpreted as reflecting physical stimulation. The N175-P260 component is also 
reduced with analgesic drugs including aspirin (Bromm, Frieling & Lankers, 1991; Chen & 
Chapman, 1980), fentanyl (Chapman, Hill, Saeger & Gavrin, 1990) and naloxone 
(Buchsbaum, Davis & Bunney, 1977).
More recent studies have found decreased late SERP components to noxious stimuli 
when attention is directed away from the painful stimulation (Miltner, Johnson, Braun & 
Larbig, 1989), and during hypnotic analgesia (De Pascalis, Mgurano & Bellusci, 1999). 
Miltner et al. (1989) examined SERPs to painful and non-painful electrical stimuli. Stimuli 
were regarded as being painful if they were 20% and 40% above the individual pain 
threshold (IPT), and non-painful if they were 20% and 40% below the IPT, and subjects 
were required to either attend to, or ignore, the stimuli. Results showed a reduction in the
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N150-P260 component, and lower pain ratings, when attention was directed away from 
both the painful and non-painful stimuli. Miltner et al. (1989) concluded that attentional 
manipulations represent a powerful method to decrease the perception of pain.
De Pascalis et al. (1999) examined SERPs to painful stimuli in high-, mid- and low- 
hypnotizable subjects and found that subjects highly susceptible to hypnosis displayed 
significantly smaller P300 and greater N200 peaks during hypnotic analgesia than did the 
other hyponotizables. De Pascalis et al. (1999) concluded that the reduction in P300 
indicates that different hypnotic analgesia suggestions produce different kinds of cognitive 
processing which are effective in attenuating pain. The enhancement of the N200 peak was 
interpreted as indicating increased inhibitory processing of painful stimulation during 
hypnotic analgesia.
Several studies have also isolated components of the P300 waveform evoked by phasic
pain stimuli, and suggest that the P300 arises from several functional processes rather than
just a reflection of pain. Becker et al. (1993) examined SERPs to painful and non-painful
electrical stimulation of the fingertip. Three levels of stimulation were individually
determined for each subject (two levels of non-pain and one level of pain). Results from the
SERP analysis identified three different positive components in the 200-550 msec window
of the midline ERP to painful stimuli. The first positive component, peaking at 223 msec,
was interpreted as reflecting the neural difference between mild and strong (but not painful)
stimuli. The second positive wave, peaking at 333 msec, was identified as a pain
component, reflecting the neural response difference between strong and non-painful
stimuli. The third positive component, peaking at 475 msec, was interpreted as reflecting
the neural response difference between physically-identical stimuli serving as low
probability and high probability targets. As the three components in the Becker et al. (1993)
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study had broad latency and topography, with significant overlap among them, it is difficult 
to determine the relative contributions of pain and target identification in each of the 
components.
Following this, Zaslansky, Sprecher, Tenke, Hemli and Yarnitsky (1996) examined the
P300 in pain-evoked potentials to determine if the pain SERP component contains elements
of the endogenous P300 potential rather than directly reflecting neurologic information
about nociception. Zaslansky et al. (1996) examined positive peaks in epochs 200 to 700
msec post stimulation in two experiments. In the first experiment, there were two task
conditions. In the first condition, subjects were requested to count backwards by sevens
from a randomly chosen three-digit number upon the presentation of painful CO2 laser heat
stimuli. At the end of each block subjects were requested to report the last number they
counted and rate the intensity of the stimuli. The second condition was similar to that
described above however the calculations were not locked to the stimulus presentation and
subjects were requested to ignore the laser stimuli presented. The task in both conditions
was of the same degree of difficulty, but served to either focus attention and expectancy
upon the pain stimulus or to encourage ignoring the stimulus. In the second experiment,
subjects were required to silently count to target and ignore non-target stimuli. This task
was performed for two sensory modalities: somatosensory using laser stimuli and auditory
using computer generated tones. Results of both experiments showed that while the
amplitude of the positive wave decreased in the ignore condition, the perception of pain
remained unchanged. The data on pain perception contrasts with that of Miltner et al.
(1989), who found that the perception of pain was reduced when subjects were instructed to
ignore pain stimuli as opposed to when subjects were instructed to attend to the painful
stimuli. Differences may be due to different experimental procedures, where Zaslansky et
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al. (1996) used CO2 laser heat stimuli and Miltner et al. (1989) manipulated attention using 
painful and non-painful electrical stimuli. From the findings, Zaslansky et al. (1996) 
concluded that SERPs evoked by painful laser stimuli cannot be interpreted as objective 
correlates of pain.
In summary, a number of studies have investigated somatosensory event-related 
potentials (SERPs) to painful phasic stimuli. SERPs have been shown to be correlated with 
the subjective report of pain and are also modified with manipulations in attention. While 
this suggests that some components of the SERP are directly related to pain, other studies 
have shown that SERPs to painful stimuli are a result of several factors including pain, 
attention, and target identification. Together, these studies have shown changes in CNS 
responses during attentional manipulation and distraction suggesting EEG changes to other 
pain stimuli (including Q-EEG changes to the cold-pressor test) may also be modified by 
distraction.
2.2.23. Brain imaging techniques
A number of studies have used functional neuroimaging techniques, such as positron 
emission tomography (PET), to examine regional cerebral blood flow (rCBF) changes 
during noxious stimulation (Casey, Minoshima, Berger, Koeppe, Morrow & Frey, 1994; 
Casey, Minoshima, Morrow & Koeppe, 1996; Di Piero, Ferracuti, Sabatani, Pantano, Cruca 
& Lenzi, 1994; Di Piero, Fiacco, Tombari & Pantano, 1997; Jones, Brown, Friston, Qi & 
Frackowiak, 1991; May, Kaube, Buchnel, Eichten, Rijntjes, Juptner, Weiller & Deiner, 
1998; Talbot, Mariett, Evana, Meyer, Bushnell & Duncan, 1991). These studies have 
consistently shown activation of parietal, insula and anterior cingulate cortices during the
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processing of noxious stimuli and the sensation of pain. Using magnetic resonance imaging 
(MRI) and PET in humans, Talbot et al. (1991) found that while non-painful heat activated 
posterior primary and secondary somatosensory cortices, painful heat produced increased 
activation in the somatosensory and anterior cingulate cortices. They suggested that, as the 
anterior cingulate cortex was implicated in the aversive nature of pain, activation in this 
area is probably related to the motivational-affective component of pain. Jones et al. (1991) 
also examined rCBF changes to painful and non-painful heat stimuli applied to the back of 
the hand during a 15CC>2 PET study. Results showed increased rCBF in the contralateral 
cingulate cortex, thalamus and lenticular nucleus to painful compared with non-painful 
heat. This suggests that the processing of painful stimuli in humans is not distributed over 
large areas of the cortex but primarily occurs in the anterior cingulate cortex and the 
primary and secondary somatosensory cortices, with activation in the anterior cingulate 
cortex thought to be related to the affective component of pain.
May et al. (1998) examined rCBF changes to cranial pain elicited by capsaicin. 
Capsaicin was administered subcutaneously to the forehead in seven healthy males and 
rCBF changes were seen in the insula, anterior cingulate cortex, the cavernous sinus and the 
cerebellum. May et al. (1998) suggested that because the anterior cingulate cortex is linked 
with both somatosensory and limbic systems, these connections may provide a route where 
nociceptive information is integrated with memory and the experience and sensations of 
painful stimuli.
Casey et al. (1996) and Di Piero et al. (1994, 1997) have also examined the pattern of
neural activation during pain and have specifically looked at rCBF changes during the cold-
pressor test. Di Piero et al. (1994) examined rCBF changes during the cold-pressor test
using Xenon-133 inhalation single photon emission tomography (SPET). Results showed
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significant activation in the contralateral primary somatosensory cortex, with changes also 
occurring in the contralateral frontal and bilateral temporal regions. There was also a non­
significant trend of activation in the cingulate and thalamic regions consistent with the 
processing of the emotional content of pain. Di Piero et al. (1994) concluded that the 
pattern of activation suggests that tonic painful stimuli activate the cortex partly via 
complex circuits and partly via direct somatosensory pathways.
Following this, Casey et al. (1996) compared the cerebral activation patterns of 
cutaneous warmth, heat pain and cold pressor pain by intravenous H2150  injection PET. 
They found that cold pain is associated with significant rCBF changes in the sensorimotor 
cortex, consistent with Di Piero et al. (1994). Casey et al. (1996) additionally found 
responses in the ipsilateral frontal cortex, at the lateral prefrontal anterior cingulate and the 
insular/precentral opercular cortices. This ipsilateral activation is contrary to the 
contralateral response observed by Di Piero et al. (1994) and Casey et al. (1996) attributed 
this laterality variation to differences in the spatial resolution techniques of SPET and PET 
and to the general methodological differences between the two studies.
Di Piero et al. (1997) conducted a subsequent SPET study of cold pressor pain and 
reported increases in rCBF in the contralateral somatosensory cortex, the frontal cortex and 
bilaterally in the temporal lobes. The earlier Di Piero et al. (1994) study reported non­
significant changes in the anterior cingulate and thalamic regions, but in this study, that 
pattern of activation reached statistical significance.
Taken together, the data obtained show a pattern of rCBF activation that is assumed to 
mediate different components of pain and pain modulation. Specifically, activation of the 
contralateral ventral thalamus and primary somatosensory cortex is thought to reflect the 
sensory-discriminative aspect of pain, while activation of structures associated with
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autonomic and limbic system functions, such as the insula and anterior cingulate cortex, 
may reflect the motivational-affective component (Casey, Minoshima, Morrow, Koeppe & 
Frey, 1995).
2.3. Summary
In summary, a number of studies have shown autonomic responses to the cold-pressor 
test, with the major responses occurring in the cardiovascular system. Studies have reported 
reliable increments in heart rate, and systolic and diastolic blood pressure, with the 
hemodynamic pattern of the cold-pressor test remaining relatively stable over as much as a 
ten-year time period. Because the cold-pressor test activates both the thermoregulatory 
(cold) and somatosensory (pain) aspects of the ANS, there is an overlap in responses 
produced to this stimulus that occurs primarily in arterial blood pressure (Peckerman et al., 
1994). Increases in respiratory rate and skin conductance level have also been reported, 
with increases in SCL modified by attentional manipulation.
A number of studies have also established a relationship between more-direct brain 
activity measures and experimental pain. Q-EEG analysis using the cold-pressor test has 
shown modifications across the EEG spectrum, with changes occurring in delta, theta, 
alpha and beta activity. Delta activity has been shown to increase, with a study by Chen et 
al. (1989b) reporting enhanced delta activity in subjects who are sensitive to pain. 
Desynchronisation of alpha activity has also been reported, with one study (Backonja et al., 
1991) showing increases in alpha activity during the cold pressor. Ferracuti et al. (1994) 
reported that the decrease in the upper alpha band, alpha-2, may be dependent on painful 
stimulation, with apha-1 reflecting a sensory response to immersion in the cold water.
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While theta activity has also been shown to increase during the cold-pressor test, the 
functional significance of this increase has not been extensively examined. It is possible 
that the increase in theta activity may reflect inhibition at the cortical level. The increases in 
beta activity have been interpreted as reflecting heightened vigilance involved in pain, 
however it has also been suggested that increased beta activity may be caused by muscle 
artifact due to the clenching of the facial and jaw muscles during the cold-pressor test. A 
number of studies examining somatosensory evoked brain potentials to phasic stimuli, such 
as electric shock and CO2 laser heat, have produced reliable correlations between 
components of the SERP and the subjective report of pain. Manipulations of attention 
during painful phasic stimuli have also shown modifications of SERP components 
concurrent with subjective reports of pain, although some studies have argued against 
SERP components being objective neurophysiological correlates of pain (Becker et al., 
1993; Zaslansky et al., 1996). The effects of pain in sub-cortical areas of the brain have 
been examined using functional neuroimaging techniques including MRI and PET. These 
studies have reported rCBF changes to experimental pain in the anterior cingulate cortex, 
and somatosensory cortices. The pattern of activation has been examined as a function of 
the different aspects of pain, with activation in the ventral thalamus and primary 
somatosensory cortex thought to reflect the sensory-discriminative aspect of pain, while 
activation in the limbic system and anterior cingulate cortex is thought to reflect the 
motivational-affective component.
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DISTRACTION AND PAIN
CHAPTER 3: DISTRACTION AND PAIN
3.1. Cognitive Distraction Strategies
Cognitive strategies of pain reduction are those which attenuate pain through the 
medium of one’s thought processes (Fernandez & Turk, 1989). Many studies examining 
distraction and pain have employed cognitive distraction strategies in an attempt to reduce 
pain to acute noxious stimulation. Tan (1982) conducted a review of the literature on 
cognitive and cognitive-behavioural methods of pain control in experimental and clinical 
situations. From this review, he identified a number of methodological issues including 
inadequate placebo and control groups, dependent variables and follow up studies, the 
limitation of subject samples and individual coping styles. Tan (1982) concluded that as 
long as these issues remained unaddressed, no definite statements supporting the efficacy of 
any cognitive interventions could be made.
Turk, Meichenbaum and Genest (1983) also examined the efficacy of cognitive coping 
strategies during experimental pain and classified these strategies into two subtypes: those 
which alter the appraisal of the painful situation, and those which divert attention away 
from the pain. Using box-score analyses that compared cognitive strategies across a number 
of experiments, Turk et al. (1983) found that, in 64 percent of the studies, coping strategies 
were useful in attenuating pain over no-treatment controls.
Following Tan’s (1982) review and Turk et al.’s (1983) cross-comparison of studies, 
Fernandez and Turk (1989) conducted a meta-analytic review of cognitive coping strategies 
in experimental pain studies. In this review, Fernandez and Turk (1989) utilised an 
empirically-based multi-dimensional taxonomy to categorise the vast array of cognitive
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coping strategies into six major classes. These six classes of coping strategies, first 
described by Wack and Turk (1984), were external focus of attention, neutral imagings, 
pleasant imagings, dramatised coping, rhythmic cognitive activity and pain acknowledging. 
The meta-analytic aggregation of data showed that in 85 percent of the studies, cognitive 
strategies were effective in attenuating pain compared to no-treatment controls. This 
exceeded the 50 percent figure reported by Tan (1982) and the 64 percent reported by Turk 
et al. (1983). Fernandez and Turk (1989) attributed this to methodological differences in the 
studies, with Tan simply conducting a cross-comparison of studies, Turk et al. (1983) using 
a box-score analysis, and Fernandez and Turk (1989) using meta-analysis. Fernandez and 
Turk (1989) also suggested that, in some studies, control groups may employ their own 
spontaneous cognitive pain-reduction techniques without the experimenter being aware of 
them, subsequently distorting results.
Distraction strategies which direct attention away from pain (external focus of attention, 
neutral imagings and pleasant imagings) have had greater success in attenuating pain than 
strategies that reappraise or acknowledge the painful situation (Fernandez & Turk, 1989), 
and are the preferred choice of strategy during experimental pain studies (McCaul & 
Haugtvedt, 1982; Rokke and Lall, 1992; Wack & Turk, 1984). Turk et al. (1983) have also 
classified distraction strategies per se into three types: -
1. Imaginative inattention: involves directing attention away from the painful stimulus 
by producing a mental image incompatible with the experience of pain.
2. Attention diversion (external): involves shifting attention away from the painful 
sensations to certain aspects of the physical environment.
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3. Attention diversion (internal): involves focusing attention on thoughts and 
cognitions without the production of an image or mental picture (e.g., mental 
arithmetic).
3.2. Distraction and Affect
The majority of studies employing distraction strategies during the cold-pressor test 
have generally incorporated pleasant affect into stimulus content. Imaginative inattention 
involves the production of a mental image incompatible with the experience of pain (Turk 
et al., 1983) and thus requires the subject to think of pleasant imagings, such as relaxing on 
a beach, or being on vacation (Hertel & Hekmat, 1994). Previous studies specifically 
examining the effects of distraction during the cold-pressor test have shown that the 
formation of a pleasant image during noxious stimulation significantly enhanced pain 
control.
Blitz and Dinnerstein (1971) examined tolerance to the cold-pressor test in a control 
condition, a pain-acknowledging condition and a distractor condition where subjects were 
instructed to imagine a pleasant scene (e.g., a hot day where the water is cool and 
refreshing). Results showed that pain tolerance was greater during both the pain- 
acknowledging and distraction conditions than during the no-treatment control condition. 
There was no difference in tolerance time between the task conditions. This may have been 
due to the inclusion of both males and females in the experiment that may have confounded 
results, as males and females differ in their pain thresholds and responses (Fillingim & 
Maixner, 1995). The effects of distraction were also examined after all groups had
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experienced three cold pressor trials. This may have affected results, as there may have 
been carry-over effects from one task to the next.
Horan and Dellinger (1974) examined the effects of both a neutral distraction task and a 
pleasant distraction task during the cold-pressor test. In the neutral condition, subjects were 
required to count backwards from 1000 during cold stimulation, while the pleasant 
condition required subjects to form a pleasant mental image of walking through a lush 
meadow and looking at a clear blue lake. Subjects in the pleasant condition tolerated the 
cold-pressor test for nearly three times as long as a control condition and nearly twice as 
long as subjects in the neutral condition, and Horan and Dellinger (1974) concluded that 
positive imagery is a promising therapeutic strategy for enhancing tolerance to noxious 
stimulation.
Grimm and Kanfer (1976) examined the effects of three different types of distractor 
tasks compared to a control condition, during the cold-pressor test. In a symbolic (pleasant 
imagery) task, subjects were instructed to form a pleasant image that involved planning a 
party or taking a trip with a friend. In a relaxation condition, subjects were instructed to 
progressively relax their muscles during the cold-pressor test, and subjects in an expectancy 
task were required to read quotes about physical adaptation to pain. Tolerance time during 
the cold-pressor test was greater for subjects in the symbolic (pleasant imagery) group 
compared with other conditions, and Grimm and Kanfer (1976) concluded that pleasant 
distractor tasks clearly reduced the perception of pain.
In a study designed to examine the effectiveness of the Lamaze childbirth technique, 
Stone, Demchik-Stone and Horan (1977) examined the effects of the Lamaze breathing 
technique compared with pleasant imagery (relaxing on a comfortable deserted lakeside) 
and focal point visualisation (focusing on a black circle on a white background) during the
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cold-pressor test. Results showed that pleasant imagery was more effective than Lamaze 
breathing and focal point visualisation for increasing subject immersion tolerance. Stone et 
al. (1977) concluded that further investigation into the use of pleasant imagery to reduce 
childbirth pain was warranted.
Scott and Leonard (1978) also examined tolerance to the cold-pressor test during 
pleasant imagery. Subjects who imagined pleasant scenes tolerated the cold pressor longer 
than subjects who imagined neutral scenes and controls. This was part of a larger study to 
examine the effects of covert reinforcement training on pain. During covert reinforcement, 
subjects first engage in the task to be adopted. When that image is clear, the subject is then 
instructed to switch to a previously determined pleasant or reinforcing image that has been 
defined beforehand. It is therefore possible that this covert reinforcement may have 
confounded the results of the study, with subjects being required to switch between tasks.
Beers and Karoly (1979) examined the effects of cold-pressor pain during four different 
distractor conditions. The first condition was a task-irrelevant condition, which required 
subjects to count backward from 1000 by threes. A second condition was an incompatible- 
imagery condition, which required the subjects to form an image of a pleasant warm scene. 
The third condition was a compatible-imagery condition where subjects imagined a 
pleasant (but cold-related) winter scene, and the fourth condition was a rational-thinking 
condition where subjects made positive self-statements and task-relevant statements 
designed to emphasise the positive and minimise the unpleasant aspects of the cold-pressor 
test. Results indicated that subjects in the incompatible imagery, compatible imagery and 
rational thinking conditions tolerated the cold-pressor test longer than control subjects.
Avia and Kanfer (1980) examined the effectiveness of training subjects in a pleasant 
task whilst manipulating self-control of pain. Subjects were instructed to form a mental
51
image of a trip they would like to take, and those subjects receiving self-management 
training were told that they had the power to control the pain and cope with the situation. 
Subjects in both pleasant imaging groups tolerated the cold-pressor test longer than control 
subjects and subjects in the self-management group tolerated the cold-pressor test the 
longest. Avia and Kanfer thus concluded that self-management is important in pain control. 
Rosenbaum (1980) also investigated self-control behaviours during pain in subjects defined 
as high self-controllers (HSC) and low self-controllers (LSC). The formation of a pleasant 
image significantly increased pain tolerance for all subjects during the cold-pressor test, 
with subjects trained in self control methods tolerating the cold pressor longer than subjects 
who were not encouraged to employ their own self-control methods. HSC also consistently 
tolerated the cold-pressor test longer than LSC subjects, and, like Avia and Kanfer (1980), 
Rosenbaum (1980) concluded that self-control methods significantly enhance tolerance to 
aversive stimulation.
Holmes, Hekmat and Mozingo (1983) examined the effects of analgesic suggestions on 
tolerance to the cold-pressor test. Subjects were assigned to one of three conditions: a 
verbal/symbolic (pleasant imagery), breathing/relaxation, and a control condition. In each 
condition, half the subjects were given either analgesic suggestion and were told that the 
strategy they were assigned would significantly reduce pain, or neutral suggestion, where 
they were told that it was not known if the strategy would reduce pain. Subjects in the 
pleasant-imagery group and relaxation group tolerated the cold-pressor test longer than the 
control, with subjects in the pleasant-imagery group tolerating the cold-pressor test the 
longest overall. The presence of a strong analgesic suggestion in the instructions to the 
participants resulted in a reduction in pain ratings and increases in pain tolerance for all
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groups. This suggests that analgesic suggestion combines additively with cognitive 
strategies to reduce the perception of pain during noxious stimulation.
Fanurik, Zelter, Roberts and Blount (1993) examined coping styles of children during 
the cold-pressor test. Fifty male and female children aged 8-10 participated in a 240 second 
baseline cold-pressor test, and from this the children were classified as ‘attenders’ (focusing 
on the stimulus) or ‘distractors’ (focusing away from the stimulus). Following this, 
participants were randomly assigned to one of three intervention conditions (sensory 
focusing, pleasant imagery, or no intervention) and completed a second cold-pressor test. 
Results showed that there was an interaction between coping style and intervention, with 
children who were classified as distractors tolerating the cold-pressor test longer when 
taught to use pleasant imagery. Fanurik et al. (1993) concluded that children’s own 
attempts at distraction were not as effective as when assisted with imagery techniques, and 
that matched intervention (i.e. distraction and pleasant imagery) is more effective in 
increasing pain tolerance than a mismatched intervention (i.e. distraction and sensory 
focusing). This study examined the effects of distraction techniques on pain in children, and 
it is possible that the coping styles of children are not yet fully developed, which would 
allow different results in adult subjects.
Hertel and Hekmat (1994) examined the effects of mood and imagery on cold-pressor 
pain. Subjects completed a pre-test baseline cold-pressor test, then worked with the 
experimenter to construct a variety of imaginal models. Imaginal models consisted of 
family members, friends or acquaintances. Following this, subjects were instructed to 
produce either pleasant (e.g., relaxing on a beach or field) or unpleasant mental images 
(e.g., receiving poor grades, or a traffic citation) and rated the imaginal models. Following 
this, subjects completed a second cold-pressor test. Results showed that subjects who used
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pleasant imagery showed a greater increase in pain tolerance from the baseline to the cold- 
pressor test than subjects who used the unpleasant imagery, however there were no 
significant differences in pain tolerance between the groups. It is possible that there may 
have been other stimulus characteristics, such as complexity or significance of the imaginal 
models, that confounded the effects of imagery in the Hertel and Hekmat (1994) study.
With studies that involve the formation of a mental image, it is impossible to directly 
control or know the thought processes or mental images of participants. Because of this, 
images may vary considerably between subjects. Given this, it is often more practical to use 
an external distractor stimulus and instruct subjects to focus on this distractor rather than to 
form a mental image. Kanfer and Goldfoot (1966) assigned subjects to either a control 
group or one of four distraction tasks during a five-minute maximum cold-pressor test. In 
the first condition, subjects received negative verbal instructions that the cold pressor 
would be very painful, while subjects in the second condition were instructed to verbalise 
their sensations out loud during cold stimulation. Subjects in the third condition were 
required to focus on a clock to see how long they kept their hands in the water, and subjects 
in the fourth condition were required to focus on pleasant slides consisting of pictures of 
landscapes, buildings, landmarks and people. Results showed that subjects who viewed the 
slides tolerated the cold-pressor test longest and also had the lowest use of any other 
cognitive strategy during cold immersion.
In a following study, Kanfer and Seidner (1973) examined the use of self-control
techniques and distraction during the cold-pressor test. Subjects either initiated their own
rate of picture change during the cold-pressor test (subject-initiated group) or watched
pictures that changed automatically (experimenter-initiated group). The pictures consisted
of a series of travel slides on the wall in front of the subject. Results showed that both
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groups tolerated the cold-pressor test for longer than a control condition, with the subject- 
initiated group tolerating the cold-pressor test longest. This provides support for self­
control enhancing tolerance to aversive stimulation.
Limited-capacity models of attention (Broadbent, 1958) have been used to explain the 
success of cognitive strategies in pain control. These models posit that the pain experience 
depends on information processing. Given the assumption that attention is limited in 
capacity, competing stimuli, such as cognitive tasks, impinge on the amount of attention 
available for processing painful stimuli, and therefore reduce the perception of pain. 
Levanthal and Everhart (1980) have explained the effect of distraction during pain in terms 
of the parallel-processing model of pain. This model suggests that through experience with 
pain, individuals form a schema that represents both the sensory and emotional aspects of 
pain. The pain schema can be modified by additional encounters with the painful stimuli, 
and acts like an attention selector where different aspects of the pain experience can be 
brought into focal awareness (Dar & Leventhal, 1993). Melzack and Wall (1965, 1988) 
have also described the modulation of pain. Melzack and Wall postulate, in their gate 
control model, that attention modifies pain by way of a ‘central control trigger'. The central 
control trigger consists of nerve impulses that activate descending efferent fibres and 
influence the gating mechanism. These descending control systems involve endogenous 
opioids, however the exact mechanism by which they come into action and elicit analgesia 
remains poorly understood (Melzack & Wall, 1988).
3.2. Distraction and Novelty
S. Maltzman (Maltzman-Greenstein, 1984; Maltzman, 1988, 1992) examined previous 
studies that incorporated pleasant affect into their stimulus content. Studies using
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techniques to distract subjects from the cold-pressor test have generally instructed subjects 
to form a pleasant image, or have presented subjects with pictures of pleasant slides, and 
have shown an increase in pain tolerance and a reduction in the perception of pain with 
such stimuli. S. Maltzman (Maltzman-Greenstein, 1984; Maltzman, 1988, 1992) criticised 
such studies on the basis that they failed to vary the affective quality of the imagery or 
slides. As a result, there is no way of knowing whether the success of distraction is in fact 
due to pleasant affect or some other aspect of the stimuli or experimental situation. Many 
studies have also used repeated-measures designs where there may be carry-over effects of 
cognitive tasks from one cold-pressor to another, and some studies have also examined self­
efficacy and self-control, and may thus have confounded the effects of distraction. It is 
therefore difficult to know which aspects of the distractor tasks are critical to their 
effectiveness.
Studies that have specifically controlled for affect have reported findings contrary to the
hypothesis that pleasant affect increases tolerance to the cold-pressor test. Worthington
(1978) examined the effect of self-control, imagery content and self-verbalisation during
the cold-pressor test. All subjects participated in a baseline cold-pressor test and the
variables manipulated were pleasant versus neutral imagery, choice versus yoked control,
and self-verbalisation. In the pleasant imagery and neutral imagery conditions, subjects
were instructed to form a mental image that was either pleasant or neutral. Neutral
imagings included activities of a routine nature, such as those done daily. In the choice
versus yoked conditions, each subject in the choice condition was asked to generate two
scenes to distract themselves from the ice water. Each subject in the yoked condition was
told to use the same conditions generated by the subject in the choice condition to which
they were yoked. In the self-verbalisation conditions (self-verbalisation versus no self-
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verbalisation), pain was conceptualised as a three-stage process, confronting the stressor, 
handling the stressor and coping with critical moments (Turk et al., 1983). Results showed 
that pleasant imagery was not superior to neutral imagery in either increasing pain tolerance 
or reducing pain perception. This may be because the production of mental images requires 
a degree of subject involvement therefore the complexity of the task rather than the content 
of the images may have contributed to the attenuation of pain. Pain tolerance was also 
greater for choice than yoked conditions and for self-verbalisation than non-self 
verbalisation conditions. This may be because subjects felt more control in the choice 
conditions and self-verbalisation may have acted as an additional form of distraction, 
thereby increasing pain tolerance (Worthington, 1978).
In an experiment designed to specifically manipulate affect, Maltzman-Greenstein 
(1984) presented subjects with pleasant slides (pictures of whales swimming in the ocean) 
and unpleasant slides (pictures of whale autopsies performed during an Oregon beaching in 
1979) during the cold-pressor test. These slides had been pre-tested for pleasantness- 
unpleasantness in an earlier study. Results showed that both slides significantly increased 
tolerance above control level, with unpleasant slides increasing tolerance significantly more 
than pleasant slides. S. Maltzman (1988) extended the earlier Maltzman-Greenstein (1984) 
study and examined the visual stimulus characteristics of the slides used in the 1984 study. 
Subject ratings on affect (pleasantness/unpleasantness), complexity (high complexity/low 
complexity) and novelty (high novelty/low novelty) showed that the unpleasant slides were 
rated as both more complex and more novel than the pleasant slides. From this, S. 
Maltzman (1988) concluded that the perception of pain might be modified by stimulus 
characteristics other than affect.
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In order to clarify which characteristics of visual stimuli modify the perception of pain, 
S. Maltzman (1992) manipulated affect, novelty, complexity and significance. Using slides 
that had been previously rated in a separate study of 122 subjects, she examined pain 
perception and pain tolerance in the cold-pressor test during varying conditions of affect, 
novelty, complexity and significance. In this study, stimulus significance was 
operationalised as the extreme evaluative ratings of affect regardless of direction. Results 
showed that novelty reduces the perception of pain, and she concluded that the reported 
success of pleasant affect is due to the confounding effect of novelty in those studies. S. 
Maltzman (1992) attributed the success of novel distractors in attenuating pain to the 
Orienting Response (OR), where a sufficiently-novel stimulus presented during noxious 
stimulation raises the threshold to pain.
3.2. The Orienting Response and endogenous opioids.
This section introduces the OR and focuses primarily on novelty as the eliciting factor of 
an OR so that a response to novelty is the defining characteristic of an OR. This section 
also reviews a related body of animal literature that has shown activation of endogenous 
opioids (beta-endorphins) during exposure to novel situations, and suggests that the OR 
may provide a physiological explanation as to why distractor stimuli reduce the perception 
of pain and increase pain tolerance.
Pavlov first described the Orienting Response (OR) in 1927 as a response to novel 
stimuli. Following Pavlov, E.N. Sokolov laid the foundation for modem western research 
into the OR. Sokolov (1963) described the OR as a complex of behavioural and 
physiological changes to novel stimuli, where novelty is defined in terms of its reduction
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with stimulus repetition. Responses include head movements, pupil dilation, muscle 
activity, increased frequency and lower amplitude of the EEG, increase in amplitude and 
decrease in frequency of respiration, and increases in electrodermal activity. Sokolov 
(1963) also distinguished between the Orienting Response and the Defensive Response 
(DR). Whereas the OR occurs to novel stimuli and habituates rapidly, the DR occurs to 
intense painful stimuli and habituates slowly. Sokolov states that the OR enhances the 
perceptibility of stimuli, while the DR protects an organism from painful stimulation.
In Sokolov’s theory of the OR, incoming stimuli are compared with representations of 
past stimuli in the cortex of the brain. If a stimulus is novel and does not match an existing 
neuronal model, an orienting response occurs. If a stimulus has occurred before, an 
orienting response may or may not occur depending on the match between the stimulus and 
its neuronal model. Novelty is defined in terms of its reduction with stimulus repetition and 
the subsequent habituation of the response. In Sokolov’s theory, the degree of novelty (the 
match between a stimulus and existing neuronal model) is the critical factor in producing an 
OR and is the defining characteristic of this response. In addition to novelty, a number of 
studies have shown that Skin Conductance Responses (SCRs) can be elicited by 
instructions providing a previously neutral stimulus significance as a signal for a response 
in a forewarned reaction time situation. An SCR may also be induced when the participant 
in a classical conditioning experiment discovers the Conditioned Stimulus (CS) that is a 
signal for an Unconditioned Stimulus (UCS) (Maltzman, 1977). Stimuli may also evoke 
SCRs because of previous learning (Sokolov, 1963, Wingard & Maltzman, 1980) however 
novelty rather than significance is the focus of the present research.
The conceptual importance of novelty in attenuating behavioural responses to pain arises
from a number of studies which have shown that exposure to novel conditions activates
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endogenous opioids in the brains of laboratory animals and produces analgesia during pain 
(Izquierdo & Netto, 1985). This increase in pain threshold is consistent with previous 
research in humans (S. Maltzman, 1992) that has shown that novelty is the defining 
characteristic of distractor stimuli that modify the perception of pain.
Endogenous opiate receptors were discovered in the central nervous system in the early 
1970s (Pert & Snyder, 1974; Simon, Hiller & Edelman, 1973; Terenius, 1973) and ligands 
for these receptors were detected shortly afterwards (Hughes, Smith & Kosterlitz, 1975; Li 
& Chung, 1976). Three families of endogenous opioids in the brain are now known: 
enkephalins, dynorphins and endorphins (Delayeun & Bergal, 1993). These endogenous 
opioids function as neurotransmitters and hormones and are involved in the modulation of 
behaviour, perception of pain and regulation of autonomic and neuroendocrine function 
(Kong, Raynor, Yasuda, Moe, Portoghese, Bell & Reisine, 1993). The opioid receptors for 
the enkephalins, dynorphins and endorphins are found throughout the brain and the spinal 
cord (Dickenson, 1991).
Beta-endorphin (P-endorphin) is the active substance in the endorphin family (Izquierdo 
& Netto, 1985), being a 31 amino acid peptide opiate derived from pro-opiomelanocortin 
(POMC) (Delayeun & Bergal, 1993). The cellular bodies of the brain p-endorphin/POMC 
system are in the hypothalamus, with their fibres projecting within the hypothalamus and to 
other areas including the thalamus and preoptic area (Bloom & McGinty, 1981).
A number of studies in laboratory rats have shown that exposure to a new task or 
situation activates the brain p-endorphin system. The release and subsequent degradation of 
p-endorphin has been shown to occur in new environments (Izquierdo, Souza, Dias, Perry, 
Carrasco, Volkmer & Netto, 1984) and new tasks, such as inhibitory avoidance training
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using high or low footshock intensity (Perry, Dias, Carrasco & Izquierdo, 1983) and shuttle 
avoidance learning (Izquierdo et al., 1984). The activation of (3-endorphin has been 
attributed to novelty (Izquierdo & McGaugh, 1985; Izquierdo & Netto, 1985) as opioid 
release occurs only with the first exposure to a task or situation, or when the task is altered 
(Izquierdo et al., 1984).
The release of brain (3-endorphin and its precursors to novel experiences occurs in the 
hypothalamus, ventral thalamus and preoptic region (Izquierdo et al., 1984), and has also 
been observed in other parts of the brain (Izquierdo, Souza, Carrasco, Dias, Perry, Eisinger, 
Elisabetsky & Vendite, 1980). Release occurs in less than three minutes, followed by 
degradation of the molecules in the brain that occurs over three hours (Izquierdo & Netto, 
1985), with pituitary and plasma levels of (3-endorphin in rats not affected by most of the 
novel behavioural procedures.
Exposure to novelty has been shown to induce analgesia in rats (Siegfried, Netto & 
Izquierdo, 1987). Using tail flick latency as an index of analgesia to a low heat stimulus, 
Siegfried et al. (1987) found analgesia occurred 10 seconds, 2 minutes and 10 minutes after 
exposure to novelty. After 10 minutes, the effect diminished and was only seen with the 
first exposure to a new environment or task. Analgesia was reversed with the opiate blocker 
naltrexone, and Siegfried et al. (1987) concluded that novelty is a sufficient stimulus to 
activate the (3-endorphin system and reduce the effects of a painful stimulus.
Drawing from animal research on endogenous opioid release during novel situations and 
environments, and Sokolov’s work on novelty and the OR, I. Maltzman (1990) suggested 
that (3-endorphin activation is a component of the organismic OR. I Maltzman (1990) has 
also suggested that (3-endorphin release during an OR to novel stimuli may provide a
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physiological mechanism explaining why distractor stimuli modify the perception of pain 
and attenuate pain responses. I. Maltzman’s suggestion is supported by research with 
humans. A study by Bell, Schwartz, Bootzin, Hau and Davis (1997) examined plasma P~ 
endorphin levels of elderly people in response to novel laboratory experiences. Two groups 
of elderly people (shy and outgoing) were exposed to novel laboratory settings (a sleep 
laboratory and clinical laboratory) over two successive days. Results showed elevated 
plasma levels of (3-endorphin in both groups, with the shy elderly persons exhibiting higher 
levels than their outgoing peers. The plasma levels were taken 15 minutes after exposure to 
the novel environment, with habituation of (3-endorphin levels occurring over time.
That is, research in laboratory rats shows that exposure to novel situations or 
environments activates the (3-endorphin system in the brain, resulting in analgesia during 
pain. Analgesia is reversed with opiate blockers, with Siegfried et al. (1987) concluding 
that novelty is a sufficient stimulus to activate the p-endorphin system and modify pain. 
Activation of p-endorphin to novel situations has also been shown to occur in humans 
(Bootzin et al., 1997). Consideration of animal studies, and the studies of distraction and 
pain tolerance in humans suggests that novel distractors increase pain tolerance because 
novelty elicits an organismic OR, which releases P-endorphins and results in analgesia 
during pain (I. Maltzman, 1990).
3.3. Summary
This chapter has reviewed the use of cognitive strategies in pain control, with an
emphasis on distraction strategies, which direct attention away from pain. The success of
distractors has been explained in terms of limited-capacity models of attention, where a
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competing stimulus limits the attentional resources available for processing the painful 
stimulus, therefore attenuating pain. Information-processing models have been the 
dominant view in the literature explaining why distractors reduce the perception of pain and 
attenuate pain responses. Psychophysiological responses to pain and pain modification are 
difficult to explain using information processing models (I. Maltzman, 1990) and it is not 
easy to link developments in neurobiology with cognitive models. Physiological models 
better describe psychophysiological responses to pain and pain modification. Drawing on 
Sokolov’s theory of the OR, previous animal studies and distraction studies during pain, it 
may be possible to link physiological models with concepts relating to the OR.
Distraction strategies include focusing on an external stimulus or focusing on internal 
thoughts, such as the production of an image or mental picture. Many studies have 
investigated the effects of distraction on experimental subjects using the cold-pressor test, 
an analogue of acute clinical pain (Chen et al., 1989a). These studies have used distractor 
stimuli that have been pleasant, such as pleasant imagings (formation of a pleasant image 
during pain) or the presentation of pleasant pictures, and have reported an increase in pain 
tolerance and reduced pain ratings. S. Maltzman (1984, 1988, 1992) suggested that these 
studies have confounded affect with novelty and argued that it is novelty that modifies the 
perception of pain and attenuates pain responses. This effect of novelty has been attributed 
to the OR, whereby a sufficiently novel stimulus elicits an OR and raises the threshold to 
pain (I. Maltzman, 1990; S. Maltzman, 1992). This concept relates to a body of animal 
literature showing (3-endorphin release and analgesia to pain during novel situations and 
environments. Human data also show that exposure to novelty elevates plasma levels of 13- 
endorphin, supporting I. Maltzman’s (1990) suggestion that P-endorphin is a component of
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the organismic OR. This may provide a general physiological mechanism explaining why 
distractor stimuli presented during experimental pain modify the perception of pain and 
attenuate pain responses.
The next chapter looks at gender differences in pain, and the modification of pain 
across the female menstrual cycle, highlighting the importance of controlling for these 
variables in pain studies.
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CHAPTER 4 
PAIN AND GENDER
CHAPTER 4: PAIN AND GENDER
4.1. Gender Differences in Pain
Demographic and epidemiological research indicates that there are more females with 
chronic pain disorders than males (Unruh, 1996). Women are also more likely to report 
more persistent and severe pain of longer duration than men (Unruh, 1996). Women show a 
higher prevalence of migraines and headaches, temporomandibular disorders, back pain and 
arthritis than men (Fillingim & Maixner, 1995; Unruh, 1996). This difference may be due 
to a combination of a number of factors, such as culture, physiological differences, 
individual history and situational factors (Fillingim & Maixner, 1995).
A number of experimental studies have shown that females are more sensitive to pain 
than males (Dubreuil & Kohn, 1986; Fillingim, Keefe, Light, Booker & Maixner, 1996; 
Lautenbacher & Strian, 1991; Liberson & Liberson, 1975; Otto & Dougher, 1985; Robin, 
Vinard. Maury & Saumet, 1987; Rollman & Harris, 1987). These studies have used a wide 
variety of pain-induction techniques, such as pressure, electrical, mechanical and ischemic, 
which differ across many dimensions including the quality of pain produced. In a review 
comparing the results from thirty-four experimental studies examining pain responses in 
males and females, Fillingim and Maixner (1995) concluded that females exhibit greater 
sensitivity to laboratory pain than males, and that the gender differences in pain occur most 
consistently with pain induction stimuli that produce longer-lasting tonic pain. Fillingim 
and Maixner (1995) also noted that pain responses vary considerably across individuals and 
that this variability probably contributes to discrepancies between studies. Riley. Robinson, 
Wise, Myers and Fillingim (1998) extended the work of Fillingim and Maixner (1995).
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Riley et al. (1998) included twenty-two of the thirty-four studies included in Fillingim and 
Maixner’s (1995) review article (considering that twelve of the thirty-four studies did not 
provide adequate statistical information and one study used an unusual methodology that 
made it difficult to compare with the other studies). Riley et al. (1998) used meta-analysis 
to determine the extent of gender differences for pain tolerance and threshold. Overall, the 
analysis showed that the largest sex effect occurs when using pressure as the pain stimulus. 
There was a moderate effect with electrical stimuli, a small effect with ischemic stimuli and 
the least effect in studies using thermal heat. In a further study, recent clinical pain as well 
as thermal pain thresholds were examined in male and female subjects by Fillingim, 
Edwards and Powell (1999). Females reported a large number of pain sites and exhibited 
greater sensitivity to thermal stimuli than males. These differences between males and 
females remained significant after controlling for psychological variables and indicate that 
experimental pain responses may be more clinically relevant for females than males.
Although the exact nature of the mechanism(s) for greater sensitivity in females is
unknown (Pfleeger, Straneva, Fillingim, Maixner & Girdler, 1997), a number of studies
have examined differences between males and females in order to explain the gender
difference in pain. Lautenbacher and Strain (1991) concluded that small people are more
responsive generally than large individuals and because women are generally smaller than
men, they then exhibit greater pain sensitivity. Lautenbacher and Rollman (1993) also
noted that intervening factors such as skin thickness, receptor density or the length of
afferent pathways might affect the temporal and summation properties in the second-order
neurons. Which would affect the degree of simultaneous arrival of the afferent impulses in
the brain, thereby influencing pain perception. Lautenbacher and Rollman (1993)
concluded that a critical factor contributing to the sex differences in pain sensitivity may be
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the degree to which spatial and temporal summation are engaged by the stimulation 
method.
Psychological variables have also been thought to produce a basis for sex differences in 
pain perception, with women showing greater anxiety and psychological reactivity than 
men (Dubreuil & Kohn, 1986; Lautenbacher & Rollman, 1993; Robin et al., 1987). Riley et 
al. (1998) have also suggested that cultural influences may explain the greater pain 
sensitivity in females, with males socialised to suppress outward signs of pain in certain 
circumstances and to under-report levels of pain. This is consistent with Levine and De 
Simone (1991), who found that gender of the experimenter significantly influenced the 
report of pain from the cold-pressor test. Males reported significantly lower pain to a 
member of the opposite sex than to another male, but there was no such difference with 
female subjects.
Fillingim and Maixner (1996) and Fillingim, Maixner, Bunting and Silva (1998) have 
suggested that the difference in pain sensitivity is related to the resting blood pressure 
differences between males and females. Fillingim and colleagues (1996, 1998) suggest that 
higher resting blood pressure is associated with greater baroreceptor-induced analgesia, in 
which it might be expected that males would exhibit decreased pain sensitivity because of 
their higher resting blood pressure. This draws on previous research by Maixner (1991) 
who suggested that baroreceptor activation produced by increased blood pressure produces 
this hypoalgesic effect, with endogenous opioids also mediating the inverse relationship 
between blood pressure and pain sensitivity.
Physiological differences in pain perception may also be due to hormonal influences that
differ between males and females. The following section reviews the influence of the
female menstrual cycle on pain perception, with a number of studies reporting increased
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sensitivity during the luteal phase compared with the follicular phase of the menstrual 
cycle.
4.2. The Influence of the Female Menstrual Cycle on Pain
4.2.1. Pain perception
A number of studies have indicated that the perception of pain in women varies 
according to the particular phase of the menstrual cycle, and thus this may be a potential 
confound in psychophysiological research (Kaplan, Whitsett & Robinson, 1990). The 
cyclical nature of pain perception is attributed to the levels of circulating hormones, which 
vary quite considerably in normally-menstruating women, but not in oral contraceptive 
users or men (Goolkasian, 1980; Hapidou & De Catanzaro, 1988; Hapidou & Rollman, 
1998).
The typical 28-day menstrual cycle is divided into two main phases, the follicular phase, 
which occurs from the end of menstruation to the onset of ovulation at mid-cycle (around 
day 14), and the luteal phase which begins after ovulation and ends with the onset of the 
menses (Hastrup & Light, 1984). At the beginning of the follicular phase, the levels of 
oestrogen, progesterone, follicular stimulating hormone (FSH) and luteinizing hormone 
(LH) are all low (Hastrup & Light, 1984). Oestrogen, FSH and LH begin to rise sharply 
around days 8-10 and peak just prior to ovulation, when they fall (Hastrup & Light, 1984). 
The levels of these hormones remain low at the beginning of the luteal phase. From days 
17-24, oestrogen rises again and progesterone also rises for the first time. After day 24 (the 
premenstrual part of the luteal phase), the levels of oestrogen and progesterone decline 
dramatically before the onset of the menses (Hastrup & Light, 1984).
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This cyclical nature of female gonadal hormones is thought to mediate pain perception, 
with higher thresholds found in the follicular phase and lower thresholds found in the luteal 
phase of the cycle. Procacci, Zoppi, Maresca and Romano (1974) conducted a series of 
investigations examining pain thresholds to radiant heat stimuli in men and women. In 
women, pain thresholds varied with the menstrual cycle, with low thresholds during the 
luteal phase of the cycle and a subsequent increase that peaked towards the end of 
menstruation. Goolkasian (1980) used a signal-detection method to examine reaction to 
radiant heat in menstruating women. Goolkasian (1980) found an enhanced ability to 
discriminate between painful stimuli in the luteal phase, and this effect was not seen in 
women who took oral contraceptives, or in men. Goolkasian (1983) extended this study and 
examined pain reactions in both dysmennorrheic women (who experience painful 
menstruation) and non-dysmennorrheic women. Non-dysmennorrheic women were found 
to vary cyclically in their ability to discriminate painful from non-painful stimuli whereas 
dysmennorrheic women showed consistent pain reactions throughout the whole cycle. This 
suggests that, across the menstrual cycle, women who experience pain with menstruation 
differ from women who do not. These differences are believed to be due to biochemical 
differences between dysmennorrheic and non-dysmennorrheic women, with non- 
dysmennorrheic women showing greater female hormonal variation across the cycle than 
non-dysmennorrheic women.
Hapidou and De Catanzaro (1988) specifically examined pain responses to a four- 
minute maximum cold-pressor test in both dysmennorrheic and non-dysmennorrheic 
women. Responses were examined in the follicular and the luteal phases of the cycle. Using 
tolerance and threshold measures, they found lower pain threshold (but not pain tolerance) 
in the luteal phase of both groups of women. The dysmennorrheic women rated the cold
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pressor as being less painful than the non-dysmennorrheic women. As these effects were 
not seen in oral contraceptive users, Hapidou and De Catanzaro (1988) attributed the results 
to pituitary-gonadal hormone variations across the cycle, whereby dysmennorrheic women 
judge cold pressor pain on the basis of their painful episodes of menstruation, and 
consequently rate the cold pressor as being less painful than the non-dysmennorrheic 
women. Another explanation related to recency effects on memory of pain suggests that 
women have a better memory of their menstrual pain during the follicular phase, which 
occurs directly after menstruation, than in the luteal phase, which occurs nearly three weeks 
later (Hapidou & De Catanzaro, 1988).
Giamberardino, Berkley, Iezzi, Bigontina and Vecchiet (1997) also examined pain 
sensitivity across the menstrual cycle. Using electrocutaneous pulses applied to the skin of 
the abdomen and limbs, Giamberardino et al. (1997) found higher pain thresholds during 
the luteal than the follicular phase. Fillingim and Maixner (1997) examined thermal and 
ischemic pain sensitivity at three points in confirmed ovulatory cycles; the midfollicular 
(i.e. postmenstrual) phase, the ovulatory phase and the mid to late luteal phase (i.e. 
premenstrual phase). Plasma levels of oestrogen, progesterone, LSH, testosterone and (3- 
endorphin were obtained at each session to examine the relationship between circulating 
hormone levels and pain sensitivity. Results were that women were less sensitive to 
ischemic but not thermal pain stimuli during the midfollicular phase compared with the 
ovulatory and mid to late luteal phases. The hormone levels confirmed the points in the 
menstrual cycle. There was no significant change in plasma (3-endorphin across the cycle, 
indicating that (3-endorphin does not change across the menstrual cycle and is not 
influenced by female hormones. Results also showed that higher oestrogen was associated
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with increased thermal pain sensitivity but not increased ischemic pain responses. Pfleeger 
et al. (1997) also examined ischemic pain sensitivity and blood pressure during the 
follicular and luteal phases of the menstrual cycle. Results showed that the luteal phase of 
the cycle is associated with greater sensitivity to ischemic pain, consistent with the findings 
of Fillingim et al. (1997).
It is evident that the cyclical nature of female sex hormones affects pain sensitivity 
during the menstrual cycle, with many studies showing enhanced sensitivity during the 
luteal phase. Pfleeger et al. (1997) have suggested that there is endogenous opioid control 
of gonadotropins, with female hormones at different cycle phases acting either directly or 
indirectly with endogenous opioids to modulate pain sensitivity in woman.
In addition to pain sensitivity, cardiovascular reactivity to laboratory stressors varies 
across the menstrual cycle. The following section reviews a number of studies that have 
shown increased cardiovascular reactivity in the luteal phase of the menstrual cycle and 
also summarises studies that have reported inconsistent and conflicting results (increased 
cardiovascular reactivity in the follicular phase).
4.2.2. Cardiovascular reactivity
Cardiovascular reactivity has been shown to differ across different stages of the 
menstrual cycle in females but not in oral contraceptive users or men (as males do not 
undergo menstruation), however studies investigating this have produced highly 
inconsistent and conflicting results.
A number of studies have reported an increase in reactivity in the luteal as compared to 
the follicular phase of the cycle. Hastrup and Light (1984) examined heart rate, systolic and
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diastolic blood pressure during a shock-avoidance reaction-time task and the cold-pressor 
test in normally-menstruating women. Responses were examined during the follicular 
phase (days 7-11) and in the middle of the luteal phase (days 17-21) in a between-subjects 
design. During the follicular phase, women showed lower heart rate and systolic blood 
pressure responses to the active-coping reaction-time task. In contrast, women were more 
reactive to this stressor during the luteal phase. No differences were observed during the 
cold-pressor test, and Hastrup and Light (1984) suggested that the lower heart rate and 
systolic responses of the follicular women during the reaction-time task reflected reduced 
sympathetic drive on the myocardium. The reduced reactivity of the follicular women is 
consistent with the hypothesis that oestrogen alone may lower cardiovascular stress 
responses more effectively than oestrogen plus progesterone (Hastrup & Light, 1984).
Tersman, Collins and Eneroth (1991) examined cardiovascular responses during a 
mental-arithmetic and cold-pressor task at two different stages of the menstrual cycle 
(follicular and luteal) in a within-subjects design. The results showed that there were 
significant differences related to the menstrual cycle in cardiovascular responses to the 
cold-pressor test but not to the mental arithmetic task. The subjects displayed higher 
systolic blood pressure levels as well as greater reactivity to the cold-pressor test in the 
luteal phase as compared with the follicular phase.
Girdler, Pedersen, Stem and Light (1993) examined cardiovascular responses to a
speech stressor, the Stroop test, the 2 and 7 test (a paper and pencil test designed to measure
selective attention), a paced auditory serial-addition test and the forehead cold-pressor test.
Each woman was tested twice (during the follicular and luteal phase), and the women were
also assessed for moderate to severe pre-menstrual syndrome (PMS). Results showed that
in women without PMS, the menstrual cycle influenced cardiovascular stress responses,
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with cardiovascular reactivity higher in the luteal phase. Specifically, the luteal phase was 
associated with greater stress-induced increases in stroke volume and lesser vascular tone 
than the follicular phase. This indicates greater plasma volume luteally, which may be 
partially mediated by the elevation of ovarian and other hormones (Girdler et al., 1993). 
The results indicated that women with PMS showed no influence of their menstrual cycle 
on any cardiovascular response however the PMS women showed reduced cardiovascular 
reactivity to the tasks during both menstrual cycle phases. Girdler et al. (1993) suggested 
that these blunted responses might be a function of neuroendocrine impairment in PMS.
Girdler and Light (1994) examined cardiovascular reactivity during a speech test, the 
Stroop test, the 2 and 7 test, a paced auditory serial addition test and the forehead cold- 
pressor test in males and females. Results showed differences between females and males, 
with females showing more myocardial reactivity than men, as indexed by their greater 
heart-rate reactivity and tendency to exhibit greater cardiac-index responses and greater 
decreases in pre-ejection period responding. In contrast, men demonstrated a tendency to be 
greater vascular reactors than women by showing greater increases or lesser decreases in 
vascular-resistance index responses. Girdler and Light (1994) also found, as with their 
previous study, that greater cardiovascular reactivity in women was associated with the 
luteal phase of the cycle than the follicular phase.
The results of the studies showing enhanced cardiovascular reactivity in the luteal phase
are consistent with research showing increased pain sensitivity during the luteal phase (i.e.
Fillingim et al., 1997; Goolkasian, 1980, 1983; Hapidou & De Catanzaro, 1988; Pfleeger et
al., 1997; Procacci et al., 1974) and have been explained by the effect of aldosterone on
blood volume (Tersman et al., 1991). High levels of aldosterone in the luteal phase of the
menstrual cycle increase cardiovascular responses via elevated blood volume in the renal
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system (Marieb, 1991). Tersman et al. (1991) have suggested that because the luteal phase 
is characterised by high levels of circulating progesterone, this hormone may play a key 
role in the secretion of aldosterone. Because of this, reactivity is higher in the luteal phase 
of the cycle.
Despite the observed increases in cardiovascular reactivity in the luteal phase of the 
cycle, contradictory evidence suggests increased cardiovascular responses to laboratory- 
induced stress in the follicular phase (Miller & Sita, 1994; Polefrone & Manuck, 1988; Sita 
& Miller, 1996), with other studies reporting no phase effects on the cardiovascular system 
(Collins, Eneroth & Landgreen, 1985; Stoney, Owens, Matthews, Davis & Caggiula, 1990).
The differences in results reported above may be due to general methodological 
variations between studies and the type of stressor used to evoke responses. Also, the actual 
specification of each phase differs significantly from study to study. Some studies report 
the follicular phase as being from days 7-11 and the luteal phase from day 17-21 (Hastrup 
& Light, 1984; Miller & Sita, 1994; Polefrone & Manuck, 1988; Sita & Miller, 1996), 
while other studies report the follicular phase occurring as early as day 4 (Girdler et al., 
1993; Girdler & Light, 1994). In order to clarify the particular phase of the cycle, most 
studies have relied on self-report. Only a few studies have used more accurate means such 
as hormone assays (Stoney et al., 1990; Tersman et al., 1991) and basal body temperature 
monitoring (Kaplan et al., 1990).
Experimental design also differs across studies, with some studies employing a within-
subjects design (Collins et al., 1995; Kaplan et al., 1990; Miller & Sita, 1994; Sita &
Miller, 1996; Stoney et al., 1990; Tersman et al., 1991) and others using a between-subjects
design (Haustrup & Light, 1984; Polefrone & Manuck, 1988). Within-subjects studies
create the possibility of response decrement and ‘carry-over effects’ with the second and
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subsequent exposure to stimuli. Attenuation of responses in later testing sessions may 
reduce the ability to detect significant phase effects, and this may be a major cause of the 
inconsistencies seen in these studies (Polerfrone & Manuck, 1988).
Inconsistent results may also be due to the type of stressor used to evoke responses. 
Some studies use cognitive challenges (Collins et al., 1985; Girdler & Light; 1994, 
Polefrone & Manuck, 1988; Stoney et al., 1990) and other studies use a combination of 
cognitive and physiological (cold-pressor test) stressors (Girdler et al., 1993; Gidler & 
Light, 1994; Hastrup & Light, 1984; Miller & Sita, 1994; Sita & Miller, 1996; Tersman et 
al., 1991). Cognitive and physiological stressors differ in their hemodynamic response. The 
hemodynamic profile of the cold-pressor test differs from that of active stressors such as 
cognitive challenges. Active tasks elicit a myocardial response and passive tasks such as the 
cold pressor produce a vascular response. Because of the different hemodynamic patterns 
evoked by the different stressors, it is difficult to compare the effect of menstrual cycle 
phase on cardiovascular reactivity in these studies.
4.3. Summary
In summary, studies have shown that females are more sensitive to pain than men, with 
this gender effect attributed to cultural influences, physiological differences and situational 
variables. Pain sensitivity and cardiovascular responses to laboratory stressors also differ 
across the stages of the menstrual cycle, with studies generally reporting increased 
sensitivity in the luteal phase of the cycle. This is attributed to the cyclical nature of female 
sex hormones, with changes in hormones acting directly, or indirectly with endogenous 
opioid peptides to modulate pain sensitivity. The body of evidence shows inconsistent
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results, with some studies suggesting increased sensitivity and corresponding increased 
cardiovascular reactivity to pain in the luteal phase, other studies reporting increased pain 
responses in the follicular phase, and some studies reporting no difference in either stage of 
the cycle. Because the female gonadal hormones vary quite considerably across the ovarian 
cycle from the onset of menstruation to the premenstrual part of the luteal phase, it may be 
that these inconsistent results are due to different specification of the phases within each 
cycle and insufficient means of examining these effects.
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It is widely recognised that pain is a multidimensional experience comprising sensory- 
discriminative, motivational-affective and cognitive-evaluative dimensions. The 
conceptualisation of pain into three psychological dimensions was first described in the 
gate control model of pain (Melzack & Wall, 1965, 1982, 1988). The gate control model 
suggests that the perception of pain is modulated in the dorsal horns of the spinal cord. This 
structure acts like a ‘gate’ that opens or closes to enhance or inhibit the perception of pain. 
Central nervous system activities such as attention, emotion and prior experience also exert 
control over pain via descending control systems, with the modulation of pain involving the 
release of endorphins in the dorsal horn. Unlike other models of pain that focus 
predominantly on the psychophysiology of chronic pain syndromes (i.e. the 
psychobiological model) or cognitive models of pain that explain pain in terms of 
information processing (i.e. the parallel processing model), the gate control theory 
incorporates both psychological and physiological aspects of pain during both acute and 
chronic pain syndromes. For this reason, it has had much success in generating research in 
the area of pain and pain management.
Nociception involves the generation of neural information from primary afferent fibres 
(nociceptors) through the spinal cord to higher structures in the brain. It is thought that 
areas of the somatosensory cortex are involved in pain perception, while structures 
including the hypothalamus, limbic cortex and anterior cingulate cortex play a role in the 
affective aspect of pain (Willis, 1995). In addition to ascending pathways, a number of 
descending pathways have been identified that are involved in pain modulation. These 
descending control pathways contain multiple receptors for endogenous opioids and are
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thought to play a vital role in the modulation of pain (Dubner & Hargreaves, 1989; Melzack 
& Wall, 1988; Willis, 1995).
The physiological responses to experimental pain have largely been investigated using 
the cold-pressor test, an analogue of acute experimental pain (Chen et al., 1989a). The cold- 
pressor test influences the thermoregulatory and somatosensory systems in the ANS 
(Lovallo, 1975) resulting in an overlap of responses in the cardiovascular system produced 
to this physical stressor. This overlap is primarily seen in arterial blood pressure, with 
increases resulting from the additive effects of both cold and pain. In addition to 
cardiovascular increases, changes in RR and increases in SCL have also been reported 
during the cold-pressor test, although these have not been as extensively examined as 
changes in the cardiovascular system. Q-EEG studies have shown changes in delta, theta, 
alpha and beta activity. Delta activity has been shown to increase, with enhanced delta 
activity seen in pain-sensitive compared with pain-tolerant individuals (Chen et al., 1989). 
Alpha desynchronisation has also been reported, with decreases in the upper alpha band 
(alpha-2) reflective of painful stimulation and the lower alpha band (alpha-1) attributed 
purely to a reaction to the stimulus. While increases in theta have been reported, the 
possible explanation surrounding the increases have not been discussed, and it may be that 
increased theta during pain may reflect inhibitory processes in an attempt to control pain 
during noxious stimulation. Increased beta activity during the cold-pressor test has been 
related to heightened vigilance during pain, however it is possible that increases in the 
higher beta bands may reflect muscle artifact from clenching of the facial and jaw muscles.
Studies examining brain responses to more phasic stimuli (e.g. electrical, mechanical or
laser stimulation) have found high correlations between components in evoked potentials
(SERPs) with the subjective report of pain. Because certain components of the SERPs to
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pain are modified during manipulations of attention (Miltner et al., 1989) and hypnotic 
analgesia (De Pascalis et al., 1999), brain responses to more tonic pain stimuli (i.e. Q-EEG 
changes during the cold-pressor test) may also be modified under similar conditions.
Studies using functional neuroimaging techniques have suggested that the pattern of 
activation during the cold-pressor test reflects different components of pain processing. 
Specifically, activation of the contralateral thalamus and primary somatosensory cortex is 
thought to reflect the sensory-discriminative aspect of pain, while activation of structures 
associated with autonomic and limbic system function may reflect the motivational­
affective component (Casey et al., 1995). Functional neuroimaging techniques provide 
higher resolution than studies examining EEG changes during pain and may help explain 
EEG changes in different areas of the cortex.
With regard to the effects of distraction on cold-pressor pain, studies have primarily 
used tolerance/threshold and subjective rating scales as dependent variables rather than 
physiological responses. Distraction strategies that have previously been successful in 
modifying the perception of pain have incorporated pleasant affect into stimulus content. 
However, S. Maltzman (1988, 1992) argued that studies using pleasant affect to distract 
subjects from pain did not vary the affective quality of the images or slides and that it is the 
novel aspect of stimuli that elicits an OR and raises the threshold to pain. I. Maltzman 
(1990) has attributed the analgesic effect of distractors during pain to the novelty-dependent 
release of endorphins during the organismic OR. Incorporated with the major models of 
pain, the OR may provide a physiological mechanism explaining why distractors modify 
the perception of pain and attenuate pain responses.
Studies have shown that females are more sensitive to pain than males, indicating the
need to control for this in pain studies. This difference in pain sensitivity is attributed to
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physiological differences, cultural influences and situation factors, where males are 
socialised to suppress outward signs of pain in certain circumstances (Riley et al., 1998). 
This has been shown in experimental situations where males report less pain to a female 
experimenter than to a male experimenter (Levine & De Simone, 1991). Pain perception 
and cardiovascular reactivity have been shown to vary across the menstrual cycle in 
normally menstruating women, but not in oral contraceptive users or men. Maximal pain 
sensitivity is reported in the luteal phase of the cycle (Fillingim & Maixner, 1997; 
Giamberadino et al., 1997; Goolkasian, 1980, 1983; Hapidou & De Catanzaro, 1988; 
Pfleeger et al., 1997; Procacci et al., 1974), attributed to the cyclical nature of female 
hormones, which differ in the luteal compared with the follicular phase (levels of FSH and 
LH are higher in the follicular phase and progesterone levels are higher in the luteal phase 
of the cycle). Consistent with this, studies have also shown that cardiovascular reactivity is 
enhanced in the luteal phase of the cycle. However, despite the observed increases in 
cardiovascular reactivity in the luteal phase, studies have also reported enhanced reactivity 
in the follicular phase and other studies have reported no difference in either stage of the 
cycle. It may be that the inconsistent results are due to varying specifications of the timing 
of each phase, different laboratory stressors across experiments and inaccurate methods of 
measuring menstrual cycle phase. Whatever the reasons, the literature indicates the need to 
control for menstrual-cycle differences in pain studies.
This thesis examines the effect of novelty on behavioural and physiological responses 
evoked in a cold-pressor test. Both a highly-novel distractor stimulus and a moderately- 
novel distractor stimulus were used to examine pain responses during the cold-pressor test. 
Study 1 investigated ANS responses to pain in a between-subjects design where subjects 
were randomly assigned to a high-novelty group, a moderate-novelty group or a control
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group. Study 2 replicated this, and extended it by examining both ANS and CNS (EEG) 
responses. A secondary aim of this thesis was to investigate and control for the influence of 
the female menstrual cycle on pain perception and the responses elicited to the cold-pressor 
test. Both studies included female subjects to control for gender differences in pain and to 
avoid opposite-sex experimenter-gender effects with the female experimenter. A 
questionnaire was employed to determine if subjects were in the follicular or luteal phase of 
the menstrual-cycle, or were oral contraceptive users reporting anovulatory cycles. 
Differences between the groups were examined and if there were any significant effects, 
menstrual-cycle phase was used as a covariate in the main analysis.
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CHAPTER 6: NOVEL DISTRACTOR EFFECTS ON AUTONOMIC RESPONSES
TO PAIN
6.1. Overview
The present study investigates behavioural and autonomic nervous system responses to 
pain using the cold-pressor test. While behavioural indices of pain are commonly used to 
examine the effects of distraction techniques during the cold-pressor test, few studies have 
investigated the modification of autonomic physiological responses. Skin conductance level 
(SCL), respiration rate (RR), heart rate (HR) and systolic and diastolic blood pressure (SBP 
and DBP) were examined in fifty-seven female subjects randomly assigned to two different 
levels of a novel distraction strategy (highly novel and moderately novel) and a control 
group. The two-distractor groups reported less affective pain than the control group during 
the cold-pressor test, with the subjects receiving the highly-novel stimulus reporting the 
least pain overall. SCL, RR, HR, SBP and DBP changes differentiated the two novel 
distractor groups from the control, with the results indicating that increases in SCL and HR 
are related to pain.
6.2. Novel Distractor Effects on Physiological Responses to Pain
The cold-pressor test affects the sympathetic division of the autonomic nervous system 
(ANS) (Lovallo, 1975). The major ANS responses to the cold-pressor test occur in the 
cardiovascular system, where substantial increases in heart rate (HR), systolic and diastolic 
blood pressure (SBP and DBP) have been well documented (Peckerman, Hurwitz, Saab, 
Llabre, McCabe & Schneiderman, 1994; Saab, Llabre, Hurwitz, Schneiderman,
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Wohlgemuth, Durel, Massie & Nagel, 1993; Sherwood, Girdler, Bragdon, West, Brownley, 
Hinderliter & Light, 1997). However, because the cold-pressor test also influences 
thermoregulatory and somatosensory mechanisms in the ANS (Lovallo, 1975), it is difficult 
to separate the cardiovascular responses produced by cold and those produced by pain. 
Peckerman et al. (1994) concluded that this overlap in cardiovascular responses to the cold 
pressor is seen primarily in arterial blood pressure, with cold (non-painful) stimulation 
elevating blood pressure via vascular constriction, and pain increasing blood pressure via 
vasomotor and cardiac mechanisms. Unlike blood pressure increases to the cold-pressor 
test, Peckerman et al. (1994) concluded that the increments in HR are primarily related to 
pain.
Increases in respiratory rate (RR) (Allen, Sherwood & Obrist, 1986; Steptoe & Vogele, 
1992) have also been shown to occur during cold pressor stimulation, but a study by Allen 
and Crowell (1989) failed to find any overall effect in RR during the cold-pressor test 
compared with baseline measurements. Allen and colleagues (Allen & Crowell, 1990; 
Allen, Shelly & Boquet, 1992) have also shown that when RR is paced during the cold 
pressor, no effect is seen in RR, indicating that RR is under some voluntary control. In 
addition to blood pressure, HR and RR increases, the cold-pressor test also evokes 
increases in skin conductance level (SCL) (Cioffi & Holloway, 1993; Dowling, 1982, 1983; 
Steptoe & Vogele, 1992), with evidence suggesting that SCL increases are related to the 
affective component of pain (Dowling, 1982, 1983).
The majority of studies employing distraction strategies to reduce cold pressor pain have 
used tolerance/threshold and subjective rating scales as dependent variables. A few early 
studies examined autonomic responses during distraction from cold stimulation and 
reported decreases in HR and SCL compared to those who did not receive a distractor task
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(Grimm & Kanfer, 1976; Mefferd & Wieland, 1965; Sadler, Wieland, Mefferd, Benton & 
McDaniel, 1967). A more recent study by Cioffi and Holloway (1993) found higher SCL in 
subjects who were instructed to suppress pain produced from the cold-pressor test 
compared with those given a distraction strategy, but research relating autonomic function 
and distraction is relatively limited.
Distraction strategies successful in modifying the perception of cold pressor pain have 
generally incorporated pleasant affect into their stimulus content (Avia & Kanfer, 1980; 
Beers & Karoly, 1979; Blitz & Dinnerstein, 1971; Fanurik, Zelter, Roberts & Blount, 1993; 
Grimm & Kanfer, 1976; Hertel & Hekmat, 1994; Holmes, Hekmat & Mozingo, 1983; 
Horan & Dellinger, 1974; Kanfer & Goldfoot, 1966; Kanfer & Seidner, 1973; Scott & 
Leonard, 1978; Stone, Demchik-Stone & Horan, 1977). S. Maltzman (Maltzman- 
Greenstein, 1984; Maltzman, 1988; 1992) has criticised studies incorporating pleasant 
affect as distractors from pain on the basis that they have failed to vary the affective quality 
of the stimuli. Because of this, pain attenuation in these studies may be due to stimulus 
characteristics other than pleasant affect. Specifically manipulating the collative 
characteristics of visual stimuli (affect, novelty, complexity and significance), S. Maltzman 
(1992) found that the novel quality of stimuli reduces the perception of pain and concluded 
that the reported success of pleasant affect is due to the confounding effect of novelty in 
those studies. This effect of novelty has been attributed to the Orienting Response (OR) to 
novel stimuli (S. Malztman, 1992). The degree of novelty is the major determining factor in 
the elicitation of an OR (Sokolov, 1963), and when a sufficiently novel stimulus is 
presented to a subject during noxious stimulation, the threshold to pain increases (I. 
Maltzman, 1990; S. Maltzman, 1992; Sokolov, 1963).
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The conceptual importance of novelty in attenuating behavioural responses to pain arises 
from a number of studies which have shown that exposure to novel conditions activates the 
brain (3-endorphin system in rats (Izquierdo & Netto, 1985) and produces analgesia during 
pain (Siegfried, Netto & Izquierdo, 1987). I. Maltzman (1990) has suggested that 13- 
endorphin activation may be a component of the organismic OR, and thus endorphin 
release during an OR to novel stimuli may provide a physiological mechanism explaining 
why distractor stimuli modify the perception of pain and attenuate pain responses.
The present study investigated the effects of two different levels of a novel distractor 
stimulus (highly novel and moderately novel) on behavioural and ANS responses (SCL, 
RR, HR, SBP and DBP) using the cold-pressor test. Modification of pain responses by 
novel distractor stimuli would provide support for the suggestion that ORs inhibit the 
response to pain. The success of novel distractor stimuli would also clarify the significance 
of novelty, rather than pleasant affect, in pain attenuation, thus having significant 
implications for the management of acute pain in clinical populations.
In accordance with previous literature (S. Maltzman, 1992), it was predicted that 
behavioural responses would be reduced with novel distractor stimuli and also that this pain 
attenuation would be extended to ANS responses, with the highly novel distractor stimulus 
having the greatest effect overall. Because increases in SCL and HR during the cold-pressor 
test have been specifically related to pain, it was predicted that the increments in these two 
measures in the present study would be attenuated with novel distractor stimuli. Although 
RR has been associated with pain (Davis, 1992), there is conflicting evidence as to the 
response pattern during cold stimulation, with some evidence suggesting an increase in RR 
(Allen et al., 1986) and other evidence suggesting no overall effect (Allen & Crowell,
85
1989). Because of this, it was predicted that RR would be modified by novel distractor 
stimuli but the direction of this modification was unable to be specified. In regard to blood 
pressure, increments in this system are due to activation of thermoregulatory and 
somatosensory systems in the ANS (Lovallo, 1975; Peckerman et al., 1994) and thus, 
although increases in blood pressure measures were anticipated, it was predicted that 
modification as a function of distraction would not be seen.
6.3. Materials and Methods
6.3.1. Subjects
Participants were sixty female volunteers 18-36 years in age (mean 21.7 years). Mean 
height and weight was 166.7 cm and 61.2 kg respectively. Subjects were predominantly 
first year Psychology students from the University of Wollongong. Subjects were recruited 
via departmental noticeboards and received extra credit for their courses. Only female 
subjects were included in the experiment to avoid opposite-sex experimenter-gender effects 
where males report lower pain ratings to a female experimenter (Levine & De Simone, 
1991) and because women have been found to be more sensitive to pain than men 
(Fillingim & Maixner, 1996). All subjects were screened for cardiovascular, circulation, 
nerve and sensory problems and the presence of pain complaints, psychiatric illness and 
medication with analgesic or vasoactive properties. The protocol was approved by the joint 
Human Research Ethics Committee of the University of Wollongong and the Illawarra 
Area Health Service, and all participants gave written informed consent prior to the study. 
Data from one subject were excluded due to circulation problems, one subject was excluded 
due to off-scale data, and data from one subject were lost due to computer disk error.
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6.3.2. Procedure
Subjects were randomly assigned to one of three conditions. In one condition, a 
distractor scene rated as having high novelty (S. Maltzman, 1992) was presented on a 43 
cm SVGA computer monitor during the cold-pressor test. The high novelty scene consisted 
of a yellow and white striped building situated on an outdoor background of grass, trees and 
blue sky. In a second condition, subjects received a scene rated as having moderate novelty 
(S. Maltzman, 1992). The moderate novelty scene consisted of a metal statue on a dark 
background. The orientation of the original distractor scenes differed, and thus, in the 
moderate novelty condition, the computer monitor was oriented at a 90° angle to ensure 
that the moderately novel stimulus and the highly novel stimulus occupied the same 
proportion of the visual field. Both distractor scenes were also rated in a previous study of 
122 subjects (S. Maltzman, 1992) as having neutral affect, neutral complexity and neutral 
significance. Subjects allocated to a third condition (control) did not receive a distractor 
stimulus during the cold-pressor test and were required to focus their eyes on a blank 
computer monitor. The computer monitor was also present during the baseline stage and 
subjects were required to focus their eyes on a fixation cross on an otherwise blank monitor 
during this period.
Prior to the cold-pressor test, subjects were seated in a sound attenuated, temperature 
controlled (21°C) testing booth approximately 100 cm from the computer monitor for a 
period averaging 15 minutes. During this 15-minute physiological adjustment period, 
subjects completed the State-Trait Anxiety Inventory (STAI) in relation to baseline anxiety 
(Speilberger, Gorsuch, Lushene, Vagg & Jacobs, 1983) and were then required to sit 
quietly at rest. The last 3 minutes of this 15-minute rest period were recorded and used as a
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baseline stage. After this baseline period, subjects completed the cold-pressor test. This 
involved immersing their non-dominant hand up to the level of their mid-forearm in a 350 
mm x 220 mm x 270 mm plastic insulated container containing a mixture of ice and water 
for a maximum period of three minutes. A plastic grid separated the ice and water and 
subjects placed their hand in water that was maintained at 2 ± 1°C throughout the 
experiment.
For ethical reasons, all subjects were aware prior to the commencement of the study that 
the purpose of the research was to evaluate the effects of distraction on physiological 
responses to pain but no information other than this was provided and subjects were told 
that any questions would be answered at the end of the study. Subjects in all three 
conditions were given the same set of instructions: “While your hand is in the water, you 
will be required to focus on the computer screen in front of you. Please focus on the 
computer screen and try to keep your hand in the water for as long as you possibly can, 
however withdraw your hand when you feel you can no longer tolerate the cold water”. 
After the cold-pressor test, subjects completed the McGill Pain Questionnaire (MPQ) 
(Melzack, 1975) and rated their pain on two visual analogue scales (VAS) of intensity and 
affect. The MPQ is primarily used with clinical populations and thus visual analogue scales 
were also included as a pain measure due to their wide application in this research area 
(Melzack & Katz, 1992). Following the cold-pressor test, subjects also completed the state 
anxiety scale of the STAI in relation to their anxiety during the cold-pressor test.
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6.3.3. Apparatus and psychophysiological recordings
SCL, RR, HR, SBP and DBP were recorded continuously over the baseline and cold 
pressor stage via AMLAB signal acquisition modules linked to an IBM-compatible 
computer. SCL in microSiemens (pS) was recorded using silver-silver chloride electrodes 
placed on the ventral surface of the distal phalanges of digits II and III of the dominant 
hand. A 0.05 M sodium chloride solution in an inert viscous ointment base was used as the 
electrolyte and a constant voltage of 0.5 V was applied across the electrode pair. Cardiac 
activity was monitored using the electrocardiogram (EKG). A pair of disposable silver- 
silver chloride electrodes was used in a bipolar configuration with one electrode placed 
over the mid-sternum and one placed over the third rib on the left mid-axillary line. HR in 
beats per minute (BPM) was computed from successive R waves of the QRS complex on a 
beat-to-beat basis. RR in breaths per minute (bpm) was recorded via a respiratory belt 
(Pneumotrace) fitted around the chest. Indirect arterial blood pressure in millimetres of 
mercury (mmHg) was measured using a FINAPRES monitor with a finger blood pressure 
cuff placed over the medial section of digit IV on the dominant hand.
6.3.4. Data reduction and statistics
Equally-spaced 15-second epochs were analysed over the baseline and cold pressor 
stages. Initially, pre-cold pressor baseline levels were examined using repeated measures 
ANOVAs across all 15 second epochs of the baseline stage, but the figures presented in the 
results section indicate that the first 15 second epoch reflects a preparatory response that 
occurred when recording started, and thus this epoch was eliminated from the analysis
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across baseline. To examine response patterns during the cold-pressor test, responses 
relative to the last epoch of the baseline stage were analysed. This immediate pre­
immersion point was chosen because it is clear that the systematic changes occurring over 
the recorded 3-minute baseline stage preclude using the average over this period. Repeated 
measures ANOVAs were used to examine trends over epochs, group effects and group by 
trend interactions. If significant linear trends across epochs, group effects or group by linear 
trend interactions were obtained across the baseline stage, then these baseline effects were 
controlled for in the response analysis by using analysis of covariance. If a linear trend or 
group by trend interaction was obtained across baseline, the last 15 second epoch from the 
baseline stage was subtracted from the second 15 second epoch (as the first epoch was 
omitted from the analysis) from this same baseline period and the difference was used as a 
covariate. If a significant group difference was found across the pre-cold pressor baseline 
stage, the average across the eleven 15 second epochs was used as a covariate. Differences 
between the high novelty (n=19), moderate novelty (n=19) and control (n=19) groups were 
analysed using orthogonal contrasts. The first contrast compared the two distractor groups 
with the control. If a significant difference was found between the two distractor groups 
and the control, a second contrast was used to compare the high novelty and moderate 
novelty groups.
6.4. Results
6.4.1. Behavioural data
Table 6.1 summarises the behavioural data for the high novelty, moderate novelty and 
control groups.
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Table 6.1. Summary of behavioural data
High Novelty Moderate Novelty Control
Trait Anxiety 43.94 37.73 40.26
State Anxiety (baseline) 32.84 32.15 31.52
State Anxiety (cold) 35.21 38.47 37.00
Tolerance Time (sec) 129.01 123.29 116.50
Affective VAS 37.64 56.11 60.63
Sensory VAS 56.16 61.16 63.74
MPQ
Sensory 18.05 18.21 20.26
Affective 3.00 2.63 3.16
Evaluative 3.26 3.15 3.84
Miscellaneous 9.58 8.84 9.42
PPI 3.05 2.84 3.11
There was a difference in state anxiety from baseline to cold pressor, F(l,55) = 15.00, p 
< .01 and Table 6.1 shows that this is represented by an increase in anxiety. However there 
were no differences between the groups, and no group by time interactions. There were no 
significant differences in tolerance time between the groups, but Table 6.1 shows that there 
was a tendency for the two distractor groups to tolerate the cold-pressor test longer than the 
control. Subjects in the two distractor groups rated the affective component of pain (as 
indexed by the affective VAS) lower than subjects in the control condition, F(l,54) = 3.71, 
p = .05, with the high novelty group indicating the least pain overall, F(l,54) = 5.01, p < 
.05. There were no group differences on the sensory VAS or on any of the scales of the 
MPQ.
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6.4.2. Psychophysiological data
Baseline measurements were recorded for three minutes prior to the onset of the cold- 
pressor test. Responses were analysed from the last epoch of baseline to the first two 
epochs in the cold-pressor test, as all subjects tolerated the cold-pressor test for this length 
of time, after which at least one subject from each group withdrew their hand. These data 
are graphically represented here in their raw form showing the epochs across baseline and 
cold-pressor test. In all figures epochs B01 to B12 indicate the twelve 15 second epochs in 
the baseline stage and epochs C01 to C12 represent the twelve epochs in the cold-pressor 
test. The broken lines during the cold-pressor stage represent incomplete data after at least 
one subject withdrew their hand from the cold water and the broken line in the first epoch 
of the baseline stage indicates data where there was a preparatory response (see Method).
6.4.2.1. Skin Conductance Level
SCL for the high novelty, moderate novelty and control conditions is shown in Figure
6.1. It appears that SCL declined over the baseline stage, with an increase during the first 
two epochs in the cold-pressor test, followed by a gradual decline over the remaining 
epochs in the cold pressor.
A repeated measures ANOVA examining experimental epochs over the baseline stage 
showed a linear effect of time, F(l,54) = 70.96, p < .001 and Figure 6.1 shows the decline 
in SCL during this period. The linear trend in SCL during the baseline differed between the 
two distractor groups and the control, F(l,54) = 10.52, p < .01 and Figure 6.1 shows that 
SCL in the control group decreased more rapidly than in the distractor groups.
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Figure 6.1. Mean SCL during baseline (epochs B01-B12) and cold pressor stages (epochs CO 1-Cl2) for the 
high novelty, moderate novelty and control groups. Dashed lines indicate some loss of data (see text).
To control for baseline effects, the difference across baseline was used as a covariate in 
the response analysis. A repeated measures ANCOVA from the end of baseline to the first 
two points in cold, using the difference across the baseline as a covariate, revealed linear, 
F(l,54) = 73.59, p < .001 and quadratic, F(l,54) = 74.70, p < .001 response components; 
this is shown by an increase in SCL in Figure 6.1. The SCL response to the cold pressor 
differed between the distractor groups and the control, with the difference in the linear 
trend approaching significance, F(l,54) = 3.11, p = .08, and the quadratic trend differing 
significantly, F(l,54) = 10.05, p < .05. Figure 6.1 shows that the increase in SCL was 
smaller in the distractor groups. The quadratic increase in SCL also differed between the 
two distractor groups, F(l,54) = 4.17, p < .05, due to the response being smaller in the high 
novelty group than in the moderate novelty group.
Overall, SCL decreased over the baseline stage and increased during the cold-pressor 
test. The increase in SCL was smaller in the two distractor groups than the control, with the
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high novelty group showing the smallest response overall. It appeared that SCL declined 
slightly over the remaining epochs in the cold-pressor test, but this was not analysed due to 
missing data, where subjects withdrew their hand from the cold-pressor test after the second 
epoch.
6.4.2.2. Respiration Rate
Mean RR is shown for each 15-second epoch in Figure 6.2 for the high novelty, 
moderate novelty and control groups. It appears from Figure 6.2 that RR increased during 
the baseline stage, with the control group showing a decrease in RR during the cold-pressor 
test and the two distractor groups showing less of a decrease or an increase.
A repeated measures ANOVA over the experimental epochs of the baseline stage 
showed a linear effect of time, F(l,54) = 6.34, p < .05, and Figure 6.2 shows this as an 
increase in RR during this period.
Figure 6.2. Mean RR during the experimental stages (baseline, cold pressor) for the three groups.
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Controlling for the linear increase in RR during the baseline stage, a repeated measures 
ANCOVA showed no overall mean time effects from the last epoch of the baseline period 
to the first two epochs in cold. The linear RR response component differed between the two 
distractor groups and the control, F(l,54) = 5.03, p < .05, with RR decreasing less in the 
distractor groups than in the control. There was a difference between the high novelty and 
moderate novelty groups in the quadratic response component that approached significance 
F(l,54) = 3.10, p = .08, and Figure 6.2 shows that there was an immediate increase in RR 
in the high novelty group and a delayed increase in the moderate novelty group.
Overall, there was a gradual increase in RR during the baseline stage, with no main 
effect on RR during the cold-pressor test. This was because the RR response differed 
between the two distractor groups and the control, with the distractor groups showing less 
respiratory slowing (or even increasing slightly) than the control. The response also 
differed between the moderate novelty and high novelty groups, with RR increasing more 
rapidly in the high novelty group.
6.4.2.3. Heart Rate
Figure 6.3 shows the mean HR activity during the baseline and cold pressor stages for 
the high novelty, moderate novelty and control groups. It appears that HR was higher 
during the baseline stage for the two distractor groups, with HR increasing during the first 
two epochs of the cold-pressor stage and remaining higher during the remaining epochs of 
the cold-pressor test than during the baseline.
A repeated measures ANOVA over the baseline stage showed that the HR level in the 
two distractor groups was significantly higher than the control, F(l,54) = 6.96, p < .05.
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Using the average across baseline as a covariate to control for this pre-stressor 
difference in HR level, a repeated measures ANCOVA showed linear, F(l,54) = 22.21, p < 
.001, and quadratic, F(l,54) = 41.90, p < .001, trends in HR from the end of baseline over 
the first two epochs in cold. Figure 6.3 shows that this reflected an increase during the cold- 
pressor test. The quadratic trend in HR differed between the two distractor groups and the 
control, F(l,54) = 8.45, p < .01 and Figure 6.3 shows that the increase in HR was less in the 
two distractor groups. There was no difference in the HR response between the high 
novelty and moderate novelty groups.
Overall, the two groups receiving the novel distractors had a higher HR level during the 
baseline stage. Controlling for this, there was an increase in HR across groups during the 
cold pressor, with the increase smaller in the two-distractor groups than controls.
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6.4.2A. Systolic Blood Pressure
Figure 6.4 shows the mean SBP activity during the baseline and cold-pressor stages. It 
appears that SBP increased during the initial epochs in the cold-pressor test, with this 
increase continuing over the remaining epochs of the cold-pressor stage.
Figure 6.4. Mean SBP during the experimental stages for the high novelty, moderate novelty and control 
groups.
Analysis showed that there were no significant effects of time over the epochs at 
baseline, and SBP did not differ between the groups. A repeated measures ANOVA from 
the last epoch of the baseline to the first epochs in the cold-pressor test showed no main 
effect of time for SBP. However, the quadratic response component differed between the 
two distractor groups and the control, F(l,54) = 4.41, p < .05, and Figure 6.4 shows that 
SBP initially increased more rapidly with distraction.
Overall, there were no effects in SBP over the baseline and no main effect of SBP 
during the cold-pressor test. There was a difference in the SBP response component
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between the two distractor groups and the control, with the increase in SBP initially more
rapid in the distractor groups than the control.
6.4.2.5. Diastolic Blood Pressure
Mean DBP for the three groups over the baseline and cold pressor stages is shown in 
Figure 6.5. It appears that DBP increased during the first two epochs in the cold-pressor 
test, with this increase continuing over the remaining epochs of the cold-pressor stage.
A repeated measures ANOVA examining experimental epochs over the baseline showed 
no group or time effects. The response analysis revealed a linear effect of time, F(l,54) =
25.09, p < .001, apparent as an increase in DBP. The quadratic response component 
differed between the two distractor groups and the control, F(l,54) = 5.37, p < .05, and 
Figure 6.5 shows that DBP initially increased more rapidly with distraction.
Figure 6.5. Mean DBP during the baseline and cold pressor stages for the three groups.
Overall, DBP did not differ across baseline and showed a significant increase in the
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cold-pressor test across all groups. The increase in DBP was initially more rapid for the
distractor groups than the control.
6.4.2.6. Summary of Results
Overall, the results showed changes in ANS activity during the baseline stage and 
during the cold-pressor test. SCL showed a decline during experimental epochs of the 
baseline stage consistent with a decrease in physiological arousal. SCL increased during the 
cold-pressor test, with the two distractor groups showing a smaller increase than the 
control, and the high novelty group showing the smallest response overall. This suggests 
that increased SCL serves as a pain response, which is attenuated with novel distractors. 
There was an increase in RR over the baseline stage but there was no overall main effect in 
RR during the cold-pressor test. The RR response differed between the distractor groups 
and the control, with the control group showing a slowing of respiratory activity and the 
distractors showing less of a decrease (or an increase). There was also a difference in the 
RR response between the high novelty and moderate novelty groups, with RR decreasing in 
the moderate novelty group and increasing in the control group. This pattern of RR 
indicates that respiratory slowing may be an indication of pain, with an increase in RR 
attributed to the novel quality of the distractor stimuli. HR activity was higher for the two 
distractor groups during the baseline stage, and after controlling for this, there was a 
significant increase in HR in the cold pressor, across all groups. The increase in HR was 
less in the two distractor groups than the control, which indicates that the increase in HR as 
a pain response is reduced with novel distractors. SBP and DBP did not differ over time or 
between groups during the baseline stage. DBP, but not SBP, increased during the cold-
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pressor test. The response pattern of SBP and DBP differed between the two distractor 
groups and the control, with the distractor groups showing a greater initial increase in cold 
than the control. A summary of these results is presented in Appendix A.
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6.5 Discussion
The behavioural results show that the distractor groups tended to tolerate the cold- 
pressor test longer than the control. Additionally, subjects presented with a novel distractor 
stimulus during the cold-pressor test rated the motivational-affective component of pain 
lower than the control, with subjects who received the highly-novel distractor indicating the 
least pain overall. These results are consistent with S. Maltzman (1992) and confirm that 
the perception of pain is modified by novel distractor stimuli. The sensory component of 
pain was not significantly reduced under the conditions of distraction, suggesting that the 
affective component of pain is more sensitive to modification by novel distractor stimuli. 
This is supported by the electrodermal data where the two distractor groups showed a 
smaller increase in SCL than the control, with the high novelty group showing the smallest 
skin conductance response overall. Because SCL is related to the affective component of 
pain (Dowling, 1982, 1983), these results suggest that this component of pain is attenuated 
by novel distractor stimuli, with the highly-novel distractor stimuli having the greatest 
overall effect in pain reduction.
There was no overall cold-pressor effect on RR in the present study, corresponding with 
previous studies that reported no difference in RR between baseline and cold pressor stages 
(Allen & Crowell, 1989, 1990; Allen et al., 1992). Although the respiratory data appeared 
to be relatively noisy (which may be attributed to respiration being under a degree of 
voluntary control), the pattern of RR differed between the groups. RR decreased in the 
control group, decreased to a lesser extent in the moderate-novelty group, and increased in 
the high-novelty group. The respiratory slowing in the control group may be an indication 
of pain, however the lesser decrease in the moderate novelty group and increase in the high
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novelty group also suggests that the RR increase may be a response to the novel aspect of 
the distractor stimuli.
HR increased significantly during the cold-pressor test, and this increase was less in the 
distractor groups than the control, indicating a greater pain response for subjects in the 
control condition. The greater HR increase in the control group is consistent with the 
conclusions of Peckerman et al. (1994) that increments in HR to cold-pressor stimulation 
reflect pain rather than thermoregulation. The difference in the pain between the high- 
novelty and moderate-novelty groups was not apparent in this measure. The fact that 
baseline HR was higher for the two distractor groups, like all the group effects across 
baseline, is attributed to random sampling error. Because each group received the same 
information prior to the experiment, all between-group baseline effects are seen as random 
and thus their effects on response measures were corrected by using analysis of covariance.
Although blood pressure increase is widely viewed as a reliable correlate of pain 
(Fillingim & Maixner, 1996), the increases in SBP and DBP that occur during the cold- 
pressor test, as opposed to other forms of experimentally induced pain, result from the 
additive effects of pain and thermoregulation (Lovallo, 1975; Peckerman et al., 1994). The 
fact that arterial blood pressure initially increased more rapidly in the two distractor groups 
during the first epoch in cold is consistent with this dual-innervation view. It seems that the 
greater initial increase in the two distractor groups reflects something other than pain and 
may be attributed to activation in the thermoregulatory rather than the somatosensory 
system. Because at least one subject withdrew their hand from the cold pressor after 30 
seconds and thus only this time period in cold was analysed, the current data do not allow 
speculation on longer-term thermoregulatory mechanisms.
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Overall, the results indicate that increases in SCL and increases in HR are related to 
pain and are attenuated by novel distractor stimuli. Increases in RR appear to be a response 
to the novel characteristic of the distractors. Although blood pressure is in part related to 
pain, the separate contributions of the thermoregulatory and somatosensory systems are 
difficult to determine and thus, blood pressure cannot be viewed in the same light as the 
other physiological indices in this study.
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CHAPTER 7
QUANTITATIVE-EEG RESPONSES TO PAIN UNDER NOVEL
DISTRACTOR CONDITIONS
CHAPTER 7: QUANTITATIVE-EEG RESPONSES TO PAIN UNDER NOVEL
DISTRACTOR CONDITIONS
7.1. Overview
The present study extended the findings of Study 1 to examine Central Nervous System 
(CNS) responses (EEG power changes) as well as Autonomic Nervous System (ANS) 
responses to pain under conditions of novel distraction. Study 1 found modification of ANS 
responses to pain when subjects were presented with novel distractors (highly-novel and 
moderately-novel) during the cold-pressor test. Study 1 showed that increases in skin 
conductance level and increases in heart rate are related to the motivational-affective 
component of pain and were reduced under conditions of distraction. The following study 
examined Quantitative EEG responses as well as ANS responses to the cold-pressor test 
under conditions of novel distraction. The ANS results were similar to those reported in 
Study 1, with increases in skin conductance level, a slowing of respiratory activity and 
increases in HR to the cold-pressor test reduced with novel distraction. The EEG results 
showed that decreases in alpha-2 and beta-1 are related to the affective component of pain 
during the cold-pressor test, with decreases in beta-2 activity also reduced with novel 
distraction.
7.2 Quantitative-EEG Responses to Pain Under Novel Distractor Conditions
The cold-pressor test produces reliable changes in the sympathetic division of the 
autonomic nervous system (ANS). As reported in Chapter 2, the major changes in the ANS 
during the cold-pressor test occur in the cardiovascular system (Peckerman et al., 1994; 
Saab et al., 1993), with increases in blood pressure related to both cold and pain, and HR 
increments primarily related to pain. Previous studies have also reported increases in skin
104
conductance level (SCL) and respiration rate (RR) during the cold-pressor test. Study 1 
found an increase in SCL across all groups during the cold-pressor test, with subjects in the 
two distractor groups showing less of an increase than subjects in the control group. There 
was no overall effect in RR during the cold-pressor test in Study 1, but the pattern of RR 
differed between the groups (RR decreased in the control group, decreased to a lesser 
extent in the moderate-novelty group, and increased in the high-novelty group). Because 
the pain ratings in Study 1 showed that the affective component of pain was reduced with 
novel distraction, the ANS results of Study 1 thus suggest that increases in SCL, and 
increases in HR, are related to the affective component of pain and are reduced under 
conditions of novel distraction.
Quantitative electroencephalogram (Q-EEG) analysis has been used over the past 
decade to investigate EEG power changes in various frequency bands during the cold- 
pressor test. As reported in Chapter 2, studies have found increases in delta activity that 
have been interpreted to reflect the aversive nature of pain processing (Chen et al., 1989b) 
and increases in theta activity. Studies have generally reported alpha desynchronisation 
during the cold-pressor test, with Ferracuti et al. (1991) interpreting the decrease in alpha-2 
to be dependent on painful stimulation and the decrease in alpha-1 as an arrest response to 
the stimulus. In addition to changes in delta, theta and alpha CPS densities, heightened beta 
activity has been reported during cold-pressor stimulation, with the increase in beta 
interpreted as reflecting heightened vigilance or scanning processes involved in pain and 
discomfort (Chen et al., 1989b). The increase in beta activity is consistent with the 
traditional view of beta activity in that it reflects an increase in arousal, however Lim et al. 
(1995) reported increases in beta and alpha activity concomitant with decreases in skin 
conductance level (SCL) suggesting decreasing arousal. Backonja et al. (1991) and
105
Veerasarn and Stohler (1992) have also suggested that EMG activity contaminates high 
frequency beta bands from clenching of the facial and jaw muscles; therefore increased 
activity in these higher bands may be due to muscle artifact in the EEG spectrum (produced 
by pain), rather than reflecting a genuine increase in beta.
When examining the effects of distraction during cold-pressor pain, studies have 
primarily used behavioural indices of pain perception rather than physiological responses 
and have incorporated pleasant affect into their distraction strategies. S. Maltzman 
(Maltzman-Greenstein, 1984; S. Maltzman, 1988, 1992) concluded that novelty rather than 
pleasant affect attenuates pain and attributed this effect of novelty to the OR - a sufficiently 
novel stimulus elicits an OR and increases the threshold to pain. Because exposure to 
novelty also induces analgesia in rats (Siegfried, Netto & Izquierdo, 1987), it has been 
suggested that novelty activates the brain P-endorphin system and reduces the effect of a 
painful stimulus (I. Maltzman, 1990; Siegfried et al., 1987).
The present study investigated the effects of two novel distractor stimuli on behavioural, 
ANS and Q-EEG responses to pain during the cold-pressor test. Attenuation of 
physiological pain responses by novel distractor stimuli would provide further support for 
the link between ORs and analgesia during painful stimulation. Modification of power 
changes in Q-EEG frequency bands that have been associated with pain (i.e. delta and 
alpha-2) would also provide objective evidence of cerebral involvement during distraction 
from painful stimulation.
In light of previous research by S. Maltzman and from the results of Study 1, it was 
predicted that behavioural responses would be reduced with novel distractor stimuli, and 
also that this pain attenuation would be reflected in ANS and Q-EEG responses, with the
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more-novel distractor stimulus having the greatest effect overall. Given the results of Study 
1, it was predicted that SCL, HR, SBP and DBP would increase during the cold-pressor 
test, with SCL and HR increasing less in the novel distractor groups, with the highly-novel 
stimulus having the greatest effect overall. As Study 1 showed that RR was related to 
novelty, it was also predicted that the pattern of RR would differ between the two distractor 
groups and the control, with RR decreasing in the control group and to a lesser extent (or 
even increasing) in the moderate-novelty and high-novelty groups.
Because increases in delta activity have been specifically related to the aversive nature 
of pain (Chen et al., 1989b), it was predicted that the augmentation of delta activity would 
be reduced with the two novel distractor stimuli. Additionally, because a number of studies 
have reported alpha desynchronisation during the cold-pressor test (Chen et al., 1989b; 
Ferracuti et al., 1994: Gotliebsen & Arendt-Neilson, 1990), with Ferracuti et al. (1994) 
associating a reduction in alpha-2 (10-12 Hz) with painful stimulation, it was predicted that 
power in both the upper (alpha-2) and lower (alpha-1) alpha bands would decrease during 
the cold-pressor test, with the reduction in alpha-2 power attenuated under novel 
distraction. Although beta activity has been shown to increase during the cold-pressor test 
(Backonja et al., 1991; Chen et al., 1989b), with this increase interpreted as reflecting 
heightened vigilance (Chen et al., 1989b), muscle artifact is thought to contribute to this 
increase, particularly in the high frequency bands. Given the findings of Lim et al. (1995), 
it was predicted that beta-1 and beta-2 would decrease during the cold-pressor test, 
reflecting higher arousal and pain, and that this decrease would be less for the two 
distractor groups than the control. It was also expected that any increases in the high beta 
band (beta-3) might be contaminated with EMG activity, with the relative contributions of 
pain and muscle activity in this upper beta band being difficult to separate.
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7.3. Materials and Methods
7.3.1. Subjects
Thirty-eight additional female volunteers from undergraduate Psychology courses at the 
University of Wollongong participated in the experiment for extra course credit. The 
average age was 22.9 years and mean height and weight was 162.2 cm and 64.2 kg 
respectively. The inclusion of females only in the subject sample was to avoid gender 
effects in pain (Fillingim & Maixner, 1996) and to prevent opposite-sex experimenter- 
gender effects where males report lower pain ratings to a female experimenter (Levine & 
De Simone, 1991). All subjects were free from chronic and acute pain complaints, 
cardiovascular, nerve and sensory problems, and psychiatric illness, and were not presently 
taking any medication with analgesic or vasoactive properties. Permission for the protocol 
was granted by the joint Human Research Ethics Committee of the University of 
Wollongong and the Illawarra Area Health Service, and written informed consent was 
obtained from all subjects prior to the commencement of the study. Data from two subjects 
were excluded due to insufficient FFT data (less than five 2-second FFTs in each epoch).
7.3.2. Procedure
The experiment followed a similar procedure to that outlined in Study 1 and consisted of 
three different groups (high novelty, moderate novelty and a control) to which subjects 
were randomly assigned. Subjects in the high novelty group received a highly-novel 
distractor scene during the cold-pressor test, subjects in the moderate novelty group 
received a moderately novel distractor scene and subjects in the control group were 
required to focus their eyes on a blank computer monitor. Both distractor scenes (from S.
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Maltzman, 1992) were the same as those used in Study 1, where they are described in more 
detail. Subjects were seated in the same testing booth described previously for a 
physiological adjustment period averaging 15 minutes. During this physiological 
adjustment period, subjects completed an Electro-oculogram (EOG) calibration task and the 
STAI (Speilberger, Gorsuch, Lushene, Vagg & Jacobs, 1983). The last three minutes of this 
physiological adjustment period were recorded and used as a baseline stage, after which 
subjects completed the cold-pressor test (described in Study 1) for a maximum period of 
three minutes. For ethical reasons, all subjects were aware that the purpose of the research 
was to evaluate the effects of distraction on physiological responses to pain but no other 
information was provided. Subjects in all three groups were given the same set of 
instructions outlined in Study 1, with subjects in the two distractor groups aware that they 
might be presented a picture during the cold-pressor test. After the cold-pressor test, 
subjects completed the MPQ (Melzack, 1975), rated the affective and sensory components 
of pain on two visual analogue scales (VAS) and completed the state anxiety scale of the 
STAI. This was to assess state anxiety during the cold-pressor test. Subjects also 
completed a post-testing questionnaire to determine menstrual cycle phase.
7.3.3. Apparatus andpsychophysiological recordings
Skin conductance level (SCL), respiration rate (RR), heart rate (HR), systolic blood 
pressure (SBP) and diastolic blood pressure (DBP), electroencephalogram (EEG) and 
electro-oculogram (EOG) were recorded continuously over the baseline and cold pressor 
stages via AMLAB signal acquisition modules linked to a PC-based computer system. SCL 
in microSiemens (pS) was recorded using silver-silver chloride electrodes placed on the
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ventral surface of the distal phalanges of digits II and III of the dominant hand. 0.05 M 
sodium chloride in an inert viscous ointment base was used as the electrolyte, and a 
constant voltage of 0.5 V was applied across the electrode pair. HR was monitored using 
the electrocardiogram (EKG). A pair of disposable silver-silver chloride electrodes was 
used in a bipolar configuration with one electrode placed over the mid-sternum and one 
placed over the third rib on the left mid-axillary line. HR in beats per minute (BPM) was 
computed from successive R waves of the QRS complex on a beat-to-beat basis. RR in 
breaths per minute (bpm) was recorded via a respiratory belt (Pneumotrace) fitted around 
the chest. Indirect arterial blood pressure in millimetres of mercury (mmHg) was measured 
using a FINAPRES monitor with a finger blood pressure cuff placed over the medial 
section of digit IV on the dominant hand.
EEG was recorded from the midline sites (Fz, Cz, Pz) using an electrode cap in the 10­
20 international system (Jasper, 1958) referenced to linked ear electrodes. Vertical EOG 
was monitored by a pair of electrodes placed above and below the left eye, and horizontal 
EOG by electrodes on the outer canthus of each eye. The signals were digitised at a rate of 
256 Hz with a time constant of 5 seconds and a low pass filter with a 3 dB comer at 35 Hz, 
and stored to hard disk for later off-line analysis.
7.3.4. Data transformation
The raw EEG was corrected for EOG contamination using a local version of the Gratton 
correction procedure (Gratton, Coles & Donchin, 1983), with beta coefficients derived from 
the EOG calibration task (which generated large eye movements and blinks). Fast Fourier 
Transforms (FFTs) were performed on 2-second epochs to examine cortical power spectra
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2 . __
(HV )• After EOG correction, FFT epochs containing any EEG signal that was off scale 
(greater than 500 pV) were discarded. Seven equally-spaced 2-second FFTs were used 
within 15 second epochs about the immersion time, with the data classified into eight 
frequency bands, delta-1 (0.5-1.5 Hz), delta-2 (2-4 Hz), theta (4.5-8 Hz), alpha-1 (8.5-10 
Hz), alpha-2 (10.5-12 Hz), beta-1 (12.5-18.5 Hz), beta-2 (19-24.5 Hz) and beta-3 (25-30.5 
Hz). These data were converted to relative power measures (%). Data were averaged over 
15 second epochs with epochs containing 5 or less FFTs being excluded from the analysis, 
as these were taken as being incomplete epochs.
7.3.5. Data reduction and statistics
All behavioural data were analysed using analysis of variance (ANOVA). Differences 
between the high novelty (n=13), moderate novelty (n=l 1) and control (n=12) groups were 
analysed using orthogonal contrasts. The first contrast compared the two novel distractor 
groups with the control. If a significant difference was obtained between the two distractor 
groups and the control, a second contrast compared the high novelty group with the 
moderate novelty group.
For the physiological data, means from equally-spaced 15-second epochs were analysed 
over the 3-minute baseline and cold pressor stages. Inspection of the baseline data indicated 
that the first 15-second epoch showed preparatory activity that occurred when recording 
started, and thus this epoch was eliminated from the analysis. Repeated-measures ANOYAs 
over the remaining eleven 15-second epochs of the baseline stage were used to examine 
effects across the baseline. Response patterns during the cold-pressor test were analysed 
relative to the last epoch of the baseline stage. Because at least one subject from each group
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withdrew their hand from the cold-pressor test after 30 seconds, responses were examined 
from the last epoch of baseline to only the first two epochs in the cold-pressor test to 
maintain a complete data set. In the results section, Figures showing dashed lines represent 
data that were excluded from the analysis. This includes the first epoch of the baseline and 
all epochs after the first two 15-second epochs in the cold-pressor test.
For ANS measures (SCL, RR, HR, SBP and DBP), repeated measures ANOVAs were 
used to examine the linear trend over epochs, group effects and group by trend interactions 
across the baseline stage. Significant effects across baseline were controlled in the response 
analysis by using analysis of covariance. If a linear trend or group by trend interaction was 
obtained across baseline, the last 15-second epoch from the baseline stage was subtracted 
from the second 15-second epoch (as the first epoch was omitted from the analysis) from 
this same baseline period and the difference was used as a covariate. If a significant group 
difference was found across the pre-cold-pressor baseline stage, the average across the 
eleven 15-second epochs was used as a covariate. Again, planned orthogonal contrasts were 
used to analyse group differences. The first contrast compared the two novel distractor 
groups with the control and the second contrast compared the high novelty group with the 
moderate novelty group.
For Q-EEG measures (delta-1, delta-2, theta, alpha-1, alpha-2, beta-1, beta-2 and beta- 
3), repeated measures ANOVAs across baseline epochs were used to examine linear trends 
over epochs, site effects, group effects and any interaction between these. Within site, 
planned contrasts compared Fz with Pz, and their mean was compared with Cz to locate the 
topographic maximum in each band. With the EEG data, the range of effects possible 
within the baseline period precluded using analysis of covariance to adjust for them in the 
response period. Therefore, within subject and site, the baseline data were regressed against
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time points and used to predict scores at the immediate pre-immersion point and the two 
points in the cold-pressor test. Deviations from these regression lines were taken as the data 
corrected for baseline effects. Response patterns to the cold-pressor test were then analysed 
relative to the last epoch of the baseline stage using repeated measures ANOVAs. The 
immediate pre-immersion point was chosen because the systematic changes occurring over 
the recorded 3-minute baseline stage precluded using the average over this period. Again, 
planned orthogonal contrasts were used to analyse differences between the high novelty 
(n=13), moderate novelty (n= 11) and control (n=12) groups. The first contrast compared 
the two distractor groups with the control. If a significant difference was found between the 
two distractor groups and the control, a second contrast was used to compare the high 
novelty and moderate novelty groups.
Correlation coefficients between the physiological response profiles were used to 
determine the strength of relationships between variables. For ANS responses, mean 
responses for each of the three groups from the last epoch of the baseline to the first epoch 
in the cold-pressor test were calculated relative to the last epoch of the baseline stage. For 
Q-EEG responses, mean responses for the three groups were also formed relative to the 
baseline, and averaged across the midline sites. For each response measure, this generated a 
response profile of 9 points over time (3) and groups (3). Cluster analysis was performed on 
the correlation matrix.
All main analyses were repeated with the addition of menstrual-cycle phase as a 
covariate. Subjects were classified as being in either the follicular phase (day 7-13) or the 
luteal phase (day 17-28) and subjects reporting anovulatory cycles or who were not in 
either the follicular or luteal phases of the cycle were classified into a third group. Seven 
subjects reported being in the follicular phase of the menstrual-cycle and nine subjects
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reported being in the luteal phase. The remaining twenty subjects reported anovulatory 
cycles or were either in the ovulatory or the menstrual stage of the cycle. The average cycle 
length was 28 days.
7.4. Results
7.4.1. Behavioural data
Table 7.1 summarises the behavioural data for the high novelty, moderate novelty and 
control groups.
Table 7.1. Summary of behavioural data
High Novelty Moderate Novelty Control
Trait Anxiety 37.92 33.90 45.75
State Anxiety (baseline) 30.46 36.82 33.66
State Anxiety (post cold) 33.23 38.45 38.58
Tolerance Time (sec) 111.83 154.83 119.67
Affective VAS 31.39 49.18 62.17
Sensory VAS 61.84 52.00 60.67
MPQ
Sensory 18.38 19.54 17.08
Affective 2.15 2.82 2.33
Evaluative 3.00 3.09 3.67
Miscellaneous 9.30 8.63 8.67
PPI 2.62 2.63 2.92
The control group reported higher levels of trait anxiety than subjects in the two 
distractor groups, F(l,33) = 7.10, p < .05, but trait anxiety did not correlate with any of the
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behavioural or physiological responses to pain. There was a difference in reported state 
anxiety from baseline levels to cold-pressor levels, F(l,33) = 7.46, p < .05 and Table 7.1 
shows that this is represented by an increase in anxiety, however there were no differences 
between the groups. There were no differences in tolerance time between the groups, but 
subjects in the two distractor groups rated the affective component of pain on the VAS 
lower than the control group, F(l,33) = 4.18, p < .05, with a non-significant tendency for 
the high-novelty group to rate their pain as being least overall, F(l,33) = 1.84, n.s. There 
were no group differences on the sensory VAS or on any of the scales of the MPQ.
7.4.2. Psychophysiological data
ANS and Q-EEG levels were examined over the baseline period, and as the response to 
the immersion (from the last epoch of the baseline to the first two epochs in the cold- 
pressor test). ANS responses were analysed using repeated measures ANOVAs or 
ANCOVAs depending on the effects across the baseline. Q-EEG responses were analysed 
using repeated measures ANOVAs after controlling for baseline effects by a regression 
procedure detailed in the Methods section. Differences between the groups were analysed 
using orthogonal contrasts.
7.4.2.1. Autonomic Nervous System Responses
7.4.2.1.1. Skin Conductance Level
SCL is shown as a function of time for the high novelty, moderate novelty and control 
groups in Figure 7.1.
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Figure 7.1. Mean SCL during the baseline (B01-B12) and the cold pressor (C01-C12) stages for all groups. 
Dashed lines indicate loss of data or exclusion due to a preparatory response (see Method).
It appears that SCL declines over the baseline, with an increase during the first two 
epochs of the cold-pressor test, followed by a decline toward baseline levels over the 
remaining epochs of the cold-pressor test. A repeated measures ANOVA examining epochs 
over the baseline stage showed a linear effect of time, F(l,33) = 31.00, p < .001, and Figure 
7.1 shows the decrease in SCL during this period. Despite the apparent difference in levels 
shown in Figure 7.1, there were no significant group differences across baseline.
To control for the baseline effects, the difference across baseline was used as a covariate 
in the response analysis. A repeated measures ANCOVA from the last epoch of the 
baseline to the first two epochs in the cold pressor revealed linear, F(l,33) = 44.06, p < 
.001, and quadratic, F(l,33) = 52.11, p < .001, response components; this is shown by an 
increase in SCL in Figure 7.1. The quadratic trend differed between the two distractor 
groups and the control, F(l,33) = 4.70, p < .05, and Figure 7.1 shows that the electrodermal 
response was smaller in the two distractor groups. Figure 7.1 also shows that the SCL 
response in the high novelty group was the least overall, but this was not significant.
116
Overall, SCL decreased during the baseline stage and increased during the cold-pressor 
test. The increase in SCL was smaller in the two distractor groups than the control, with a 
tendency for the high-novelty group to show the smallest response overall (this was not 
significant). It appeared that SCL showed a gradual decline over the remaining epochs of 
the baseline, but this was not analysed due to missing data, where subjects withdrew their 
hand from the cold-pressor test after the second epoch.
7.4.2.1.2. Respiration Rate
Mean RR across the baseline and cold-pressor stages for the high-novelty, moderate- 
novelty and control groups, is shown in Figure 7.2. From Figure 7.2, it appears that RR 
increased during the baseline, with RR decreasing in the cold-pressor test for the control 
group, and decreasing less (or even increasing) in the distractor groups.
Figure 7.2. Mean RR during the experimental stages for the high novelty, moderate novelty and control 
groups.
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A repeated-measures ANOVA over the baseline stage showed a significant linear effect 
of time, F(l,33) = 10.72, p < .01, apparent as an increasing RR during this period. 
Controlling for the increase in RR during the baseline period using analysis of covariance, 
there were no overall mean time effects from the last epoch of the baseline to the first two 
epochs in the cold-pressor test. There was a difference in the linear response component 
between the two distractor groups and the control, F(l,32) = 4.62, p < .05, with Figure 7.2 
showing that RR decreased less (or even increased slightly) in the two distractor groups 
compared with the slowing apparent in the control group. There were no differences 
between the responses of the moderate-novelty and high-novelty groups.
Overall, there was an increase in RR during the baseline stage, but no main effect of 
time during the cold-pressor test. The response differed between the two distractor groups 
and the control, with RR decreasing less in the distractor groups (or even increasing 
slightly), compared with the control group, where there was respiratory slowing.
7.4.2.1.3. Heart Rate
Figure 7.3 shows the mean HR activity over experimental epochs for the high-novelty, 
moderate-novelty and control groups. It appears that HR was higher for the two distractor 
groups during the baseline stage, with HR increasing during the first two epochs in the 
cold-pressor test and remaining higher during the cold-pressor test than during the baseline 
stage.
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Figure 7.3. Mean HR during baseline and cold pressor stages for the three groups.
Analysis across baseline showed a significant difference in the mean heart rate level 
between the two distractor groups and the control, F(l,33) = 5.72, p < .05, and Figure 7.3 
shows that HR was greater in the two distractor groups. Using the average heart rate level 
across baseline as a covariate, the response analysis revealed linear, F(l,32) = 21.96, p < 
.01, and quadratic, F(l,32) = 21.81, p < .01, response components. Figure 7.3 shows that 
this reflected an increase in HR during the cold-pressor test. It appears that this HR 
response was smaller in the two distractor groups than in the control, but there were no 
significant group effects or group by time interactions.
Overall, HR was greater in the two distractor groups during the baseline stage. 
Controlling for this, there was a significant increase in HR during the cold-pressor test that 
appeared smaller in the distractor groups than the control.
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7.4.2.1.4. Systolic Blood Pressure
Mean SBP for the three groups over the baseline and cold pressor stages is shown in 
Figure 7.4. It appears that SBP increased during the first two epochs in the cold-pressor 
test, with this increase continuing over the remaining epochs of the cold pressor stage.
Figure 7.4. Mean SBP during experimental stages for high novelty, moderate novelty and control groups.
Analysis showed that there were no significant effects of time over the epochs at 
baseline, and SBP did not differ between the groups during the baseline period. A repeated 
measures ANOVA from the last epoch of the baseline to the first two epochs in the cold- 
pressor test revealed a linear effect of time, F(l,33) = 15.72, p < .001, apparent as an 
increase in SBP. The quadratic response component differed between the two distractor 
groups and the control, F(l,33) = 6.51, p < .05, and Figure 7.4 shows that the increase in 
SBP with cold was initially more rapid for the distractors than the control.
Overall, there were no effects of SBP during the baseline stage. SBP increased 
significantly during the cold-pressor test, with the increase in SBP initially more rapid in 
the distractor groups than the control.
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7.4.2.1.5. Diastolic Blood Pressure
Figure 7.5 shows mean DBP during experimental stages for the three groups. It appears 
that DBP increased during the initial epochs of the cold-pressor test, with this increase 
continuing over the remaining epochs in cold.
A repeated measures ANOVA across the baseline stage showed no group or time 
effects. The response analysis revealed a linear effect of time, F(l,33) = 16.35, p < .001, 
apparent as an increase in DBP. The quadratic response component differed between the 
two distractor groups and the control, F(l,33) = 8.46, p < .01, and Figure 7.5 shows that 
DBP initially increased more rapidly in the distractor groups than the control.
Figure 7.5. Mean DBP during experimental stages for high novelty, moderate novelty and control groups.
Overall, there were no effects of DBP during the baseline stage. DBP increased 
significantly during the cold-pressor test, with DBP increasing more rapidly in the 
distractor groups than the control.
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In summary, the results revealed changes in ANS activity before and during the cold- 
pressor test, with responses differing between groups. SCL showed a decline over the 
baseline consistent with a decrease in physiological arousal, and increased significantly 
during the cold-pressor test. The SCL response differed between the two distractor groups 
and the control, with the distractor groups showing less of an increase in SCL than the 
control. There was an increase in RR during the baseline across all groups, but no main 
effect during the response period. The response analysis did show however that RR 
decreased less in the two distractor groups (or even increased) compared with the control. 
HR differed between the groups during the baseline, with the distractor groups showing 
greater HR levels than the control. There was a significant increase in HR across all groups 
during the cold-pressor test, but after controlling for the baseline differences in HR level, 
there was no group difference in response. There were no effects during baseline for SBP 
and DBP, however the response analyses showed significant increases in both SBP and 
DBP during the cold-pressor test. The increases in SBP and DBP differed between the two 
distractor groups and the control, with the two distractor groups showing a faster initial 
increase in blood pressure than the control.
7.4.2.1.6. Summary of ANS Results
7.4.2.2. Q-EEG Responses
7.4.2.2.1. Delta-1 activity
Figure 7.6 shows mean delta-1 activity during the baseline and cold-pressor stages at 
each site, averaged over subjects. From Figure 7.6, it appears that delta-1 declined over the
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baseline stage and increased during the cold-pressor test, appearing to recover to pre-cold 
levels towards the final stages of the cold-pressor test.
A repeated-measures ANOVA of delta-1 over the baseline stage showed no significant 
effects of time but revealed greater activity at Fz and Pz than Cz, F(l,33) = 21.39, p < .001. 
This is shown on the left-hand side of Figure 7.6, where delta-1 activity appears greater at 
Fz and Pz than Cz. After controlling for these baseline effects, the response analysis 
revealed significant linear, F(l,33) = 7.50, p < .05, and quadratic, F(l,33) = 5.18, p < .05, 
increases in delta-1 from the last epoch of baseline to the first two epochs of the cold- 
pressor test. Figure 7.6 shows the increase in delta-1 from the last epoch of baseline to the 
first two epochs in the cold-pressor test (B12 to C01 and C02) before adjusting for baseline 
differences.
Figure 7.6. Mean delta-1 across groups during baseline (epochs B01-B12) and the cold pressor test (epochs 
C01-C12) at each site. Dashed lines indicate some loss of data (see Method).
Figures 7.7, 7.8 and 7.9 show the mean response of delta-1 activity (corrected for 
baseline effects) from the last epoch of the baseline stage to the first two epochs in the cold-
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pressor test.
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Figure 7.7. Mean delta-1 response Figure 7.8. Mean delta-1 response Figure 7.9. Mean delta-1 response
across groups at each site. across site for each group. at the midline sites for each group.
Figure 7.7 shows the response in delta-1 across groups at the three sites. The delta-1 
response did not differ as a function of site. Figure 7.8 shows the mean response of delta-1 
across site for the three groups. It appeared that the quadratic response component was 
different in the high novelty group but there were no differences between the two distractor 
groups and the control. Figure 7.9 shows the mean response of delta-1 across time points at 
the midline sites for the high-novelty, moderate-novelty and control groups. There were no 
group by site interactions.
Overall, there was greater delta-1 activity at Fz and Pz than Cz over the baseline stage. 
The response analysis showed a significant increase in delta-1 as a response during the 
cold-pressor test but there were no significant differences in this response between the sites. 
It appeared that the response was reduced in the high novelty group but this was not 
significant. From the uncorrected data in Figure 7.6, it appeared that delta-1 declined over
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the remaining epochs of the cold-pressor test (epochs C03 to C l2) but this was not analysed 
due to missing data, where subjects withdrew their hand from the cold-pressor test after the 
second epoch.
7.4.2.2.2. Delta-2 activity
Mean delta-2 activity across groups at each site during the baseline and cold-pressor 
stages is shown in Figure 7.10. It appears that there was greater activity at fronto-central 
sites during the baseline stage, with a decrease in delta-2 during the initial epochs in the 
cold-pressor.
A repeated-measures ANOVA over the baseline stage showed a significant difference in 
delta-2 activity between Fz and Pz, F(l,33) = 15.55, p < .001, and between Cz and the 
average of Fz and Pz, F(l,33) = 14.98, p < .01. This is shown on the left-hand side of 
Figure 7.10 where the activity of delta-2 at Cz is greater than the average of Fz and Pz, and 
the activity at Fz is greater than Pz, indicating a fronto-central distribution. There was also 
a difference between Fz and Pz in the linear trend over baseline, F(l,33) = 4.46, p < .05, 
with delta-2 increasing over epochs at Fz and decreasing at Pz, indicating that the 
distribution of delta-2 became more frontal during the baseline.
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Figure 7.10. Mean delta-2 activity at the midline sites during baseline and cold pressor stages.
After controlling for baseline differences using linear regression, there was a significant 
response during the cold-pressor test apparent as a linear decrease in delta-2, F(l,33) = 
4.36, p < .05. Figure 7.10 shows the decrease in delta-2 before correcting for baseline 
differences using linear regression. Figures 7.11 and 7.12 show the mean response in delta- 
2 (corrected for baseline differences) from the last epoch of baseline-1 (B12) to the first 
two epochs in the cold-pressor test (C01 and C02) and Figure 7.13 shows the mean delta-2 
response at the midline sites for each of the groups.
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Figure 7.11. Mean delta-2 response Figure 7.12. Mean delta-2 response Figure 7.13 . Mean delta-2 response 
across groups at each site. across site for each group. at the midline sites for each group.
Figure 7.11 shows the effects across group for each site. It appears that the delta-2 response 
was greater at fronto-central sites, but this was not significant. Figure 7.12 shows the delta- 
2 response for the three groups averaged across sites, and there were no group differences. 
Figure 7.13 shows the mean response in delta-2 across time at each site for the three 
groups. It appears that there was a difference at Pz compared with Fz between the two 
distractor groups and the control, with a larger decrease in delta-2 at Pz for the control 
group, but this was not significant, F(l,33) = 2.06, n.s.
Overall, the results showed a significant decrease in delta-2 as the response during the 
cold pressor. It appeared that the topography of the response differed between the two 
distractor groups and the control, with a larger decrease posteriorly for the control group, 
but this was not significant.
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Figure 7.14 shows mean theta activity during the baseline and cold-pressor stages at each 
site. From Figure 7.14, there appears to be a fronto-central distribution of theta activity over 
the baseline, with theta activity decreasing during the initial epochs in the cold pressor and 
remaining at levels lower than seen during the baseline stage.
A repeated measures ANOVA across the baseline stage showed a difference in theta 
activity between Fz and Pz, F(l,33) = 43.65, p < .001, and also between Cz and the average 
of Fz and Pz, F(l,33) = 18.30, p < .01. This is shown on the left side of Figure 7.14 where 
there is greater theta activity at Fz and Cz than Pz, confirming a fronto-central topography.
7.4.2.2.3. Theta activity
Figure 7.14. Mean theta activity across groups for the experimental epochs at Fz, Cz and Pz.
Figure 7.14 shows the decrease in theta from the last epoch of baseline to the first two 
epochs in the cold-pressor test (B12 to C01 and C02) before adjusting for baseline 
differences. The response analysis on the baseline-adjusted data revealed a significant 
response during the cold-pressor test, apparent as linear, F(l,33) = 10.20, p < .01, and 
quadratic, F(l,33) = 11.70, p < .01, decreases in theta. Figures 7.15, 7.16 and 7.17 show the
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mean corrected response in theta activity, from the last epoch of the baseline stage to the 
first two epochs in the cold pressor, in greater detail. Figure 7.15 shows the decrease in 
theta activity across groups at Fz, Cz and Pz. The quadratic response component appeared 
to differ between Fz and Pz, with a greater response occurring at Fz, and this approached
significance, F(l,33) = 3.64, p =.065. Figure 7.16 shows the mean theta response across site 
for the high novelty, moderate novelty and control groups. There were no significant 
differences between the two distractor groups and the control. Figure 7.17 shows the mean
theta response at each site for the three groups and there were no group by site interactions.
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Figure 7.15. Mean theta response 
across groups at each site.
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Figure 7.16. Mean theta response 
across site for each group.
Figure 7.17. Mean theta response 
at the midline sites for each group.
Overall, there was greater activity frontally over the baseline stage. The response
analysis showed a significant decrease in theta as the response during the cold-pressor 
stage, with no significant topographical differences or group differences noted.
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Figure 7.18 shows mean alpha-1 activity at each site across groups during the baseline 
and cold-pressor stages. From Figure 7.18, it appears that there was an increase in alpha-1 
across the baseline, followed by a decrease in the cold pressor, with alpha-1 activity 
remaining lower than during the baseline stage for the duration of the cold pressor. It also 
appears that there was greater alpha-1 activity toward the back of the scalp.
A repeated measures ANOVA over the baseline showed a parietal distribution of alpha- 
1 activity, with differences between Fz and Pz, F( 1,33) = 47.07, p < .001, and between Cz 
and the average of Fz and Pz, F(l,33) = 5.53, p < .05. Together these indicate the expected 
posterior alpha maximum. There was also a linear increase of alpha-1 across the baseline, 
F(l,33) = 9.65, p < .01, with the linear trend greater at Pz than Fz, F(l,33) = 6.28, p < .05. 
This increase in alpha-1 is shown on the left of the stimulus marker in Figure 7.18
7.4.2.2.4. Alpha-1 activity
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Figure 7.18 shows the decrease in alpha-1 from the last epoch of baseline to the first two 
epochs in the cold-pressor test (B12 to C01 and C02) before adjusting for baseline 
differences. Controlling for the baseline effects, the response analysis revealed a difference 
in alpha-1 between Fz and Pz, F(l,33) = 19.28, p < .001. The response analysis also 
revealed significant linear F(l,33) = 19.84, p < .001, and quadratic, F(l,33) = 37.50, p < 
.001, decreases in alpha-1 from the last epoch of baseline to the first two epochs in the 
cold-pressor test. Figures 7.19, 7.20 and 7.21 show the mean alpha-1 response in the cold 
pressor, with Figure 7.19 showing the alpha-1 response across the three groups at each of 
the midline sites, Figure 7.20 showing the alpha-1 response across site for the three groups, 
and Figure 7.21 showing the mean response at each site for each group.
The quadratic response component differed between Fz and Pz, F(l,33) = 17.39, p < 
.001 and between Cz and the average of Fz and Pz, F(l,33) = 14.53, p < .01; Figure 7.19 
shows greater desynchronisation of alpha-1 at Pz.
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Figure 7.19. Mean alpha-1 response Figure 7.20.Mean alpha-1 response Figure 7.21. Mean alpha-1 response 
across groups at each site. across site for each group. at the midline sites for each group.
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Figure 7.20 shows the mean alpha-1 response across site for the high novelty, moderate 
novelty, and control groups. There were no significant differences between the groups. 
Figure 7.21 shows the mean alpha-1 response at the midline sites for the three groups. 
There were no significant group by site interactions.
Overall, alpha-1 increased during the baseline and showed significant desynchronisation 
during the cold-pressor test. There was a parietal distribution of alpha-1 over the baseline 
and the decrease during the cold-pressor test was also greatest at the back of the scalp. 
There were no group differences or group by site interactions affecting this profile.
7.4.2.2.5. Alpha-2 activity
Figure 7.22 shows mean alpha-2 activity across groups during the baseline and cold- 
pressor stages. There was a parietal distribution of alpha-2 at all stages. The alpha-2 
response was apparent as a decline during the cold-pressor test. It appears that the decrease 
in alpha-2 recovered after the first two epochs in the cold-pressor test, however the measure 
remained at levels lower than seen during the baseline.
A repeated measures ANOVA over the baseline showed a significant difference in 
alpha-2 between Fz and Pz, F(l,33) = 32.31, p < .001 and between Cz and the average of 
Fz and Pz, F(l,33) = 14.93, p < .001. This is shown on the left-hand side of Figure 7.22 
where there is greater alpha-2 activity at the back of the scalp.
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Figure 7.22. Mean alpha-2 activity at Fz, Cz and Pz during the experimental epochs.
The response analysis revealed a significant decrease in alpha-2, apparent as linear, 
F(l,33) = 4.69, p < .05, and quadratic, F(l,33) = 12.32, p < .01 trends over the data points. 
This decrease in alpha-2 (before adjusting for baseline differences) is shown around the 
stimulus marker in Figure 7.22 (epochs B12 to C01 and C02). Figures 7.23, 7.24 and 7.25 
show the mean alpha-2 response after correcting for baseline differences.
Figure 7.23. Mean alpha-2 response Figure 7.24. Mean alpha-2 response Figure 7.25. Mean alpha-2 response 
across groups at each site. across site for each group. at the midline sites for each group.
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Figure 7.23 shows the response of alpha-2 across groups at the three sites. The alpha-2 
response did not differ across site. Figure 7.24 shows the mean response of alpha-2 across site 
for the three groups. There was a difference in the alpha-2 response between the two distractor 
groups and the control, F(l,33) = 5.39, p < .05, with Figure 7.24 showing a smaller response in 
the two distractor groups. This indicates that the alpha-2 response during the cold-pressor test 
was modified by novel distraction. Figure 7.24 also shows that the high novelty group had the 
smallest overall alpha-2 response, but this was not significant. Figure 7.25 shows the mean alpha- 
2 response topography at the midline for the three groups. There were no significant interactions.
Overall, there was a parietal distribution of alpha-2 during the baseline. The response analysis 
showed an alpha-2 desynchronisation across all groups, with the alpha-2 response less in the two 
distractor groups than the control.
7.4.2.2.6. Beta-1 activity
Figure 7.26 shows mean beta-1 activity across groups during the baseline and cold 
pressor stages at Fz, Cz and Pz. From Figure 7.26, it appears that there was a decrease in 
beta-1 during the initial epochs in the cold-pressor test, with beta-1 appearing to increase 
over the remaining epochs in cold.
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Figure 7.26. Mean beta-1 during baseline and cold pressor stages.
A repeated-measures ANOVA over the baseline stage revealed no effects in beta-1. The 
response analysis showed a significant response during the cold-pressor test, apparent as a 
quadratic response with an initial decrease in beta-1, F(l,33) = 5.21, p < .05. Figure 7.26 
shows the data uncorrected for baseline differences and shows the quadratic decrease in 
beta-1. The decrease in beta-1 during experimental epochs can also be seen in Figures 7.27, 
and 7.28, and the mean effects at Fz, Cz and Pz for the three groups are shown in Figure 
7.29.
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Figure 7.27. Mean beta-1 response 
across groups at each site.
Figure 7.28. Mean beta-1 response 
across site for each group.
Figure 7.29. Mean beta-1 response 
at the midline sites for each group.
Figure 7.27 shows the beta-1 response across groups at the three sites. The response 
analysis from the last epoch of baseline-1 to the first two epochs in the cold-pressor test 
revealed a difference in the mean beta-1 response between Fz and Pz, F(l,33) = 4.74, p < 
.05, and Figure 7.27 shows that the response was greater at Fz. Figure 7.28 shows the beta- 
1 response across site for the three groups. There was a difference in the beta-1 response 
between the two distractor groups and the control, F(l,33) = 5.09, p < .05, with Figure 7.28 
showing a smaller response in the two distractor groups. Figure 7.29 shows the mean 
response in beta-1 at the midline sites for the three groups. There was a difference in the 
quadratic response component of beta-1 between the two distractor groups and the control 
at Cz compared with the average of Fz and Pz, F(l,33) = 6.34, p < .05. This is shown more 
clearly in Figure 7.30 where the distractor groups show a smaller vertex increase in the 
beta-1 response than the control group.
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Figure 7.30. Mean beta-1 response at Fz/Pz and Cz for the distractor and the control groups.
Overall, there was a significant decrease in beta-1 as the response during the cold- 
pressor test, which was greatest at Fz. The beta-1 response to the cold pressor was smaller 
in the two distractor groups than the control. There was also a difference in the topography 
of the response between the distractor groups and the control, with the distractor groups 
showing a relatively smaller beta-1 response at the vertex than the control group.
7.4.2.2.7. Beta-2 activity
Figure 7.31 shows mean beta-2 activity across groups at each site during the baseline 
and cold-pressor stages. It appears that beta-2 increased during the first two epochs of the 
cold-pressor test, with beta-2 appearing to remain elevated over the remaining epochs of the 
cold-pressor stage.
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A repeated-measures ANOVA over the baseline stage showed that there was greater 
beta-2 activity at Fz than Pz, F(l,33) = 13.67, p < .01. This is shown on the left-hand side 
of the stimulus event marker in Figure 7.31 and indicates a frontal topography.
Figure 7.31. Mean beta-2 activity across groups at Fz, Cz and Pz during baseline and cold pressor stages.
The response analysis on the baseline-adjusted data revealed a significant linear time 
effect in beta-2, apparent as an initial increase during the cold-pressor test, F(l,33) = 11.44, 
p < .01. Figure 7.31 shows the data uncorrected for baseline differences, where the 
increase in beta-2 can be seen from the last epoch of the baseline (B12) to the first two 
epochs in the cold-pressor test (C01 and C02).
Figures 7.32, 7.33 and 7.34 show the mean response of beta-2 corrected for baseline 
effects. Figure 7.32 shows the mean beta-2 response across group for the three sites, Figure 
7.33 shows the mean beta-2 response across site for the three groups and Figure 7.34 shows 
the mean response at each site for each group.
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Figure 7.32. Mean beta-2 response Figure 7.33. Mean beta-2 response Figure 7.34. Mean beta-2 response
across groups at each site. across site for each group. at the midline sites for each group.
Figure 7.32 shows that the beta-2 response was greater at Pz than Fz, F(l,33) = 8.83, p < 
.01. There was also a difference in the linear, F(l,33) = 5.10, p < .05, and quadratic, 
F(l,33) = 7.05, p < .05, components of this response between Fz and Pz; Figure 7.32 shows 
that there was a rapid increase in the beta-2 response at Pz during the first epoch of the 
cold-pressor test, whereas there was an initial decrease at Fz. Figure 7.33 shows the beta-2 
response across site for the three groups. There was a difference in the mean beta-2 
response between the two distractor groups and the control, F(l,33) = 7.66, p < .01 and 
Figure 7.33 shows that beta-2 increased in the distractor groups and decreased in the 
control. There was also a difference in the quadratic response component between the two 
distractor groups and the control that approached significance, F(l,33) = 3.78, p =.06, and 
Figure 7.33 shows that beta-2 increased initially for the two distractor groups and decreased 
in the control. Figure 7.34 shows the mean response of beta-2 at the midline sites for the
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high-novelty, moderate-novelty and control groups. There were no group by site 
interactions.
Overall, the analyses showed that there was a frontal distribution of beta-2 during the 
baseline stage. Controlling for baseline effects, there was a significant increase in beta-2 as 
a response during the cold-pressor test. The beta-2 response was greatest at Pz. The beta-2 
response differed between the two distractor groups and the control, with beta-2 increasing 
in the distractor groups and decreasing in the control.
7.4.2.2.8. Beta-3 activity
Mean beta-3 activity across groups at Fz, Cz and Pz during the baseline and cold-pressor 
stages is shown in Figure 7.35. It appears that there was a frontal distribution of beta-3 over 
the baseline followed by an apparent increase of beta-3 during the initial epochs of the 
cold-pressor test. It also appears that the level of beta-3 activity continued higher during the 
remaining epochs of the cold-pressor test than during the baseline stage.
A repeated measures ANOVA across the baseline stage showed greater beta-3 activity at 
Fz than Pz, F(l,33) = 10.68, p < .01. This is shown on the left-hand side of Figure 7.35, 
where the level of beta-2 is greater at Fz than Pz. There was also a difference in beta-3 
between the two distractors and the control at Cz compared with the average of Fz and Pz, 
F(l,33) = 5.29, p < .05. The control group showed greater beta-3 activity at Cz (3.0%) than 
the average of Fz and Pz (2.0%) while the two distractor groups did not (Cz = 2.2%, mean 
Fz and Pz = 2.3%).
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Figure 7.35. Mean beta-3 activity across baseline and cold pressor stages at Fz, Cz and Pz.
After controlling for the baseline differences using linear regression, the response 
analysis showed significant linear, F(l,33) = 9.18, p < .01, and quadratic, F(l,33) = 4.09,/? 
= .05 increases in beta-3 over the initial response epochs. Figure 7.35 shows the increase in 
beta-3 uncorrected for baseline effects. Figures 7.36, 7.37 and 7.38 show the mean beta-3 
response during the cold-pressor test that has been corrected for differences over the 
baseline.
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Figure 7.36. Mean beta-3 response Figure 7.37. Mean beta-3 response Figure 7.38. Mean beta-3 response
across groups at each site. across site for each group. at the midline for each group.
Figure 7.36 shows the beta-3 response across groups at each site. There was a difference 
in the beta-3 response between Fz and Pz, F(l,33) = 5.80, p < .05, and Figure 7.36 shows a 
greater response at Pz. Figure 7.37 shows the beta-3 response across site for the three 
groups. There were no differences between the two distractor groups and the control. 
Figure 7.38 shows the mean beta-2 response at the midline sites for each of the three 
groups. There was a difference in the quadratic response component between the two 
distractor groups and the control at Cz compared with the average of Fz and Pz, F(l,33) = 
7.53, p =.01. This is shown in greater detail in Figure 7.39 where the beta-3 response is 
greater at Cz for the two distractor groups than the control group. There also appeared to be 
a difference between the distractors and control and Fz/Pz but this was not significant.
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Figure 7.39. Mean beta-3 response at Fz/Pz and Cz for the distractor and the control groups.
Overall, there was greater fronto-central activity of beta-3 over the baseline. The control 
group also showed relatively greater beta-3 activity at Cz than the distractor groups. 
Controlling for baseline effects, there was a significant increase in beta-3 as a response 
during the cold-pressor test, with the response greater at Pz. The quadratic response 
component differed at Cz compared with the average of Fz and Pz between the two 
distractor groups and the control, with the distractor groups showing a larger response at 
Cz.
7.4.2.2.9. Summary o f Q-EEG Results
In summary, Q-EEG analysis showed that the cold-pressor test evoked power changes in 
all bands of the EEG spectrum analysed in this study. There was greater delta-1 activity at 
Fz and Pz than Cz during the baseline. After controlling for this using linear regression, 
there were linear and quadratic increases in delta-1 from the last epoch of the baseline to
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the first two epochs in the cold pressor. There were no differences in response between the 
sites or between the groups, and no group by site interactions. Delta-2 showed a fronto- 
central distribution during the baseline and delta-2 also became more frontal over the 
baseline, increasing at Fz and decreasing at Pz over epochs. After controlling for these 
effects, the response analysis showed a linear decrease during the cold-pressor test that 
appeared to be relatively frontal. It also appeared that there was a difference at Pz compared 
with Fz between the two distractor groups and the control, with a larger decrease in delta-2 
at Pz for the control, but this did not reach significance.
There was a fronto-central distribution of theta activity during the baseline stage. The 
response analysis showed linear and quadratic decreases in theta during the cold-pressor 
test. The quadratic response component appeared to differ between Fz and Pz, with a 
greater response occurring at Fz (this approached significance). There were no group 
effects or group by site interactions found.
There was a strong parietal distribution of alpha-1 during the baseline stage, with 
differences between Fz and Cz and also between Cz and the average of Fz and Pz. There 
was also a linear increase in alpha-1 during the baseline stage, with the increase greater at 
Pz than Fz. Controlling for these effects during the baseline, the response analysis revealed 
linear and quadratic decreases in alpha-1 during the cold-pressor test. The response analysis 
also revealed a difference in alpha-1 between Fz and Pz, with the response greater at Pz. 
There were no significant group effects or group by site interactions. There was also a 
strong parietal distribution of alpha-2 during the baseline, with alpha-2 greater at Pz. The 
response analysis showed linear and quadratic decreases in alpha-2 with no difference 
between the sites. The alpha-2 response was smaller in the two distractor groups than the 
control, with the high-novelty group appearing to show the smallest response overall (this
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did not reach significance). This indicates that the alpha-2 response to cold-pressor pain is 
reduced with novel distraction.
There were no effects in beta-1 over the baseline stage. The response analysis revealed a 
quadratic decrease in beta-1 that was greatest at Fz. The beta-1 response was smaller in the 
two distractor groups than the control, with the distractor groups also showing a smaller 
response at the vertex than the control. These results indicate that the beta-1 response to 
pain is modified by novel distraction. There was a frontal distribution of beta-2 over the 
baseline stage, with greater beta-2 activity at Fz than Pz. Controlling for baseline effects, 
the response analysis revealed a significant linear increase in beta-2 that was greater at Pz 
than Fz. The beta-2 response was also more rapid at Pz than Fz during the cold-pressor test. 
The beta-2 response differed between the two distractor groups and the control, with beta-2 
increasing in the two novel distractor groups and decreasing in the control, indicating that 
the beta-2 response is modified by novel distractor stimuli. There was greater beta-3 
frontally during the baseline stage, with greater beta-3 activity at Fz than Pz. There was 
also greater beta-3 activity at Cz in the control group than the two distractor groups. 
Controlling for these effects, the response analysis revealed linear and quadratic increases 
in beta-3, with a greater response at Pz. There was also a difference in the quadratic 
response at Cz between the two distractor groups and the control, with the distractor groups 
showing a larger response at Cz.
7.4.3. Summary and Interim Discussion
In summary, the behavioural data showed that the distractor groups reported less pain 
(as indexed by the affective VAS) than the control, with the high-novelty group reporting
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the least pain overall. This suggests that the affective component of pain was reduced with 
novel distraction. The physiological results indicated that increased SCL and increased HR 
during the cold-pressor test reflect pain that is modified by novel distraction. Decreased 
alpha-2 and beta-1 activity also reflected the onset of pain, with the alpha-2 and beta-1 
response modified by the novel distractor stimuli. The RR response profile during the cold- 
pressor test was unlike the pattern of the other autonomic variables, with RR decreasing in 
the control, decreasing to a lesser extent in the moderate novelty group and increasing in 
the high novelty group. The respiration results indicated that the increase in RR in the 
distractor groups may have been a direct response to novelty rather than reflecting 
analgesia during pain. The fact that the pattern of RR was unlike that of other physiological 
variables may also be due to the fact that RR is under a degree of voluntary control.
The arterial blood pressure results showed an increase in both SBP and DBP during the 
cold-pressor test, with the increase more rapid for the distractor groups than the control. 
Given the behavioural results, the pattern of other ANS results and the thermoregulatory 
nature of blood pressure changes during cold, it is likely that the increases in SBP and DBP 
are due to an overlap of components reflecting both cold and pain and novelty.
The increase in delta-1 activity, and increase in beta-2 and beta-3 activity during the
cold-pressor test followed a similar pattern across the three groups and suggests a global
increase in arousal. The fact that these responses were not modified by novel distractor
stimuli indicates that they reflect an increase in arousal during cold stimulation rather than
reflecting the affective component of pain. The response pattern of beta-2 showed an
increase in the distractor groups and a decrease in the control, which may also be due to the
novel quality of the distractor stimuli, similar to that observed in respiration rate. Delta-2,
theta and alpha-1 activity also followed a similar pattern, with an initial decrease during the
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cold-pressor that was not sustained. The fact that the responses in these bands were not 
sustained and were not modified by novel distraction suggests that the responses in these 
three Q-EEG bands are a response to immersion in (or reaction to) the sensory nature of the 
ice-cold water. The next section further examines the response patterns of the ANS and Q- 
EEG responses during the cold-pressor test to pain and other stimulus attributes through 
cluster analysis. A summary table of all physiological results is presented in Appendix B.
7.4.4. Cluster Analysis
Mean responses across each of the groups are shown in Table 7.2. There were nine 
points in the response profile of each measure with responses in the high-novelty, 
moderate-novelty and control groups analysed from the last epoch of the baseline to the 
first two epochs in the cold-pressor test. Table 7. 3 shows this profile with the last epoch of 
each baseline subtracted from that group’s response, in order to bring the response profiles 
to comparable baseline levels. Table 7.4 summarises the correlations between the response 
patterns shown by the different measures, across time and level of distractor. Correlation 
co-efficients greater than 0.67 are significant, with 7 (n-2) degrees of freedom (since 
correlations were over n=9 pairs of measures). Cluster analysis was performed on the 
correlations to examine how these profiles of the measures grouped together, in order to see 
whether the groupings of variables reached above were supported statistically. Table 7.4 
also shows the groupings from the six-cluster solution, which appeared to be the most 
informative. Cluster 1 included SCL and HR, cluster 2 comprised RR alone, and cluster 3 
included delta-2, theta and alpha-1. Cluster 4 incorporated alpha-2 and beta-1, cluster 5
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comprised delta-1, beta-2 and beta-3 and cluster 6 included SBP and DBP. As shown in 
Table 7.5, this clustering appeared to correspond well with the observed data.
7.4.3. Variables grouped in cluster analysis
In the main analysis, five groups of variables were identified. SCL, HR, alpha-2 and 
beta-1 were identified as being related to pain, with the pain response reduced with novelty. 
Although under a degree of voluntary control, increased RR was recognised as being 
related to novelty, while the increase in SBP and DBP was attributed to activation in both 
the somatosensory and thermoregulatory systems as well as to the novel quality of the 
stimuli. The increase in delta-1, beta-2 and beta-3 was attributed as reflecting a general 
increase in arousal and the decrease in delta-2, theta and alpha-1 activity were attributed to 
the reaction to the onset of the stimulus.
That is, the five groups of variables identified in the main analysis in terms of the 
individual response analyses are very similar to the six clusters identified from correlations 
between response patterns. The separation of SCL and HR from alpha-2 and beta-1 in the 
cluster analysis -  the only difference -  may be attributed to the different response patterns 
between the variables, with SCL and HR increasing during cold pressor stimulation and 
alpha-2 and beta-1 decreasing. The results indicate that increased SCL, increased HR, 
decreased alpha-1 and decreased beta-1 reflect pain, with these responses modified by 
novel distraction.
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Table 7.2. Mean raw response profiles for the three groups
gplbl2 gplcOl gplc02 gp2bl2 gp2c01 gp2c02 gp3bl2 gp3c01 gp3c02
SCL 6.73 8.25 7.81 6.55 7.66 7.77 5.55 7.90 7.43
HR 73.51 79.53 77.92 74.11 83.59 81.93 65.66 78.06 74.39
RR 14.67 15.38 15.31 14.83 14.46 15.13 16.31 14.01 13.52
SPB 135.71 144.38 139.57 130.21 139.45 142.54 132.22 134.74 144.24
DBP 82.15 85.84 86.12 83.77 91.37 92.94 83.53 83.77 90.01
DELTA-1 -0.26 4.86 4.69 0.48 1.76 4.21 1.52 5.57 1.95
DELTA-2 1.40 -2.10 -1.22 0.03 0.24 -1.79 -0.98 -0.98 -2.76
THETA 0.33 -8.62 -6.81 -0.47 -0.74 -1.27 -0.58 -2.85 -1.58
ALPHA-1 -0.51 -9.05 -7.68 -1.00 -7.67 -6.32 -0.73 -6.10 -3.57
ALPHA-2 -0.37 -2.08 -1.64 0.07 -0.61 0.33 -0.53 -3.50 -2.64
BETA-1 0.51 -0.59 0.61 0.31 -0.07 0.07 -0.64 -1.78 -1.08
BETA-2 -0.11 0.44 1.27 0.26 1.29 0.80 -0.24 -0.58 0.14
BETA-3 0.00 1.55 1.72 0.02 1.04 0.42 0.17 0.50 1.00
grp 1 Moderate Novelty 
grp 2 High Novelty 
grp 3 Control
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T able 7.3. Mean response profiles relative to the last baseline epoch of each group.
gplbl2 gplcOl gplc02 gp2bl2 gp2c01 gp2c02 gp3bl2 gp3c01 gp3c02
SCL 0 1.52 1.09 0 1.11 1.23 0 2.35 1.88
RR 0 0.71 0.63 0 -0.37 0.30 0 -2.29 -2.79
HR 0 6.02 4.41 0 9.48 7.82 0 12.39 8.72
SPB 0 8.67 3.86 0 9.24 12.34 0 2.53 12.03
DBP 0 3.69 3.96 0 7.60 9.18 0 0.24 6.48
DELTA-1 0 5.12 4.95 0 1.29 3.73 0 4.05 0.43
DELTA-2 0 -3.51 -2.62 0 0.21 -1.82 0 -0.01 -1.78
THETA 0 -8.96 -7.14 0 -0.27 -0.80 0 -2.26 -1.00
ALPHA-1 0 -8.54 -7.16 0 -6.66 -5.31 0 -5.37 -2.85
ALPHA-2 0 -1.71 -1.27 0 -0.68 0.26 0 -2.97 -2.11
BETA-1 0 -1.10 0.10 0 -0.37 -0.24 0 -1.14 -0.44
BETA-2 0 0.55 1.37 0 1.03 0.54 0 -0.34 0.38
BETA-3 0 1.55 1.72 0 1.02 0.40 0 0.33 0.83
grp 1 Moderate Novelty 
grp 2 High Novelty 
grp 3 Control
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T able 7.4. Correlation matrix
SCL
SCL
1.00 0.
HR 0.93 1.
RR -0.58 -0.
SPB 0.61 0.
DBP 0.42 0.
DELTA-1 0.62 0.
DELTA-2 -0.40 -0.
THETA -0.39 -0.
ALPHA-1 -0.69 -0.
ALPHA-2 -0.86 -0.
BETA-1 -0.78 -0.
BETA-2 0.12 0.
BETA-3 0.48 0.
RR SPB DBP
-0.58 0.61 0.42
-0.56 0.65 0.55
1.00 -0.19 -0.01
-0.19 1.00 0.93
-0.01 0.93 1.00
0.23 0.33 0.28
-0.27 -0.53 -0.42
-0.34 -0.18 -0.07
-0.14 -0.59 -0.56
0.65 -0.21 0.03
0.39 -0.33 -0.06
0.41 0.47 0.65
0.20 0.49 0.47
HR
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DO
56
65
55
50
17
16
68
70
70
16
38
DELTA-1 DELTA-2
0.62 
0.50 
0.23 
0.33
THETA ALPHA-1 ALPHA-2 BETA-1 BETA-2
-0.40 -0.39 -0.69|
-0.17 -0.16 -0.68]
-0.27 -0.34 -0.14
-0.53 -0.18 -0.59
-0.42 -0.56
-0,70 f i l i l i -0.87
1.00 0.64
0.84 0.74
0.64 0.74 , < X 'M :
0.28 0.45 “ I ?
0.26 0.41 0.56
-0.53 -0.47 -0.64
-0.77 -0.83 \ ^ M \
BETA-3
0.48
0.38
0.20
0.49
0.47
-0.44
-0.27
Cluster 1 
Cluster 2 
Cluster 3 Cluster 6
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Table 7.5. Results of cluster analysis compared with observed data
Response Cluster Analysis Observed Data
painSCL Cluster 1
RR Cluster 2
HR Cluster 1
SBP Cluster 6
DBP Cluster 6
delta-1 Cluster 5
delta-2 Cluster 3
theta Cluster 3
alpha-1 Cluster 3
alpha-2 Cluster 4
beta-1 Cluster 4
beta-2 Cluster 5
beta-3 Cluster 5
cold, pain, novelty 
pain
cold, pain, novelty 
cold, pain, novelty 
arousal
response to stimulus
response to stimulus
response to stimulus
pain
pain
arousal
arousal
7.4.5. Menstrual-cycle Effects
In order to examine and control for menstrual-cycle effects, subjects were classified 
into one of three groups. Seven subjects reported being in the follicular phase of the 
menstrual-cycle (days 7-13) and nine subjects reported being in the luteal phase (days 
17-21). The remaining twenty subjects reported anovulatory cycles or were either in the 
ovulatory, the pre-menstrual or the menstrual stage of the cycle. The average cycle 
length was 28 days. Menstrual-cycle phase (follicular, luteal, neither) was used as a 
covariate and all the original analyses were carried out a second time with the addition 
of menstrual-cycle phase as a covariate. This was to determine if any of the results were 
altered significantly by menstrual-cycle phase. There were no effects of menstrual cycle 
on any behavioural measures. The results also showed that no effects reported in the 
main physiological analyses above changed significantly with the addition of menstrual-
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cycle as a variable. A summary of F values across all measures with menstrual-cycle 
phase as a covariate is presented in Appendix C.
7.5. Discussion
The behavioural data showed that subjects who received a novel distractor stimulus 
rated the motivational-affective component of pain in the cold pressor lower than the 
control group, with a tendency for the high-novelty group to rate their pain as being 
least overall. This supports previous research by S. Maltzman (1992) and is consistent 
with the findings of Study 1, confirming that novel distractor stimuli modify the 
perception of pain. As in Study 1, the sensory component was not modified by the novel 
distractor stimuli, supporting the suggestion that the sensory component of pain is less 
sensitive to modification by novel distractor stimuli.
The electrodermal results showed that there was a smaller increase in SCL during the 
cold-pressor test for the two novelty groups than the control, with a tendency for the 
high-novelty group to show the least response overall. This is consistent with the 
results of Study 1, where the two distractor groups showed a smaller increase in SCL 
than the control, and the high-novelty group showed the smallest response overall. 
Dowling (1982, 1983) suggested that SCL is related to the affective component of pain. 
The SCL data confirmed that SCL indexes the affective component of pain, as it 
showed a novelty-reduced response profile compatible with the motivational-affective 
behavioural change.
There was no overall main effect of the cold-pressor test on RR. This is consistent 
with previous studies that have reported no difference in RR between baseline and cold 
pressor stages (Allen & Crowell, 1990; Allen et al., 1992) and is also consistent with the 
results of Study 1. The pattern of RR differed between the two distractor groups and the
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control, with RR decreasing in the control group and decreasing to a lesser extent (or 
increasing slightly) in the high-novelty and moderate-novelty groups. This supports the 
findings of Study 1 and indicates that the increase in RR in the novelty groups reflects a 
direct response to novelty rather than a reduction in pain.
HR was higher during the baseline stage for the two distractor groups and this is 
consistent with the pre-cold-pressor HR levels in Study 1. In Study 1, the baseline HR 
differences were attributed to random sampling differences, but it is unlikely that such a 
sampling effect would be found in both studies. It could be that higher HR in the 
distractor groups reflected the anticipation of a more-involved task (i.e. the presentation 
of pictures as well as the cold-pressor test). Controlling for the differences in baseline 
HR levels using analysis of covariance, it appeared that the increase in HR was less for 
the two distractor groups than the control. Despite not reaching statistical significance in 
the present study, the results parallel those of Study 1, compatible with the suggestion 
there that increases in HR during the cold-pressor test reflect pain that is modified by 
novel distractor stimuli. This is also supported by the results of the cluster analysis, 
which showed SCL and HR in a separate cluster, suggesting that these responses are 
related to pain and modified by novel distraction.
HR, SBP and DBP increased significantly during the cold-pressor test, supporting 
previous studies that have shown reliable increases in activity of the cardiovascular 
system during cold stimulation (Lovallo, 1975; Peckerman et al., 1994; Saab et al., 
1993). Although blood pressure increases may reflect pain (Fillingim & Maixner, 1996), 
their increases during the cold-pressor test are thought to be the result of the additive 
effects of both cold and pain, with the cold pressor activating both the thermoregulatory 
and somatosensory systems (Peckerman et al., 1994). The increase in SBP and DBP to 
the cold pressor differed between the groups, with a greater initial increase in the
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distractor groups. This is consistent with the results of Study 1, and given the pain 
ratings and responses of SCL, RR and HR, it is unlikely that the greater initial increase 
in blood pressure in the distractor groups reflects greater pain. It could be that the 
greater initial increase in blood pressure was due to the presence of a novel distractor in 
the two distractor groups’ stimulus complex, increasing blood pressure more rapidly 
than the control group.
In summary, the ANS results are consistent with those reported in Study 1, 
and indicate that increased SCL and HR are components of the pain response, and are 
modified by a novel distractor stimulus. The results also indicate the increase in RR in 
the novel distractor groups reflected a response to novelty of the visual stimulus rather 
than a direct reflection of pain. The increases in blood pressure (SBP and DBP) are 
probably best considered as resulting from the additive effects of both cold and pain, 
produced by activation in the thermoregulatory and somatosensory systems. The greater 
initial increase in BP in the two distractor groups may be due to additional BP increases 
due to the novel visual stimulus. Therefore, the ANS results show the differential 
responses of the variables during the cold-pressor test, with some measures changing 
due to pain, necessarily showing a reduction with the distractors (SCL and HR), some 
directly due to the novelty of the visual stimulus (RR) and some as a result of novelty, 
cold and pain (SBP and DBP).
The electrocortical data revealed greater relative delta-1 activity at Fz and Pz than Cz 
across baseline, with the response showing an increase in delta-1 during the cold- 
pressor test. The delta-1 response is consistent with previous studies showing 
heightened delta activity during the cold-pressor test (Chen et al., 1989b; Ferracuti et 
al., 1994; Gotliebsen & Arendt-Nielson, 1990). In this study, the delta-1 response was 
not modified by novel distractor stimuli, and from this, we can conclude that an increase
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in delta-1 during the cold-pressor test may reflect a global increase in arousal rather than 
reflecting an increase in the affective component of pain. There was a fronto-central 
distribution of relative delta-2 power during the baseline stage, with delta-2 becoming 
more frontal over the baseline. The response analysis showed a decrease in delta-2 that 
appeared to be more frontal. Activation in the frontal areas of the brain (such as in the 
insula and anterior cingulate cortex) is thought to reflect the motivational-affective 
component of pain (Casey et al., 1995), and the greater delta-2 response in frontal areas 
may reflect activation of these cortical structures. As the decrease in delta-2 was not 
sustained and was not modified by distraction, we can conclude the delta-2 response 
reflects a sensory response to the cold-pressor test. The present study analysed both the 
upper and lower delta bands, whereas previous studies have restricted their analysis to 
broad band delta, or delta-2, and from the current results, it is suggested that increased 
delta activity in previous studies primarily reflects an increase in delta-1.
The current data showed a fronto-central distribution of theta during the baseline 
stage. Controlling for this, the theta response was a decrease during the cold-pressor test 
that was greater frontally. The theta response did not differ between the groups. 
Backonja et al. (1991) and Ferracuti et al. (1994) reported increases in theta activity 
during the cold-pressor test but the functionality of this was not discussed. Theta may be 
indicative of a more relaxed state (Ray, 1990), and the decrease in theta activity in the 
present study may denote a disruption of this relaxed state, corresponding to an increase 
in arousal. Increased theta activity in Backonja et al. (1991) and Ferracuti et al. (1994) 
may have reflected the anticipation of pain or an attempt to control pain during noxious 
stimulation (Larbig et al., 1982). It is unlikely that the theta results in the present study 
are a direct reflection of pain, since there were no group differences. It appears likely 
that the response in theta activity reflects an arousal reaction to the immersion of the
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hand in the cold pressor.
There was greater alpha-1 activity posteriorly during the baseline stage, with alpha-1 
increasing over the baseline epochs. Desynchronisation of alpha-1 activity during the 
cold-pressor test occurred at all sites, with greater desynchronisation parietally. This 
finding of alpha desynchronisation concurs with previous studies showing decreases in 
alpha activity during the cold-pressor test (Ferracuti et al., 1994; Gotliebsen & Arendt- 
Nielson, 1990) and contrasts with the increases reported by Backonja et al. (1991). 
Ferracuti et al. (1994) interpreted the decrease in alpha-1 (alpha-blocking) as a response 
to the ice-cold water that recovered quickly to pre-test levels. Because the decrease in 
alpha-1 did not differ between the two distractor groups and the control, we can 
conclude that alpha-1 is not modified by distraction and hence is not related to the 
affective component of pain.. Rather, the present results indicate that alpha-1 
desynchronisation to the cold pressor reflects a more general arousal response to the 
cold water stimulus. There was a parietal distribution of relative alpha-2 power during 
the baseline stage. The relative power in the alpha-2 band showed desynchronisation 
during the cold-pressor test. This desynchronisation of alpha-2 differed between the two 
distractor groups and the control, with the distractor groups showing less alpha-2 
desynchronisation than the control. It also appeared that the high-novelty group showed 
least alpha-2 desynchronisation overall, but this was not significant. Ferracuti et al. 
(1994) interpreted desynchronisation of alpha-2 during the cold-pressor test to be 
dependent on painful stimulation and the results of the present study are consistent with 
this, with the two novel distractors attenuating this pain response and resulting in less
desynchronisation than in the control group.
There were no effects in beta-1 during the baseline stage and the decrease in beta-1 
followed a similar pattern to the decrease in alpha-2, with the two novel distractor
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groups showing less of a decrease in beta-1 than the control. The topography of the 
beta-1 response differed from that of the alpha 2 response, with a greater response 
occurring at Fz. Because activation in structures in the frontal area of the brain have 
been associated with the affective component of pain (Casey et al., 1995), the smaller 
response shown in the distractor groups in the present study suggests that the decrease 
in beta-1 is also related to the affective component of pain that is reduced with novel 
distraction. There was a frontal distribution of relative beta-2 power during the baseline 
stage, with greater beta-2 at Fz than Pz. Beta-2 increased during the cold-pressor test 
and the increase was greater at Pz. The increase in beta-2 corresponds with previous 
studies that have shown increases in beta activity during the cold-pressor test (Backonja 
et al., 1991; Chen et al., 1989b). The beta-2 response differed between the two distractor 
groups and the control, with beta-2 decreasing in the control and increasing in the 
distractor groups. It is likely that the increase in beta-2 primarily reflects an increase in 
arousal, with greater arousal due to the distractor stimuli in the high novelty and 
moderate novelty groups. There was greater beta-3 activity frontally during the baseline, 
with greater beta-3 activity also reported in the control group at Cz. Controlling for 
these effects, the relative amount of beta-3 increased during the cold-pressor test, and 
the increase was greater at Pz. The topography of the response differed between the two 
distractor groups and the control, with a larger response at Cz in the distractor groups. 
The increase in beta-3 activity is attributed in a similar manner to beta-2, reflecting an 
increase in arousal. It is also possible that the increases in beta-2 and beta-3 may have 
been contaminated by muscle artifact in the EEG spectrum from clenching of the facial 
and jaw muscles (Backonja et al., 1991; Veerasarn & Stohler, 1992).
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Table 7.6. Summary Table
Measure Cold Pain Novelty Arousal Reaction to 
Stimulus
SCL X V X X X
RR V V V X X
HR X V X X X
SBP V V V X X
DBP V V V X X
Delta-1 X X X V X
Delta-2 X X X X V
Theta X X X X V
Alpha-1 X X X X V
Alpha-2 X V X X X
Beta-1 X V X X X
Beta-2 X X V V X
Beta-3 X X V V X
Table 7.6 summarises the responses during the cold-pressor test and attributes the 
results in terms of five factors (cold, pain, novelty, arousal and a sensory response to the 
stimulus). Overall, the results from the main analyses examining the effects of novel 
distraction on ANS and Q-EEG responses to pain together with the cluster analysis 
indicate that the variables were grouped into five groups. Increases in SCL and 
increases in HR are related to the affective component of pain that was modified by 
novel distractors. The results also indicate that decreases in alpha-2 and beta-1 activity 
reflect increases in the affective component of pain that was modified by novel 
distractors, with response patterns in alpha-2 and beta-1 correlating negatively with the
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SCL and HR response. Respiratory slowing in the control group may have been an 
indication of pain or cold (deeper and slower respiration), however the smaller decrease 
in the moderate-novelty group and increase in the high-novelty group reflects an 
additional direct response to novelty. The results indicate that increases in delta-1, beta- 
2 and beta-3 activity reflect an increase in arousal, with decreases in delta-2, theta and 
alpha-1 activity reflective of a reaction to the ice-cold water.
The next chapter discusses the outcome and implications of the results from both 
studies. Conclusions relate pain modification to the OR where a sufficiently novel 
stimulus elicits an OR and raises the threshold to pain.
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CHAPTER 8
GENERAL DISCUSSION
CHAPTER 8. GENERAL DISCUSSION
Previous research by S. Maltzman (1992) demonstrated the behavioural control of 
pain through novel stimuli, and the present research consolidates and extends these 
findings to include the modification of physiological responses. Although the highly- 
novel stimulus produced the greatest reduction in reported pain (the motivational 
affective component), both distractor stimuli were successful in modifying ANS and 
CNS responses produced to the cold pressor. Specifically, HR, SCL, alpha-2 and beta-1 
responses reflected pain and were modified by novel distraction, with RR changes 
interpreted as a response to the novelty of the stimuli.
The novelty-dependent release of (3-endorphins during an OR provides a 
physiological explanation for analgesia during pain. When an individual is exposed to 
novel stimuli during pain, an OR occurs, inducing (3-endorphin activation that produces 
an analgesic effect and raises the threshold to pain (I. Maltzman, 1990). This is 
supported by previous research involving laboratory rats where exposure to novel 
situations or environments activates the brain (3-endorphin system and produces 
analgesia during pain (Perry et al., 1983; Izquierdo et al., 1984; Izquierdo & McGaugh, 
1985; Izquierdo & Netto, 1985; Siegfried et al., 1987). The fact that analgesia is 
reversed with naltrexone (an opioid blocker) further supports (3-endorphin induced 
analgesia to pain (Siegfried et al., 1987). More recently, Bell et al. (1997) found 
activation of (3-endorphin to novelty in humans, with elevated plasma levels occurring 
15 minutes after exposure to novelty. This confirms an OR-based mechanism by which 
novel distractors reduce the perception of pain and attenuate pain responses.
Information-processing models have explained the success of distraction strategies
during pain in terms of limitations in attentional capacity. Attentional capacity posits
that pain involves processing of a noxious stimulus and this draws on attentional
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resources. Distraction tasks during pain also consume some degree of attentional 
capacity that would have otherwise been devoted to pain perception, thus reducing pain- 
produced distress (McCaul and Malott, 1984). Leventhal and Everhart’s (1980) parallel­
processing model of pain also explains pain in terms of attention, where individuals 
form a schema of pain through experience. This schema is modified by further 
encounters with painful stimuli and acts as an attention selection, where different 
aspects of the pain experience can be brought into focal awareness.
Cognitive models of pain fail to adequately explain the physiology of pain and pain 
reduction. The novelty-dependent release of (3-endorphin during an OR provides a 
physiological explanation as to why distractor stimuli attenuate pain responses. This can 
also be linked in with physiological models of pain, such as the gate control model. 
According to the gate control model of pain, brainstem inhibitory fibres descend from 
the brain through the spinal cord and inhibit the transmission of nociceptive information 
at the dorsal horns. This occurs during conditions of distraction, with the inhibition of 
nociceptive information involving the release of endogenous opioid peptides in the 
substantia gelatinosa. Melzack and Wall (1988) maintain that while these endogenous 
pain control systems exist and modify pain during distraction, but it is not clear how 
these distraction techniques induce the release of endorphins and produce analgesia 
during pain. S. Maltzman (Maltzman-Greenstein, 1984; Maltzman, 1988, 1992) has 
shown that the success of distraction strategies in attenuating pain is due to the novel 
characteristic of the distractor stimuli. As novelty is the eliciting factor in an OR, (3- 
endorphin release during an OR provides a physiological mechanism explaining why 
distraction produces analgesia during pain. As descending control systems have been 
implicated in the control of pain, with a number of pathways containing multiple
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receptors for endogenous opioid peptides, it is likely that novelty-induced p-endorphin 
release activates a number of these pathways.
The menstrual-cycle analysis did not reveal any behavioural or physiological 
differences between the follicular and luteal phases of the cycle. Given that a number of 
subjects reported anovulatory cycles, only a broad analysis of the follicular and luteal 
phases was possible. The female hormones vary quite considerable across the ovarian 
cycle from the onset of menstruation through follicular development, ovulation and 
formation of the corpus luteum. The perception of pain and cardiovascular reactivity 
varies according to the level of hormones in a particular phase and it may be that 
differences in pain perception occurred at more specific levels in each phase than the 
broad analysis applied in this study.
The lack of significant phase effects may also have been due to the measure of self­
report of last menstrual period in order to determine the target phase. This method has 
been criticised for its inaccuracies due to intra-subject variability (Miller & Sita, 1994) 
where the level of gonadal hormones varies significantly across each cycle. The use of 
between-group designs examining follicular and luteal phases between two groups of 
subjects has also been criticised given the large inter-subject variability of hormones 
(Miller & Sita, 1994). Within-group designs are regarded as providing more precise 
measures where each subject is tested in both the follicular and luteal phases of the 
cycle thus participating in two testing sessions. However, within-group designs create 
the possibility of response decrement and ‘carry-over effects’ in subsequent exposure to 
the cold-pressor test, and Polefrone and Manuck (1988) have argued that this is also a 
potential problem in examining the influence of the menstrual-cycle on pain responses 
using this stimulus.
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Due to the inclusion of only females, the results of this research are directly 
applicable only to women. Because men have been found to have a greater tolerance to 
pain than women (Fillingim & Maixner, 1996), results in males may be significantly 
different from those reported in the present thesis, and this should be investigated in 
future research. The effects of novel distractor stimuli may also be different for other 
forms of experimentally-induced pain (e.g. phasic pain elicited by electric shock or laser 
heat impulses) and this also warrants further investigation. However, because the cold- 
pressor test has been described as analogue of acute clinical pain, the results can be 
generalised to clinical pain, such as acute dental and menstrual pain, and it is anticipated 
that these forms of pain would be modified by novel distractor stimuli. Further research, 
more directly exploring the association between (3-endorphin activation during an OR 
and pain attenuation, using both male and females, would strengthen the current results 
and have useful applications in the clinical area of pain management. The current 
research focused on pain attenuation during the presentation of novel distractor stimuli. 
As stimuli that are significant or meaningful also elicit ORs, further research could 
explore the role of significance in pain attenuation during the presentation of 
meaningful stimuli such as pictures of family and friends.
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APPENDIX A: SUMMARY OF PHYSIOLOGICAL RESULTS STUDY 1
Contrasts:
Group (1) compares the two distractor groups with the control
Group (2) compares the high-novelty group with the moderate-novelty group
Measure F value df p value
Skin Conductance Level
Baseline
Main effect Time (linear) 
Decrease over baseline
70.96 1,54 <.001
Group (1) by Time (linear) 
Decrease more rapid in control
10.52 1,54 <.01
Cold
Main effect Time (linear) 
Increase in cold pressor
73.59 1,54 <.001
Main effect Time (quadratic) 
Increase in cold pressor
74.70 1,54 <.001
Group (1 ) by Time (quadratic) 
Less increase in distractors than control
10.05 1,54 <.01
Group (2) by Time (quadratic) 
Less increase in high novelty group
4.17 1,54 <.05
Respiration Rate
Baseline
Main effect Time (linear) 
Increase over baseline
6.34 1,54 <.05
Cold
Group (1) by Time (linear)
Smaller decrease in distractors than control
5.03 1,54 <.05
Group (2) by Time (quadratic)
Smaller decrease (increase) in high novelty group
3.10 1,54 .08
Heart Rate
Baseline
Main effect Group (1) 
Greater HR level in distractors
6.96 1,54 <.05
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Cold
Main effect Time (linear) 
Increase in cold pressor
22.21 1,54 <.001
Main effect Time (quadratic) 
Increase in cold pressor
41.90 1,54 <.001
Group (1) by Time (quadratic) 
Less increase in distractors than control
8.45 1,54 <.01
Systolic Blood Pressure
Cold
Group (1) by Time (quadratic) 
Greater increase in distractors
4.41 1,54 <.05
Diastolic Blood Pressure
Cold
Main effect Time (linear) 
Increase in cold pressor
25.09 1,54 <.001
Group (1) by Time (quadratic) 
Greater increase in distractors
5.37 1,54 <.05
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APPENDIX B: SUMMARY OF PHYSIOLOGICAL RESULTS STUDY 2
(MAIN ANALYSIS)
Contrasts:
Group (1) compares the two distractor groups with the control
Group (2) compares the high-novelty group with the moderate-novelty group
Measure F value df p value
Skin Conductance Level
Baseline
Main effect Time (linear) 
Decrease over baseline
31.00 1,33 <.001
Cold
Main effect Time (linear) 
Increase in cold pressor
44.06 1,33 <.001
Main effect Time (quadratic) 
Increase in cold pressor
52.11 1,33 <.001
Group (1) by Time (quadratic) 
Less increase in distractors than control
4.70 1,33 <.05
Respiration Rate
Baseline
Main effect Time (linear) 
Increase over baseline
10.72 1,33 <.01
Cold
Group (1) by Time (linear)
Smaller decrease in distractors than control
4.62 1,33 <.05
Heart Rate
Baseline
Main effect Group (1) 
Greater HR level in distractors
5.72 1,33 <.05
Cold
Main effect Time (linear) 
Increase in cold pressor
21.96 1,33 <.001
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Main effect Time (quadratic) 21.81 1,33 < .001
Systolic Blood Pressure
Cold
Main effect Time (linear) 
Increase in cold pressor
15.72 1,33 < .001
Group (1) by Time (quadratic) 
Greater increase in distractors
6.51 1,33 < .05
Diastolic Blood Pressure
Cold
Main effect Time (linear) 
Increase in cold pressor
16.35 1,33 < .001
Group (1) by Time (quadratic) 
Greater increase in distractors
8 .46 1,33 <.01
Delta-1
Baseline
Main effect Site (Cz vs Fz and Pz) 
Greater activity at Fz and Pz than Cz
21 .3 9 1,33 < .001
Cold
Main effect Time (linear) 
Increase in cold pressor
7 .5 0 1,33 < .05
Main effect Time (quadratic) 
Increase in cold pressor
5 .18 1,33 < .05
Delta-2
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
15.55 1,33 < .001
Main effect Site (Cz vs Fz and Pz) 
Greater activity at Cz than Fz and Pz
14.98 1,33 <.01
Site by Times (Fz vs Pz)
Increase over epochs at Fz, decrease over epochs at Pz
4 .4 6 1,33 < .05
Cold
Main effect Time (linear) 
Decrease in cold pressor
4 .3 6 1,33 < .05
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Theta
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
43.65 1,33 <.001
Main effect Site (Cz vs Fz and Pz) 
Greater activity at Cz than Fz and Pz
18.30 1,33 <.01
Cold
Main effect Time (linear) 
Increase in cold pressor
10.20 1,33 <.01
Main effect Time (quadratic) 
Increase in cold pressor
11.70 1,33 <.01
Main effect Site (Fz vs Pz) 
Greater response at Fz than Pz
3.64 1,33 .06
Alpha-1
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
47.07 1,33 <.001
Main effect Site (Cz vs Fz and Pz) 
Greater activity at Pz and Fz than Cz
5.53 1,33 <.05
Main effect Time (linear) 
Increase over baseline
9.65 1,33 <.01
Site by Time (Fz vs Pz)
Linear increase greater at Pz than Fz
6.28 1,33 <.05
Cold
Main effect Site (Fz vs Pz) 
Greater response at Pz
19.28 1,33 <.001
Main effect Time (linear) 
Decrease in cold pressor
19.84 1,33 <.001
Main effect Time (quadratic) 
Decrease in cold pressor
37.50 1,33 <.001
Site by Time (quadratic Fz vs Pz) 
Greater decrease at Pz
17.39 1,33 <.001
Site by Times (quadratic Cz vs Fz and Pz) 
Greater decrease at Pz and Fz than Cz
14.53 1,33 <.001
Alpha-2
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Pz
32.31 1,33 <.001
Cold
Main effect Time (linear) 
Increase in cold pressor
4.69 1,33 <.05
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Main effect Time (quadratic) 
Increase in cold pressor
12.32 1,33 <.01
Main effect Group (1)
Less response in distractors than control
5.39 1,33 <.05
Beta-1
Cold
Main effect Group (1)
Less activity in distractors than control
5.09 1,33 <.05
Main effect Site (Fz vs Pz) 
Greater response at Fz
4.64 1,33 <.01
Main effect Time (quadratic) 
Decrease in cold pressor
5.21 1,33 <.05
Group (1) by Site (Cz vz Fz and Pz) by Times 
(quadratic)
Greater response at vertex for control
6.34 1,33 <.05
Beta-2
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
13.67 1,33 <.01
Cold
Main effect Group (1) 
Greater activity in distractors
7.66 1,33 <.01
Main effect Site (Fz vs Pz) 
Greater response at Pz than Fz
8.83 1,33 <.01
Main effect Time (linear) 
Increase in cold pressor
11.44 1,33 <.01
Group (1) by Time (quadratic) 
Increase in cold pressor
3.78 1,33 =.06
Site (Fz vs Pz) by Time (linear) 
Sustained increase at Pz
5.10 1,33 <.05
Site (Fz vs Pz) by Time (quadratic) 
Sustained increase at Pz
7.05 1,33 <.05
Beta-3
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz
10.68 1,33 <.01
Group (1) by Site (Cz vs Fz and Pz) 
Less activity at Cz in distractors than control
5.29 1,33 <.05
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Cold
Main effect Site (Fz vz Pz) 
Greater activity at Pz than Fz
5.80 1,33 <.05
Main effect Time (linear) 
Increase in cold pressor
9.18 1,33 <.01
Main effect Time (quadratic) 
Increase in cold pressor
4.09 1,33 =.05
Group (1) by Site (Cz vs Fz and Pz) by Time 
(quadratic)
Greater response in distractors at Cz
7.53 1,33 =.01
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APPENDIX C: SUMMARY OF PHYSIOLOGICAL RESULTS STUDY 2
(WITH MENSTRUAL CYCLE PHASE)
Contrasts:
Group (1) compares the two distractor groups with the control
Group (2) compares the high-novelty group with the moderate-novelty group
Measure F value df P value
Skin Conductance Level
Baseline
Main effect Time (linear) 
Decrease over baseline
31.00 1.33 <.001
Cold
Main effect Time (linear) 
Increase in cold pressor
44.06 1,33 <.001
Main effect Time (quadratic) 
Increase in cold pressor
52.11 1,33 <.001
Group (1) by Time (quadratic) 
Less increase in distractors than control
4.69 1.33 <.05
Respiration Rate
Baseline
Main effect Time (linear) 
Increase over baseline
10.72 1.33 <.01
Cold
Group (1) by Time (linear)
Smaller decrease in distractors than control
4.62 1.33 <.05
Heart Rate
Baseline
Main effect Group (1) 
Greater HR level in distractors
6.05 1,32 <.05
Cold
Main effect Time (linear) 
Increase in cold pressor
21.96 1,33 <.001
Main effect Time (quadratic) 
Increase in cold pressor
21.81 1.33 <.001
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Systolic Blood Pressure
Cold
Main effect Time (linear) 
Increase in cold pressor
15.72 1,33 <.001
Group (1) by Time (quadratic) 
Greater increase in distractors
6.51 1,33 <.05
Diastolic Blood Pressure
Cold
Main effect Time (linear) 
Increase in cold pressor
16.35 1,33 <.001
Group (1) by Time (quadratic) 
Greater increase in distractors
8.46 1,33 <.01
Delta-1
Baseline
Main effect Site (Cz vs Fz and Pz) 
Greater activity at Fz and Pz than Cz
21.39 1,33 <.001
Cold
Main effect Time (linear) 
Increase in cold pressor
7.50 1,33 <.05
Main effect Time (quadratic) 
Increase in cold pressor
5.18 1,33 <.05
Delta-2
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
15.55 1,33 <.001
Main effect Site (Cz vs Fz and Pz) 
Greater activitv at Cz than Fz and Pz
14.98 1,33 <.01
Site by Times (Fz vs Pz)
Increase over epochs at Fz. decrease over epochs at Pz
4.46 1,33 <.05
Cold
Main effect Time (linear) 
Decrease in cold pressor
4.36 1,33 <.05
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Theta
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
43.65 1,33 <.001
Main effect Site (Cz vs Fz and Pz) 
Greater activity ar Cz than Fz and Pz
18.30 1,33 <.01
Cold
Main effect Time (linear) 
Increase in cold pressor
10.20 1,33 <.01
Main effect Time (quadratic) 
Increase in cold pressor
11.70 1,33 <.01
Main effect Site (Fz vs Pz) 
Greater response at Fz than Pz
3.64 1,33 .06
Alpha-1
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
47.07 1,33 <.001
Main effect Site (Cz vs Fz and Pz) 
Greater activity at Pz and Fz than Cz
5.53 1,33 <.05
Main effect Time (linear) 
Increase over baseline
9.65 1,33 <.01
Site by Time (Fz vs Pz)
Linear increase greater at Pz than Fz
6.28 1,33 <.05
Cold
Main effect Site (Fz vs Pz) 
Greater response at Pz
19.28 1,33 <.001
Main effect Time (linear) 
Decrease in cold pressor
19.84 1,33 <.001
Main effect Time (quadratic) 
Decrease in cold pressor
37.50 1,33 <.001
Site by Time (quadratic Fz vs Pz) 
Greater decrease at Pz
17.39 1,33 <.001
Site by Times (quadratic Cz vs Fz and Pz) 
Greater decrease at Pz and Fz than Cz
14.53 1,33 <.001
Alpha-2
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Pz
32.31 1,33 <.001
Main effect Site (Cz vs Fz and Pz) 
Greater activity at Pz and Fz than Cz
14.93 1,33 <.001
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Cold
Main effect Time (linear) 
Increase in cold pressor
4 .6 9 1,33 < .05
Main effect Time (quadratic) 
Increase in cold pressor
12.32 1,33 <.01
Main effect Group (1)
Less response in distractors than control
5 .3 9 1,32 < .05
Beta-1
Cold
Main effect Group (1)
Less activity in distractors than control
5 .09 1,33 < .05
Main effect Site (Fz vs Pz) 
Greater response at Fz
4 .6 4 1,33 <.01
Main effect Time (quadratic) 
Decrease in cold pressor
5.21 1,33 < .05
Group (1) by Site (Cz vz Fz and Pz) by Times 
(quadratic)
Greater response at vertex for control
6 .3 4 1,33 < .05
Beta-2
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz than Pz
13.67 1,33 <.01
Cold
Main effect Group (1) 
Greater activity in distractors
7 .66 1,32 <.01
Main effect Site (Fz vs Pz) 
Greater response at Pz than Fz
8.83 1,33 <.01
Main effect Time (linear) 
Increase in cold pressor
11.44 1,33 <.01
Group (1) by Time (quadratic) 
Increase in cold pressor
3 .78 1,33 = .06
Site (Fz vs Pz) by Time (linear) 
Sustained increase at Pz
5 .1 0 1,33 < .05
Beta-3
Baseline
Main effect Site (Fz vs Pz) 
Greater activity at Fz
10.68 1,33 <.01
Group (1) by Site (Cz vs Fz and Pz) 
Less activity at Cz in distractors than control
5 .29 1,33 < .05
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Cold
Main effect Site (Fz vz Pz) 
Greater activity at Pz than Fz
5.80 1,33 <.05
Main effect Time (linear) 
Increase in cold pressor
9.18 1,33 <.01
Main effect Time (quadratic) 
Increase in cold pressor
4.09 1,33 =.05
Group (1) by Site (Cz vs Fz and Pz) by Time 
(quadratic)
Greater response in distractors at Cz
7.53 1,33 =.01
Group (2) by Site (Fz vs Pz) by Time (linear) 
Sustained increase at Cz for moderate novelty group
10.39 1,33 <.01
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APPENDIX D
APPENDIX D: CONSENT FORM STUDY 1
University of Wollongong 
Human Research Ethics Committee
CONSENT FORM
Research project: The Effects of Distraction on Physiological Responses to Pain
Researcher: Rana O’Donohue
This research project is being conducted as part of a PhD in Psychology 
supervised by Professor Robert J. Barry in the Department of Psychology at the 
University of Wollongong.
This experiment examines the physiological responses to pain. The experiment 
will involve placing your hand in ice-cold water for a maximum period of 3 
minutes, or for as long as you can tolerate. Measuring your responses to the cold 
water involves recording your heart rate using an electrocardiograph (EKG), your 
blood pressure, respiration rate and your skin conductance (sweat gland) levels. 
During the experiment, you may be asked to view a pictorial slide and you will be 
in close contact with the experimenter at all times via an audio link and closed 
circuit television camera. The procedures for recording these measures should 
have been explained to you in detail for your satisfaction, and are described in the 
enclosed Information for Participants sheet. Please read the Information for 
Participants sheet and ask any question about the experiment before signing this 
consent form. You should retain the information sheet for your records.
If you decide to participate in the project, you will be asked to complete 
questionnaires on your medical history, stage of menstrual cycle and on the level of 
pain and discomfort that you may experience during the experiment. This 
information will be recorded on separate data sheets that will not contain your 
name. The information from these questionnaires, together with any physiological 
data will be identified by subject code only, to ensure your anonymity and 
confidentiality.
The experiment should take approximately one and a half hours. You are free 
to withdraw from the research at any time without penalty.
PLEASE REMEMBER. THIS EXPERIMENT IS NOT A TEST OF STRENGTH 
OR ENDURANCE. IT IS IN YOUR BEST INTEREST TO WITHDRAW YOUR 
HAND FROM THE ICE-WATER WHEN YOU CAN NO LONGER TOLERATE 
IT.
I understand that the data collected may be used for publication in scientific 
journals and for a report submitted to the University, and that individual data will 
not be identifiable in these reports. I consent for the data to be used in that 
manner.
If you wish to take part in this research, please sign below;
NAME:
(Signature) (Date)
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APPENDIX E: INFORMATION SHEET STUDY 1
INFORMATION FOR PARTICIPANTS
Aims and Significance: Pain is one of the most challenging problems in 
medicine and biology today. Pain is viewed as a complex experience 
comprising several sensory and affective dimensions (Melzack & Wall, 1988). 
Physiological changes are a necessary factor in the pain response and thus has 
been viewed as potentially useful measures of change in emotional reactivity 
(Moltner, Holzl & Strain, 1990). These physiological responses include changes 
in EEG (brain wave) activity, heart activity and skin conductance (sweat gland) 
levels (Turk & Melzack, 1992).
In attempting to determine the changes in these physiological responses to 
perceived pain intensity, researchers use painful stimuli with healthy pain-free 
volunteers to examine similarities with the type of pain and discomfort 
experienced by clinical pain patients. One such painful stimulus is the cold- 
pressor, which involves placing limbs in ice-cold water until the subject decides 
to withdraw them or for a maximum of 3 minutes. The cold pressor has been 
used in pain research for over 60 years, and is a safe method of inducing pain 
without any physical damage or lasting effects for the participants.
Despite its widespread use, few studies have directly examined the role of 
physiological activity during the cold-pressor test. Given the role of cognitive 
processes in influencing the perception of pain and the different patterns of 
physiological responses to the cold pressor, this method of pain research has 
the potential to identify psychological and physiological aspects of experimental 
pain in healthy pain-free subjects. The present study was designed to examine 
the physiological correlates of pain (heart activity, skin conductance, respiration 
rate and blood pressure).
Procedure: You will complete demographic, screening and behavioural 
questionnaires. The measuring equipment (i.e. heart rate electrodes, finger 
pulse blood pressure cuff, skin conductance level and a respiratory belt around 
the chest) will be fitted, during which explanations of the equipment’s functions 
will be given in an attempt to make the session more understandable for you.
Once the equipment has been fitted, you will be asked to sit quietly in the 
testing booth for 3 minutes, while your heart rate, blood pressure, skin 
conductance and respiratory levels are recorded while you are sitting quietly. 
You will then be asked to place your non-dominant hand in ice-cold water (2° C) 
for a period of 3 minutes while your physiological measures are recorded. 
Please try and keep your hand in for as long as possible, however withdraw it 
immediately from the ice-cold water when you feel you can no longer tolerate it. 
While your hand is in the ice-cold water, a pictorial slide may be presented on 
the computer screen in front of you. Please pay close attention to the computer 
screen. While you are in the testing booth, you will be in contact with the 
experimenter via a microphone and closed circuit television camera. You may 
indicate at any stage during testing that you wish to withdraw from the
experiment. .
Once you have completed the cold pressor test, you will rate the level of pain 
or discomfort that you experienced. You will then be asked to sit quietly at rest 
and complete some other questionnaires.
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If you have any enquiries regarding the conduct of this research, please contact 
the Secretary of the University of Wollongong Human Research Ethics 
Committee on 42214457.
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APPENDIX F: CONSENT FORM STUDY 2
University of Wollongong 
Human Research Ethics Committee 
CONSENT FORM
Research project: The Effects of Distraction on Physiological Responses to Pain
Researcher: Rana O’Donohue
This research project is being conducted as part of a PhD in Psychology 
supervised by Professor Robert J. Barry in the Department of Psychology at the 
University of Wollongong.
This experiment examines the physiological responses to pain. The experiment 
will involve placing your hand in ice-cold water for a maximum period of 3 
minutes, or for as long as you can tolerate. Measuring your responses to the cold 
water involves recording the electrical activity of your brain using an 
electroencephalograph (EEG), your heart rate using an electrocardiograph (EKG), 
your blood pressure, respiration rate and your skin conductance (sweat gland) 
levels. During the experiment, you may be asked to view a pictorial slide and you 
will be in close contact with the experimenter at all times via an audio link and 
closed circuit television camera. The procedures for recording these measures 
should have been explained to you in detail for your satisfaction, and are described 
in the enclosed Information for Participants sheet. Please read the Information for 
Participants sheet and ask any question about the experiment before signing this 
consent form. You should retain the information sheet for your records.
If you decide to participate in the project, you will be asked to complete 
questionnaires on your medical history, stage of menstrual cycle and on the level of 
pain and discomfort that you may experience during the experiment. This 
information will be recorded on separate data sheets that will not contain your 
name. The information from these questionnaires, together with any physiological 
data will be identified by subject code only, to ensure your anonymity and 
confidentiality.
The experiment should take approximately one and a half hours. You are free 
to withdraw from the research at any time without penalty.
PLEASE REMEMBER. THIS EXPERIMENT IS NOT A TEST OF STRENGTH 
OR ENDURANCE. IT IS IN YOUR BEST INTEREST TO WITHDRAW YOUR 
HAND FROM THE ICE-WATER WHEN YOU CAN NO LONGER TOLERATE 
IT.
I understand that the data collected may be used for publication in scientific 
journals and for a report submitted to the University, and that individual data will 
not be identifiable in these reports. I consent for the data to be used in that 
manner.
If you wish to take part in this research, please sign below;
N A M E:...............................  ...........................................  ....................
(Signature) (Date)
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APPENDIX G: INFORMATION SHEET STUDY 2
INFORMATION FOR PARTICIPANTS
Aims and Significance: Pain is one of the most challenging problems in 
medicine and biology today. Pain is viewed as a complex experience 
comprising several sensory and affective dimensions (Melzack & Wall, 1988). 
Physiological changes are a necessary factor in the pain response and thus has 
been viewed as potentially useful measures of change in emotional reactivity 
(Moltner, Holzl & Strain, 1990). These physiological responses include changes 
in EEG (brain wave) activity, heart activity and skin conductance (sweat gland) 
levels (Turk & Melzack, 1992).
In attempting to determine the changes in these physiological responses to 
perceived pain intensity, researchers use painful stimuli with healthy pain-free 
volunteers to examine similarities with the type of pain and discomfort 
experienced by clinical pain patients. One such painful stimulus is the cold- 
pressor, which involves placing limbs in ice-cold water until the subject decides 
to withdraw them or for a maximum of 3 minutes. The cold pressor has been 
used in pain research for over 60 years, and is a safe method of inducing pain 
without any physical damage or lasting effects for the participants.
Despite its widespread use, few studies have directly examined the role of 
physiological activity during the cold-pressor test. Given the role of cognitive 
(brain) processes in influencing the perception of pain and the different patterns 
of physiological responses to the cold pressor, this method of pain research has 
the potential to identify psychological and physiological aspects of experimental 
pain in healthy pain-free subjects. A study by Chen (1989) using a cold pressor 
and EEG has identified specific brain patterns related to pain. The present study 
was designed to examine the physiological effects of pain on these brain 
processes and further examine other physiological correlates of pain (heart 
activity skin conductance, respiration rate and blood pressure).
Procedure: You will complete demographic, screening and behavioural 
questionnaires. The measuring equipment (i.e. EEG cap, heart rate electrodes, 
finger pulse blood pressure cuff, skin conductance electrodes and a respiratory 
belt around the chest) will then be fitted, during which detailed explanations of 
the equipment’s functions will be given in an attempt to make the session more 
understandable for you.
In order to record EEG, a cap containing electrodes will be fitted on your 
head. This method is much easier and less time consuming than placing 
individual electrodes over your head and will take approximately 10 minutes. 
Eye movement and blink will be monitored by electrooculograph (EOG) 
recordings. EOG electrodes will be placed above and below the left eye and on 
the outside of each eye and are used to measure the vertical and horizontal eye 
movements respectively. It is important to monitor eye movement because even 
with careful electrode attachments, artifacts can be seen in the EEG record if 
subjects blink their eyes. These unwanted signals interfere and make it difficult 
to record the EEG. The experimenter can control for the interference produced 
by eye movement and blink by monitoring their effects through EOG.
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In order to record your heart rate activity, you will be asked to place a 
disposable electrode on the left side of your rib cage and on the middle of your 
chest. Blood pressure will be monitored by a finger pulse blood pressure cuff 
that will be placed over the middle section of digit IV of your dominant hand. By 
using a blood pressure cuff, blood pressure can be monitored continuously and 
readings can be obtained at short intervals. Your skin conductance level (the 
activity of your sweat glands) will be measured by placing electrodes on digits II 
and III of your dominant hand. Respiration rate will be measures by placing a 
respiratory belt around your chest to monitor the rise and fall of your diaphragm.
Once the equipment has been fitted, you will be asked to sit quietly in the 
testing booth for 3 minutes, while your heart rate, blood pressure, skin 
conductance and respiratory levels are recorded while you are sitting quietly. 
You will then be asked to place your non-dominant hand in ice-cold water (2° C) 
for a period of 3 minutes while your physiological measures are recorded. 
Please try and keep your hand in for as long as possible, however withdraw it 
immediately from the ice-cold water when you feel you can no longer tolerate it. 
While your hand is in the ice-cold water, a pictorial slide may be presented on 
the computer screen in front of you. Please pay close attention to the computer 
screen. While you are in the testing booth, you will be in contact with the 
experimenter via a microphone and closed circuit television camera. You may 
indicate at any stage during testing that you wish to withdraw from the 
experiment.
Once you have completed the cold pressor test, you will rate the level of pain 
or discomfort that you experienced. You will then be asked to sit quietly at rest 
and complete some other questionnaires.
If you have any enquiries regarding the conduct of this research, please contact 
the Secretary of the University of Wollongong Human Research Ethics 
Committee on 42214457.
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APPENDIX H
APPENDIX H: SCREENING QUESTIONNAIRE 
SCREENING QUESTIONNAIRE
Subject No.
Age: Height: cms
Sex: ___________________  Weight ______kgs
Handedness: (LEFT) (RIGHT) (circle one)
Please indicate whether you have used any of the following substances in the 
past 12 hours:
CAFFEINE (eg. Tea/coffee)
(circle
one)
YES NO
If YES 
When Qty
ALCOHOL YES NO When Qty
TOBACCO YES NO When Qty
Are you receiving treatment for any medical 
condition?
YES NO
If YES, please specifv:
Are you taking any medications? YES NO
If YES, please specifv:
Are you pregnant? YES NO
Have you received treatment for any of the following:
(circle one) (If YES)
HEART PROBLEMS YES NO (details?)
CIRCULATION PROBLEMS YES NO (details?)
(eg. Raynaud’s disease)
NERVE OR SENSORY PROBLEMS YES NO (details?)
PAIN (Acute or Chronic) YES NO (details?)
Are you experiencing any of these YES NO (details?)
problems now?
Have you ever suffered epileptic seizures? YES NO 
If YES please specify:
Have you ever suffered serious head injuries or periods of unconsciousness? 
YES NO
If YES please specify:
Have you ever sought treatment for any psychiatric illness? YES NO 
If YES please specify:
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APPENDIX I: MCGILL PAIN QUESTIONNAIRE
Date: Time:
PRI: S A E
(1-10) (11-15) (16)
Subject Number: 
PPIM PRI(T)
(17-20) (1-20)
CHOOSE ONLY THE WORDS THAT DESCRIBE YOUR FEELINGS AND 
SENSATIONS AT THE MOMENT THAT YOU WITHDREW YOUR HAND 
FROM THE ICED WATER.
1 FLICKERING 2 JUMPING 3 PRICKING
QUIVERING FLASHING BORING
PULSING SHOOTING DRILLING
THROBBING STABBING
BEATING LANCINATING
POUNDING
4 SHARP 5 PINCHING 6 TUGGING
CUTTING PRESSING PULLING
LACERATING GNAWING WRENCHING
CRAMPING
CRUSHING
7 HOT 8 TINGLING 9 DULL
BURNING ITCHY SORE
SCALDING SMARTING HURTING
SEARING STINGING ACHING
HEAVY
10 TENDER 11 TIRING 12 SICKENING
TAUT EXHAUSTING SUFFOCATING
RASPING
SPLITTING
13 FEARFUL 
FRIGHTFUL 
TERRIFYING
16 ANNOYING
TROUBLESOME
MISERABLE
INTENSE
UNBEARABLE
19 COOL 
COLD 
FREEZING
14 PUNISHING 15
GRUELLING 
CRUEL 
VICIOUS 
KILLING
WRETCHED
BLINDING
17 SPREADING 
RADIATING 
PENETRATING 
PIERCING
18 TIGHT 
NUMB 
DRAWING 
SQUEEZING 
TEARING
20 NAGGING PPI
NAUSEATING 
AGONISING 
DREADFUL 
TORTURING
NO PAIN
MILD PAIN
DISCOMFORTING
DISTRESSING
HORRIBLE
EXCRUCIATING
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PUT A CROSS ON THE LINE TO SHOW HOW STRONG YOUR PAIN WAS
NO PAIN WORST
POSSIBLE
PAIN
PUT A CROSS ON THE LINE TO SHOW HOW STRONG YOUR FEELINGS 
WERE ABOUT YOUR PAIN
NOT 
BAD AT 
ALL
THE MOST 
UNPLEASANT 
FEELING 
POSSIBLE 
FOR ME
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POST-TESTING QUESTIONNAIRE 
(MENSTRUAL CYCLE QUESTIONNAIRE)
APPENDIX J
Recent evidence investigating women in pain has found that the menstrual 
cycle phase at the time of testing can influence a female subject’s responses to 
a cold pressor (Hapidou & De Catanzaro, 1988; Girdler & Light, 1994; Sita & 
Miller, 1996). These findings relate to the levels of hormones produced during 
difference phases of the menstrual cycle, which are in turn influenced by oral 
contraception. In other words, the intensity at which female subjects rate the 
cold pressor test depends on their hormone levels at that phase of their 
menstrual cycle, which are in turn influenced by whether they are using oral 
contraception. In order to control for the influence of menstrual cycle phase on 
the cold pressor, you are asked to answer the following questions.
This information is strictly confidential and your identity on the 
questionnaire remains completely anonymous
When did your current menstrual period begin?
(please circle approximate date)
JULY
APPENDIX J: POST-TESTING QUESTIONNAIRE
M 5 12 19 26
T 6 13 20 27
W 7 14 21 28
T 1 8 15 22 29
F 2 9 16 23 30
S 3 10 17 24 31
S 4 11 18 25
AUGUST
M 30 2 9 16 23
T 31 3 10 17 24
W 4 11 18 25
T 5 12 19 26
F 6 13 20 27
S 7 14 21 28
S 1 8 15 22 29
How often does your menstrual period occur?
Less than 28 days (specify approx) ----------------
Greater than 28 days (specify approx)---------------
Exactly 28 days
Did you take oral contraceptives (birth control pills) during the cycle before your 
current menstrual period? YES/NO (please circle)
THANK YOU FOR YOUR PARTICIPATION
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APPENDIX K
SELF-EVALUATION QUESTIONNAIRE
Developed by Charles D. Spielberger
in collaboration with
R. L. Got such, R. Fusitene, P. R. Yagg, and G. A. Jacobs 
S TAI Form Y-l
N am e--- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - _ _ _ _ _  D ate
A ge_________ Sex: M _ _ _ _ _  F _ _ _ _
DIRECTIONS: A number of statements which people have used to 
describe themselves are given below. Read each statement and then 
blacken in the appropriate circle to the right of the statement to indi­
cate how you feel right now, that is, at this moment. There are no right 
or wrong answers. Do not spend too much time on any one statement 
but give the answer which seems to describe your present feelings best.
1. I feel calm
2. I feel secure
3. I am tense ..........................................................................
4. I feel strained ....................................................................
5. I feel at ease .....................................................................
6. I feel upset ......................................................................
7. I am presently worrying over possible misfortunes
8. I feel satisfied .................................................................
9. I feel frightened ...........................................................
10. I feel comfortable .........................................................
11. I feel self-confident .......................................................
12. I feel nervous .................................................................
13. I am jittery .....................................................................
14. I feel indecisive .............................................................
15. I am relaxed ...................................................................
16. I feel content .................................................................
17. I am worried .................................................................
18. I feel confused ...............................................................
19. I feel steady .................................................................
20. I feel pleasant ...............................................................
Consulting Psychologists Press, Inc.
3803 E. Bayshore Road • Palo Alto, CA 94303
SEl T; - E V A L L1 ATl O N QUESTIONN AIRE
STAI Form Y-t!
N a m e n.m-
DIRECTIONS: A number of statements which people have used to 
describe themselves are given below. Read each statement and then 
blacken in the appropriate circle to the right ot the statement to in­
dicate how you generally feel. There are no right or wrong answers. Do 
not spend too much time on any one statement but give the answer 
which seems to describe how you generally feel.
y v
V  t,
- i f  ,-, 4 .
/o  V. s.
■V J I //  '/. /
21.  I feel pleasant ............................................................................................................  T Cf T
22.  I ieel  nervous  and restless .................................................................................  vl 4 T
23. I feel satisfied with mvselt .................................................................................  T l
24.  I wish I could be as happv as others seem to be ...................................  I ? 1
25.  I feel like a failure ................................................................................................  1 \ 1
2(5. I feel rested .............................................................................................................  I i 'I
27. I am "calm. cool, and collected" .......................................................... 7 i
28. 1 feel that difficulties are piling up so that I cannot overcome them i ?
2d. I worry too much over something that reallv doesn't matter ............  i :
30. I am happv ......................................................................................................  7 \
31. I have disturbing thoughts ........................................................................  t i
32. I lack self-confidence .......................................................... ' ......................  g g
33. I feel secure .................................................................................................... T \
34. I make decisions easilv ................................................................................. 7- 2
35. I feel inadequate ....................................................................................... 7 2
3(5. I am content .................................................................................  7 2
37. Some unimportant thought runs through my mind and bothers me T i
38. I take disappointments so kecnlv that I can t put them out of mv
mind .........................................................................
30. I am a steady person .............................................  ,,
40. I get m a state of tension or turmoil as I think over my recent < oncerns
and interests .............................  ,
Copyright m s, 1977 by Charles D. Spielberger. Reproduction of this test or any portion thereof 
by any process mlhout written permission of the Publisher is prohibited. Sixteenth printing.
APPENDIX L 
SPSS OUTPUT: STUDY 1
Study 1 - State Trait Anxiety Inventory
M A N O V A
s l s t a i  B Y  g r o u p  (1,3)
/ C O N T R A S T ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2  1 - 1 0 )
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
Manova
★ ★ ★ ★ ★ ★ A n a l y s i s  o f  V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a ] _ y S i s o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
C o m b i n e d  O b s e r v e d  M e a n s  for G R O U P  
V a r i a b l e  .. S 1 S T A I
G R O U P
1 W G T . 3 2 . 1 5 7 8 9
UNW G T . 3 2 . 1 5 7 8 9
2 WGT. 3 2 . 8 4 2 1 1
U N W G T . 3 2 . 8 4 2 1 1
3 WGT. 3 1 . 5 2 6 3 2
U N W G T . 3 1 . 5 2 6 3 2
* * * * * A n a l y s i s  o f V a r i a n c e —  d e s i g n  1 *  *  •
T e s t s  of S i g n i f i c a n c e for S 1 S T A I u s i n g  U N I Q U E  sums of s q u a r e s
O f  FS o u r c e  o f  V a r i a t i o n SS D F M S F S i g
W I T H I N  C E L L S 3 0 5 9 . 7 9 54 5 6 . 6 6 .647G R O U P (1) 12.01 1 12.01 .21
G R O U P (2) 4. 4 5 1 4.45 .08 .780
( M o d e l ) 1 6 .46 2 8.23 .15 .865
(Total) 3 0 7 6 . 2 5 56 5 4 . 9 3
R - S q u a r e d  = .005
A d j u s t e d  R - S q u a r e d  = .000
Page 1
M A N O V A
s 2 s t a i  B Y  g r o u p  (1,3)
/CONTRAST(group)^special ( 1 1 1 1 1 - 2  1-10)
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV) '
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/design=group (1) group (2).
Manova
* * * * * * ^ n a ; L y S i s 0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  o u t - o f - r a n g e  f a c t o r  va l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A  n  a 1 y s i s o f  V  ,
C o m b i n e d O b s e r v e d  :M e a n s  for G R O U P
V a r i a b l e .. S 2 S T A I
G R O U P
1 W G T . 3 8 . 4 7 3 6 8
U N W G T . 3 8 . 4 7 3 6 8
2 WGT. 3 5 . 2 1 0 5 3
U N W G T . 3 5 . 2 1 0 5 3
3 WGT. 3 7 . 0 0 0 0 0
U N W G T . 3 7 . 0 0 0 0 0
d e s i g n  1 * * * *
* * * * * A n a l y s i s  o f V  a r i a n c e —  d e s i g n  1 * * ■
T e s t s  of S i g n i f i c a n c e for S 2 S T A I u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F Si g o f  F
W I T H I N  C E L L S 4 4 0 3 . 8 9 54 8 1 .55
G R O U P (1) .32 1 .32 .00 . 951
G R O U P (2) 1 0 1 . 1 6 1 1 0 1 . 1 6 1.24 .270
(Model) 1 0 1 . 4 7 2 50.74 .62 .541
(Total) 4 5 0 5 . 3 7 56 8 0 . 4 5
R - S q u a r e d  = .023
A d j u s t e d  R - S q u a r e d  = .000
MANOVA
t s t a i  B Y  g r o u p  (1,3)
/CONTRAST(group)^special ( 1 1 1 1 1 - 2  1-10)
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
Manova
* * * * * * A n a l y s i s  0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a ; L y S : L S 0 f V a r i a n c e  —  d e s i g n  1 * * * *
C o m b i n e d  O b s e r v e d  M e a n s  for G R O U P  
V a r i a b l e  .. T S T A I
G R O U P
1 W G T . 3 7 . 7 3 6 8 4
U N W G T . 3 7 . 7 3 6 8 4
2 WGT. 4 3 . 9 4 7 3 7
U N W G T . 4 3 . 9 4 7 3 7
3 WGT. 4 0 . 2 6 3 1 6
U N W G T . 4 0 . 2 6 3 1 6
* * * * * A n a l y s i s  o f V a r i a n c e  — d e s i g n 1 * * ■
T e s t s  o f  S i g n i f i c a n c e for T S T A I u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g of F
W I T H I N  C E L L S 4 8 9 8 . 3 2 54 90.71
G R O U P (1) 4 . 2 5 1 4. 2 5 .05 .830
G R O U P (2) 3 6 6 . 4 2 1 3 6 6 . 4 2 4.04 .049
(Model) 3 7 0 . 6 7 2 1 8 5 . 3 3 2.04 .140
(Total) 5 2 6 8 . 9 8 56 9 4 . 0 9
R - S q u a r e d  = .070
A d j u s t e d  R - S q u a r e d  = .036
M A N O V A
s l s t a i  s 2 s t a i  B Y  g r o u p  (1 3)
/ W S F A C T O R S = t i m e s  (2)
/ C O N T R A S T  (group) =  s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ O M E A N S  T A B L E S ( g r o u p )
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ D E S I G N = g r o u p (1) g r o u p ( 2 ) .
Manova
Note: t h e r e  a r e  2 l e v e l s  for th e  T I M E S  ef f e c t .  A v e r a g e  t e s t s  ar e  i d e n t i c a l  
to th e  u n i v a r i a t e  t e s t s  of s i g n i f i c a n c e .
* * * * * * ^ n a ^ y S j _ s 0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  val u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
C o m b i n e d  O b s e r v e d  M e a n s  for G R O U P  
V a r i a b l e  .. S 1 S T A I
G R O U P
1 WGT. 3 2 . 1 5 7 8 9
UNWG T . 3 2 . 1 5 7 8 9
2 WGT. 3 2 . 8 4 2 1 1
U N W G T . 3 2 . 8 4 2 1 1
3 WGT. 3 1 . 5 2 6 3 2
U N W G T . 3 1 . 5 2 6 3 2
V a r i a b l e  .. S 2 S T A I
G R O U P
1 WGT. 3 8 . 4 7 3 6 8
U N W G T . 3 8 . 4 7 3 6 8
2 WGT. 3 5 . 2 1 0 5 3
U N W G T . 3 5 . 2 1 0 5 3
3 WGT. 3 7 . 0 0 0 0 0
U N W G T . 3 7 . 0 0 0 0 0
* * * * * * ^ n a  l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e s t s  of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  of S i g n i f i c a n c e  
S o u r c e  o f  V a r i a t i o n
for T1 u s i n g  
SS
U N I Q U E
D F
sums of 
M S
s q u a r e s
F S i g  of F
W I T H I N  C E L L S  
G R O U P (1)
5 1 7 9 . 0 5
4.21
54
1
95.91
4.21 .04 .835
G R O U P (2) 3 1 . 5 9 1 3 1 . 5 9 .33 .568
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
Page 1
T e s t s  i n v o l v i n g  ’ T I M E S '  W i t h i n - S u b j e c t  E f f e c t .
T e s t s  o f  S i g n i f i c a n c e for T2 u s i n g U N I Q U E su m s  of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 2 2 8 4 . 6 3 54 4 2 .31
T I M E S 6 3 4 . 7 5 1 6 3 4 . 7 5 1 5 . 0 0 .000
G R O U P (1) B Y  T I M E S 8.11 1 8.11 .19 .663
G R O U P (2) B Y  T I M E S 7 4 . 0 1 1 74.01 1.75 .192
Page 2
Study 1 - Tolerance Time
M A N O V A
t o l t i m e  B Y  g r o u p  (1,3)
/ C O N T R A S T ( g r o u p ) = s p e c i a 1 ( 1 1 1 1 1 - 2  1 - 1 0 )
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
Manova
* * * * * * A n a l y s i s  0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
k  k  k  k  * * A  n  a l y s i s o f  V a
C o m b i n e d O b s e r v e d M e a n s  for G R O U P
V a r i a b l e .. T O L T I M E
G R O U P
1 W G T . 1 2 3 . 2 8 6 4 7
U N W G T . 1 2 3 . 2 8 6 4 7
2 WGT. 1 2 9 . 0 0 8 0 5
U N W G T . 1 2 9 . 0 0 8 0 5
3 WGT. 1 1 6 . 4 9 8 7 4
U N W G T . 1 1 6 . 4 9 8 7 4
d e s i g n  1 * * * * *  *
* * * * * A n a l y s i s  o f V  a r i a n  c e - - d e s i g n  1 ■k -k '
T e s t s  of S i g n i f i c a n c e for T O L T I M E u s i n g U N I Q U E  sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS DF M S F Si g of F
W I T H I N  C E L L S 2 1 8 4 6 7 . 8 4 54 4 0 4 5 . 7 0
G R O U P (1) 1 1 7 9 . 1 9 1 1 1 7 9 . 1 9 .29 .592
G R O U P (2) 3 1 1 . 0 0 1 311. 0 0 .08 .783
(Model) 1 4 9 0 . 1 9 2 7 4 5 . 0 9 .18 .832
(Total) 2 1 9 9 5 8 . 0 2 56 392 7 . 8 2
R - S q u a r e d  = .007
A d j u s t e d  R - S q u a r e d  = .000
Page 1
Study 1 - Affective Visual Analogue Scale
M A N O V A
v a s a  B Y  g r o u p  (1,3)
/ C O N T R A S T ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2  1 - 1 0 )
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
Manova
* * * * * * A n a l y S ¿ s o f  V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * £ L n a l y S i s
C o m b i n e d  O b s e r v e d  M e a n s  for 
V a r i a b l e  .. V A S A
G R O U P
1 W G T . 
U N W G T .
2 WGT.
U N W G T .
3 WGT.
U N W G T .
o f  V a r i a n c e  —  d e s i g n  
G R O U P
5 6 . 1 0 5 2 6
5 6 . 1 0 5 2 6
3 7 . 6 3 6 8 4
3 7 . 6 3 6 8 4
6 0 . 6 3 1 5 8
6 0 . 6 3 1 5 8
f * * * * *  *
* * * * * A n a l y s i s  o f V  a r i a n  c e - - d e s i g n 1 'k 'k '
T e s t s  of S i g n i f i c a n c e for V A S A  u s i n g  U N I Q U E  su m s  of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F S i g of F
W I T H I N  C E L L S 3 4 9 5 2 . 3 1 54 647.27
G R O U P (1) 2 3 9 8 . 4 6 1 2 3 9 8 . 4 6 3.71 .060
G R O U P (2) 3 2 4 0 . 2 8 1 3 2 4 0 . 2 8 5.01 .029
(Model) 5 6 3 8 . 7 4 2 2 8 1 9 . 3 7 4.36 .018
(Total) 4 0 5 9 1 . 0 6 56 7 2 4 . 8 4
R - S q u a r e d  = .139
A d j u s t e d  R - S q u a r e d  = .107
Page 1
Study 1 - Skin Conductance Level
M A N O V A
s c b l 2  s c b l 3  s c b l 4  s c b l 5  s c b l 6  s c b l 7  s c b l 8  s c b l 9  s c b l l O  s c b l l l  s c b l l 2  B Y  g r o u p  
(1 3)
/ W S F A C T O R S = t i m e (11)
/ C O N T R A S T  (t i m e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U L T )
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a l y S j _ s 0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
1 c a s e  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cel l s .
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a ; L y S j _ s o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 3 1 1 2 . 4 9 54 5 7 . 6 4
G R O U P (1) .00 1 .00 .00 .999
G R O U P (2) 2 2 . 1 4 1 2 2 . 1 4 .38 .538
* * * * * * A n a ] _ y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  E f f e c t .
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
1 . 3 1 8 6 5 E - 0 7
7 9 9 . 4 6 6 8 7  w i t h  54 D. F.
.000
.15593
.16567
. 10000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  a r e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for t h e  A V E R A G E D  r e s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 1 . 4 3 8 2 4 2 0 . 6 4 4 9 1  1 . 4 3 8 2 4 .38231 3 . 7 6 1 9 3 .058
Page  1
T3 .02223 1 . 8 0 9 7 6 .02223 .03351 .66335 .419
T4 .00 7 3 5 1 . 2 1 3 2 6 .00735 .02247 .32732 .570
T5 .00230 .43040 .00230 .00797 .28860 .593
T6 .00574 .51146 .00574 .00947 .60649 .440
T7 .00020 .48003 .00020 .00889 .02196 .883
T8 .00024 .35403 .00024 .00656 .03665 .849
T9 .00030 .22383 .00030 .00414 .07322 .788
T10 .00004 .22415 .00004 .00415 .01060 .918
Til .00657 .29172 .00657 .00540 1 . 2 1 5 6 5 .275
E F F E C T  . . G R O U P (1) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 4 . 0 2 2 2 7 2 0 . 6 4 4 9 1 4 . 0 2 2 2 7 .38231 1 0 . 5 2 0 8 7 .002
T3 .00512 1 . 8 0 9 7 6 .00512 .03351 .15290 . 697
T4 .00511 1 . 2 1 3 2 6 .00511 .02247 .22749 .635
T5 .00321 .43040 .00321 .00797 .40259 .528
T6 .01403 .51146 .01403 .00947 1 . 4 8 1 3 6 .229
T7 .00070 .48003 .00070 .00889 .07821 .781
T8 .01807 .35403 .01807 .00656 2 . 7 5 6 8 7 .103
T9 .00002 .22383 .00002 .00414 .00424 .948
T10 .00014 .22415 .00014 .00415 .03298 .857
Til . 02577 .29172 .02577 .00540 4 . 7 6 9 9 7 . 033
E F F E C T  .. 
U n i v a r i a t e
T I M E
F - t e s t s  w i t h (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 2 7 . 1 2 8 7 6 2 0 . 6 4 4 9 1 2 7 . 1 2 8 7 6 .38231 7 0 . 9 5 9 5 2 . 000
T3 .86957 1 . 8 0 9 7 6 .86957 .03351 2 5 . 9 4 6 4 8 . 000
T4 .10957 1 . 2 1 3 2 6 .10957 .02247 4 . 8 7 6 8 3 .031
T5 .01992 .43040 .01992 .00797 2 . 4 9 9 3 6 .120
T6 .00629 .51146 .00629 .00947 .66459 .419
T7 .00256 .48003 .00256 .00889 .28848 .593
T8 .00002 .35403 .00002 .00656 .00285 . 958
T9 .01338 .22383 .01338 .00414 3 . 2 2 8 3 5 .078
T10 .00091 .22415 .00091 .00415 .21816 . 642
Til .01175 .29172 . 0 1 1 7 5 .00540 2 . 1 7 5 5 4 .146
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  E f fect.
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  fo
S o u r c e  of V a r i a t i o n  SS
W I T H I N  C E L L S  2 6 . 1 8
T I M E  2 8 . 1 6
G R O U P (1) B Y  T I M E  4. 0 9
G R O U P (2) B Y  T I M E  1.48
SC B  u s i n g U N I Q U E sums of s q u a r e s
D F M S F S i g  of F
540 .05
10 2.82 58.08 .000
10 .41 8.44 .000
10 .15 3.06 .001
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MANOVA
s c b l l 2  s c c l  s c c 2  B Y  g r o u p (1 3) w i t h  ( s cdifbl) 
/ W S F A C T O R S = t i m e s (3)
/ C O N T R A S  T (t i m e  s )= p o 1 y n o m i  a 1
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U L T )
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * ^ n a ] _ y s : j _ s 0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  o u t - o f - r a n g e  f a c t o r  v a l u e s .
1 c a s e  r e j e c t e d  b e c a u s e  o f  m i s s i n g  d a t a .
3 n o n - e m p t y  c e l l s .
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y s i s  o f  
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e f o r  T1 u s i n g
S o u r c e  o f  V a r i a t i o n SS
W I T H I N  C E L L S 9 9 0 . 4 3
R E G R E S S I O N 1 . 2 9
G R O U P (1) 1 . 2 9
G R O U P (2) 7 . 7 9
V  a r i a n  c e —  d e s i g n 1 * * ■
U N I Q U E s u m s  o f s q u a r e s
D F M S F S i g o f  F
53 1 8 . 6 9
1 1 . 2 9 .07 .794
1 1 . 2 9 .07 .794
1 7 . 7 9 .42 .521
R e g r e s s i o n  a n a l y s i s  f o r  W I T H I N  C E L L S  e r r o r  t e r m
---  I n d i v i d u a l  U n i v a r i a t e  . 9 5 0 0  c o n f i d e n c e  i n t e r v a l s
D e p e n d e n t  v a r i a b l e  .. T1
C O V A R I A T E B B e t a Std. Err. t - V a l u e Sig. o f  t
T S C D I F B 1 - . 1 4 8 4 7 - . 0 3 9 8 6 .565 - . 2 6 3 .794
C O V A R I A T E
T S C D I F B 1
L o w e r  - 9 5 %  
- 1 . 2 8 1
C L -  U p p e r  
.984
* * * * * * ĵ ]-i a f y s i s  o f  V a r i a n c e  d e s i g n  ] _ • * ■ * * * *  
T e s t s  i n v o l v i n g  ' T I M E S '  W i t h i n - S u b j e c t  E f f e c t .
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.49198
3 7 . 5 9 3 4 0  w i t h  2 D. F. 
. 0 0 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.66312
.69860
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for th e  A V E R A G E D  re s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 .87355 3 9 . 0 7 6 0 8 .87355 .72363 1 . 2 0 7 1 8 .277
T3 1 . 3 5 5 0 5 1 7 . 5 3 3 3 8 1 . 3 5 5 0 5 .32469 4 . 1 7 3 3 4 .046
E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2
T3
2 . 2 4 7 2 0
3 . 2 6 2 9 2
3 9 . 0 7 6 0 8
1 7 . 5 3 3 3 8
2 . 2 4 7 2 0
3 . 2 6 2 9 2
.72363
.32469
3 . 1 0 5 4 6
1 0 . 0 4 9 2 8
.084
.003
E F F E C T  .. T I M E S
U n i v a r i a t e F - t e s t s  w i t h (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F Sig. of F
T2
T3
5 3 . 2 5 4 5 1
2 4 . 2 5 5 7 4
3 9 . 0 7 6 0 8
1 7 . 5 3 3 3 8
5 3 . 2 5 4 5 1
2 4 . 2 5 5 7 4
.72363
.32469
7 3 . 5 9 3 4 4
7 4 . 7 0 3 7 9
.000
.000
o f  V a r i a n c e  - d e s i g n  1 * * * * *  *
T e s t s  i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  E f fect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of s q u a r e s  
S o u r c e  of V a r i a t i o n  SS D F  M S  F S i g  of F
W I T H I N  C E L L S  5 6 .61 
T I M E S  77.51  
G R O U P (1) B Y  T I M E S  5.51 
G R O U P (2) B Y  T I M E S  2.23
108 .52
2 3 8 . 7 6 7 3 .94 .000
2 2.76 5.26 .007
2 1.11 2.13 .124
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MANOVA
r e b l 2  r e b l 3  r e b l 4  r e b l 5  r e b l 6  r e b l 7  r e b l 8  r e b l 9  r e b l l O  r e b l l l  r e b l l 2  B Y  g r o u p  
(1 3)
/ W S F A C T O R S = t i m e (11)
/ C O N T R A S T  (t i m e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Study 1 - Respiration Rate
Manova
* * * * * * A n a ; L y S i s o f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
1 c a s e  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  be p r o c e s s e d .
* * * * * * A n a l y s i s  o f
T e s t s  of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  of S i g n i f i c a n c e  for T1 u s i n g  
S o u r c e  of V a r i a t i o n  SS
W I T H I N  C E L L S  7 4 7 6 . 2 8
G R O U P (1) 182 . 2 7
G R O U P (2) 125.64
* * * * * * A n a l y S i S  o f
V a r i a n c e -- d e s i g n 1 * *
U N I Q U E sums of s q u a r e s
D F M S F Sig of F
54 138,.45
1 182..27 1.32 .256
1 125,.64 .91 .345
V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e s t s  i n v o l v i n g  ' T I M E 1 W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p prox. = 
S i g n i f i c a n c e  =
.01837
2 0 1 . 7 1 1 3 3  w i t h  54 D. F.
.000
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.51232
.59338
.10000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 6 . 1 5 4 6 4 3 6 2 . 4 9 6 2 3 6. 1 5 4 6 4 6 . 7 1 2 8 9 .91684 .343
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T3 .01 6 1 5 1 6 8 . 1 7 4 0 0 .01615 3 . 1 1 4 3 3 .00519 .943
T4 1 . 1 4 4 0 8 1 3 7 . 7 4 0 0 4 1 . 1 4 4 0 8 2 . 5 5 0 7 4 .44853 .506
T5 .06891 8 1 . 0 3 9 5 4 .06891 1 . 5 0 0 7 3 .04592 .831
T6 .00 4 1 6 5 9 . 5 0 5 6 3 .00416 1 . 1 0 1 9 6 .00378 .951
T7 .73710 6 4 . 8 1 7 4 9 .73710 1 . 2 0 0 3 2 .61408 .437
T8 .47807 5 4 . 1 5 8 2 4 .47807 1 . 0 0 2 9 3 .47667 .493
T9 .36976 7 3 . 4 6 2 4 0 .36976 1 . 3 6 0 4 1 .27180 .604
T10 1 . 9 0 6 9 1 4 8 . 8 3 1 2 3 1 . 9 0 6 9 1 .90428 2 . 1 0 8 7 5 .152
Til .13542 4 1 . 8 8 5 0 9 .13542 .77565 .17459 .678
E F F E C T  .. G R O U P (1) B Y T I M E
U n i v a r i a t e F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 .03948 3 6 2 . 4 9 6 2 3 .03948 6 . 7 1 2 8 9 .00588 .939
T3 .13528 1 6 8 . 1 7 4 0 0 .13528 3 . 1 1 4 3 3 .04344 .836
T4 .00297 1 3 7 . 7 4 0 0 4 .00297 2 . 5 5 0 7 4 .00116 .973
T5 1 . 7 3 3 2 6 8 1 . 0 3 9 5 4 1 . 7 3 3 2 6 1 . 5 0 0 7 3 1 . 1 5 4 9 4 .287
T6 .30016 5 9 . 5 0 5 6 3 .30016 1 . 1 0 1 9 6 .27239 . 604
T7 .34971 6 4 . 8 1 7 4 9 .34971 1 . 2 0 0 3 2 .29134 .592
T8 .44782 5 4 . 1 5 8 2 4 .44782 1 . 0 0 2 9 3 .44651 .507
T9 .42356 7 3 . 4 6 2 4 0 .42356 1 . 3 6 0 4 1 .31134 .579
T10 .57581 4 8 . 8 3 1 2 3 .57581 .90428 .63676 .428
Til .58109 4 1 . 8 8 5 0 9 .58109 .77565 .74916 .391
E F F E C T  .. T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  MS F Sig. of F
T2 4 2 . 5 6 7 2 1 3 6 2 . 4 9 6 2 3 4 2 . 5 6 7 2 1 6 . 7 1 2 8 9 6 . 34111 .015
T3 2 . 8 2 5 1 0 1 6 8 . 1 7 4 0 0 2 . 8 2 5 1 0 3 . 1 1 4 3 3 .90713 .345
T4 1 . 4 5 5 9 2 1 3 7 . 7 4 0 0 4 1 . 4 5 5 9 2 2 . 5 5 0 7 4 .57078 .453
T5 5 . 5 6 0 9 4 8 1 . 0 3 9 5 4 5 . 5 6 0 9 4 1 . 5 0 0 7 3 3 . 7 0 5 4 9 .060
T6 1 . 1 6 1 0 1 5 9 . 5 0 5 6 3 1 . 16101 1 . 1 0 1 9 6 1 . 0 5 3 5 9 .309
T7 2 . 4 0 7 8 1 6 4 . 8 1 7 4 9 2 . 4 0 7 8 1 1 . 2 0 0 3 2 2 . 0 0 5 9 7 .162
T8 .01057 5 4 . 1 5 8 2 4 .01057 1 . 0 0 2 9 3 .01054 .919
T9 .94843 7 3 . 4 6 2 4 0 .94843 1 . 3 6 0 4 1 .69716 .407
T10 .00147 4 8 . 8 3 1 2 3 .00147 .90428 .00163 .968
Til .00038 4 1 . 8 8 5 0 9 .00038 .77565 .00049 . 982
k  k  'k -k k * A  n  a 1 y s i s  o f V a r i a n e e  —  d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for R E B  u s i n g U N I Q U E  sums of s q u a r e s
S o u r c e  of: V a r i a t i o n SS DF M S F Si g or b
W I T H I N  C E L L S 1 0 9 2 . 1 1 540 2.02
TIME 56.94 10 5.69 2 .82 .002
G R O U P (1) B Y  T I M E 4.59 10 .46 .23 .994
G R O U P (2) B Y  T I M E 11.02 10 1.10 . 54 . 858
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M A N O V A
r e b l l 2  r e e l  r e c 2  B Y  g r o u p (1 3) w i t h  (redifbl) 
/ W S F A C T O R S = t i m e s (3)
/ C O N T R A S T  ( t i m e s ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U L T )
/ d e s i g n = g r o u p (1) g r o u p (2).
Manova
* * * * * * A n a l y s i s  0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
1 c a s e  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
★ ★ ★ ★ ★ ★ A  n  a 1 y s i s o f V a r i a n  c e —  d e s i g n 1 * * *
T e s t s  o f  B e t w e e n - S u b j e c t s E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e  for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F S i g O f  F
W I T H I N  C E L L S 1 6 5 2 . 7 3 53 3 1 .18
R E G R E S S I O N .29 1 .29 .01 .924
G R O U P (1) 1 7 .22 1 17.22 .55 .461
G R O U P (2) .00 1 .00 .00 .996
R e g r e s s i o n a n a l y s i s  for W I T H I N  C E L L S e r r o r t e r m
---  I n d i v i d u a l  U n i v a r i a t e  .9500 c o n f i d e n c e i n t e r v a l s
D e p e n d e n t v a r i a b l e  .. T1
C O V A R I A T E B B e t a Std. Err. t - V a l u e Sig., of t
T R E D I F B 1 .01 5 6 9 .01339 .163 .096 .924
C O V A R I A T E L o w e r  - 9 5 % C L -  U p p e r
T R E D I F B 1 - . 3 1 1 .342
* * * * * * j ^ j - ^ a 2 y s i s  o f  V a r i a n c e  d e s i g n  ^ * * * * 
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  E f f e c t .
M a u c h l y  s p h e r i c i t y  t e s t ,  W = . 8 4 4 2 6
C h i - s q u a r e  a p p r o x .  = 8 . 9 7 2 4 4  w i t h  2 D. F.
S i g n i f i c a n c e  =  .011
G r e e n h o u s e - G e i s s e r  E p s i l o n  = .86525 
H u y n h - F e l d t  E p s i l o n  = .92442 
L o w e r - b o u n d  E p s i l o n  = .50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  r e s ults.
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. o f  F
T2 1 5 . 9 6 4 8 5 4 4 8 . 2 5 0 8 8 1 5 . 9 6 4 8 5 8 . 3 0 0 9 4 1 . 9 2 3 2 6 .171
T3
E F F E C T  .. 
U n i v a r i a t e
2 9 . 4 0 2 4 1  5 1 1 . 5 9 9 1 1
G R O U P (1) B Y  T I M E S  
F - t e s t s  w i t h  (1,54) D
2 9 . 4 0 2 4 1  
. F.
9 . 4 7 4 0 6 3 . 1 0 3 4 7 .084
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  MS E r r o r  MS F Sig. o f  F
T2 4 1 . 7 2 0 4 0 4 4 8 . 2 5 0 8 8 4 1 . 7 2 0 4 0 8 . 3 0 0 9 4 5 . 0 2 5 9 8 .029
T3 4 . 2 9 0 8 0 5 1 1 . 5 9 9 1 1 4 . 2 9 0 8 0 9 . 4 7 4 0 6 .45290 .504
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  MS E r r o r  M S F Sig. of F
T2 2 . 7 1 2 0 3 4 4 8 . 2 5 0 8 8 2 . 7 1 2 0 3 8.3 0 0 9 4 .32671 .570
T3 .75351 5 1 1 . 5 9 9 1 1 .75351 9 . 4 7 4 0 6 .07953 .779
* * * * * * A n a l y s i s  o f V  a r i a n  c e -- d e s i g n 1 * * *
T ests i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for MEAS. 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F Si g of F
W I T H I N  C E L L S 9 5 9 . 8 5 108 8.89
T I M E S 3.47 2 1.73 .19 . 823
G R O U P (1) B Y  T I M E S 4 6 .01 2 23.01 2 . 5 9 .080
G R O U P (2) B Y  T I M E S 45.37 2 22.68 2.55 .083
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Study 1 - Heart Rate
M A N O V A
h r b l 2  h r b l 3  h r b l 4  h r b l 5  h r b l 6  h r b l 7  h r b l 8  h r b l 9  h r b l l O  h r b l l l  h r b l l 2  B Y  g r o u p  
(1 3)
/ W S F A C T O R S = t i m e (11)
/ C O N T R A S T  ( t i m e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a l y S j _ s 0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v alues.
1 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a l y s i s o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e  
S o u r c e  o f  V a r i a t i o n
for T1 u s i n g  
SS
U N I Q U E
D F
sums of 
M S
s q u a r e s
F Si g of F
W I T H I N  C E L L S  
G R O U P (1)
6 0 7 8 0 . 9 0
7 6 9 0 . 9 7
54
1
1 1 05.11
7 6 9 0 . 9 7 6.96 .011
G R O U P (2) 2 1 1 . 4 6 1 2 1 1 . 4 6 .19 . 664
■ * * * * * A n a l y s i s  o f V  a r i a n  c e —  d e s i g n 1 * *
T e s t s  i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  E f fect.
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  re s u l t s .
.08584
1 2 6 . 3 6 6 4 2  w i t h  54 D. F. 
. 0 0 0
.63236 
.74937 
.10000
E F F E C T  .. G R O U P (2) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS H y p o t h .  M S  E r r o r  M S F Sig. of F
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T2 1 3 . 9 0 0 6 6 8 8 3 . 3 3 0 1 4 1 3 . 9 0 0 6 6 1 6 . 0 6 0 5 5 .86552 .356T3 3 . 6 7 3 3 3 4 2 2 . 9 8 4 5 4 3 . 6 7 3 3 3 7 . 6 9 0 6 3 .47764 .492T4 4 . 5 0 7 6 7 3 7 2 . 5 0 0 4 2 4 . 5 0 7 6 7 6 . 7 7 2 7 3 .66556 .418T5 .68688 3 2 6 . 8 6 1 0 8 .68688 5 . 9 4 2 9 3 .11558 .735T6 2 . 4 9 4 6 2 2 7 8 . 1 2 5 9 0 2 . 4 9 4 6 2 5 . 0 5 6 8 3 .49332 .485T7 2 5 . 0 9 9 2 3 3 0 3 . 0 6 5 8 8 2 5 . 0 9 9 2 3 5 . 5 1 0 2 9 4 . 5 5 4 9 8 .037T8 .04017 2 9 6 . 6 2 5 8 0 .04017 5 . 3 9 3 2 0 .00745 .932
T9 .34368 2 3 5 . 5 4 6 9 7 .34368 4 . 2 8 2 6 7 .08025 .778
T10 3 . 6 4 4 3 1 2 7 5 . 7 8 9 6 3 3 . 6 4 4 3 1 5 . 0 1 4 3 6 .72677 .398
Til 4 . 4 0 1 1 0 2 2 9 . 8 2 3 4 7 4 . 4 0 1 1 0 4 . 1 7 8 6 1 1 . 0 5 3 2 5 .309
E F F E C T  .. G R O U P (1) B Y T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D,. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  MS E r r o r  M S F Sig. o f  F
T2 5 . 6 4 7 2 4 8 8 3 . 3 3 0 1 4 5 . 6 4 7 2 4 1 6 . 0 6 0 5 5 .35162 .556
T3 .64234 4 2 2 . 9 8 4 5 4 .64234 7 . 6 9 0 6 3 .08352 .774
T4 .99789 3 7 2 . 5 0 0 4 2 .99789 6 . 7 7 2 7 3 .14734 .703
T5 9 . 6 9 0 3 9 3 2 6 . 8 6 1 0 8 9 . 6 9 0 3 9 5 . 9 4 2 9 3 1 . 6 3 0 5 8 .207
T6 1 . 1 7 5 3 4 2 7 8 . 1 2 5 9 0 1. 1 7 5 3 4 5 . 0 5 6 8 3 .23243 . 632
T7 .55348 3 0 3 . 0 6 5 8 8 .55348 5 . 5 1 0 2 9 .10044 .752
T8 8 . 2 5 6 9 2 2 9 6 . 6 2 5 8 0 8 . 2 5 6 9 2 5 . 3 9 3 2 0 1 . 5 3 0 9 9 .221
T9 1 4 . 2 5 6 8 2 2 3 5 . 5 4 6 9 7 1 4 . 2 5 6 8 2 4 . 2 8 2 6 7 3 . 3 2 8 9 5 .074
T10 .11516 2 7 5 . 7 8 9 6 3 .11516 5 . 0 1 4 3 6 .02297 .880
Til 1 . 2 1 4 2 5 2 2 9 . 8 2 3 4 7 1 . 2 1 4 2 5 4.1 7 8 6 1 .29059 .592
E F F E C T  .. T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T2 3 2 5 . 9 1 1 4 6 8 8 3 . 3 3 0 1 4 3 2 5 . 9 1 1 4 6 1 6 . 0 6 0 5 5 2 0 . 2 9 2 6 7 . 000
T3 1 1 . 4 6 9 4 3 4 2 2 . 9 8 4 5 4 1 1 . 4 6 9 4 3 7 . 6 9 0 6 3 1 . 4 9 1 3 5 .227
T4 6 . 2 9 3 7 3 3 7 2 . 5 0 0 4 2 6 . 2 9 3 7 3 6 . 7 7 2 7 3 .92927 .339
T5 3 . 7 5 1 6 3 3 2 6 . 8 6 1 0 8 3 . 7 5 1 6 3 5 . 9 4 2 9 3 .63128 .430
T6 3 6 . 2 0 2 5 6 2 7 8 . 1 2 5 9 0 3 6 . 2 0 2 5 6 5 . 0 5 6 8 3 7 . 1 5 9 1 4 .010
T7 4 . 8 4 6 5 6 3 0 3 . 0 6 5 8 8 4 . 8 4 6 5 6 5 . 5 1 0 2 9 .87955 .352
T8 .02553 2 9 6 . 6 2 5 8 0 .02553 5 . 3 9 3 2 0 .00473 .945
T9 5 . 5 4 1 1 7 2 3 5 . 5 4 6 9 7 5 . 5 4 1 1 7 4 . 2 8 2 6 7 1 . 2 9 3 8 6 .260
T10 4 . 0 2 6 3 5 2 7 5 . 7 8 9 6 3 4 . 0 2 6 3 5 5 . 0 1 4 3 6 .80296 .374
Til .17306 2 2 9 . 8 2 3 4 7 .17306 4.1 7 8 6 1 .04142 .839
k * * * * * A  n a 1 y s i s  o f V a r i a n e e - -  d e s i g n  1 * * * ★ 'k 'k
rests i n v o l v i n g  ’TIME' W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  o f  S i g n i f i c a n c e  for H R B  u s i n g U N I Q U E  sums of s q u a r e s
S o u r c e  ofr V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 3 6 2 4 . 6 5 550 6.59
TI M E 3 9 8 . 2 4 10 39.82 6 .04 .000
G R O U P (1) B Y  T I M E 4 2 . 5 5 10 4.25 .65 .775
G R O U P (2) B Y  T I M E 5 8 . 7 9 10 5.88 .89 .540
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MANOVA
h r b l l 2  h r c l  h r c 2  B Y  g r o u p (1 3) w i t h  (hravebl) 
/ W S F A C T O R S = t i m e s (3)
/CONTRAST (t i m e s )= p o l y n o m i a l
/CONTRAST ( g r o u p ) = s p e c ia l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/METHOD UNIQUE 
/ERROR W IT H IN  
/P R IN T
S IG N IF ( U N IV  )
/N O P R IN T PARAM (ESTIM )
S IG N IF ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a l y s i s  Q f  V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a lues.
1 c a s e  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a ; L y S ^ s o f  V a r i a n c e - -  d e s i g n  1 * * * * 
T e s t s  of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  of S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 4 7 0 7 . 2 8 53 88.82
R E G R E S S I O N 1 0 6 3 0 . 6 7 1 1 0 6 3 0 . 6 7 1 1 9 . 6 9 .000
G R O U P (1) 2 4 3 . 0 4 1 243 . 0 4 2.74 .104
G R O U P (2) 2 2 5 . 0 5 1 2 2 5 . 0 5 2.53 .117
R e g r e s s i o n  a n a l y s i s  for W I T H I N  C E L L S  e r r o r  t e r m
---  I n d i v i d u a l  U n i v a r i a t e  .9500 c o n f i d e n c e  i n t e r v a l s
D e p e n d e n t  v a r i a b l e  .. T1
C O V A R I A T E B B e t a Std. Err. t - V a l u e Sig. of t
T H R A V E B 1 .88777 .86631 .081 10.940 .000
C O V A R I A T E L o w e r  -95% C L -  U p p e r
T H R A V E B 1 .725 1.051
* * * * * * A n a ] _ y S i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * 
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  Ef f e c t .
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.98005
1 . 0 6 7 8 7  w i t h  2 D. F. 
.586
G r e e n h o u s e - G e i s s e r  E p s i l o n  = .98044 
H u y n h - F e l d t  E p s i l o n  = 1 . 0 0 0 0 0  
L o w e r - b o u n d  E p s i l o n  = .50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  a re e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  r e s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T2 9 6 . 1 5 4 7 9 2 7 2 6 . 2 1 3 7 3 9 6 . 1 5 4 7 9 5 0 . 4 8 5 4 4 1 . 9 0 4 6 0 .173
T3
E F F E C T  .. 
U n i v a r i a t e
7 9 . 9 6 1 5 3  3 5 9 5 . 2 9 3 5 9
G R O U P (1) B Y  T I M E S  
F - t e s t s  w i t h  (1,54) D,
7 9 . 9 6 1 5 3  
. F.
66 . 5 7 9 5 1 1 . 2 0 0 9 9 .278
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  MS F Sig. of F
T2 5 6 . 9 4 8 1 9 2 7 2 6 . 2 1 3 7 3 5 6 . 9 4 8 1 9 5 0 . 4 8 5 4 4 1. 1 2 8 0 1 .293
T3 5 6 2 . 5 4 8 8 8 3 5 9 5 . 2 9 3 5 9 5 6 2 . 5 4 8 8 8 6 6 . 57951 8 . 4 4 9 2 8 .005
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H ypoth. MS E r r o r  M S F Sig. of F
T2 1 1 2 1 . 0 8 1 8 5 2 7 2 6 . 2 1 3 7 3 1 1 2 1 . 0 8 1 8 5 5 0 . 4 8 5 4 4 2 2 . 2 0 6 0 4 .000
T3 2 7 8 9 . 8 3 2 3 2 3 5 9 5 . 2 9 3 5 9 2 7 8 9 . 8 3 2 3 2 66.57 9 5 1 4 1 . 9 0 2 2 7 .000
* * * * * * ^ n a ] _ y s i s o f  V a r i a n c e - -  d e s i g n  1 * * * * *  * 
Tests i n v o l v i n g  ’TIMES' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  of V a r i a t i o n  SS
W I T H I N  C E L L S  632 1 . 5 1
TIMES 3 9 1 0 . 9 1
G R O U P (1) B Y  T I M E S  619 . 5 0
G R O U P (2) B Y  T I M E S  176.12
DF M S F S i g  of F
108
2
58.53
1 9 5 5 . 4 6 33.41 .000
2 309 . 7 5 5.29 .006
2 88.06 1.50 .227
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Study 1 - Systolic Blood Pressure
M A N O V A
s b b l 2  s b b l 3  s b b l 4  s b b l 5  s b b l 6  s b b l 7  s b b l 8  s b b l 9  s b b l l O  s b b l l l  s b b l l 2  B Y  g r o u p  
(1 3)
/ W S F A C T O R S = t i m e (11)
/ C O N T R A S T  ( t i m e ) p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * j ^ n a ^ y S ^ s 0 f V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  va l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a ; L y S : j_s o f  V a r i a n c e - -  d e s i g n  1 * * * * * * 
Tests o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e sts o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
of FS o u r c e  of V a r i a t i o n SS D F M S F S i g
W I T H I N  C E L L S 1 4 9 3 6 8 . 2 4 54 2 7 6 6 . 0 8
G R O U P (1) 4 5 3 6 . 0 5 1 4 5 3 6 . 0 5 1.64 .206
G R O U P (2) 3 3 4 3 . 4 4 1 3 3 4 3 . 4 4 1.21 .276
* * * * * A n a l y s i s  o f V  a r i a n c e —  d e s i g n 1 * * ■
Tests i n v o l v i n g  ’TIME' W i t h i n - S u b j e c t  E f fect.
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t —p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for th e  A V E R A G E D  r e s u l t s .
.00382
2 8 0 . 9 7 9 6 8  w i t h  54 D. F. 
. 0 0 0
.35830
.40112
. 1 0 0 0 0
E F F E C T  .. G R O U P (2) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 5 1 . 1 9 9 3 5 3 2 7 4 . 3 0 5 0 9 5 1 . 1 9 9 3 5 6 0 . 6 3 5 2 8 .84438 .362
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T3 1 . 6 9 0 6 8 8 9 2 . 6 9 5 4 4
T4 1 1 . 3 5 3 0 5 7 2 9 . 0 2 8 1 6
T5 .55641 3 1 0 . 3 4 1 8 1
T6 8 . 4 8 4 0 6 4 8 0 . 4 9 8 7 1
T7 2 . 4 5 5 0 7 3 0 3 . 8 7 8 4 9
T8 2 . 8 2 0 2 0 4 5 3 . 4 5 5 2 5
T9 8 . 7 9 6 2 3 2 0 9 . 7 4 7 3 5
T10 2 . 8 2 5 8 0 3 4 2 . 3 2 1 5 1
Til 5 . 9 2 1 2 4 1 7 0 . 4 7 3 8 8
1 . 6 9 0 6 8 1 6 . 5 3 1 4 0 .10227 .750
1 1 . 3 5 3 0 5 1 3 . 5 0 0 5 2 .84093 .363
.55641 5 . 7 4 7 0 7 .09682 .757
8 . 4 8 4 0 6 8 . 8 9 8 1 2 .95347 .333
2 . 4 5 5 0 7 5 . 6 2 7 3 8 .43627 .512
2 . 8 2 0 2 0 8 . 3 9 7 3 2 .33585 .565
8 . 7 9 6 2 3 3 . 8 8 4 2 1 2 . 2 6 4 6 1 .138
2 . 8 2 5 8 0 6 . 3 3 9 2 9 .44576 .507
5 . 9 2 1 2 4 3 . 1 5 6 9 2 1 . 8 7 5 6 3 .176
E F F E C T  .. iG R O U P (1) B Y T I M E
U n i v a r i a t e F - t e s t s  w i t h  (1,54) D,. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 5 4 . 6 7 8 2 8 3 2 7 4 . 3 0 5 0 9 5 4 . 6 7 8 2 8 6 0 . 6 3 5 2 8 .90176 .347
T3 .55067 8 9 2 . 6 9 5 4 4 .55067 1 6 . 5 3 1 4 0 .03331 .856
T4 7 . 5 0 7 9 3 7 2 9 . 0 2 8 1 6 7 . 5 0 7 9 3 1 3 . 5 0 0 5 2 .55612 .459
T5 .185 2 6 3 1 0 . 3 4 1 8 1 .18526 5 . 7 4 7 0 7 .03224 .858
T6 4 . 5 8 7 5 4 4 8 0 . 4 9 8 7 1 4 . 5 8 7 5 4 8 . 8 9 8 1 2 .51556 .476
T7 .05 4 5 5 3 0 3 . 8 7 8 4 9 .05455 5 . 6 2 7 3 8 .00969 .922
T8 .83004 4 5 3 . 4 5 5 2 5 .83004 8 . 3 9 7 3 2 .09885 .754
T9 .57707 2 0 9 . 7 4 7 3 5 .57707 3 . 8 8 4 2 1 .14857 .701
T10 6 . 0 1 6 4 9 3 4 2 . 3 2 1 5 1 6 . 0 1 6 4 9 6 . 3 3 9 2 9 .94908 .334
Til 1 . 8 5 9 2 0 1 7 0 . 4 7 3 8 8 1 . 8 5 9 2 0 3 . 1 5 6 9 2 .58893 .446
E F F E C T  .. T I M E
U n i v a r i a t e F - t e s t s  w i t h  (1,54) D . F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 1 . 1 9 7 4 8 3 2 7 4 . 3 0 5 0 9 1 . 1 9 7 4 8 6 0 . 6 3 5 2 8 .01975 .889
T3 7 6 . 0 2 3 1 1 8 9 2 . 6 9 5 4 4 7 6 . 0 2 3 1 1 1 6 . 5 3 1 4 0 4 . 5 9 8 7 1 .037
T4 1 . 0 9 5 6 6 7 2 9 . 0 2 8 1 6 1 . 0 9 5 6 6 1 3 . 5 0 0 5 2 .08116 .777
T5 2 7 . 3 0 1 1 4 3 1 0 . 3 4 1 8 1 2 7 . 3 0 1 1 4 5 . 7 4 7 0 7 4 . 7 5 0 4 5 .034
T6 2 5 . 2 7 9 6 9 4 8 0 . 4 9 8 7 1 2 5 . 2 7 9 6 9 8 . 8 9 8 1 2 2 . 8 4 1 0 1 .098
T7 3 . 2 2 3 7 4 3 0 3 . 8 7 8 4 9 3 . 2 2 3 7 4 5 . 6 2 7 3 8 .57287 .452
T8 .09078 4 5 3 . 4 5 5 2 5 .09078 8 . 3 9 7 3 2 .01081 .918
T9 4 . 3 9 4 0 8 2 0 9 . 7 4 7 3 5 4 . 3 9 4 0 8 3 . 8 8 4 2 1 1 . 1 3 1 2 7 .292
T10 1 7 . 4 3 8 4 4 3 4 2 . 3 2 1 5 1 1 7 . 4 3 8 4 4 6 . 3 3 9 2 9 2 . 7 5 0 8 5 .103
Til .13573 1 7 0 . 4 7 3 8 8 .13573 3 . 1 5 6 9 2 .04299 .837
k k ~k k ~k k A  n  a 1 y s i s  o f V a r i a n e e  —  -d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  E f fect.
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  for S B B  u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 7 1 6 6 . 7 5 540 13.27
TIME 1 5 6 . 1 8 10 15.62 1.18 .304
G R O U P (1) B Y  T I M E 7 6 . 8 5 10 7.68 .58 .832
G R O U P (2) B Y  T I M E 9 6 . 1 0 10 9.61 .72 .702
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M A N O V A
s b b l l 2  s b c l  s b c 2  B Y  g r o u p (1 3)
/ W S F A C T O R S = t i m e s (3)
/ C O N T R A S T  ( t i m e s ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U L T )
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a 2. y S j _ s o f  V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A . n a l y s i s  o f
T e sts of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e  for T1 u s i n g  
S o u r c e  o f  V a r i a t i o n  SS
W I T H I N  C E L L S  4 9 6 2 2 . 7 4
G R O U P (1) 2 3 6 7 . 6 9
G R O U P (2) 5 9 6 . 2 8
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e sts i n v o l v i n g  ’T I M E S ’ W i t h i n - S u b j e c t  E f f e c t .
V a r i a n c e —  d e s i g n 1 * • * ■ • * • * * *
U N I Q U E sums of s q u a r e s
D F M S F S i g of F
54 918,.94
1 2367,.69 2.58 .114
1 596,.28 .65 .424
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.62983
2 4 . 5 0 2 3 3  w i t h  2 D. F. 
. 0 0 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.72984
.77275
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for t h e  A V E R A G E D  r e s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS H y p o t h .  M S  E r r o r  M S F Sig. of F
Page 3
T2
T3
5 0 . 4 6 9 2 0  7 0 5 0 . 6 4 8 1 4  5 0 . 4 6 9 2 0  1 3 0 . 5 6 7 5 6
9 . 6 7 8 0 9  2 0 4 3 . 1 9 8 0 4  9 . 6 7 8 0 9  3 7 . 8 3 7 0 0
.38654
.25578
.537
.615
E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e
T2
T3
H y p o t h .  SS
8 . 8 7 4 2 0
1 6 6 . 8 9 1 8 7
E r r o r  SS
7 0 5 0 . 6 4 8 1 4
2 0 4 3 . 1 9 8 0 4
H y p o t h .  M S
8 . 8 7 4 2 0
1 6 6 . 8 9 1 8 7
E r r o r  M S
1 3 0 . 5 6 7 5 6
3 7 . 8 3 7 0 0
F
.06797
4 . 4 1 0 8 1
Sig. o f  F
.795
.040
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e
T2
T3
H y p o t h .  SS
3 9 9 . 9 6 3 0 4
.39207
E r r o r  SS
7 0 5 0 . 6 4 8 1 4
2 0 4 3 . 1 9 8 0 4
H y p o t h .  M S
3 9 9 . 9 6 3 0 4
.39207
E r r o r  M S
1 3 0 . 5 6 7 5 6
3 7 . 8 3 7 0 0
F
3 . 0 6 3 2 7
.01036
Sig. of F
.086
.919
* * * * * * ^ n a l y s i s  o f  V a r i a n c e  —  d e s i g n  ] _ * * * * * *  
T e sts i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  E f f e c t .
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums o f  s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g  o f  F
W I T H I N  C E L L S 9 0 9 3 . 8 5 108 8 4 . 2 0
T I M E S 4 0 0 . 3 6 2 2 0 0 . 1 8 2.38 .098
G R O U P (1) B Y  T I M E S 1 7 5 . 7 7 2 87.88 1.04 .356
G R O U P (2) B Y  T I M E S 6 0 . 1 5 2 30.07 .36 .700
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Study 1 - Diastolic Blood Pressure
M A N O V A
d b b l 2  d b b l 3  d b b l 4  d b b l 5  d b b l 6  d b b l 7  d b b l 8  d b b l 9  d b b l l O  d b b l l l  d b b l l 2  B Y  g r o u p  
(1 3)
/ W S F A C T O R S = t i m e (11)
/ C O N T R A S T  (time) p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) ^ s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a l y s i s  0 f  V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  val u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y S i s o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e sts of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  of S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F MS F S i g of F
W I T H I N  C E L L S 8 8 9 9 1 . 2 5 54 1 6 4 7 . 9 9
G R O U P (1) 3 2 0 6 . 0 3 1 3 2 0 6 . 0 3 1.95 .169
G R O U P (2) 1 1 3 4 . 0 0 1 1 1 3 4 . 0 0 .69 .410
★ ★ ★ ★ * A  n  a 1 y s i s  o f V  a r i a n c e -- d e s i g n 1 * * ■
T e s t s  i n v o l v i n g  ' T I M E ’ W i t h i n - S u b j e c t  E f fect.
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t -p l o t  or m i x e d —m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  re s u l t s .
.04316
1 5 8 . 6 0 8 4 0  w i t h  54 D. F. 
. 00 0
.53867 
.62749 
. 1 0 0 0 0
E F F E C T  .. G R O U P (2) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 1 7 . 7 0 1 0 6 6 7 8 . 2 3 1 2 2 1 7 . 7 0 1 0 6 1 2 . 5 5 9 8 4 1 . 4 0 9 3 4  .240
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T3 1 2 . 2 0 4 5 2 3 6 7 . 1 2 3 7 6 1 2 . 2 0 4 5 2 6 . 7 9 8 5 9 1 . 7 9 5 1 6 .186
T4 .99748 1 8 5 . 6 2 1 4 7 .99748 3 . 4 3 7 4 3 .29018 .592
T5 . 1 3 5 5 6 1 2 5 . 0 1 5 0 4 .13556 2 . 3 1 5 0 9 .05855 .810
T6 1 . 2 5 2 7 1 1 6 6 . 1 5 9 8 6 1 . 2 5 2 7 1 3 . 0 7 7 0 3 .40712 .526
T7 .11 1 6 3 1 6 7 . 2 8 9 4 7 .11163 3 . 0 9 7 9 5 .03603 .850
T8 8 . 3 7 8 8 3 1 1 4 . 1 2 9 5 2 8 . 3 7 8 8 3 2 . 1 1 3 5 1 3 . 9 6 4 4 1 .052
T9 .16413 1 1 2 . 3 7 9 7 1 .16413 2 . 0 8 1 1 1 .07887 .780
T10 . 0 0 5 4 5 1 9 5 . 4 6 2 5 5 .00545 3 . 6 1 9 6 8 .00150 .969
Til .78097 1 5 1 . 1 1 6 8 0 .78097 2 . 7 9 8 4 6 .27907 .599
E F F E C T  .. G R O U P (1) B Y T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. o f  F
T2 .47224 6 7 8 . 2 3 1 2 2 .47224 1 2 . 5 5 9 8 4 .03760 .847
T3 .817 0 9 3 6 7 . 1 2 3 7 6 .81709 6 . 7 9 8 5 9 .12018 .730
T4 .65136 1 8 5 . 6 2 1 4 7 .65136 3 . 4 3 7 4 3 .18949 .665
T5 1 6 . 9 0 5 1 7 1 2 5 . 0 1 5 0 4 1 6 . 9 0 5 1 7 2 . 3 1 5 0 9 7 . 3 0 2 1 5 .009
T6 2 . 1 0 3 9 1 1 6 6 . 1 5 9 8 6 2 . 1 0 3 9 1 3 . 0 7 7 0 3 .68375 .412
T7 .13758 1 6 7 . 2 8 9 4 7 .13758 3 . 0 9 7 9 5 .04441 .834
T8 .01680 1 1 4 . 1 2 9 5 2 .01680 2 . 1 1 3 5 1 .00795 .929
T9 .03159 1 1 2 . 3 7 9 7 1 .03159 2 . 0 8 1 1 1 .01518 .902
T10 3 . 2 6 7 3 1 1 9 5 . 4 6 2 5 5 3 . 2 6 7 3 1 3 . 6 1 9 6 8 .90265 .346
Til .04449 1 5 1 . 1 1 6 8 0 .04449 2 . 7 9 8 4 6 .01590 .900
E F F E C T  .. T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D., F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F Sig. of F
T2 2 5 . 2 6 4 4 2 6 7 8 . 2 3 1 2 2 2 5 . 2 6 4 4 2 1 2 . 5 5 9 8 4 2 . 0 1 1 5 2 .162
T3 8 . 7 4 6 1 3 3 6 7 . 1 2 3 7 6 8 . 7 4 6 1 3 6 . 7 9 8 5 9 1 . 2 8 6 4 6 .262
T4 1 4 . 6 4 8 1 6 1 8 5 . 6 2 1 4 7 1 4 . 6 4 8 1 6 3 . 4 3 7 4 3 4 . 2 6 1 3 6 .044
T5 7 . 1 7 9 2 0 1 2 5 . 0 1 5 0 4 7 . 1 7 9 2 0 2 . 3 1 5 0 9 3 . 1 0 1 0 4 .084
T6 5 . 0 5 8 9 8 1 6 6 . 1 5 9 8 6 5 . 0 5 8 9 8 3 . 0 7 7 0 3 1 . 6 4 4 1 1 .205
T7 1 0 . 5 5 3 9 3 1 6 7 . 2 8 9 4 7 1 0 . 5 5 3 9 3 3 . 0 9 7 9 5 3 . 4 0 6 7 4 .070
T8 .52505 1 1 4 . 1 2 9 5 2 .52505 2 . 1 1 3 5 1 .24843 . 620
T9 2 . 7 2 7 6 0 1 1 2 . 3 7 9 7 1 2 . 7 2 7 6 0 2 . 0 8 1 1 1 1 . 3 1 0 6 5 .257
T10 2 . 3 7 2 0 9 1 9 5 . 4 6 2 5 5 2 . 3 7 2 0 9 3 . 6 1 9 6 8 .65533 .422
Til 2 . 6 2 9 4 9 1 5 1 . 1 1 6 8 0 2 . 6 2 9 4 9 2 . 7 9 8 4 6 .93962 .337
* A  n  a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 k  k  k * * *
Tests i n v o l v i n g  ’TIME' W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for D B B  u s i n g U N I Q U E  sums of s q u a r e s
S o u r c e  of' V a r i a t i o n SS D F M S F Si g or h
W I T H I N  C E L L S 2 2 6 2 . 5 3 540 4.19
TIME 7 9 .71 10 7.97 1.90 . 042
G R O U P (1) B Y  T I M E 2 4 . 4 5 10 2.44 .58 .828
G R O U P (2) B Y  T I M E 4 1 . 7 3 10 4.17 1.00 .446
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M A N O V A
d b b l l 2  d b c l  d b c 2  B Y  g r o u p (1 3)
/ W S F A C T O R S = = t i m e s  (3)
/C O N T R A S  T (t i m e  s )= p o 1 y n o m i  a 1
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U L T )
/ d e s i g n = g r o u p (1) g r o u p (2).
Manova
* * * * * * ^ n a 2 y S j [ s o f  V a r i a n c e * * * * * *
57 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  c e l l s .
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y s i s  o f V  a r i a n c e —  d e s i g n 1 Jr Jr ■
Tests of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e f or T1 u s i n g U N I Q U E s u m s  of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g O f  F
W I T H I N  C E L L S 3 2 5 4 8 . 8 9 54 6 0 2 . 7 6
G R O U P (1) 1 9 4 4 . 3 3 1 1 9 4 4 . 3 3 3.23 .078
G R O U P (2) 4 5 1 . 8 5 1 4 5 1 . 8 5 .75 .390
J r J r J r J r J r J r j ^ n a l y S i s  o f V  a r i a n c e —  d e s i g n 1 'k 'k
■Jr Jr
Jr Jr
Jk-
Jr
Tests i n v o l v i n g  ’T I M E S ’ W i t h i n - S u b j e c t  E f f e c t .
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.67763 
2 0 . 6 2 5 1 2  
.000
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.75622
.80218
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  a r e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t —p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. fo r  t h e  A V E R A G E D  r e s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS H y p o t h .  M S  E r r o r  M S
T2 2 . 0 5 1 6 1  2 6 8 2 . 4 4 9 3 5  2 . 0 5 1 6 1  4 9 . 6 7 4 9 9
T3 1 . 2 8 4 5 0  1 0 0 7 . 0 6 3 4 1  1 . 2 8 4 5 0  1 8 . 6 4 9 3 2
F Sig. o f  F
0 4 1 3 0 .840
0 6 8 8 8 .794
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E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,54) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  MS E r r o r  M S F Sig. o f  F
T2 9 . 8 4 6 1 9 2 6 8 2 . 4 4 9 3 5 9 . 8 4 6 1 9 4 9 . 6 7 4 9 9 .19821 . 658
T3
E F F E C T  .. 
U n i v a r i a t e
1 0 0 . 2 2 1 4 0  1 0 0 7 . 0 6 3 4 1  
T I M E S
F - t e s t s  w i t h  (1,54) D.
1 0 0 . 2 2 1 4 0  
. F.
1 8 . 6 4 9 3 2 5 . 3 7 4 0 0 .024
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  MS F Sig. of F
T2 1 2 4 6 . 1 6 6 2 9 2 6 8 2 . 4 4 9 3 5 1 2 4 6 . 1 6 6 2 9 4 9 . 6 7 4 9 9 2 5 . 0 8 6 3 9 .000
T3 7 . 7 3 7 8 4 1 0 0 7 . 0 6 3 4 1 7.7 3 7 8 4 1 8 . 6 4 9 3 2 .41491 .522
* * * * * * A n a l y s i s  0 f V a r i a n c e  —  d e s i g n  1 * * * * *  * 
Tests i n v o l v i n g  'TIMES' W i t h i n - S u b ject Effect.
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  for M E A S . 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F MS F S i g  of F
W I T H I N  C E L L S 3 6 8 9 . 5 1 108 3 4 .16
TIMES 1 2 5 3 . 9 0 2 626.95 18.35 .000
G R O U P (1) B Y  T I M E S 110.07 2 55.03 1.61 .204
G R O U P (2) B Y  T I M E S 3.34 2 1.67 .05 .952
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APPENDIX M 
SPSS OUTPUT: STUDY 2
M A N O V A
s l s t a i  B Y  g r o u p  (1,3)
/ C O N T R A S T ( g r o u p ) = s p e c i a 1 ( 1 1 1 1 1 - 2  1 - 1 0 )
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
Study 2 - State Trait Anxiety Inventory
Manova
* * * * * * A n a l y s i s  o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  va l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A  n  a 1 y s i s o f  V  ,
C o m b i n e d O b s e r v e d  :M e a n s  for G R O U P
V a r i a b l e . . S 1 S T A I
G R O U P
1 W G T . 3 6 . 8 1 8 1 8
U N W G T . 3 6 . 8 1 8 1 8
2 WGT. 3 0 . 4 6 1 5 4
U N W G T . 3 0 . 4 6 1 5 4
3 WGT. 3 3 . 6 6 6 6 7
U N W G T . 3 3 . 6 6 6 6 7
d e s i g n  1 * * * * *  *
* * * * * A n a l y s i s  o f V  a r i a n c e —  d e s i g n  1 •;k 'k '
T e s t s  o f  S i g n i f i c a n c e for S I STAI u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS DF M S  F S i g o f  F
W I T H I N  C E L L S 2 8 1 5 . 5 3 33 85.32
G R O U P (1) .01 1 .01 .00 . 994
G R O U P (2) 2 4 0 . 7 6 1 2 4 0 . 7 6  2.82 .102
(Model) 2 4 1 . 4 4 2 1 2 0 . 7 2  1.41 .257
(Total) 3 0 5 6 . 9 7 35 87.34
R - S q u a r e d  = .079
A d j u s t e d  R - S q u a r e d  = .023
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/ C O N T R A S T ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2  1 - 1 0 )
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
MANOVA
s 2 s t a i  B Y  g r o u p  ( 1 , 3 )
Manova
* * * * * * A n a l y S - L S o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  m i s s i n g  d a ta.
3 n o n - e m p t y  c e l l s .
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a ; L y S i s o f  V a r i a n c e - -  d e s i g n  1 * * * *
C o m b i n e d  O b s e r v e d  M e a n s  f o r  G R O U P  
V a r i a b l e  .. S 2 S T A I
G R O U P
1 W G T . 3 8 . 4 5 4 5 5
U N W G T . 3 8 . 4 5 4 5 5
2 W G T . 3 3 . 2 3 0 7 7
U N W G T . 3 3 . 2 3 0 7 7
3 W G T . 3 8 . 5 8 3 3 3
U N W G T . 3 8 . 5 8 3 3 3
: * * * * * A n a l y s i s  o f V  a r i a n  c e —  d e s i g n  1 k k '
T e s t s  o f  S i g n i f i c a n c e f o r  S 2 S T A I u s i n g  U N I Q U E  s u m s o f  s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g o f  F
W I T H I N  C E L L S 3 1 3 7 . 9 5 33 9 5 . 0 9
G R O U P (1) 5 9 . 9 5 1 5 9 . 9 5 . 63 .433
G R O U P (2) 1 6 2 . 5 9 1 1 6 2 . 5 9 1.71 .200
(Model) 2 3 2 . 6 0 2 1 1 6 . 3 0 1. 2 2 .307
(Total) 3 3 7 0 . 5 6 35 9 6 . 3 0
R - S q u a r e d  = .069
A d j u s t e d  R - S q u a r e d  = .013
/ C O N T R A S T ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2  1 - 1 0 )
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
MANOVA
t s t a i  B Y  g r o u p  ( 1 , 3 )
Manova
* * * * * * A n a l y s i s  0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a lues.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * j \ n a l y S i s o f  V a r i a n c e - -  d e s i g n  1 * * * * *  *
C o m b i n e d  O b s e r v e d  M e a n s  for G R O U P  
V a r i a b l e  .. T S T A I
G R O U P
1 W G T . 3 3 . 9 0 9 0 9
U N W G T . 3 3 . 9 0 9 0 9
2 WGT. 3 7 . 9 2 3 0 8
U N W G T . 3 7 . 9 2 3 0 8
3 WGT. 4 5 . 7 5 0 0 0
UNWG T . 4 5 . 7 5 0 0 0
* * * * * * A n a l y s i s  o f  V a r i a n c e - -  d e s i g n
T e sts o f  S i g n i f i c a n c e  for T S T A I  usi
S o u r c e  o f  V a r i a t i o n  SS
W I T H I N  C E L L S  3 5 8 8 . 0 8
G R O U P (1) 7 7 1 . 8 5
G R O U P (2) 9 6.00
(Model) 8 4 3 . 5 6
(Total) 4 4 3 1 . 6 4
R - S q u a r e d  = .190
A d j u s t e d  R - S q u a r e d  = .141
U N I Q U E  sums of s q u a r e s
D F M S F S ig of F
33
1
1
108.73
7 7 1 . 8 5
96.00
7.10 
.88
.012
.354
2
35
421.78
126.62
3.88 .031
*
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HANOVA
slstai s2stai b y  g r o u p  (1 3)
/WS FACTORS = t i m e s  (2)
/CONTRAST (group) =  s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/METHOD U N I Q U E  
/e r r o r  W I T H I N
/PRINT
SIGNIF (UNIV)
/NOPRINT P A R A M  (ESTIM)
SIGNIF (MULT)
/design=group (1) g r o u p  (2).
Manova
Note: there ar e  2 l e v e l s  f or t h e  T I M E S  e f f e c t .  A v e r a g e  t e s t s  a r e  i d e n t i c a l  
to the u n i v a r i a t e  t e s t s  o f  s i g n i f i c a n c e .
* * * * * * A n a l y s i s  o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  c e l l s .
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a l y S i s o f  V a r i a n c e  —  d e s i g n  1 * * * * *
Tests of B e t w e e n - S u b j e c t s  E f f e c t s .
Tests of S i g n i f i c a n c e f or T1 u s i n g U N I Q U E s u m s  of s q u a r e s
Source of V a r i a t i o n SS D F M S F Si g of F
WITHIN CELLS 5 1 8 8 . 6 0 33 1 5 7 . 2 3
GROUP (1) 3 0 . 5 6 1 3 0 . 5 6 .19 .662
GROUP(2) 3 9 9 . 5 2 1 3 9 9 . 5 2 2.54 .120
* * * * * * A n a l y s i s  o f V  a r i a n  c e —  d e s i g n 1 * * ■
Tests i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  E f f e c t .
Tests of S i g n i f i c a n c e for T2 u s i n g U N I Q U E s u m s  of s q u a r e s
Source of V a r i a t i o n SS D F M S F S i g of F
WITHIN C E LLS 7 6 4 . 8 8 33 2 3 . 1 8
TIMES 1 7 3 . 0 0 1 1 7 3 . 0 0 7 . 4 6 .010
GROUP (1) B Y  T I M E S 2 9 . 3 9 1 2 9 . 3 9 1.27 .268
GROUP (2) B Y  T I M E S 3. 8 2 1 3.82 .16 . 687
Study 2 - Tolerance Time
M A N O V A
t o l t i m e  B Y  g r o u p  (1,3)
/ C O N T R A S T ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2  1 - 1 0
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
Manova
★ 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
C o m b i n e d  O b s e r v e d  M e a n s  for G R O U P  
V a r i a b l e  .. T O L T I M E
G R O U P
1 W G T . 1 5 4 . 8 3 3 0 0
U N W G T . 1 5 4 . 8 3 3 0 0
2 WGT. 1 1 1 .83254
U N W G T . 1 1 1 . 8 3 2 5 4
3 WGT. 1 1 9 . 6 7 1 3 3
U N W G T . 1 1 9 . 6 7 1 3 3
* * * * * A n a l y s i s  o f V  a r i a n c e •—  d e s i g n  1 * * •
T e s t s  of S i g n i f i c a n c e for T O L T I M E u s i n g U N I Q U E  sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g of F
W I T H I N  C E L L S 1 2 1 6 7 5 . 2 6 33 3 6 8 7 . 1 3
G R O U P (1) 1 4 8 9 . 6 1 1 148 9 . 6 1 .40 . 529
G R O U P (2) 1 1 0 1 7 . 1 9 1 1 1 0 1 7 . 1 9 2 . 9 9 . 093
(Model) 1 2 1 4 4 . 3 2 2 6 0 7 2 . 1 6 1.65 .208
(Total) 1 3 3 8 1 9 . 5 8 35 3 8 2 3 . 4 2
R - S q u a r e d  = .091
A d j u s t e d  R - S q u a r e d  = . 036
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m a n o v a
v a s a  B Y  g r o u p  (1,3)
/ C O N T R A S T ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2  1 - 1 0
/ M E T H O D  U N I Q U E
/ E R R O R  W I T H I N
/ O M E A N S  T A B L E S  (group)
/ P R I N T
S I G N I F  (UNIV)
/ N O P R I N T  P A R A M  (ESTIM)
S I G N I F  (MULT)
/ d e s i g n = g r o u p  (1) g r o u p  (2).
Study 2 - Affective Visual Analogue Scale
Manova
* * * * * * ^ n a i y S j _ s 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A  n  a l y s i s o f  V ;
C o m b i n e d O b s e r v e d M e a n s  for G R O U P
V a r i a b l e .. V A S A
G R O U P
1 W G T . 4 9 . 1 8 1 8 2
U N W G T . 4 9 . 1 8 1 8 2
2 WGT. 3 3 . 0 0 7 6 9
U N W G T . 3 3 . 0 0 7 6 9
3 WGT. 6 2 . 1 6 6 6 7
U N W G T . 6 2 . 1 6 6 6 7
* * * * * * A  n  a l y s i s o f  V
a r i a n c e  —  d e s i g n * * * * * *
—  d e s i g n  1 * * * * * *
T e s t s  o f  S i g n i f i c a n c e  for V A S A  u s i n g  U N I Q U E  sums of s g u a r e s
S o u r c e  o f  V a r i a t i o n  SS D F  M S  F S i g  of F
W I T H I N  C E L L S  2 8 0 0 3 . 9 1
G R O U P (1) 3 5 4 3 . 9 4
G R O U P (2) 1 5 5 8 . 7 1
(Model) 5 3 4 1 . 7 6
(Total) 3 3 3 4 5 . 6 8
R - S g u a r e d  = .160
A d j u s t e d  R - S q u a r e d  = .109
33
1
8 4 8 . 6 0
3 5 4 3 . 9 4 4.18 .049
1 1 5 5 8 . 7 1 1.84 .185
2 2 6 7 0 . 8 8 3.15 .056
35 9 5 2 . 7 3
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Study 2 - Skin Conductance Level
M A N O V A
s c b l 2  s c b l 3  s c b l 4  s c b l 5  s c b l 6  s c b l 7  s c bl8 s c b l 9  s c b l l O  s c b l l l  s c b l l 2  B Y  g r o u p  
( 1 3 )
/ W S F A C T O R S = t i m e (11)
/ C O N T R A S T  ( t i m e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a l y s i s  0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a lues.  
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * j 3 L n a f y S i s o f V a r i a n c e —  d e s i g n 1 * * ■
Tests of B e t w e e n - S u b j e c t s E f f e c t s .
T ests of S i g n i f i c a n c e  for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F MS F S i g of F
W I T H I N  C E L L S 1 1 7 9 . 0 1 33 35.73
G R O U P (1) 7 1.47 1 71.47 2.00 .167
G R O U P (2) 5.63 1 5.63 .16 .694
* * * * * * A n a l y s i s  0 f V a r i a n c e  —  d e s i g n  1 * * * * *  * 
Tests i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
7 . 0 1 2 7 1 E - 1 0
6 2 1 . 1 0 2 1 5  w i t h  54 D. F.
.000
.12866
.13975.100 00
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t —p l o t  o r  m i x e d —m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for th e  A V E R A G E D  re s u l t s .
E F F E C T  .. 
U n i v a r i a t e
G R O U P (2) B Y  T I M E  
F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 .03538 2 1 . 5 5 2 0 7 .03538 .65309 .05417 .817
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T3 .07 9 0 1 1 . 2 3 8 9 8 .07901 .03754 2 . 1 0 4 5 3 .156
T4 . 0 2 1 0 6 .42661 .02106 .01293 1 . 6 2 8 7 7 .211
T5 .00037 .22216 .00037 .00673 .05475 .816
T6 .000 3 2 .40484 .00032 .01227 .02598 .873
T7 .00658 .22176 .00658 .00672 .97949 .330
T8 . 0 0 3 7 0 .16650 .00370 .00505 .73425 .398
T9 . 0 0 0 1 9 .15400 .00019 .00467 .03985 .843
T10 .00362 .16200 .00362 .00491 .73698 .397
Til .00124 .12258 .00124 .00371 .33291 .568
E F F E C T  .. G R O U P (1) B Y T I M E
U n i v a r i a t e  F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 .47962 2 1 . 5 5 2 0 7 .47962 .65309 .73438 .398
T3 . 0 4 7 6 6 1 . 2 3 8 9 8 .04766 .03754 1 . 2 6 9 5 1 .268
T4 .04247 .42661 .04247 .01293 3 . 2 8 5 5 6 .079
T5 .013 8 9 .22216 .01389 .00673 2 . 0 6 2 7 0 .160
T6 .01037 .40484 .01037 .01227 .84541 .365
T7 .03652 .22176 .03652 .00672 5 . 4 3 4 8 0 .026
T8 .02040 .16650 .02040 .00505 4 . 0 4 2 9 2 .053
T9 .00034 .15400 .00034 .00467 .07202 .790
T10 .00000 .16200 .00000 .00491 .00041 .984
Til .01157 .12258 .01157 .00371 3 . 1 1 5 0 0 .087
E F F E C T  .. T I M E
U n i v a r i a t e  F - t e s t s  w i t h (1,33) D., F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 2 0 . 2 4 6 4 5 2 1 . 5 5 2 0 7 2 0 . 2 4 6 4 5 .65309 3 1 . 0 0 0 8 6 .000
T3 .81950 1 . 2 3 8 9 8 .81950 .03754 2 1 . 8 2 7 3 1 .000
T4 .01330 .42661 .01330 .01293 1 . 0 2 8 7 6 .318
T5 .00 0 9 9 .22216 .00099 .00673 .14730 .704
T6 .00083 .40484 .00083 .01227 .06733 .797
T7 .00168 .22176 .00168 .00672 .25013 .620
T8 .00027 . 1 6 650 .00027 .00505 .05335 .819
T9 .00342 .15400 .00342 .00467 .73223 .398
T10 .00524 .16200 .00524 .00491 1 . 0 6 6 5 7 .309
Til .00135 .12258 .00135 .00371 .36291 .551
k k  k  k  k * A  n  a 1 y s i s  o f V a r i a n e e  —  d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  ' T I M E 1 W i t h i n - S u b j e c t E f f e c t .
A V E R A G E D T e s t s  o f  S i g n i f i c a n c e  for S C B  u s i n g U N I Q U E  sums of s q u a r e s
S o u r c e  of: V a r i a t i o n SS D F M S F S i g or f
W I T H I N  C E L L S 2 4 . 6 7 330 .07
T I M E 2 1 . 0 9 10 2.11 28 .21 .000
G R O U P (1) B Y  T I M E . 6 6 10 .07 .89 . 54 6
G R O U P (2) B Y  T I M E .15 10 .02 .20 . 996
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M A N O V A
s c b l l 2  s c c l  s c c 2  B Y  g r o u p (1 3)
/ W S F A C T O R S = t i m e s (3)
/ C O N T R A S T  ( t i m e s ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U L T )
/ d e s i g n = g r o u p (1) g r o u p (2).
Manova
* * * * * * £ L n a l y S : L s 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .  
0 c a s e s  r e j e c t e d  b e c a u s e  o f  m i s s i n g  data.
3 n o n - e m p t y  cell s .
1 d e s i g n  w i l l  b e p r o c e s s e d .
* * * * * * ^ n a l y s i s o f V a r i a n c e —  d e s i g n 1 * * * *
T e sts o f  B e t w e e n - S u b j e c t s E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e  for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g o f  F
W I T H I N  C E L L S 4 2 2 . 5 4 33 1 2.80
G R O U P (1) 5.38 1 5.38 .42 .521
G R O U P (2) 1.32 1 1.32 .10 .750
* * * * * * A n a l y S i s o f V a r i a n c e —  d e s i g n 1 ★ ★ ★ ★
*
*
T e sts i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  E f f e c t .
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.41082
2 8 . 4 6 7 0 2  w i t h  2 D. F. 
. 0 0 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.62926 
.68217 
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  a r e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for t h e  A V E R A G E D  r e s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2
T3
. 0 5 8 6 3
. 9 2 7 0 6
2 5 . 5 6 3 3 6
1 3 . 2 4 2 6 6
.05863 
.92706
.77465
.40129
.07568
2 . 3 1 0 1 7
.785
.138
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E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 1 . 7 7 8 8 9 2 5 . 5 6 3 3 6 1 . 7 7 8 8 9 .77465 2 . 2 9 6 3 9 .139
T3 1 . 8 8 5 4 1 1 3 . 2 4 2 6 6 1 . 8 8 5 4 1 .40129 4 . 6 9 8 3 3 .038
E F F E C T  . . T I M E S
U n i v a r i a t e  F - t e s t s  w i t h (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 3 4 . 1 3 1 5 0 2 5 . 5 6 3 3 6 3 4 . 1 3 1 5 0 .77465 4 4 . 0 6 0 6 9 .000
T3 2 0 . 9 1 3 0 8 1 3 . 2 4 2 6 6 2 0 . 9 1 3 0 8 .40129 5 2 . 1 1 4 2 8 .000
* * * * * * A  n  a 1 y s i s  o f V a r i a n e e - - d e s i g n  1 * * * * * *
T e sts i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  E f f e c t •
A V E R A G E D T e s t s  o f  S i g n i f i c a n c e  for M E A S .1 us i ng U N I Q U E su m s  of s q u a r e s
S o u r c e  ofr V a r i a t i o n SS D F M S F S i g o f  F
W I T H I N  C E L L S 38.81 66 .59
T I MES 5 5 .04 2 2 7 .52 46.81 .000
G R O U P (1) B Y  T I M E S 3.66 2 1.83 3.12 .051
G R O U P (2) B Y  T I M E S .99 2 .49 .84 .437
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Study 2 - Respiration Rate
M A N O V A
reb l 2  r e b l 3  r e b l 4  r e b l 5  r e b l 6  r e b l 7  r e bl8 r e b l 9  r e b l l O  r e b l l l  r e b l l 2  B Y  g r o u p  (1 3 )
/ W S F A C T O R S = t i m e (11)
/C O N T R A S  T (t i m e )= p o 1 y n o m i  a 1
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U LT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * j ^ n a ^ y S ^ g  o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a f y g f s o f V a r i a n c e -- d e s i g n 1 * *
Tests of B e t w e e n - S u b j e c t s E f f e c t s .
Tests of S i g n i f i c a n c e  for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F MS F S i g of F
W I T H I N  C E L L S 5 1 4 9 . 0 4 33 156.03
G R O U P (1) 106 . 0 4 1 106.04 . 68 .416
G R O U P (2) 2 3 . 9 5 1 2 3 .95 .15 . 698
* * * * * * A n a l y S j _ s 0 f V a r i a n c e - -  d e s i g n  i * * * * *  *
Tests i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
. 01038
1 3 4 . 5 8 6 2 4  w i t h  54 D. F. 
. 00 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.50376 
.64140 
.10000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e sts are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d —m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T2 .57935 1 3 5 . 0 9 9 4 6 .57935 4 . 0 9 3 9 2 .14152 .709
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T3 3 . 6 9 4 9 7 8 3 . 3 9 6 1 6 3 . 6 9 4 9 7 2 . 5 2 7 1 6 1 . 4 6 2 1 0 .235
T4 .00677 8 8 . 9 0 5 6 0 .00677 2 . 6 9 4 1 1 .00251 .960
T5 .078 6 3 4 7 . 7 3 7 1 8 .07863 1.4 4 6 5 8 .05435 .817
T6 6 . 4 4 2 5 9 3 8 . 5 2 9 0 2 6 . 4 4 2 5 9 1 . 1 6 7 5 5 5 . 5 1 8 0 6 .025
T7 .13707 3 5 . 9 1 2 2 0 .13707 1 . 0 8 8 2 5 .12595 .725
T8 2 . 7 4 2 5 2 1 5 . 5 6 7 1 6 2 . 7 4 2 5 2 .47173 5 . 8 1 3 7 2 .022
T9 .46397 4 7 . 2 9 1 9 9 .46397 1 . 4 3 3 0 9 .32375 .573
T10 1 . 2 9 1 4 1 2 1 . 8 2 3 2 0 1. 2 9 1 4 1 .66131 1 . 9 5 2 8 1 .172
Til .00227 2 4 . 2 1 1 8 7 .00227 .73369 .00309 .956
E F F E C T  .. G R O U P (1) B Y T I M E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D., F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  MS F Sig. of F
T2 .82610 1 3 5 . 0 9 9 4 6 .82610 4 . 0 9 3 9 2 .20179 . 656
T3 6 . 8 9 9 5 5 8 3 . 3 9 6 1 6 6 . 8 9 9 5 5 2 . 5 2 7 1 6 2 . 7 3 0 1 6 .108
T4 .19836 8 8 . 9 0 5 6 0 .19836 2 . 6 9 4 1 1 .07363 .788
T5 .47232 4 7 . 7 3 7 1 8 .47232 1 . 4 4 6 5 8 .32651 .572
T6 .07395 3 8 . 5 2 9 0 2 .07395 1 . 1 6 7 5 5 .06334 .803
T7 .05463 3 5 . 9 1 2 2 0 .05463 1 . 0 8 8 2 5 .05020 .824
T8 .13802 1 5 . 5 6 7 1 6 .13802 .47173 .29258 .592
T9 .01388 4 7 . 2 9 1 9 9 .01388 1 . 4 3 3 0 9 .00969 .922
T10 .05060 2 1 . 8 2 3 2 0 .05060 .66131 .07651 .784
Til .14751 2 4 . 2 1 1 8 7 .14751 .73369 .20105 .657
E F F E C T  .. T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e
T2
T3
T4
T5
T6
T7
T8
T9
T10
Til
H y p o t h .  SS
4 3 . 8 8 4 5 3  
8 . 9 4 8 1 9  
9 . 3 8 0 4 6  
2 . 2 1 3 9 9  
.01812 
1 . 7 1 0 2 0  
1 . 5 2 7 9 6  
3 . 4 2 9 7 0  
.18905 
2 . 0 0 2 1 1
E r r o r  SS
1 3 5 . 0 9 9 4 6
8 3 . 3 9 6 1 6
8 8 . 9 0 5 6 0
4 7 . 7 3 7 1 8
3 8 . 5 2 9 0 2
3 5 . 9 1 2 2 0
1 5 . 5 6 7 1 6
4 7 . 2 9 1 9 9
2 1 . 8 2 3 2 0
2 4 . 2 1 1 8 7
Hyp o t h .  M S
4 3 . 8 8 4 5 3
8 . 9 4 8 1 9
9 . 3 8 0 4 6
2 . 2 1 3 9 9
.01812
1 . 7 1 0 2 0
1 . 5 2 7 9 6
3 . 4 2 9 7 0
.18905
2.00211
E r r o r  M S
4 . 0 9 3 9 2  
2 . 5 2 7 1 6  
2 . 6 9 4 1 1  
1. 4 4 6 5 8  
1 . 1 6 7 5 5  
1 . 0 8 8 2 5  
.47173 
1 . 4 3 3 0 9  
.66131 
.73369
F
1 0 . 7 1 9 4 3
3 . 5 4 0 8 1
3 . 4 8 1 8 4
1 . 5 3 0 5 0
.01552
1. 5 7 1 5 2
3 . 2 3 9 0 5
2 . 3 9 3 2 2
.28588
2 . 7 2 8 8 2
Sig. of F
. 0 0 2
.069
.071
.225
.902
.219
.081
.131
.596
.108
* * * * * * j Y n a l y s i s  o f  V a r i a n c e - -  d e s i g n
T e sts i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of Sign: " ' —  —  '
S o u r c e  o f  V a r i a t i o n
W I T H I N  C E L L S  
TIME
G R O U P (1) B Y  T I M E  
G R O U P (2) B Y  T I M E
SS D F MS F S i g  of F
5 3 8 . 4 7 330 1.63
7 3 .30 10 7.33 4.49 .000
8.87 10 .89 .54 .858
15.44 10 1.54 .95 .491
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r e b l l 2  r e e l  r e c 2  B Y  g r o u p (1 3) w i t h  (redifbl) 
/ W S F A C T O R S = t i m e s (3)
/ C O N T R A S T  ( t i m e s ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U L T )
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
MANOVA
Manova
* * * * * * ^ n a l y s i s  o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a ^ y S - L S 0 f V a r i a n c e  —  d e s i g n  1 * * * 
T e sts o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 1 0 3 6 . 3 0 32 32.38
R E G R E S S I O N 4.62 1 4.62 .14 .708
G R O U P (1) 4.86 1 4.86 .15 .701
G R O U P (2) 1.04 1 1.04 .03 .859
*
R e g r e s s i o n  a n a l y s i s  for W I T H I N  C E L L S  e r r o r  t e r m
---  I n d i v i d u a l  U n i v a r i a t e  .9500 c o n f i d e n c e  i n t e r v a l s
D e p e n d e n t  v a r i a b l e  .. T1
C O V A R I A T E B B e t a Std. Err. t - V a l u e Sig. of t
T R E D I F B 1 - . 0 8 3 6 8 - . 0 6 9 5 0 .222 - . 3 7 8 .708
C O V A R I A T E L o w e r  - 9 5 % C L -  U p p e r
T R E D I F B 1 - . 5 3 5 .368
* * * * * * ^ n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * 
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  Eff e c t .
M a u c h l y  s p h e r i c i t y  t e s t ,  W -
C h i - s q u a r e  a p p r o x .  =
.73616
9 . 8 0 1 9 8  w i t h  2 D. F.
S i g n i f i c a n c e  = .007
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.79124
.87482
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  r e s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2
T3
. 3 2 9 5 5
3 . 3 1 6 7 7
3 0 1 . 9 9 1 5 4
1 9 9 . 7 3 3 5 4
.32955
3 . 3 1 6 7 7
9 . 1 5 1 2 6
6 . 0 5 2 5 3
.03601
.54800
.851
.464
E F F E C T  .. i 
U n i v a r i a t e
G R O U P (1) B Y  T I M E S  
F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2
T3
4 2 . 2 9 2 4 9
3 . 6 9 6 0 8
3 0 1 . 9 9 1 5 4
1 9 9 . 7 3 3 5 4
4 2 . 2 9 2 4 9
3 . 6 9 6 0 8
9 . 1 5 1 2 6
6 . 0 5 2 5 3
4 . 6 2 1 4 9
.61067
.039
.440
E F F E C T  .. 
U n i v a r i a t e
T I M E S
F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F Sig. of F
T2
T3
6 . 8 1 2 5 7
2 . 8 2 8 3 4
3 0 1 . 9 9 1 5 4  
1 9 9 . 7 3 3 5 4
6 . 81257
2 . 8 2 8 3 4
9 . 1 5 1 2 6
6 . 0 5 2 5 3
.74444
.46730
.394
.499
* * * * * * A  n  a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * * * *
T e sts i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  Ef f e c t .
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums o f  s q u a r e s  
S o u r c e  o f  V a r i a t i o n  SS D F  M S  F S i g  o f  F
W I T H I N  C E L L S  5 0 1 . 7 3  
T I M E S  9.64 
G R O U P (1) B Y  T I M E S  4 5 . 9 9  
G R O U P (2) B Y  T I M E S  3 . 6 5
66 7.60
2 4.82 . 63 .534
2 2 2 . 9 9 3.02 .055
2 1.82 .24 .787
Page 4
Study 2 - Heart Rate
MANOVA
hrbi2 hrb13 hrbl4 hrbl5 hrbl6 hrb!7 hrblS hrbl9 hrbUO hrblll hrbU2 BY group
/WSFACTORS=time(11)
/CONTRAST (time)=polynomial
/CONTRAST (group)=special ( 1 1 1 1 1 - 2 1 - 1 0 )/METHOD UNIQUE 
/ERROR WITHIN 
/PRINT
SIGNIF( UNIV )
/NOPRINT PARAM(ESTIM)
SIGNIF( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * ^ n a ; L y S : ^ s 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  * 
Tests of B e t w e e n - S u b j e c t s  E f f e c t s .
Tests o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F MS F Si g of F
W I T H I N  C E L L S 3 4 7 4 1 . 3 8 33 1052.77
G R O U P (1) 602 6 . 6 4 1 6026.64 5.72 .023
G R O U P (2) 9.47 1 9.47 .01 .925
* * * * * A n a l y s i s  o f V a r i a n c e -- d e s i g n 1 * * -
Tests i n v o l v i n g  ’TIME' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.02665
1 0 6 . 8 1 7 3 8  w i t h  54 D. F. 
. 00 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.56651
.73877
.10000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t —p l o t  or m i x e d —m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. 
U n i v a r i a t e
G R O U P (2) B Y  T I M E  
F - t e s t s  w i t h  (1,33) D., F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h . M S E r r o r  M S F Sig. of F
T2 9 4 . 0 6 1 5 6 5 1 7 . 0 5 4 6 2 9 4 . 0 6 1 5 6 1 5 . 6 6 8 3 2 6 . 0 0 3 3 0  .020
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T3 .76619 1 8 9 . 6 6 2 5 2 .76619 5 . 7 4 7 3 5 .13331 .717
T4 3 0 . 8 0 5 5 8 3 2 0 . 2 7 8 0 0 3 0 . 8 0 5 5 8 9 . 7 0 5 3 9 3 . 17407 .084
T5 1 . 4 2 2 2 5 2 2 7 . 3 3 9 6 0 1 . 4 2 2 2 5 6.88908 .20645 .653
T6 1 2 . 5 9 1 4 8 2 2 3 . 9 9 7 9 2 1 2 . 59148 6.78782 1.85501 .182
T7 2 . 7 3 9 5 5 2 2 4 . 3 3 5 7 0 2 . 7 3 9 5 5 6 .79805 .40299 .530
T8 .00179 1 9 3 . 8 3 6 5 2 .00179 5.8 7 3 8 3 .00030 .986
T9 .98208 1 2 3 . 2 8 6 4 3 .98208 3 . 7 3 5 9 5 .26287 . 612
T10 3 . 3 2 7 7 8 8 2 . 5 0 5 3 4 3 . 32778 2 . 5 0 0 1 6 1 . 3 3 1 0 3 .257
Til 1 . 2 7 3 9 4 6 8 . 5 7 7 9 3 1.27394 2. 0 7 8 1 2 .61303 .439
E F F E C T  .. G R O U P (1) B Y TI M E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2 3 . 9 1 7 4 8 5 1 7 . 0 5 4 6 2 3.91748 15.66 8 3 2 .25003 .620
T3 1 . 4 0 9 3 9 1 8 9 . 6 6 2 5 2 1.4 0 9 3 9 5 . 7 4 7 3 5 .24522 .624
T4 1 . 0 5 8 5 1 3 2 0 . 2 7 8 0 0 1.05851 9.7 0 5 3 9 .10906 .743
T5 .13780 2 2 7 . 3 3 9 6 0 .13780 6.88908 .02000 .888
T6 5 . 4 4 3 1 6 2 2 3 . 9 9 7 9 2 5 . 4 4 3 1 6 6.78782 .80190 .377
T7 1 . 8 5 3 7 6 2 2 4 . 3 3 5 7 0 1. 8 5 3 7 6 6 . 79805 .27269 . 605
T8 3 . 3 0 1 4 7 1 9 3 . 8 3 6 5 2 3.30147 5 .87383 .56206 .459
T9 8 . 4 0 2 6 6 1 2 3 . 2 8 6 4 3 8 . 4 0 2 6 6 3 . 7 3 5 9 5 2 . 2 4 9 1 3 .143
T10 4 . 5 7 6 4 8 82 . 5 0 5 3 4 4 . 57648 2 . 5 0 0 1 6 1.83047 .185
Til 2 . 5 6 7 3 8 68 . 5 7 7 9 3 2.5 6 7 3 8 2 .07812 1 . 23543 .274
E F F E C T  .. T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS Hypoth. M S  E r r o r  M S  F Sig. of F
T2 2 2 . 9 0 6 4 7 5 1 7 . 0 5 4 6 2
T3 4 7 . 9 3 0 0 0 1 8 9 . 6 6 2 5 2
T4 2 . 4 2 9 2 4 3 2 0 . 2 7 8 0 0
T5 .35737 2 2 7 . 3 3 9 6 0
T6 5 . 1 8 8 6 1 2 2 3 . 9 9 7 9 2
T7 4 . 3 2 9 1 9 2 2 4 . 3 3 5 7 0
T8 1 . 3 0 6 6 5 1 9 3 . 8 3 6 5 2
T9 .64708 1 2 3 . 2 8 6 4 3
T10 9 . 3 6 0 0 0 82 . 5 0 5 3 4
Til .09601 6 8 . 5 7 7 9 3
22 . 9 0 6 4 7 15.66832 1 . 4 6 1 9 6 .235
4 7 . 9 3 0 0 0 5. 7 4 7 3 5 8.33950 .007
2.42924 9 . 70539 .25030 . 620
.35737 6.88908 .05188 .821
5.18861 6.78782 .76440 .388
4.3 2 9 1 9 6.79805 .63683 .431
1 . 30665 5 . 87383 .22245 . 640
.64708 3 . 7 3 5 9 5 .17320 .680
9.36000 2.5 0 0 1 6 3.7 4 3 7 6 .062
.09601 2 . 07812 .04620 .831
* * * * * * A . n a i y S i s  o f  V a r i a n c e  d e s i g n  1 * * * * *  * 
Tests i n v o l v i n g  ’TIME' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for H R B  u s i n g  U N I Q U E  sums of squ a r e s  
S o u r c e  of V a r i a t i o n  SS D F  M S  F Sig of F
W I T H I N  C E L L S
T I M E  
T I M E
G R O U P (1) B Y  
G R O U P (2) B Y
2 1 7 0 . 8 7  
94.55 
32.67 
147.97
330
10
1010
6.58
9.46
3.27
14.80
1.44
.50
2.25
.162
.892
.015
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hrbll2 hrcl hrc2 BY group(1 3) with (hravebl) 
/WSFACTORS=times(3)
/CONTRAS T (t ime s)=po1ynomi a1
/CONTRAST (group)=special ( 1 1 1 1 1 - 2 1 - 1 0  
/METHOD UNIQUE 
/ERROR WITHIN 
/PRINT
SIGNIF( UNIV )
/NOPRINT PARAM(ESTIM)
SIGNIF( MULT)
/design=group(1) group(2).
MANOVA
Manova
* * * * * * A n a l y s i s  o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a lues.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y S i s o f  V a r i a n c e  —  d e s i g n  1 * * * * * 
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e  for T1 u s i n g  U N I Q U E  sums of s q u a r e s  _
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 2 7 2 3 . 0 1 32 8 5 .09
R E G R E S S I O N 7 1 9 7 . 3 0 1 7 1 9 7 . 3 0 84.58 .000
G R O U P (1) 6 7 .10 1 67.10 .79 .381
G R O U P (2) 2 4 7 . 5 4 1 2 4 7 . 5 4 2.91 .098
R e g r e s s i o n  a n a l y s i s  for W I T H I N  C E L L S e r r o r t e r m
---  I n d i v i d u a l  U n i v a r i a t e  .9500 c o n f i d e n c e i n t e r v a l s
D e p e n d e n t  v a r i a b l e  .. T1
C O V A R I A T E  B B e t a Std. Err. t--Va l u e Sig. of t
T H R A V E B 1  .86183 .88406 .094 9.197 .000
C O V A R I A T E  L o w e r  - 9 5 % CL -  U p p e r
T H R A V E B 1  .671 1.053
* * * * * * j ^ n a l y s i s  o f  V a r i a n c e  d e s i g n  1 
T e s t s  i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  Eff e c t .
M a u c h l y  s p h e r i c i t y  t e s t ,  W -
C h i - s q u a r e  a p p r o x .  =
.99401
.19229 w i t h  2 D. F.
S i g n i f i c a n c e  = . 9 0 8
G r e e n h o u s e - G e i s s e r  E p s i l o n  = .99404
H u y n h - F e l d t  E p s i l o n  = 1 . 0 0 0 0 0
L o w e r - b o u n d  E p s i l o n  =  .50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  r e s ults.
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS Hyp o t h .  M S  E r r o r  MS F Sig. o f  F
T2
T3
3 6 . 8 0 6 6 3  1 2 9 9 . 4 1 5 3 2  3 6 . 8 0 6 6 3  3 9 . 3 7 6 2 2  .93474
9 . 8 6 0 2 4  1 2 4 2 . 8 8 4 1 5  9 . 8 6 0 2 4  3 7 . 6 6 3 1 6  .26180
.341
.612
E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS H y poth. M S  E r r o r  M S F Sig. of F
T2
T3
2 8 . 3 4 7 0 2  1 2 9 9 . 4 1 5 3 2  2 8 . 3 4 7 0 2  3 9 . 3 7 6 2 2  .71990
5 6 . 2 6 0 0 3  1 2 4 2 . 8 8 4 1 5  5 6 . 2 6 0 0 3  3 7 . 6 6 3 1 6  1 . 4 9 3 7 7
.402
.230
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T2
T3
8 6 4 . 7 0 5 5 3
8 2 1 . 5 7 3 7 1
1 2 9 9 . 4 1 5 3 2
1 2 4 2 . 8 8 4 1 5
8 6 4 . 7 0 5 5 3
8 2 1 . 5 7 3 7 1
3 9 . 3 7 6 2 2
3 7 . 6 6 3 1 6
2 1 . 9 6 0 0 9
2 1 . 8 1 3 7 2
.000
.000
* * * * * * j ^ ^ £ ] _ y s i s  o f  V a r i a n c e  d e s i g n  2. * * * * *  * 
T e sts i n v o l v i n g  ’TIMES' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S . l  u s i n g  U N I Q U E  sums of s q u a r e s  
S o u r c e  o f  V a r i a t i o n  SS D F  M S  F Si g  of F
W I T H I N  C E L L S  
T I M E S
G R O U P (1) B Y  T I M E S  
G R O U P (2) B Y  T I M E S
2542..30 66 38.
1686..28 2 843.
84..61 2 42.
46..67 2 23.
52
14 21..89 .000
30 1,.10 .339
33 .61 .549
Page 4
Study 2 - Systolic Blood Pressure
M A N O V A
s b b l 2  s b b l 3  s b b l 4  s b b l 5  s b b l 6  s b b l 7  s b b l 8  s b b l 9  s b b l l O  s b b l l l  s b b l l 2  B Y  g r o u p  
(1 3)
/ W S F A C T O R S = t i m e  (11)
/C O N T R A S  T (t i m e )= p o 1 y n o m i  a 1
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U LT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * j \ n a l y S - L S o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  val u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e sts o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n e  
S o u r c e  o f  V a r i a t i o n
W I T H I N  C E L L S  
G R O U P (1)
G R O U P (2)
T e s t s  i n v o l v i n g  'TIME* W i t h i n - S u b j e c t  E f fect.
for T1 u s i n g U N I Q U E sums of s q u a r e s
SS D F M S F Si g of F
1 5 9 9 2 4 . 1 5 33 4 8 4 6 . 1 9
3 5 1 . 6 7 1 351 . 6 7 .07 .789
1 5 7 5 . 3 5 1 1 5 7 5 . 3 5 .33 .572
; i s o f V  a r i a n c e —  d e s i g n 1 'k 'k
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.00530
1 5 4 . 4 2 3 5 3  w i t h  54 D. F. 
. 00 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.45280 
.56550 
. 10000
A V E R A G E D  T e s t s  of Significance that follow multivariate t e s t s  are equivalent to
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i lo n s  L y  b e P i s e d P to a d j u s t  d.f. for t h e  A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS H y p o t h .  M S
T2 8 3 . 5 5 8 8 7  2 2 6 7 . 5 6 5 7 9  8 3 . 5 5 8 8 7
E r r o r  M S  
6 8 . 7 1 4 1 1
F Sig. of F 
1 . 2 1 6 0 4  .278
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T3
T4
T5
T6
T7
T8
T9
TlO
Til
1 0 9 . 3 2 4 1 5
9 . 4 4 5 2 9
6 . 0 6 2 3 3
1 . 0 7 2 4 4
1 0 . 0 0 1 1 3
.05170
1 . 6 2 2 8 3
.00275
.67189
1 0 4 8 . 9 0 7 6 9  
1 0 5 0 . 5 6 9 3 1  
8 0 4 . 2 8 0 3 6  
3 6 2 . 6 0 6 6 8  
2 0 3 . 7 1 2 0 4  
3 9 3 . 4 9 4 7 2  
2 2 4 . 6 8 3 1 1  
3 4 3 . 5 9 5 3 4  
2 9 7 . 1 8 0 8 7
1 0 9 . 3 2 4 1 5 3 1 . 7 8 5 0 8
9 . 4 4 5 2 9 3 1 . 8 3 5 4 3
6 . 0 6 2 3 3 2 4 . 3 7 2 1 3
1.0 7 2 4 4 1 0 . 9 8 8 0 8
1 0 . 0 0 1 1 3 6 . 1 7 3 0 9
.05170 1 1 . 9 2 4 0 8
1 . 6 2 2 8 3 6 . 80858
.00275 1 0 . 4 1 1 9 8
.67189 9. 0 0 5 4 8
3 . 4 3 9 4 8 .073
.29669 .590
.24874 .621
. 09760 .757
1 . 6 2 0 1 2 .212
.00434 .948
.23835 . 629
.00026 .987
.07461 .786
E F F E C T  .. G R O U P (1) B Y  T I M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  MS E r r o r  M S F Sig. of F
T2 1 8 5 . 7 8 2 6 5 2 2 6 7 . 5 6 5 7 9 1 8 5 . 7 8 2 6 5 6 8 . 71411 2 . 7 0 3 7 0 .110
T3 6 5 . 3 6 1 9 0 1 0 4 8 . 9 0 7 6 9 6 5 . 3 6 1 9 0 3 1 . 7 8 5 0 8 2 . 0 5 6 3 7 .161
T4 1 . 8 4 6 7 5 1 0 5 0 . 5 6 9 3 1 1 . 8 4 6 7 5 3 1 . 8 3 5 4 3 .05801 .811
T5 8 7 . 9 4 2 8 0 8 0 4 . 2 8 0 3 6 8 7 . 9 4 2 8 0 2 4 . 3 7 2 1 3 3 . 6 0 8 3 3 .066
T6 1 8 . 7 4 3 1 3 3 6 2 . 6 0 6 6 8 1 8 . 7 4 3 1 3 1 0 . 9 8 8 0 8 1. 7 0 5 7 7 .201
T7 .26750 2 0 3 . 7 1 2 0 4 .26750 6.1 7 3 0 9 .04333 . 836
T8 2 8 . 3 2 8 7 5 3 9 3 . 4 9 4 7 2 2 8 . 3 2 8 7 5 1 1 . 9 2 4 0 8 2 . 3 7 5 7 6 . 133
T9 3 . 5 6 9 7 2 2 2 4 . 6 8 3 1 1 3 . 5 6 9 7 2 6.80858 .52430 .474
T10 2 3 . 0 3 3 6 3 3 4 3 . 5 9 5 3 4 2 3 . 0 3 3 6 3 10 . 4 1 1 9 8 2 . 2 1 2 2 2 .146
Til .34241 2 9 7 . 1 8 0 8 7 .34241 9.0 0 5 4 8 .03802 .847
E F F E C T  .. T I M E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  M S F Sig. of F
T2 7 3 . 3 8 9 1 4 2 2 6 7 . 5 6 5 7 9 7 3 . 3 8 9 1 4 6 8 . 71411 1 . 06804 .309
T3 1 9 4 . 8 4 0 4 0 1 0 4 8 . 9 0 7 6 9 1 9 4 . 8 4 0 4 0 3 1 . 7 8 5 0 8 6 . 12993 .019
T4 1 2 . 4 3 8 2 8 1 0 5 0 . 5 6 9 3 1 1 2 . 4 3 8 2 8 3 1 . 8 3 5 4 3 .39071 .536
T5 4 4 . 7 7 5 3 2 8 0 4 . 2 8 0 3 6 4 4 . 7 7 5 3 2 2 4 . 3 7 2 1 3 1 . 8 3 7 1 5 . 184
T6 8 . 3 2 0 7 4 3 6 2 . 6 0 6 6 8 8. 3 2 0 7 4 1 0 . 9 8 8 0 8 .75725 .390
T7 7 . 9 4 4 6 0 2 0 3 . 7 1 2 0 4 7 . 9 4 4 6 0 6. 1 7 3 0 9 1.28697 .265
T8 1 4 . 1 3 8 7 8 3 9 3 . 4 9 4 7 2 1 4 . 1 3 8 7 8 1 1 . 9 2 4 0 8 1 . 18573 .284
T9 1 7 . 1 8 8 9 5 2 2 4 . 6 8 3 1 1 1 7 . 1 8 8 9 5 6.80858 2 . 5 2 4 6 0 .122
T10 2 . 3 9 8 2 5 3 4 3 . 5 9 5 3 4 2 . 3 9 8 2 5 1 0 . 4 1 1 9 8 .23034 . 634
Til 2 . 6 8 5 7 1 2 9 7 . 1 8 0 8 7 2 . 6 8 5 7 1 9 . 00548 .29823 .589
•x-X-X-X-X * A  n a 1 y s i s  o f V a r i a n e e  —  'd e s i g n  1 * * * k  k  -k
T e s t s  i n v o l v i n g  ’T I M E 1 W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for SB B  u s i n g U N I Q U E  sums of s q u a r e s
S o u r c e  ofr V a r i a t i o n SS D F M S F Si g  of F
W I T H I N  C E L L S 6 9 9 6 . 6 0 330 2 1 .20
TIME 378.12 10 37.81 1.78 .063
G R O U P (1) B Y  T I M E 4 1 5 . 2 2 10 41.52 1.96 .037
G R O U P (2) B Y  T I M E 2 2 1 . 8 1 10 22.18 1.05 .404
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M A N O V A
s b b l l 2  s b c l  s b c 2  B Y  g r o u p (1 3)
/ W S F A C T O R S = t i m e s (3)
/ C O N T R A S T  ( t i m e s )= p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) ^ s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( M U LT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * ^ n a l y s j _ s 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  va l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * ^ n a ^ y S ^ s 0 f V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g of F
W I T H I N  C E L L S 4 6 3 8 0 . 2 0 33 1 4 0 5 . 4 6
G R O U P (1) 5 9 . 2 0 1 5 9 .20 .04 .839
G R O U P (2) 1 1 0 . 3 2 1 110.32 . 08 .781
* * * * * A n a l y s i s  o f V a r i a n c e —  d e s i g n 1 'k * '
T e s t s  i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  E f fect.
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.80664
6 . 8 7 6 1 2
.032
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.83797 
.93113 
.50000
2 D. F.
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  resul t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS H y p o t h .  M S  E r r o r  M S
T2 2 1 4 . 1 2 5 5 6  3 3 2 9 . 6 8 1 7 3  2 1 4 . 1 2 5 5 6  1 0 0 . 8 9 9 4 5
T3 5 3 . 4 2 7 3 7  1 9 0 0 . 4 1 8 4 2  5 3 . 4 2 7 3 7  5 7 . 5 8 8 4 4
F Sig. o f  F
2 . 1 2 2 1 7  .155
.92774 .342
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E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2
T3
6 1 . 7 0 8 3 2
3 7 4 . 7 6 8 0 3
3 3 2 9 . 6 8 1 7 3
1 9 0 0 . 4 1 8 4 2
6 1 . 7 0 8 3 2
3 7 4 . 7 6 8 0 3
1 0 0 . 8 9 9 4 5
5 7 . 5 8 8 4 4
.61158 
6 . 5 0 7 7 0
.440
.016
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 1 5 8 5 . 7 9 0 9 5 3 3 2 9 . 6 8 1 7 3 1 5 8 5 . 7 9 0 9 5 1 0 0 . 8 9 9 4 5 1 5 . 7 1 6 5 5 .000
T3 1 0 6 . 1 4 7 6 2 1 9 0 0 . 4 1 8 4 2 1 0 6 . 1 4 7 6 2 5 7 . 5 8 8 4 4 1 . 8 4 3 2 1 .184
★ 0 f V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e s t s  i n v o l v i n g  ’T I M E S ’ W i t h i n - S u b j e c t  E ffect.
A V E R A G E D  T e s t s  o f S i g n i f i c a n c e  for M E A S . 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F S i g  o f  F
W I T H I N  C E L L S 5 2 3 0 . 1 0 66 79.24
T I M E S 1 6 9 1 . 9 4 2 845 . 9 7 10.68 .000
G R O U P (1) B Y  T I M E S 4 3 6 . 4 8 2 2 1 8 . 2 4 2.75 .071
G R O U P (2) B Y  T I M E S 2 6 7 . 5 5 2 133. 7 8 1.69 .193
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Study 2 - Diastolic Blood Pressure
M A N O V A
d b b l 2  d b b l 3  d b b l 4  d b b l 5  d b b l 6  d b b l 7  d b b ! 8  d b b l 9  d b b l l O  d b b l l l  d b b l l 2  B Y  g r o u p  
(1 3)
/ W S F A C T O R S = t i m e (11)
/ C O N T R A S T  (t i m e ) = p o  1 y n o m i  a 1
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p (2).
Manova
* * * * * * ^ n a ; L y S i s 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a l y s i s  o f V  a r i a n c e —  d e s i g n 1 * * -
T e sts of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  of S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F MS F Si g of F
W I T H I N  C E L L S 9 3 2 9 7 . 8 8 33 28 2 7 . 2 1
G R O U P (1) 2.84 1 2.84 .00 .975
G R O U P (2) 54.53 1 54.53 .02 .890
* * * * * * A n a ] _ y S i s  o f V  a r i a n c e -- d e s i g n 1 * *
T e sts i n v o l v i n g  'TIME' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  th a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
.05592
8 4 . 9 7 9 1 0  w i t h  54 D. F. 
.005
.62981 
.84164 
.10000
E F F E C T  .. G R O U P (2) B Y T I M E
, F.U n i v a r i a t e F - t e s t s  w i t h  (1,33) D.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  MS E r r o r  M S F Sig. of F
T2 2 . 4 9 0 5 2 4 9 9 . 4 5 6 7 5 2 . 4 9 0 5 2 1 5 . 1 3 5 0 5 .16455 .688
Page 1
T3 4 3 . 3 3 6 9 6 2 9 5 . 9 3 6 1 7
T4 .00026 2 5 5 . 5 0 6 6 9
T5 1 0 . 5 5 1 7 2 1 4 5 . 1 8 9 8 3
T6 .02080 1 1 0 . 3 9 8 6 9
T7 .00701 1 2 5 . 1 8 4 9 9
T8 6 . 9 7 9 8 5 9 4 . 3 0 6 3 0
T9 .10431 1 7 1 . 6 6 0 0 1
T10 3 . 6 5 4 3 6 1 8 2 . 1 3 9 6 2
Til .07466 1 4 8 . 6 3 9 3 2
4 3 . 3 3 6 9 6 8.9 6 7 7 6 4.8 3 2 5 3 .035
.00026 7 . 74263 .00003 .995
10 . 5 5 1 7 2 4 . 3 9 9 6 9 2 . 3 9 8 2 9 .131
.02080 3.34541 .00622 .938
.00701 3.79348 .00185 .966
6.9 7 9 8 5 2. 8 5 7 7 7 2. 4 4 2 4 2 .128
.10431 5.20182 .02005 .888
3 . 6 5 4 3 6 5.51938 .66210 .422
.07466 4 . 50422 .01658 .898
E F F E C T  .. G R O U P (1) B Y  TI M E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h . MS E r r o r  MS F Sig. of F
T2 5 1 . 2 0 0 1 6 4 9 9 . 4 5 6 7 5 5 1 . 2 0 0 1 6 1 5 . 1 3 5 0 5 3 . 3 8 2 8 9 .075
T3 . 12027 2 9 5 . 9 3 6 1 7 .12027 8. 9 6 7 7 6 .01341 .909
T4 4 . 5 6 8 0 7 2 5 5 . 5 0 6 6 9 4.56807 7 .74263 .58999 .448
T5 2 . 9 8 7 9 4 1 4 5 . 1 8 9 8 3 2.9 8 7 9 4 4 . 3 9 9 6 9 .67912 .416
T6 1 5 . 0 4 0 0 4 1 1 0 . 3 9 8 6 9 15.04004 3.34541 4.49572 . 042
T7 4 . 9 6 4 0 7 1 2 5 . 1 8 4 9 9 4 .96407 3.79348 1.30858 .261
T8 7 . 0 2 1 5 3 9 4 . 3 0 6 3 0 7 .02153 2 . 8 5 7 7 7 2. 4 5 7 0 0 . 127
T9 5 . 5 4 8 5 0 1 7 1 . 6 6 0 0 1 5.5 4 8 5 0 5.20182 1 .06665 .309
T10 9.1 1 4 9 1 1 8 2 . 1 3 9 6 2 9.11491 5.51938 1.65144 .208
Til 4 . 5 5 3 3 7 1 4 8 . 6 3 9 3 2 4 .55337 4 . 50422 1.01091 .322
E F F E C T  .. T I M E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2 2 3 . 6 2 0 4 3 4 9 9 . 4 5 6 7 5 2 3 . 6 2 0 4 3 15 . 1 3 5 0 5 1.56064 .220
T3 3 . 8 2 1 3 2 2 9 5 . 9 3 6 1 7 3.82132 8. 9 6 7 7 6 .42612 .518
T4 1 . 3 8 2 3 7 2 5 5 . 5 0 6 6 9 1.38237 7 .74263 .17854 .675
T5 3 3 . 1 8 3 9 8 1 4 5 . 1 8 9 8 3 33 . 1 8 3 9 8 4 . 3 9 9 6 9 7.54234 .010
T6 .45616 1 1 0 . 3 9 8 6 9 .45616 3.34541 .13635 .714
T7 4 . 2 2 8 2 7 1 2 5 . 1 8 4 9 9 4.22827 3.79348 1.11461 .299
T8 .36374 9 4 . 3 0 6 3 0 .36374 2.85777 .12728 .724
T9 1 7 . 9 3 4 1 4 1 7 1 . 6 6 0 0 1 17.93 4 1 4 5.20182 3.44767 .072
T10 1 . 3 6 7 0 0 1 8 2 . 1 3 9 6 2 1.36700 5.51938 .24767 . 622
Til 7 . 4 8 9 3 9 1 4 8 . 6 3 9 3 2 7 . 4 8 9 3 9 4.50422 1.66275 .206
* * * * * * ^ n a ] _ y s : L S o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e sts i n v o l v i n g  'TIME* W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for DBB u s i n g  U N I Q U E  sums of s q uares
S o u r c e  of V a r i a t i o n
W I T H I N  C E L L S  
TIME
G R O U P (1) B Y  T I M E  
G R O U P (2) B Y  TI M E
SS DF MS F Sig of F
2 0 2 8 . 4 2 330 6.15
93.85 10 9.38 1.53 .128
105.12 10 10.51 1.71 .077
67.22 10 6.72 1.09 .366
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MANOVA
d b b l l 2  d b c l  d b c 2  B Y  g r o u p (1 3)
/ W S F A C T O R S = t i m e s (3)
/C O N T R A S  T (t i m e  s )= p o 1 y n o m i  a 1
/CONTRAST (group)=special ( 1 1 1 1 1 - 2 1 - 1 0 )  /METHOD UNIQUE 
/ERROR WITHIN 
/PRINT
SIGNIF( UNIV )
/NOPRINT PARAM(ESTIM)
SIGNIF( MULT)
/d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a l y s i s  Q f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a l u e s .
0 c a s e s  r e j e c t e d  b e c a u s e  o f  m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
* * * * * * A n a 2 y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F S i g of F
W I T H I N  C E L L S 3 1 3 4 2 . 1 7 33 9 4 9 . 7 6
G R O U P (1) 3 8 .07 1 38.07 .04 .843
G R O U P (2) 3 8 7 . 6 3 1 3 8 7 . 6 3 .41 .527
* * * * * A n a l y s i s  o f V a r i a n c e -- d e s i g n 1 •Jr Jr '
T e s t s  i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  E f f e c t .
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.71235
1 0 . 8 5 3 9 6  w i t h  2 D. F. 
.004
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.77661
.85725
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for th e  A V E R A G E D  re s u l t s .
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2
T3
8 0 . 9 8 8 5 0
6 . 7 7 5 1 9
1 5 4 6 . 9 7 1 9 9
5 9 7 . 1 0 2 7 6
8 0 . 9 8 8 5 0
6 . 7 7 5 1 9
4 6 . 8 7 7 9 4
1 8 . 0 9 4 0 2
1 . 7 2 7 6 5
.37444
.198
.545
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E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  M S F Sig. of F
T2 .03255 1 5 4 6 . 9 7 1 9 9 .03255 4 6 . 8 7 7 9 4 .00069 .979
T3
E F F E C T  .. 
U n i v a r i a t e
1 5 3 . 1 6 4 4 7  5 9 7 . 1 0 2 7 6  
T I M E S
F - t e s t s  w i t h  (1,33) D,
1 5 3 . 1 6 4 4 7  
. F.
1 8 . 0 9 4 0 2 8 . 4 6 4 9 2 . 006
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  MS E r r o r  M S F Sig. of F
T2 7 6 6 . 4 2 9 3 8 1 5 4 6 . 9 7 1 9 9 7 6 6 . 4 2 9 3 8 4 6 . 8 7 7 9 4 1 6 . 3 4 9 4 7 .000
T3 7 . 8 6 7 7 2 5 9 7 . 1 0 2 7 6 7.8 6 7 7 2 18 . 0 9 4 0 2 .43482 .514
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  ] _ * * * * * *  
T e s t s  i n v o l v i n g  ’T I M E S ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F Si g  of F
W I T H I N  C E L L S 2 1 4 4 . 0 7 66 32.49
T I M E S 7 7 4 . 3 0 2 387.15 11.92 .000
G R O U P (1) B Y  T I M E S 153. 2 0 2 76.60 2.36 .103
G R O U P (2) B Y  T I M E S 87.76 2 43.88 1.35 .266
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Study 2 - Delta-1
M A N O V A
d l f z b l 2  d l f z c O l  d l f z c 0 2  d l c z b l 2  d l c z c O l  d l c z c 0 2  d l p z b l 2  dl p z c O l  d l p z c 0 2  BY 
g r o u p
(1 3)
/ W S F A C T O R S =  s i t e (3) t i m e s (3)
/ C O N T R A S T ( t i m e s ) = p o l y n o m i a l  
/ C O N T R A S T  ( s i t e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ O M E A N S
/ N O P R I N T  PARAM(ESTIM)
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) group(2).
Manova
* * * * * * ^ n a l y s f s 0 f V a r i a n c e * * * * * *
36 c a ses accepted.
0 cases r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  factor values.
0 cases r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  be p r o c essed.
Cell M e a n s  a n d  S t a n d a r d  D e v i a t i o n s  
V a r i a b l e  .. D1F Z B 1 2
F A C T O R CODE M e a n Std. Dev. N
G R O U P 1 -.503 4.854 11
G R O U P 2 1.018 4.224 13
G R O U P 3 1.095 2.530 12
For e n t i r e  sample .579 3.923 36
V a r i a b l e  .. D1F Z C 0 1
F A C T O R CODE M e a n Std. Dev. N
G R O U P 1 4.357 7.966 11
G R O U P 2 1.020 6.470 13
G R O U P 3 4.898 5.053 12
For e n t i r e  sample 3.332 6.608 36
V a r i a b l e  .. D 1 F Z C 0 2
F A C T O R CODE M e a n Std. Dev. N
G R O U P 1 2.948 7.889 11
G R O U P 2 4.188 7.397 13
G R O U P 3 2.518 4.404 12
For e n t i r e  samp l e 3.252 6.571 36
V a r i a b l e  .. D 1 C Z B 1 2
F A C T O R CODE M e a n Std. Dev. N
G R O U P 1 . 635 4.594 11
G R O U P 2 . 032 4.234 13
G R O U P 3 1.253 3.409 12
For e n t i r e  sample . 623 4.012 36
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V a r i a b l e  . .  D 1 C Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 4 . 7 8 8 3 . 7 8 1 11
G R O U P 2 1 . 7 2 3 6 . 4 8 4 13
G R O U P 3 6 . 0 6 0 4 . 1 0 2 12
F o r  e n t i r e  s a m p l e 4 . 1 0 5 5 . 2 3 0 36
V a r i a b l e  .. D 1 C Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 5 . 2 2 5 6 . 6 1 5 11
G R O U P 2 5 . 3 1 4 7 . 1 9 1 13
G R O U P 3 2 . 0 7 2 6 . 0 6 6 12
F or e n t i r e  s a m p l e 4 . 2 0 6 6.644 36
V a r i a b l e  .. D 1 P Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - . 9 0 8 3 . 3 2 5 11
G R O U P 2 .380 5 . 2 3 3 13
G R O U P 3 2 . 2 1 0 4 . 3 2 5 12
Fo r  e n t i r e  s a m p l e .597 4 . 4 7 7 36
V a r i a b l e  .. D 1 P Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 5 . 4 2 5 4 . 6 3 3 11
G R O U P 2 2 . 5 4 4 7 . 6 2 5 13
G R O U P 3 5 . 7 5 7 5 . 5 8 3 12
For e n t i r e  s a m p l e 4 . 4 9 5 6.172 36
V a r i a b l e  .. D 1 P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 5 . 908 8 . 3 2 6 11
G R O U P 2 3 . 1 1 6 4 . 3 3 1 13
G R O U P 3 1 . 252 7 . 1 2 3 12
F o r  e n t i r e  s a m p l e 3 . 3 4 8 6 . 766 36
* * * * * * A n a l y s i s  o f
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e  fo r  T1 u s i n g  
S o u r c e  o f  V a r i a t i o n  SS
W I T H I N  C E L L S  2 7 2 9 . 5 5
G R O U P (1) 1 0 . 9 3
G R O U P (2) 4 8 . 2 8
* * * * * * A n a l y s i s  o f  
T e s t s  i n v o l v i n g  ' S I T E ’ W i t h i n - S u b j e c t
V a r i a n c e  —  d e s i g n  1 * * * * *
U N I Q U E  sums o f  s q u a r e s
D F M S F S i g of F
33 82.71
1 1 0 . 9 3 .13 .719
1 4 8 . 2 8 .58 .450
a r i a n c e —  d e s i g n  1 *
E f f e c t
M a u c h l y  s p h e r i c i t y  test, W  
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
. 6 4 2 8 6
1 4 . 1 3 8 4 6  w i t h  2 D. F. 
. 001
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.73684
.80969
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  a r e  e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for th e  A V E R A G E D  r e s u l t s .
E F F E C T  .. G R O U P (2) B Y  S I T E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 1 4 . 4 1 4 4 0 9 9 4 . 9 1 6 9 5  1 4 . 4 1 4 4 0 3 0 . 1 4 9 0 0 .47811 .494
T3 1 . 6 0 0 1 6 2 5 2 . 2 3 1 9 8  1 . 6 0 0 1 6 7 . 6 4 3 3 9 .20935 .650
E F F E C T  .. <G R O U P (1) B Y S I T E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. o f  F
T2 1 . 3 5 8 9 7 9 9 4 . 9 1 6 9 5  1 . 3 5 8 9 7 3 0 . 1 4 9 0 0 .04508 .833
T3 1 . 6 5 2 0 3 2 5 2 . 2 3 1 9 8  1 . 6 5 2 0 3 7 . 6 4 3 3 9 .21614 . 645
E F F E C T  .. S I T E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T2 1 1 . 4 0 5 6 6 9 9 4 . 9 1 6 9 5  1 1 . 4 0 5 6 6 3 0 . 1 4 9 0 0 .37831 .543
T3 1 0 . 7 7 7 2 9 2 5 2 . 2 3 1 9 8  1 0 . 7 7 7 2 9 7 . 6 4 3 3 9 1 . 4 1 0 0 1 .244
* * * * * * A  n a 1 y s i s  o f  V a r i a n e e  — d e s i g n  1 * * * ■k -k -k
T e s t s  i n v o l v i n g  'SITE' W i t h i n - S u b j e c t  Eff e c t .
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of s q u a r e s  
S o u r c e  of V a r i a t i o n
W I T H I N  C E L L S  
SI T E
G R O U P (1) B Y  S I T E  
G R O U P (2) B Y  S I T E
SS D F M S F Sig of F
1 2 4 7 . 1 5 66 18.90
2 2 . 1 8 2 1 1 .09 .59 .559
3.01 2 1.51 .08 .924
16.01 2 8.01 .42 .656
. s o f V a r i a n c e —  d e s i g n 1 k *
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  E f f e c t
M a u c h l y  s p h e r i c i t y  test, W  
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
9 7 1 1 9
9 3 5 5 3  w i t h  2 D. F. 
.626
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.971991.00000
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  
u n i v a r i a t e  o r  s p l i t - p l o t  o r  m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for th e  A V E R A G E D  r e s u l t s .
a re e q u i v a l e n t  
m e a s u r e s .
to
E F F E C T  . .  G R O U P (2 )  B Y  T IM E S
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U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. M S E r r o r  M S F Sig. of F
T4 1 3 . 3 7 3 4 7 2 1 7 9 . 9 5 6 8 6 13.37347 6 6 . 0 5 9 3 0 .20245 .656
T5 1 2 3 . 4 5 6 4 5 1 7 6 4 . 2 3 7 7 5 1 2 3 . 4 5 6 4 5 5 3 . 4 6 1 7 5 2 . 3 0 9 2 5 .138
E F F E C T  .. G R O U P (1) B Y T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D., F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  M S F Sig. of F
T4 1 8 3 . 2 9 3 6 4 2 1 7 9 . 9 5 6 8 6 1 8 3 . 2 9 3 6 4 6 6 . 05930 2 . 7 7 4 6 8 .105
T5 1 2 5 . 9 3 4 9 2 1 7 6 4 . 2 3 7 7 5 1 2 5 . 9 3 4 9 2 5 3 . 4 6 1 7 5 2 . 3 5 5 6 1 .134
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. M S E r r o r  MS F Sig. of F
T4 4 9 5 . 5 9 9 1 3 2 1 7 9 . 9 5 6 8 6 4 9 5 . 5 9 9 1 3 6 6 . 05930 7 . 50234 .010
T5 2 7 7 . 0 4 1 9 1 1 7 6 4 . 2 3 7 7 5 2 7 7 . 0 4 1 9 1 5 3 . 4 6 1 7 5 5 . 1 8 2 0 6 .029
* * * * * * A  n a 1 y s i s  o f V a r i a n c e  — d e s i g n  1 * * * ★ ★ ★
Tests i n v o l v i n g  'TIMES ' W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums of sq u a r e s
S o u r c e  of V a r i a t i o n SS DF MS F Si g  of F
W I T H I N  C E L L S 3 9 4 4 . 1 9 66 59.76
TIMES 772. 6 4 2 386.32 6.46 .003
G R O U P (1) B Y  T I M E S 3 0 9 . 2 3 2 154.61 2.59 .083
G R O U P (2) B Y  T I M E S 136. 8 3 2 68.41 1.14 .325
* * * * * * A  n a 1 y s i s  o f V a r i a n c e - - d e s i g n  1 * * * * * *
Tests i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
.22680
4 6 . 6 1 2 3 8  w i t h  9 D. F. 
. 0 0 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.62624 
.72289 
.25000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  that f o l l o w  m u l t i v a r i a t e  t e sts are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e
T6
T7
T8
T9
H y p o t h .  SS
2 1 . 5 0 3 4 1
1 3 . 3 0 9 7 8
1 6 . 3 6 4 8 9
1 . 0 0 2 4 3
E r r o r  SS
8 8 7 . 5 2 8 1 6  
5 3 2 . 7 8 0 3 5  
2 1 2 . 6 3 5 7 3  
1 0 2 . 5 4 6 8 4
H y poth. MS
2 1 . 5 0 3 4 1
13 . 3 0 9 7 8
1 6 . 3 6 4 8 9
1 . 0 0 2 4 3
E r r o r  M S
2 6 . 8 9 4 7 9
1 6 . 1 4 4 8 6
6.44351
3. 1 0 7 4 8
F Sig. of F
.79954 .378
.82440 .370
2 . 5 3 9 7 5 . 121
.32259 .574
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E F F E C T  .. G R O U P (1) BY SITE BY TIMES 
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e Hypoth. SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T6 2 9 . 5 1 8 6 5 8 8 7 . 5 2 8 1 6 2 9 . 5 1 8 6 5 2 6 . 8 9 4 7 9 1.09756 .302
T7 .06027 5 3 2 . 7 8 0 3 5 .06027 16.14486 .00373 .952
T8 .24754 2 1 2 . 6 3 5 7 3 .24754 6.44351 .03842 .846
T9
E F F E C T  .. 
U n i v a r i a t e
10.28792
SI T E  B Y  TIMES 
F - t e s t s  w i t h
1 0 2.54684  
. (1,33) D.
10.28792 
. F.
3.10748 3 . 31069 .078
V a r i a b l e Hypoth. SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T6 .30180 8 8 7 . 5 2 8 1 6 .30180 2 6 . 8 9 4 7 9 .01122 .916
T7 12.77764 5 3 2 . 7 8 0 3 5 12.77764 16.14486 .79144 .380
T8 7. 4 7 3 8 9 2 1 2 . 6 3 5 7 3 7.47389 6.44351 1.15991 .289
T9 1.40056 102.54684 1.40056 3.10748 .45071 .507
k  k  k  k  k  k A  n a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * k k * *
T e s t s  i n v o l v i n g  'SITE BY TIMES' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  Tests of S i g n i f i c a n c e  for M E A S  . 1 u s i n g  UNI Q U E sums of squares
S o u r c e  of V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E LLS 1735.49 132 13.15
SITE BY TIMES 21.95 4 5.49 .42 .796
G R O U P (1) BY SITE BY 40.11 4 10.03 .76 .551
TIMES
G R O U P (2) BY SITE BY 52.18 4 13.05 .99 .414
TIMES
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Study 2 - Delta-2
M A N O V A
d 2 f z b l 2  d 2 f z c O l  d 2 f z c 0 2  d 2 c z b l 2  d 2 c z c 0 1  d 2 c z c 0 2  d 2 p z b l 2  d 2 p z c 0 1  d 2 p z c 0 2  B Y  
g r o u p
(1 3)
/WSFACTORS= site (3) times(3)
/CONTRAS T (t ime s)=po1ynomi a1 
/CONTRAST (site)=polynomial
/CONTRAST (group)=special ( 1 1 1 1 1 - 2 1 - 1 0 )/METHOD UNIQUE 
/ERROR WITHIN 
/PRINT
SIGNIF( UNIV )
/OMEANS
/NOPRINT PARAM (ESTIM)
SIGNIF( MULT)
/design=group(1) group(2).
Manova
* * * * * * ^ n a ^ y s - ^ s o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  fac t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
Cell M e a n s  a n d  S t a n d a r d  D e v i a t i o n s  
V a r i a b l e  .. D 2 F Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1.827 4.090 11
G R O U P 2 -1.133 3.275 13
G R O U P 3 -.574 3.360 12
For e n t i r e  s a m p l e -.042 3.693 36
V a r i a b l e  .. D 2 F Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -2.918 8.468 11
G R O U P 2 -.813 6.471 13
G R O U P 3 -.249 8.307 12
For e n t i r e  s a m p l e -1.268 7.604 36
V a r i a b l e  .. D 2 F Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -2.491 7.881 11
G R O U P 2 -2.1 6 9 6.182 13
G R O U P 3 -2.855 4.577 12
For e n t i r e  s a m p l e - 2 . 4 9 6 6.125 36
V a r i a b l e  .. D 2 C Z B 1 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
For e n t i r e  s a m p l e
M e a n Std. Dev. N
1.181 4.263 11
.706 5.110 13
- 1 . 0 9 6 4.025 12
.251 4.495 36
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V a r i a b l e  .. D 2 C Z C 0 1
F A C T O R CO D E M e a n Std. D e v . N
G R O U P 1 -2. 4 5 1 7 .396 11
G R O U P 2 .567 5.422 13
G R O U P 3 -1.282 4.927 12
For e n t i r e  s a m p l e -.972 5.911 36
V a r i a b l e  .. D 2 C Z C 0 2
F A C T O R CO D E M e a n Std. Dev. N
G R O U P 1 - 1 . 1 3 9 7.324 11
G R O U P 2 - 2 . 3 1 0 6.218 13
G R O U P 3 - 3 . 0 5 0 5.068 12
For e n t i r e  s a m p l e - 2 . 1 9 9 6.104 36
V a r i a b l e  .. D 2 P Z B 1 2
F A C T O R CODE M e a n Std. Dev. N
G R O U P 1 1.198 4.307 11
G R O U P 2 .513 3.641 13
G R O U P 3 - 1 . 2 5 5 4.660 12
For e n t i r e  s a m p l e . 133 4.212 36
V a r i a b l e  .. D 2 P Z C 0 1
F A C T O R C O D E M e a n Std. D e v . N
G R O U P 1 -.942 7.412 11
G R O U P 2 .963 4.239 13
G R O U P 3 -1.418 3.927 12
For e n t i r e  s a m p l e -.413 5.277 36
V a r i a b l e  .. D 2 P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.029 6.190 11
G R O U P 2 -.903 3.894 13
G R O U P 3 -2.3 7 0 7.270 12
Fo r  e n t i r e  s a m p l e - 1 . 1 2 5 5.804 36
r * * * * * A n a l y s i s  o f V  a r i a n c e d e s i g n 1 * * * *
?ests of B e t w e e n - S u b j e c t s  Effects.
T e s t s  of S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E L L S 3 8 76.44 33 117.47
G R O U P (1) 71.51 1 71.51 . 61 .441
G R O U P (2) .93 1 . 93 .01 .930
* * * * * * A n a i y S i s  o f  V a r i a n c e - -  d e s i g n  1 * * * * 
T e s t s  i n v o l v i n g  'SITE' W i t h i n - S u b j e c t  Effect.
.58573
1 7 . 1 1 6 4 5  w i t h  2 D. F. 
. 0 0 0
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.70708
.77424
.50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y S I T E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. O f  F
T2 .76824 6 7 2 . 8 3 5 8 6 .76824 2 0 . 3 8 8 9 7 .03768 .847
T3 2 . 8 4 5 8 7 1 7 5 . 4 4 2 9 0 2 . 8 4 5 8 7 5 . 3 1 6 4 5 .53530 .470
E F F E C T  .. G R O U P (1) B Y S I T E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H ypoth. MS E r r o r  MS F Sig. of F
T2 4 1 . 9 3 7 7 4 6 7 2 . 8 3 5 8 6 41 . 9 3 7 7 4 2 0 . 3 8 8 9 7 2 . 0 5 6 8 8 .161
T3 2 . 0 2 8 5 1 1 7 5 . 4 4 2 9 0 2 . 0 2 8 5 1 5 . 3 1 6 4 5 .38155 .541
E F F E C T  . . S I T E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  M S F Sig. of F
T2 3 3 . 7 5 5 2 9 6 7 2 . 8 3 5 8 6 3 3 . 7 5 5 2 9 2 0 . 3 8 8 9 7 1.65557 .207
T3 1 . 0 0 2 7 9 1 7 5 . 4 4 2 9 0 1 . 0 0 2 7 9 5 . 3 1 6 4 5 .18862 . 667
k  k  k  k  k * A  n  a 1 y s i s  o f V a r i a n e e - - d e s i g n  1 * * * k  k  k
Tests i n v o l v i n g  'SITE' W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for M E A S .1 us ing U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F MS F Sig O f  F
W I T H I N  C E L L S 848 . 2 8 66 12.85
SITE 3 4 . 7 6 2 17.38 1.35 .266
G R O U P (1) B Y  SI T E 43.97 2 21.98 1.71 .189
G R O U P (2) B Y  SI T E 3.61 2 1.81 .14 .869
k  k  k  k  k * A  n  a 1 y s i s  o f V a r i a n e e - - d e s i g n  1 * * * k  k  k
T e sts i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  a p p r o x .  = 
S i g n i f i c a n c e  =
.90787
3 . 0 9 2 9 3  w i t h  2 D. F. 
.213
G r e e n h o u s e - G e i s s e r  E p s i l o n  = .91564 
H u y n h - F e l d t  E p s i l o n  = 1 . 0 0 0 0 0  
L o w e r - b o u n d  E p s i l o n  = .50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  r e s ults.
E F F E C T  .. G R O U P (2) B Y  T I M E S
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U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y poth. SS E r r o r  SS Hypoth. MS E r r o r  M S F Sig., of F
T4 5.6 9 7 5 2 1 7 5 3 . 5 8 0 9 9 5.69752 53.13 8 8 2 .10722 .745
T5 1 3 1 . 0 5 7 3 8 1 4 6 5 . 0 3 5 9 5 1 3 1 . 0 5 7 3 8 44 . 3 9 5 0 3 2 . 9 5 2 0 7 .095
E F F E C T  .. G R O U P (1) BY TIMES
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H ypoth. SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig., of F
T4 2 . 3 0 7 1 2 1 7 5 3 . 5 8 0 9 9 2.30712 53.13882 .04342 .836
T5 3 2 . 2 0 1 1 9 1 4 6 5 . 0 3 5 9 5 3 2 . 2 0 1 1 9 44.39 5 0 3 .72533 .401
E F F E C T  .. TIMES
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e Hypoth. SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T4 2 3 1 . 6 1 5 0 6 1 7 5 3 . 5 8 0 9 9 2 3 1 . 6 1 5 0 6 53.13882 4.35868 .045
T5 .28454 1 4 6 5 . 0 3 5 9 5 .28454 4 4 . 39503 .00641 .937
* * * * * * A  n a 1 y s i s  o f V a r i a n e e - - ' d e s i g n  1 * -*• * * * *
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e sts of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums of squares
S o u r c e  of V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C ELLS 3218.62 66 48.77
T IMES 231.90 2 115.95 2.38 .101
G R O U P (1) BY TIMES 34.51 2 17.25 .35 .703
G R O U P (2) BY TIMES 136.75 2 68.38 1.40 .253
* * * * * * ^ n a ] _ y S j _ s o f  V a r i a n c e - -  d e s i g n  1 * - * * * * * 
T e s t s  i n v o l v i n g  'SITE BY TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
.19198
51.84 8 5 8  w i t h  9 D. F. 
. 000
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.55328 
.63073 
.25000
A V E R A G E D  T e sts of S i g n i f i c a n c e  that f o l l o w  m u l t i v a r i a t e  tests are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m easures.
E p s i l o n s  m a y  be u s e d  to adj u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) BY SITE BY TIMES 
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e
T6
T7
T8
T9
Hypoth. SS
17.93 2 6 8  
1.08498  
9.98092  
1.64011
E r r o r  SS
340.0 8 4 6 4  
942.5 4 8 0 4  
1 2 9 . 6 6 1 5 0  
1 4 0 . 9 1 9 1 6
Hypoth. MS
17.93268 
1.08498 
9.98092 
1.64011
E r r o r  MS
10.30560
2 8 . 5 6 2 0 6
3.92914
4.27028
F
1.74009
.03799
2. 5 4 0 2 3
.38408
Sig. of F
.196
.847
.121
.540
Page 4
E F F E C T  .. G R O U P (1) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  MS E r r o r  MS F Sig., of F
T6 .07232 3 4 0 . 0 8 4 6 4 .07232 1 0 . 3 0 5 6 0 .00702 . 934
T7 8 . 2 6 0 9 6 9 4 2 . 5 4 8 0 4 8 . 2 6 0 9 6 2 8 . 5 6 2 0 6 .28923 .594
T8 .45547 1 2 9 . 6 6 1 5 0 .45547 3.9 2 9 1 4 .11592 .736
T9
E F F E C T  .. 
U n i v a r i a t e
.04834
S I T E  B Y  T I M E S  
F - t e s t s  w i t h
1 4 0 . 9 1 9 1 6  
(1,33) D.
.04834
. F.
4. 2 7 0 2 8 .01132 . 916
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  MS F Sig. of F
T6 1 4 . 9 6 7 7 5 3 4 0 . 0 8 4 6 4 1 4 . 9 6 7 7 5 1 0 . 3 0 5 6 0 1. 4 5 2 3 9 .237
T7 . 12648 9 4 2 . 5 4 8 0 4 .12648 2 8 . 5 6 2 0 6 . 00443 .947
T8 3 . 3 7 4 9 8 1 2 9 . 6 6 1 5 0 3 . 37498 3.92914 .85896 .361
T9 .06053 1 4 0 . 9 1 9 1 6 .06053 4.2 7 0 2 8 .01418 . 906
★ ★ ★ ★ ★ ★ A  n a 1 y s i s  o f V a r i a n e e - - ' d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS DF MS F Si g  of F
W I T H I N  C E L L S 1553.21 132 11.77
S I T E  B Y  T I M E S 18.53 4 4.63 .39 .813
G R O U P (1) B Y  S I T E  BY  
T I M E S
8.84 4 2.21 .19 .944
G R O U P (2) B Y  S I T E  B Y 30.64 4 7.66 .65 . 627
T I M E S
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Study 2 - Theta
M A N O V A
t f z b l 2  t f z c O l  t f z c 0 2  t c z b l 2  t c z c O l  t c z c 0 2  
/ W S F A C T O R S =  s i t e (3) t i m e s (3)
/ C O N T R A S T ( t i m e s ) = p o l y n o m i a l  
/ C O N T R A S T  ( s i t e ) = p o l y n o m i a l  
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2  
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ O M E A N S
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
t p z b l 2  t p z c O l  t p z c 0 2  B Y  g r o u p
1 -1  0 )
/d e s i g n = g r o u p (1) g r o u p ( 2 ) .
(1 3)
Manova
* * * * * * ^ n a ] _ y s ^ s o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  v a lues.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
C e l l  M e a n s  a n d  S t a n d a r d  D e v i a t i o n s  
V a r i a b l e  .. T F Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 .553 4 . 726 11
G R O U P 2 - . 5 1 9 1.633 13
G R O U P 3 .215 2.288 12
For e n t i r e  s a m p l e . 053 3.025 36
V a r i a b l e  .. T F Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 9 . 2 1 2 7.997 11
G R O U P 2 - 1 . 2 7 5 5.767 13
G R O U P 3 - 3 . 5 8 2 4.548 12
For e n t i r e  s a m p l e - 4 . 4 6 9 6.878 36
V a r i a b l e  .. T F Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 5 . 4 8 6 6.676 11
G R O U P 2 - 1 . 5 4 4 4 . 9 0 5 13
G R O U P 3 - 1 . 7 8 1 4.967 12
For e n t i r e  s a m p l e -2.8 2 8 5.652 36
V a r i a b l e  .. T C Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.291 5 . 6 0 6 11
G R O U P 2 - . 674 2 . 8 0 2 13
G R O U P 3 - . 4 6 3 2 . 5 2 9 12
Fo r  e n t i r e  s a m p l e - . 4 8 7 3.702 3 6
V a r i a b l e  .. T C Z C 0 1
F A C T O R  C O D E M e a n  Std. Dev. N
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G R O U P 1 -8.5 6 1 6.940 11
G R O U P 2 - . 2 1 7 3 . 9 5 6 13
G R O U P 3 - 1 . 9 2 3 4.617 12
Fo r  e n t i r e  s a m p l e - 3 . 3 3 5 6.221 36
V a r i a b l e  .. T C Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 6 . 9 6 7 6.851 11
G R O U P 2 - . 7 7 9 5 .195 13
G R O U P 3 - . 7 8 5 6.630 12
F or e n t i r e  s a m p l e - 2 . 6 7 2 6.696 36
V a r i a b l e  .. T P Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 .735 7.041 11
G R O U P 2 - .210 3.057 13
G R O U P 3 - 1 . 4 9 5 2 . 4 5 9 12
For e n t i r e  s a m p l e - . 3 4 9 4.483 36
V a r i a b l e  .. T P Z C 0 1
F A C T O R CO D E M e a n Std. Dev. N
G R O U P 1 -8.101 6.067 11
G R O U P 2 - . 7 2 5 1.876 13
G R O U P 3 -3. 0 3 1 4.526 12
For e n t i r e  s a m p l e -3. 7 4 8 5.262 36
V a r i a b l e  .. T P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -7.9 7 0 7.197 11
G R O U P 2 -1.491 4.112 13
G R O U P 3 -2.187 7.824 12
F or e n t i r e  s a m p l e - 3 . 7 0 3 6.940 36
* * * * * * A n a ] _y s i s  o f V a r i a n c e -- d e s i g n 1 -k 'k •Jr
Pests of B e t w e e n - S u b j e c t s  Effec t s .
T e s t s  of S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS DF M S F Sig of F
W I T H I N  C E L L S 3 1 9 6 . 8 9 33 96.88
G R O U P (1) 113 . 9 3 1 113.93 1.18 .286
G R O U P (2) 949 . 2 5 1 949 . 2 5 9.80 . 004
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  ’S I T E ’ W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
.70910
1 1 . 0 0 0 2 7  w i t h  2 D. F. 
.004
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.77465 
. 85491 
.50000
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A ^ ^ ? ^ +_T e S t S  0 ^ . ^ 9 ^ ^ c a n c e  that f o l l o w  m u l t i v a r i a t e  t e s t s  ar e  e q u i v a l e n t  to
v i inn S ° rK S^  1 m ixec*-niodel a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  SI T E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2
T3
4 . 3 8 3 7 0
6 . 9 5 1 9 8
9 8 0 . 8 9 3 8 0
3 0 5 . 9 1 8 6 3
4 . 38370
6.95198
2 9 . 7 2 4 0 5
9.2 7 0 2 6
.14748
.74992
.703
.393
E F F E C T  .. 
U n i v a r i a t e
G R O U P (1) B Y  S I T E  
F - t e s t s  w i t h  (1,33) D. F.
- - - - - - - - - - - - - - -
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. Of F
T2
T3
2 . 7 0 3 4 8
1 2 . 8 6 2 5 5
9 8 0 . 8 9 3 8 0
3 0 5 . 9 1 8 6 3
2 . 70348
1 2 . 8 6 2 5 5
2 9 . 7 2 4 0 5
9 . 27026
.09095
1.38751
.765
.247
E F F E C T  .. S I T E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2 2 . 2 5 4 6 3 9 8 0 . 8 9 3 8 0 2.2 5 4 6 3 2 9 . 7 2 4 0 5 .07585 .785
T3 7 . 4 0 1 4 8 3 0 5 . 9 1 8 6 3 7.40148 9. 2 7 0 2 6 .79841 .378
* * * * * * A n a l y s i s  o f V a r i a n c e — d e s i g n 1 * * * * * *
Tests i n v o l v i n g  'SITE'1 W i t h i n - S u b j e c t E f f e c t .
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for MEAS. 1 u s i n g  U N I Q U E sums of sq u a r e s
S o u r c e  of V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E L L S 1 2 86.81 66 19.50
SITE 9.66 2 4.83 .25 .781
G R O U P (1) B Y  S I T E 15.57 2 7.78 .40 . 672
G R O U P (2) B Y  S I T E 11.34 2 5.67 .29 .749
* * * * * * A n a l y s i s  o f  V a r i a n c e - -  d e s i g n  1 * * * * *  * 
T ests i n v o l v i n g  * TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  = 
C h i - s q u a r e  ap p r o x .  = 
S i g n i f i c a n c e  =
.86066
4 . 8 0 1 8 3
.091
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.87770 
.97928 
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t —p l o t  or m i x e d —m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS Hyp o t h .  M S  E r r o r  M S  F Sig. of F
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T4
T5
3 5 8 . 8 4 4 7 2  1 5 4 6 . 9 2 9 0 2  3 5 8 . 8 4 4 7 2  46.87 6 6 4
3 6 2 . 7 7 0 3 4  1 1 0 6 . 7 7 5 9 4  3 6 2 . 7 7 0 3 4  3 3 . 5 3 8 6 6
7 . 6 5 5 0 9
10.81648
.009 
. 002
E F F E C T  .. G R O U P (1) B Y  T IMES 
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H ypoth. SS E r r o r  SS Hypoth. MS E r r o r  MS
T4 1 0 5 . 5 1 7 6 0  1 5 4 6 . 9 2 9 0 2  1 0 5 . 5 1 7 6 0  46.87 6 6 4
T5 1 1 . 9 4 5 2 3  1 1 0 6 . 7 7 5 9 4  1 1 . 9 4 5 2 3  3 3 . 5 3 8 6 6
F Sig. of F
2 . 2 5 0 9 6  .143
.35616 .555
E F F E C T  .. TIMES
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y poth. SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T4 4 7 8 . 0 9 0 1 5 1 5 4 6 . 9 2 9 0 2 4 7 8 . 0 9 0 1 5 46.87664 10.19890 .003
T5 3 9 2 . 3 5 2 8 5 1 1 0 6 . 7 7 5 9 4 3 9 2 . 3 5 2 8 5 33 . 5 3 8 6 6 11.69852 .002
* * * * * * A n a l y S ^ s 0 f V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S  . 1 u s i n g  U N I Q U E sums of s quares
S o u r c e  of V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E L L S 2 6 5 3 . 7 0 66 40.21
T I MES 870.44 2 435.22 10.82 .000
G R O U P (1) B Y  T I MES 117.46 2 58.73 1.46 .239
G R O U P (2) B Y  TIMES 721.62 2 360.81 8.97 .000
* * * * * * A n a ] _ y S j _ s 0 f V a r i a n c e - -  d e s i g n  ] _ * *  + * * *
T e s t s  i n v o l v i n g  'SITE BY TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
.45887
2 4 . 4 7 2 9 8  w i t h  9 D. F. 
.004
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.70992 
. 83079 
.25000
A V E R A G E D  T e sts of S i g n i f i c a n c e  that f o l l o w  m u l t i v a r i a t e  tests are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e asures.
E p s i l o n s  m a y  be u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) BY SITE BY TIMES 
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e Hypoth. SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T6 8.65524 3 8 3 . 1 7 3 2 3 8.65524 11.61131 .74541 .394
T7 7. 1 2 2 3 3 2 1 5 . 9 4 1 9 6 7.12233 6.54370 1.08843 .304
T8 .24458 1 2 7 . 0 6 9 6 3 .24458 3 . 85059 .06352 .803
T9 .03465 8 5 . 1 4 3 2 3 .03465 2.5 8 0 1 0 .01343 . 908
E F F E C T  .. G R O U P (1) B Y  SITE B Y  TIMES 
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  Hypoth. SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
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T6 1 5 . 2 5 9 9 9 3 8 3 . 1 7 3 2 3 1 5 . 2 5 9 9 9 1 1 . 6 1 1 3 1 1 . 3 1 4 2 3 .260
T7 .22951 2 1 5 . 9 4 1 9 6 .22951 6 . 5 4 3 7 0 .03507 . 853
T8 .06117 1 2 7 . 0 6 9 6 3 .06117 3 . 8 5 0 5 9 .01589 .900
T9 .01724 8 5 . 1 4 3 2 3 .01724 2 . 5 8 0 1 0 .00668 .935
E F F E C T  .. 
U n i v a r i a t e
V a r i a b l e
S I T E  B Y  T I M E S  
F - t e s t s  w i t h
H y p o t h .  SS
(1,33) D. 
E r r o r  SS
. F.
H y p o t h .  M S E r r o r  M S F Sig. of F
T6 2 . 6 0 2 8 7 3 8 3 . 1 7 3 2 3 2 . 6 0 2 8 7 1 1 . 6 1 1 3 1 .22417 . 639
T7 2 3 . 8 4 9 5 6 2 1 5 . 9 4 1 9 6 2 3 . 8 4 9 5 6 6 . 5 4 3 7 0 3 . 6 4 4 6 6 .065
T8 1 0 . 1 5 7 0 9 1 2 7 . 0 6 9 6 3 1 0 . 1 5 7 0 9 3 . 8 5 0 5 9 2 . 6 3 7 8 0 .114
T9 6 . 7 1 4 4 9 8 5 . 1 4 3 2 3 6 . 7 1 4 4 9 2 . 5 8 0 1 0 2 . 6 0 2 4 2 .116
* * * * * * A n a l y s i s  o f V a r i a n  c e -- d e s i g n 1 'k -k 'k -k "k -k
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Eff e c t .
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E AS. 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F Si g of F
W I T H I N  C E L L S 8 1 1 . 3 3 132 6.15
S I T E  B Y  T I M E S 43.32 4 10.83 1.76 .140
G R O U P (1) B Y  S I T E  B Y  
T I M E S
15.57 4 3.89 . 63 . 640
G R O U P (2) B Y  S I T E  BY 1 6 .06 4 4.01 . 65 . 626
T I M E S
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Study 2 - Alpha -1
MAN OVA
a l f z b l 2  a l f z c O l  a l f z c 0 2  a l c z b l 2  a l c z c O l  alc z c 0 2  a l p z b l 2  a l p z c O l  a l p z c 0 2  B Y  
g r o u p
(1 3)
/ W S F A C T O R S =  s i t e  (3) t i m e s (3)
/ C O N T R A S T ( t i m e s ) = p o l y n o m i a l  
/ C O N T R A S T  ( s i t e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ O M E A N S
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * ^ n a l y s i s  Q f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
Cell M e a n s  a n d  S t a n d a r d  D e v i a t i o n s
V a r i a b l e  .. A 1 F Z B 1 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
For e n t i r e  s a m p l e
V a r i a b l e  .. A 1 F Z C 0 1
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
For e n t i r e  s a m p l e
M e a n Std. Dev. N
.171 3.320 11
-.340 5.215 13
- .456 2.758 12
-.223 3.865 36
M e a n Std. Dev. N
•6.532 4.979 11
•4.488 5.877 13
■4.872 6.370 12
•5.241 5.697 36
V a r i a b l e  .. A 1 F Z C 0 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
For e n t i r e  s a m p l e
V a r i a b l e  .. A 1 C Z B 1 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
For e n t i r e  s a m p l e
M e a n Std. Dev. N
-5.630 5 . 006 11
-2.592 5.632 13
-2.5 3 5 6.368 12
-3.501 5.730 36
M e a n Std. Dev. N
-.722 4.057 11
- 1 . 1 3 5 5.968 13
-.392 3.624 12
-.761 4.598 36
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V a r i a b l e  .. A 1 C Z C 0 1
F A C T O R C O D E M e a n S t d . Dev. N
G R O U P 1 - 7 . 5 8 9 5.314 11
G R O U P 2 -7.5 5 4 8.817 13
G R O U P 3 -5. 1 9 8 7 . 4 1 5 12
For e n t i r e  s a m p l e - 6 . 7 7 9 7 . 300 36
V a r i a b l e  .. A 1 C Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -6. 8 2 8 5 . 935 11
G R O U P 2 - 6 . 9 6 5 8.332 13
G R O U P 3 -4.0 9 0 6.202 12
For e n t i r e  s a m p l e - 5 . 9 6 5 6.911 36
V a r i a b l e  .. A 1 P Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.993 8.953 11
G R O U P 2 -1.538 5.105 13
G R O U P 3 -1.337 4.690 12
For e n t i r e  s a m p l e -1.304 6.229 36
V a r i a b l e  .. A 1 P Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 1 3 . 0 3 8 8.910 11
G R O U P 2 - 1 0 . 9 5 3 11.766 13
G R O U P 3 - 8 . 2 2 5 9.685 12
For e n t i r e  s a m p l e - 1 0 . 6 8 1 10.172 36
V a r i a b l e  .. A 1 P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 1 0 . 5 7 0 10.497 11
G R O U P 2 -9. 3 9 0 11.337 13
G R O U P 3 -4.098 7.144 12
For e n t i r e  s a m p l e - 7 . 9 8 6 9.980 36
* * * * * * j ^ n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  *
T e s t s  of B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  of S i g n i f i c a n c e  for T1 u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n  SS D F  M S  F S ig of F
W I T H I N  C E L L S  
G R O U P (1)
G R O U P (2)
* * * * * * A n a l y s i s  o f  V a r i a n c e  d e s i g n  1
T e s t s  i n v o l v i n g  ' S I T E ’ W i t h i n - S u b j e c t  E f fect.
8 9 1 6 . 0 6
2 6 0 . 5 1
3 0 . 3 9
33 270.18
1 260.51
1 30.39
.96
.11
.333
.739
M a u c h l y  s p h e r i c i t y  t e s t ,  W
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
.51948
2 0 . 9 5 7 8 1  w i t h  2 D. F.
.000
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G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
.67544 
.73669 
.50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  th a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) BY SI T E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  MS F Sig. of F
T2 3 . 4 0 1 2 6 1 2 2 6 . 6 2 0 4 8 3 . 4 0 1 2 6 3 7 . 1 7 0 3 2 .09150 .764
T3 2 2 . 9 1 6 9 7 2 4 0 . 0 9 0 2 8 2 2 . 9 1 6 9 7 7 . 2 7 5 4 6 3 . 1 4 9 9 0 . 085
E F F E C T  .. G R O U P (1) BY SI T E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D,. F.
V a r i a b l e Hy p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2 7 9 . 6 4 8 7 5 1 2 2 6 . 6 2 0 4 8 7 9 . 6 4 8 7 5 3 7 . 1 7 0 3 2 2 . 1 4 2 8 1 .153
T3 . 0 0005 2 4 0 . 0 9 0 2 8 .00005 7 . 2 7 5 4 6 .00001 . 998
E F F E C T  .. SI T E
U n i v a r i a t e F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e Hy p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2 7 1 6 . 8 2 9 3 6 1 2 2 6 . 6 2 0 4 8 7 1 6 . 8 2 9 3 6 3 7 . 1 7 0 3 2 1 9 . 2 8 4 9 9 .000
T3 9. 2 5 9 6 1 2 4 0 . 0 9 0 2 8 9.25961 7 . 2 7 5 4 6 1 .27272 .267
* * * * * * A n a ] _ y S j _ s 0 f V a r i a n c e - -  d e s i g n  ] _ * * * * * *  
T e s t s  i n v o l v i n g  ’SITE' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E L L S 1466.71 66 22.22
S I T E 7 2 6 . 0 9 2 363.04 16.34 .000
G R O U P (1) B Y  SITE 7 9 . 6 5 2 39.82 1.79 . 175
G R O U P (2) B Y  S I T E 26.32 2 13.16 .59 .556
* * * * * A n a l y s i s  o f V  a r i a n c e -- d e s i g n 1 * * ■
T e s t s  i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W = 
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
.48018
2 3 . 4 7 5 1 7  w i t h  2 D. F. 
. 00 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.65797
.71604
.50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  that f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  . .  G R O U P (2) B Y  T IM E S
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U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS Hy p o t h .  M S  E r r o r  M S
T4 3 0 . 6 0 6 8 0  2 3 3 1 . 4 7 0 3 4  3 0 . 6 0 6 8 0  7 0 . 6 5 0 6 2
T5 1 0 . 8 0 6 8 5  1 1 6 7 . 9 4 5 7 9  1 0 . 8 0 6 8 5  3 5 . 3 9 2 3 0
F Sig. of F
.43321 .515
.30534 .584
E F F E C T  .. G R O U P (1) B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS Hypoth. M S  E r r o r  MS
T4 1 3 7 . 5 7 4 5 8  2 3 3 1 . 4 7 0 3 4  1 3 7 . 5 7 4 5 8  7 0 . 6 5 0 6 2
T5 4 . 5 6 3 0 1  1 1 6 7 . 9 4 5 7 9  4 . 5 6 3 0 1  3 5 . 3 9 2 3 0
F Sig. of F
1 . 9 4 7 2 5  .172
.12893 .722
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  MS F Sig. of F
T4 1 4 0 1 . 4 4 8 4 1 2 3 3 1 . 4 7 0 3 4 1 4 0 1 . 4 4 8 4 1 7 0 . 6 5 0 6 2 1 9 . 8 3 6 3 2 .000
T5 1 3 2 7 . 1 5 1 7 3 1 1 6 7 . 9 4 5 7 9 1 3 2 7 . 1 5 1 7 3 3 5 . 3 9 2 3 0 3 7 . 4 9 8 3 2 .000
* * * * * * A n a l y S i s 0 f V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  ’T I M E S ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of squ a r e s
S o u r c e  o f  V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E L L S 3 4 9 9 . 4 2 66 53.02
T I MES 2 7 2 8 . 6 0 2 1 3 64.30 25.73 .000
G R O U P (1) B Y  T I M E S 142 . 1 4 2 71.07 1.34 .269
G R O U P (2) B Y  T I M E S 41.41 2 20.71 .39 . 678
* * * * * A n a l y s i s  o f V  a r i a n c e -- d e s i g n 1 * *
T e sts i n v o l v i n g  ’S I T E  B Y  T I M E S ’ W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  app r o x .  =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  th a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
.16762
5 6 . 1 1 2 4 0  w i t h  9 D. F. 
. 0 0 0
.52454
.59490
.25000
E F F E C T  .. G R O U P (2) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T6
T7
T8
T9
4 . 9 5 5 3 3  
1 . 9 3 5 5 4  
1 1 . 0 6 4 9 6  
2 . 4 6 4 9 8
6 1 8 . 7 4 1 4 1  
1 6 3 . 3 4 2 0 3  
1 9 2 . 9 9 1 5 7  
6 2 . 7 8 5 6 4
4 . 9 5 5 3 3  
1.9 3 5 5 4  
1 1 . 0 6 4 9 6  
2 . 4 6 4 9 8
1 8 . 7 4 9 7 4
4 . 9 4 9 7 6
5 . 8 4 8 2 3
1 . 9 0 2 6 0
.26429
.39104
1.8 9 2 0 2
1 . 2 9 5 5 9
. 611 
.536 
.178 
.263
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E F F E C T  .. G R O U P (1) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  M S F Sig. of F
T6 3 2 . 0 3 2 4 7 6 1 8 . 7 4 1 4 1 3 2 . 0 3 2 4 7 1 8 . 7 4 9 7 4 1 . 7 0 8 4 2 .200
T7 1 . 8 3 4 0 7 1 6 3 . 3 4 2 0 3 1 . 83407 4 . 9 4 9 7 6 .37054 .547
T8 7 . 5 0 9 8 7 1 9 2 . 9 9 1 5 7 7. 5 0 9 8 7 5 . 8 4 8 2 3 1 . 2 8 4 1 3 .265
T9 .22351 6 2 . 7 8 5 6 4 .22351 1 . 9 0 2 6 0 .11748 .734
E F F E C T  .. S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F Sig. of F
T6 1 0 0 . 7 0 4 4 8 6 1 8 . 7 4 1 4 1 1 0 0 . 7 0 4 4 8 1 8 . 7 4 9 7 4 5 . 3 7 0 9 8 .027
T7 8 6 . 0 5 2 9 2 1 6 3 . 3 4 2 0 3 8 6 . 0 5 2 9 2 4 . 9 4 9 7 6 1 7 . 3 8 5 2 8 .000
T8 .29697 1 9 2 . 9 9 1 5 7 .29697 5 . 8 4 8 2 3 .05078 .823
T9 2 7 . 6 5 2 4 7 6 2 . 7 8 5 6 4 2 7 . 6 5 2 4 7 1.9 0 2 6 0 1 4 . 5 3 4 0 8 .001
* * * * * * A  n a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  E f fect. 
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F MS F Si g of F
W I T H I N  C E L L S  
S I T E  B Y  T I M E S
1 0 3 7 . 8 6
2 1 4 . 7 1
132
4
7.86
53.68 6.83 .000
G R O U P (1) B Y  S I T E  B Y 4 1 .60 4 10.40 1.32 .265
T I M E S  
G R O U P (2) B Y  S I T E  B Y 2 0 .42 4 5.11 . 65 . 628
T I M E S
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Study 2 - Alpha-2
M A N O V A
a 2 f z b l 2  a 2 f z c 0 1  a 2 f z c 0 2  a 2 c z b l 2  a 2 c z c 0 1  a 2 c z c 0 2  a 2 p z b l 2  a 2 p z c 0 1  a 2 p z c 0 2  BY  
g r o u p
(1 3)
/ W S F A C T O R S =  s i t e  (3) t i m e s (3)
/ C O N T R A S T ( t i m e s )= p o l y n o m i a l  
/ C O N T R A S T  ( s i t e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ O M E A N S
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a ] _ y S i s  o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
C e l l  M e a n s  a n d  S t a n d a r d  D e v i a t i o n s  
V a r i a b l e  .. A 2 F Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - . 2 1 9 1.290 11
G R O U P 2 -.051 .874 13
G R O U P 3 -.371 1.083 12
F or e n t i r e  s a m p l e - . 2 0 9 1.060 36
V a r i a b l e  .. A 2 F Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 1 . 8 7 0 2.597 11
G R O U P 2 - . 8 2 9 1.161 13
G R O U P 3 - 2 . 9 4 6 2 . 580 12
Fo r  e n t i r e  s a m p l e - 1 . 8 5 3 2 . 298 36
V a r i a b l e  .. A 2 F Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -1.4 6 1 2 . 5 6 5 11
G R O U P 2 - . 3 3 5 .978 13
G R O U P 3 -1.841 1.972 12
Fo r  e n t i r e  s a m p l e -1.1 8 1 1.967 36
V a r i a b l e  .. A 2 C Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - . 4 4 0 1.640 11
G R O U P 2 .083 1.519 13
G R O U P 3 - . 4 8 5 2.631 12
For e n t i r e  s a m p l e - . 2 6 6 1.951 36
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V a r i a b l e  .. A 2 C Z C 0 1
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
F o r  e n t i r e  s a m p l e
V a r i a b l e  .. A 2 C Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 1 . 6 5 5 2 . 9 5 9 11
G R O U P 2 - . 1 1 6 3.518 13
G R O U P 3 - 2 . 6 0 6 2 . 390 12
For e n t i r e  s a m p l e - 1 . 4 1 6 3.110 36
V a r i a b l e  .. A 2 P Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.451 2 . 0 7 9 11
G R O U P 2 .187 1.555 13
G R O U P 3 - . 723 4.164 12
For e n t i r e  s a m p l e -.311 2 . 7 6 9 36
V a r i a b l e  .. A 2 P Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 2 . 6 1 5 3.577 11
G R O U P 2 - . 3 3 9 3.142 13
G R O U P 3 - 4 . 2 4 2 4 . 375 12
For e n t i r e  s a m p l e - 2 . 3 3 5 3.976 36
V a r i a b l e  .. A 2 P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - 1 . 7 9 6 3.482 11
G R O U P 2 1.456 6.627 13
G R O U P 3 -3.474 4.118 12
For e n t i r e  s a m p l e -1.181 5 . 3 2 5 36
M e a n Std. Dev. N
-1. 7 6 8 2 . 8 1 6 11
- . 6 6 6 2 .148 13
- 3 . 3 0 3 2.581 12
-1.8 8 2 2.681 36
* * * * * * A n a l y S i s  o f  V a r i a n c e - -  d e s i g n  
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
★ ★ ★ ★ ★ ★
S o u r c e  o f  V a r i a t i o n
W I T H I N  C E L L S  
G R O U P (1)
G R O U P (2)
SS D F  M S F Si g of F
996.42
162.78
33 3 0 .19  
1 162.78 5.39 .027
90.08 1 90.08 2.98 .093
s o f V a r i a n c e  — d e s i g n 1 * * •
T e s t s  i n v o l v i n g  'SITE' W i t h i n - S u b j e c t  E ffect.
M a u c h l y  s p h e r i c i t y  t e s t ,  W
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
.64590
1 3 . 9 8 7 7 4  w i t h  2 D. F.
.001
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G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
.73850
.81166
.50000
R A G E D  T e s t s  of S i g n i f i c a n c e  that f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h . SS E r r o r  SS Hypoth. MS E r r o r  M S F Sig. of F
T2
T3
1 4 . 5 8 6 0 9
1 . 5 6 6 3 8
2 7 1 . 0 4 5 9 2
7 1 . 4 0 4 7 5
1 4 . 5 8 6 0 9
1 . 56638
8 . 21351
2 . 1 6 3 7 8
1 . 7 7 5 8 6
.72391
.192
.401
E F F E C T  .. 
U n i v a r i a t e
G R O U P (1) 
F - t e s t s
B Y  SITE  
w i t h  (1,33) D,. F.
V a r i a b l e H y p o t h . SS E r r o r  SS H y poth. M S E r r o r  MS F Sig. of F
T2
T3
2 0 . 0 8 1 9 6  
.65026
2 7 1 . 0 4 5 9 2
7 1 . 4 0 4 7 5
2 0 . 0 8 1 9 6  
.65026
8.21351
2.1 6 3 7 8
2 . 4 4 4 9 9
.30052
.127
.587
E F F E C T  .. 
U n i v a r i a t e
S I T E
F - t e s t s w i t h  (1,33) D,. F.
V a r i a b l e H y p o t h . SS E r r o r  SS H y poth. MS E r r o r  MS F Sig. of F
T2
T3
2 . 8 5 5 8 1
.00001
2 7 1 . 0 4 5 9 2
7 1 . 4 0 4 7 5
2 . 8 5 5 8 1  
.00001
8.21351
2.1 6 3 7 8
.34770
.00001
.559
.998
* * * * * * A n a l y s i s  o f V a r i a n c e — d e s i g n 1 * "k -k 'k *
T e s t s  i n v o l v i n g  'SITE'' W i t h i n - S u b j e c t E f f e c t .
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums of squ a r e s
S o u r c e  of V a r i a t i o n SS D F M S F Sig of F
W I T H I N  C E L L S 3 4 2 . 4 5 66 5.19
SI T E 2 . 8 6 2 1.43 .28 .760
G R O U P (1) B Y  S I T E 2 0 . 7 3 2 10.37 2.00 .144
G R O U P (2) B Y  S I T E 1 6 .15 2 8.08 1.56 .219
* * * * * * A n a l y s i s  o f  V a r i a n c e - -  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  app r o x .  = 
S i g n i f i c a n c e  =
.92705
2 . 4 2 4 0 8  w i t h  2 D. F. 
.298
G r e e n h o u s e - G e i s s e r  E p s i l o n  = .93201 
H u y n h - F e l d t  E p s i l o n  = 1 . 0 0 0 0 0  
L o w e r - b o u n d  E p s i l o n  = .50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e sts are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  . .  G R O U P (2) B Y  T IM E S
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U n i v a r i a t e F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T4
T5
2 0 . 9 0 1 5 1
.83925
4 0 8 . 8 2 2 7 9
3 0 9 . 5 6 9 5 2
2 0 . 9 0 1 5 1
.83925
1 2 . 3 8 8 5 7
9 . 3 8 0 8 9
1 . 6 8 7 1 6
.08946
.203
.767
E F F E C T  .. 
U n i v a r i a t e
G R O U P (1) B Y  T I M E S  
F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T4
T5
3 1 . 0 7 6 4 2
1 4 . 8 8 9 5 8
4 0 8 . 8 2 2 7 9
3 0 9 . 5 6 9 5 2
3 1 . 0 7 6 4 2
1 4 . 8 8 9 5 8
12 . 3 8 8 5 7
9 . 3 8 0 8 9
2 . 5 0 8 4 8
1.5 8 7 2 2
.123
.217
E F F E C T  . . 
U n i v a r i a t e
T I M E S
F - t e s t s  w i t h (1,33) D., F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T4
T5
5 8 . 1 1 4 7 9
1 1 5 . 5 7 0 0 8
4 0 8 . 8 2 2 7 9
3 0 9 . 5 6 9 5 2
5 8 . 1 1 4 7 9
1 1 5 . 5 7 0 0 8
12 . 3 8 8 5 7
9 . 3 8 0 8 9
4 . 6 9 1 0 0
1 2 . 3 1 9 7 3
.038
.001
* * * * * * A  n  a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  ' T I M E S ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S . 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS DF M S F Sig of F
W I T H I N  C E L L S 7 1 8 . 3 9 66 10.88
T I M E S 173.68 2 86.84 7.98 .001
G R O U P (1) B Y  T I M E S 45.97 2 22.98 2.11 .129
G R O U P (2) B Y  T I M E S 21.74 2 10.87 1.00 .374
* * * * * * A n a ] _ y S j _ s o f  V a r i a n c e - -  d e s i g n  ] _ * * * * * *  
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
.10242
7 1 . 5 8 9 5 8  w i t h  9 D. F. 
. 0 0 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.51771
.58643
.25000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  th a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e
T6
T7
T8
T9
H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  MS F Sig. of F
4 . 0 8 5 8 5 2 5 4 . 3 1 1 6 3 4 . 0 8 5 8 5 7 . 7 0 6 4 1 .53019 .472
.00795 1 2 2 . 5 9 6 4 4 .00795 3 . 7 1 5 0 4 .00214 .963
1 . 1 7 8 1 5 5 3 . 3 9 9 4 5 1 . 1 7 8 1 5 1 . 6 1 8 1 7 .72807 .400
.22664 2 0 . 4 0 2 9 1 .22664 .61827 .36656 .549
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E F F E C T  . .  G R O U P (1 ) B Y  S I T E  B Y  T IM E S
U n i v a r i a t e F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F Sig. of F
T6 8 . 0 2 8 0 0 2 5 4 . 3 1 1 6 3 8 . 0 2 8 0 0 7.7 0 6 4 1 1 . 0 4 1 7 3 .315
T7 .09493 1 2 2 . 5 9 6 4 4 .09493 3.7 1 5 0 4 .02555 .874
T8 .23082 5 3 . 3 9 9 4 5 .23082 1 .61817 .14264 .708
T9 .09146 2 0 . 4 0 2 9 1 .09146 .61827 .14793 .703
E F F E C T  .. S I T E  B Y  T I M E S
U n i v a r i a t e F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  M S F Sig. of F
T6 .02844 2 5 4 . 3 1 1 6 3 .02844 7 . 7 0 6 4 1 .00369 .952
T7 2 . 2 0 5 7 1 1 2 2 . 5 9 6 4 4 2 . 2 0 5 7 1 3 . 71504 .59372 .446
T8 .51290 5 3 . 3 9 9 4 5 .51290 1 . 61817 .31696 .577
T9 1 . 8 5 2 8 4 2 0 . 4 0 2 9 1 1.8 5 2 8 4 .61827 2 . 9 9 6 8 1 .093
* * * * * * A  n  a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * •k  :k * * *
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S . 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS DF M S F S i g  of F
W I T H I N  C E L L S 4 5 0 . 7 1 132 3.41
S I T E  B Y  T I M E S 4.60 4 1.15 .34 .853
G R O U P (1) B Y  S I T E  B Y 8.45 4 2.11 .62 . 650
T I M E S
G R O U P (2) B Y  S I T E  B Y 5.50 4 1.37 .40 .807
T I M E S
Page 5
Study 2 - Beta-1
M A N O V A
b l f z b l 2  b l f z c O l  b l f z c 0 2  b l c z b l 2  b l c z c O l  b l c z c 0 2  b l p z b l 2  b l p z c O l  b l p z c 0 2  B Y  
g r o u p
(1 3)
/ W S F A C T O R S =  s i t e (3) t i m e s (3)
/ C O N T R A S T ( t i m e s ) = p o l y n o m i a l  
/ C O N T R A S T  ( s i t e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ O M E A N S
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a l y s i s  o f  V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  be p r o c e s s e d .
C e l l  M e a n s  a n d  S t a n d a r d  D e v i a t i o n s
V a r i a b l e  .. B 1 F Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.102 1.187 11
G R O U P 2 .113 1.165 13
G R O U P 3 -.581 1.904 12
For e n t i r e  s a m p l e -.184 1.448 36
V a r i a b l e  .. B 1 F Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -1.238 2 . 505 11
G R O U P 2 -1.303 2.080 13
G R O U P 3 -1.4 6 5 3.928 12
Fo r  e n t i r e  s a m p l e -1.337 2.852 36
V a r i a b l e  .. B 1 F Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1
G R O U P 2
G R O U P 3
For e n t i r e  s a m p l e
.080 2.213 11
-.650 2.245 13
-1.258 2 . 630 12
-.630 2 . 3 6 5 36
V a r i a b l e  .. B 1 C Z B 1 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
F or e n t i r e  s a m p l e
M e a n Std. Dev. N
.417 .879 11
.401 .911 13
-.660 2.693 12
.052 1.745 36
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V a r i a b l e  .. B 1 C Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - . 2 4 6 2 . 417 11
G R O U P 2 .219 2 . 507 13
G R O U P 3 - 2 . 2 0 3 3 . 660 12
F o r  e n t i r e  s a m p l e -.731 3.031 36
V a r i a b l e  .. B 1 C Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1 . 065 2.911 11
G R O U P 2 - . 1 3 0 2 . 977 13
G R O U P 3 - . 9 0 5 3.024 12
Fo r  e n t i r e  s a m p l e -.024 2 . 9 9 6 36
V a r i a b l e  .. B 1 P Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1.217 1.637 11
G R O U P 2 .402 1.268 13
G R O U P 3 - . 690 2 .538 12
F or e n t i r e  s a m p l e .287 1.986 36
V a r i a b l e  .. B 1 P Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.277 2.928 11
G R O U P 2 .881 2 . 4 4 5 13
G R O U P 3 - 1 . 6 6 9 3.674 12
For e n t i r e  s a m p l e - . 323 3.147 36
V a r i a b l e  .. B 1 P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 . 699 2 . 3 7 6 11
G R O U P 2 .979 2.304 13
G R O U P 3 - 1 . 0 8 9 2 . 9 6 9 12
F o r  e n t i r e  s a m p l e .204 2 . 6 6 0 36
* * * * * * A n a l y s i s o f V a r i a n c is —  d e s i g n 1 k  k  k  k
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
of FS o u r c e  o f  V a r i a t i o n SS D F M S F S i g
W I T H I N  C E L L S 798 .75 33 2 4 . 2 0
G R O U P (1) 123 .13 1 123.13 5.09 .031
G R O U P (2) .33 1 .33 .01 .908
* * * * * * A n a l y s i s  o f  V a r i a n c e  d e s i g n  
T e s t s  i n v o l v i n g  ’S I T E ’ W i t h i n - S u b j e c t  E f fect.
M a u c h l y  s p h e r i c i t y  t e s t ,  W
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
.91419
2 . 8 7 1 0 1  w i t h  2 D. F. 
.238
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
.92097
1.00000
.50000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  M S F Sig. O f  F
T2 1 . 4 3 8 7 8 2 1 7 . 2 9 2 8 5 1 . 43878 6 . 5 8 4 6 3 .21851 . 643
T3 .78058 1 2 7 . 1 9 8 9 2 .78058 3 . 8 5 4 5 1 .20251 . 656
E F F E C T  . . G R O U P (1) B Y S I T E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H ypoth. M S E r r o r  M S F Sig. of F
T2 1 7 . 6 6 0 7 6 2 1 7 . 2 9 2 8 5 1 7 . 6 6 0 7 6 6.5 8 4 6 3 2 . 6 8 2 1 2 .111
T3 1 . 9 7 4 6 5 1 2 7 . 1 9 8 9 2 1 . 9 7 4 6 5 3. 8 5 4 5 1 .51230 .479
E F F E C T  . . S I T E
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  M S F Sig. of F
T2 3 1 . 2 2 1 3 8 2 1 7 . 2 9 2 8 5 3 1 . 2 2 1 3 8 6 .58463 4 . 7 4 1 5 5 .037
T3 .76983 1 2 7 . 1 9 8 9 2 .76983 3 . 85451 .19972 . 658
* * * * * * A  n a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  ’S I T E ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for M E A S .1 us ing U N I Q U E sums of s q u a r e s
S o u r c e  of: V a r i a t i o n SS D F M S F Sig of F
W I T H I N  C E L L S 3 4 4 . 4 9 66 5.22
S I T E 3 1 . 9 9 2 16.00 3.06 .053
G R O U P (1) B Y  S I T E 19.64 2 9.82 1.88 .161
G R O U P (2) B Y  S I T E 2.22 2 1.11 .21 .809
* * * * * * A  n a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  ’T I M E S ’ W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
.96706
1 . 0 7 1 6 8  w i t h  2 D. F. 
.585
.96811
1.00000
.50000
E F F E C T  . .  G R O U P (2 ) B Y  T IM E S
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U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F S i g . o f  F
T4 1 . 0 4 9 7 1 1 9 2 . 4 0 3 5 7 1. 0 4 9 7 1 5 . 8 3 0 4 1 .18004 .674T5 9 . 5 7 0 7 2 2 7 0 . 9 9 8 3 8 9 . 5 7 0 7 2 8. 2 1 2 0 7 1.1 6 5 4 4 .288
E F F E C T  .. G R O U P (1) B Y T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D . F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F S i g . of F
T4 1 . 6 6 2 9 7 1 9 2 . 4 0 3 5 7 1. 6 6 2 9 7 5 . 8 3 0 4 1 .28522 .597
T5 .72648 2 7 0 . 9 9 8 3 8 .72648 8.2 1 2 0 7 .08846 .768
E F F E C T  .. T I M E S
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D . F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  MS F Sig.. of F
T4 1 . 9 7 9 6 6 1 9 2 . 4 0 3 5 7 1 . 9 7 9 6 6 5 . 8 3 0 4 1 .33954 .564
T5 4 2 . 7 9 2 8 4 2 7 0 . 9 9 8 3 8 4 2 . 7 9 2 8 4 8. 2 1 2 0 7 5. 2 1 0 9 7 .029
‘k "k "k "k 'k * A  n a 1 y s i s  o f V a r i a n e e  —  d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  E f f e c t •
A V E R A G E D T e s t s  o f  S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of: V a r i a t i o n SS DF M S F S i g  of F
W I T H I N  C E L L S 4 6 3 . 4 0 66 7.02
T I M E S 44.77 2 2 2 . 3 9 3.19 .048
G R O U P (1) B Y  T I M E S 2. 3 9 2 1.19 .17 .844
G R O U P (2) B Y  T I M E S 10.62 2 5.31 .76 .473
'k k  k  k  k * A  n a 1 y s i s  o f V a r i a n e e - -  d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W 
C h i - s q u a r e  app r o x .  = 
S i g n i f i c a n c e  =
.37743
3 0 . 6 1 1 5 2  w i t h  9 D. F. 
. 0 0 0
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.66391 
.77117 
.25000
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  th a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E  B Y  T I M E S
U n i v a r i a t e F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  MS E r r o r  MS F Sig. of F
T6 6 . 1 9 3 6 9 9 9 . 1 7 7 7 7 6 . 1 9 3 6 9 3 . 0 0 5 3 9 2 . 0 6 0 8 6 .161
T7 3 . 0 2 0 0 6 8 3 . 8 5 3 4 7 3 . 0 2 0 0 6 2. 5 4 1 0 1 1 . 1 8 8 5 2 .284
T8 3 . 1 2 0 4 2 3 7 . 2 1 7 0 4 3 . 1 2 0 4 2 1 . 1 2 7 7 9 2 . 7 6 6 8 5 .106
T9 .18088 2 3 . 6 9 4 0 9 .18088 .71800 .25193 . 619
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E F F E C T  .. G R O U P (1) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hyp o t h .  M S E r r o r  M S F Sig. of F
T6 .00351 9 9 . 1 7 7 7 7 .00351 3 . 0 0 5 3 9 .00117 .973
T7 1 . 8 9 2 0 7 8 3 . 8 5 3 4 7 1 . 89207 2 . 5 4 1 0 1 .74461 .394
T8 .02881 3 7 . 2 1 7 0 4 .02881 1 . 1 2 7 7 9 .02555 .874
T9 4 . 5 5 1 4 2 2 3 . 6 9 4 0 9 4.5 5 1 4 2 .71800 6. 3 3 9 0 0 . 017
E F F E C T  . . S I T E  B Y  T I M E S
U n i v a r i a t e F - t e s t s  w i t h (1,33) D,. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H ypoth. M S E r r o r  MS F Sig., of F
T6 .84014 9 9 . 1 7 7 7 7 .84014 3 . 0 0 5 3 9 .27954 . 601
T7 1 . 2 8 1 4 8 8 3 . 8 5 3 4 7 1 .28148 2 . 5 4 1 0 1 .50432 .483
T8 .59588 3 7 . 2 1 7 0 4 .59588 1 . 1 2 7 7 9 .52836 .472
T9 .00014 2 3 . 6 9 4 0 9 .00014 .71800 .00019 .989
* * * * * * A  n  a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  ’S I T E  B Y  T I M E S ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F MS F S i g  of F
W I T H I N  C E L L S 2 4 3 . 9 4 132 1.85
S I T E  B Y  T I M E S 2.72 4 . 68 .37 .831
G R O U P (1) B Y  S I T E  B Y 6.48 4 1.62 .88 .480
T I M E S
G R O U P (2) B Y  S I T E  B Y 12.52 4 3.13 1.69 .155
T I M E S
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Study 2 - Beta-2
M A N O V A
b 2 f z b l 2  b 2 f z c O l  b 2 f z c 0 2  b 2 c z b l 2  b 2 c z c 0 1  b 2 c z c 0 2  b 2 p z b l 2  b 2 p z c 0 1  b 2 p z c 0 2  B Y  
g r o u p
(1 3)
/ W S F A C T O R S =  s i t e (3) t i m e s (3)
/C O N T R A S T ( t i m e s )= p o l y n o m i a l  
/ C O N T R A S T  (s i t e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ O M E A N S
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a ^ y S ^ s 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  be p r o c e s s e d .
C e l l  M e a n s  a n d  S t a n d a r d  D e v i a t i o n s  
V a r i a b l e  .. B 2 F Z B 1 2
F A C T O R  C O D E  M e a n  Std. Dev. N
G R O U P 1 - .039 . 611 11
G R O U P 2 .203 .555 13
G R O U P 3 - . 1 9 5 .956 12
For e n t i r e  s a m p l e -.004 .727 36
V a r i a b l e  .. B 2 F Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.084 1.358 11
G R O U P 2 .736 1.620 13
G R O U P 3 -.940 2 . 0 6 9 12
For e n t i r e  s a m p l e -.073 1.809 36
V a r i a b l e  .. B 2 F Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1.545 1.656 11
G R O U P 2 .396 1.631 13
G R O U P 3 -.408 1.601 12
For e n t i r e  s a m p l e .479 1.769 3 6
V a r i a b l e  .. B 2 C Z B 1 2
F A C T O R  C O D E  M e a n  Std. Dev.
G R O U P 1
G R O U P 2
G R O U P 3
F o r  e n t i r e  s a m p l e
-.207 .542 11
.455 .959 13
-.171 .927 12
.044 .877 36
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V a r i a b l e  .. B 2 C Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 .461 1 . 4 7 9 11
G R O U P 2 1.544 1.724 13
G R O U P 3 - . 8 6 5 2 .017 12
F o r  e n t i r e  s a m p l e .410 1 . 9 8 9 36
V a r i a b l e  .. B 2 C Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 .978 1.563 11
G R O U P 2 .871 2 . 154 13
G R O U P 3 - . 127 1.381 12
Fo r  e n t i r e  s a m p l e .571 1.772 36
V a r i a b l e  .. B 2 P Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 - . 0 7 3 .713 11
G R O U P 2 . 129 .594 13
G R O U P 3 - . 357 . 657 12
Fo r  e n t i r e  s a m p l e - . 0 9 5 . 666 36
V a r i a b l e  .. B 2 P Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 .941 1.637 11
G R O U P 2 1 . 5 8 6 1 . 6 8 6 13
G R O U P 3 .072 1 .876 12
Fo r  e n t i r e  s a m p l e .884 1 . 805 36
V a r i a b l e  .. B 2 P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1 . 2 7 9 1.140 11
G R O U P 2 1 .136 1.828 13
G R O U P 3 .941 1.353 12
F o r  e n t i r e  s a m p l e 1 . 115 1.453 36
* * * * * * ^ i ^ £ ] _ y s i s  o f  V a r i a n c e d e s ig n  1 * * * * *  *
T e s t s  o f  B e t w e e n - S u b j e c t s  E f f e c t s .
T e s t s  o f  S i g n i f i c a n c e  for T1 u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n  SS D F  M S  F S i g  of F
W I T H I N  C E L L S  
G R O U P (1) 
G R O U P (2)
2 4 3 . 2 2
5 6 . 4 5
3 . 3 6
33
1
7.37
5 6 . 4 5 7.66 .009
1 3.36 .46 .504
* * * * * * j ^ n a i y s i s  o f  V a r i a n c e  d e s i g n  1 
T e s t s  i n v o l v i n g  ’SITE' W i t h i n - S u b j e c t  E f f e c t .
M a u c h l y  s p h e r i c i t y  t e s t ,  W
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
.96930
.99765 w i t h  2 D. F. 
.607
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G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
.970221. 0 0 0 0 0
.50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  that f o l l o w  m u l t i v a r i a t e  t e sts are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E
U n i v a r i a t e  F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. M S E r r o r  MS F Sig. of F
T2 . 61865 4 8 . 9 0 5 8 2 .61865 1 . 4 8 1 9 9 .41744 .523
T3 2 . 3 3 9 2 7 4 8 . 2 7 8 8 1 2. 3 3 9 2 7 1 . 4 6 2 9 9 1 . 5 9 8 9 6 .215
E F F E C T  . . G R O U P (1) B Y  SITE
U n i v a r i a t e  F - t e s t s  w i t h (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2 1 . 5 4 7 2 2 4 8 . 9 0 5 8 2 1.54722 1.4 8 1 9 9 1.04401 .314
T3 1 . 2 2 5 9 1 4 8 . 2 7 8 8 1 1.22591 1.4 6 2 9 9 .83794 .367
E F F E C T  . . SI T E
U n i v a r i a t e  F - t e s t s  w i t h (1,33) D,. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T2 1 3 . 0 7 8 7 9 4 8 . 9 0 5 8 2 1 3 . 0 7 8 7 9 1.4 8 1 9 9 8 . 82513 .006
T3 .21581 4 8 . 2 7 8 8 1 .21581 1.4 6 2 9 9 .14751 .703
Jr Jr Jr J r Jr * A  n a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 *  *  * *  *  *
T e s t s  i n v o l v i n g  ’S I T E ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for M E A S . 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of' V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E L L S 97.18 66 1.47
S I T E 13.29 2 6.65 4.51 .015
G R O U P (1) B Y  S I T E 2.77 2 1.39 .94 .395
G R O U P (2) B Y  SITE 2.96 2 1.48 1.00 .372
Jr J r 'k 'k 'k * A  n a 1 y s i s  o f V a r i a n e e - - d e s i g n  1 *  *  * J r J r Jr
T e s t s  i n v o l v i n g  ’TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  a p prox. =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  that f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
.97666
.75584 w i t h  2 D. F. 
.685
.97719
1 . 0 0 0 0 0
.50000
E F F E C T  . .  G R O U P (2) B Y  T IM E S
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U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h . M S E r r o r  M S F Sig. of F
T4 6 . 2 3 9 2 5 9 0 . 1 9 2 9 6 6 . 2 3 9 2 5 2 . 7 3 3 1 2 2 . 2 8 2 8 3 .140
T5 9 . 6 1 3 0 8 9 6 . 6 7 1 1 7 9 . 6 1 3 0 8 2 . 9 2 9 4 3 3 . 2 8 1 5 5 .079
E F F E C T  . . iG R O U P (1) B Y  T I M E S
U n i v a r i a t e F - t e s t s  w i t h (1,33) D., F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  M S E r r o r  M S F Sig. of F
T4 4 . 0 2 0 9 2 9 0 . 1 9 2 9 6 4 . 0 2 0 9 2 2 . 7 3 3 1 2 1 . 4 7 1 1 8 .234
T5 1 1 . 0 7 2 5 1 9 6 . 6 7 1 1 7 1 1 . 0 7 2 5 1 2 . 9 2 9 4 3 3 . 7 7 9 7 5 .060
E F F E C T  .. T I M E S
U n i v a r i a t e F - t e s t s  w i t h (1,33) D . F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y p o t h .  MS E r r o r  M S F Sig. of F
T4 3 1 . 2 7 2 8 8 9 0 . 1 9 2 9 6 3 1 . 2 7 2 8 8 2 . 7 3 3 1 2 1 1 . 4 4 2 1 9 .002
T5 .06628 9 6 . 6 7 1 1 7 .06628 2 . 9 2 9 4 3 .02262 .881
* * * * * * A  n a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * * * *
T e s t s  i n v o l v i n g  ’TIMES' W i t h i n - S u b j e c t  Ef f e c t .
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S . 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F S i g  of F
W I T H I N  C E L L S 1 8 6 . 8 6 66 2.83
T I M E S 31.34 2 15.67 5.53 .006
G R O U P (1) B Y  T I M E S 1 5 . 0 9 2 7. 5 5 2.67 .077
G R O U P (2) B Y  T I M E S 1 5 . 8 5 2 7.93 2.80 .068
* * * * * * A n a l y s i s  o f  V a r i a n c e  d e s i g n  ^ * * * * *  * 
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Eff e c t .
M a u c h l y  s p h e r i c i t y  test, W  =
C h i - s q u a r e  a p p r o x .  =
S i g n i f i c a n c e  =
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
A V E R A G E D  T e s t s  o f  S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for th e  A V E R A G E D  resul t s .
.68067
1 2 . 0 8 5 2 3  w i t h  9 D. F. 
.209
.84624 
1 .00000  
.25000
E F F E C T  .. G R O U P (2) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e  H y p o t h .  SS E r r o r  SS H y p o t h .  M S  E r r o r  M S F Sig. of F
T6
T7
T8
T9
1 . 6 3 0 0 8  2 8 . 2 3 3 9 8
.85904 2 7 . 6 6 3 5 9
.01942 1 7 . 1 5 1 6 6
.05148 1 5 . 5 0 5 5 5
1 . 6 3 0 0 8  .85558
.85904 .83829
.01942 .51975
.05148 .46987
1 . 9 0 5 2 4 .177
1 . 0 2 4 7 6 .319
.03737 .848
.10956 .743
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E F F E C T  . .  G R O U P (1) B Y  S I T E  B Y  T IM E S
U n i v a r i a t e F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F Sig. of F
T6 2 . 9 6 2 4 5 2 8 . 2 3 3 9 8 2 . 9 6 2 4 5 .85558 3 . 4 6 2 5 2 .072
T7 .48432 2 7 . 6 6 3 5 9 .48432 .83829 .57775 .453
T8 .18661 1 7 . 1 5 1 6 6 .18661 .51975 .35903 .553
T9 1 . 0 3 8 7 8 1 5 . 5 0 5 5 5 1.0 3 8 7 8 .46987 2 . 2 1 0 8 0 . 147
E F F E C T  .. S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  M S F Sig. of F
T6 4 . 3 6 0 2 3 2 8 . 2 3 3 9 8 4 . 3 6 0 2 3 .85558 5 . 0 9 6 2 5 .031
T7 5 . 9 0 9 5 3 2 7 . 6 6 3 5 9 5 . 9 0 9 5 3 .83829 7 . 0 4 9 5 0 .012
T8 1 . 2 3 6 6 9 1 7 . 1 5 1 6 6 1 . 2 3 6 6 9 .51975 2 . 3 7 9 4 1 .132
T9 .08819 1 5 . 5 0 5 5 5 .08819 .46987 .18770 . 668
* * * * * * j ^ n a l y S - L S 0 f V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  ’S I T E  B Y  T I M E S ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S . l  u s i n g  U N I Q U E  sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F Sig of F
W I T H I N  C E L L S 88.55 132 .67
S I T E  B Y  T I M E S 1 1 .59 4 2.90 4.32 .003
G R O U P (1) B Y  S I T E  B Y 4.67 4 1.17 1.74 .145
T I M E S
G R O U P (2) B Y  S I T E  B Y 2.56 4 .64 .95 .435
T I M E S
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Study 2 - Beta-3
M A N O V A
b 3 f z b l 2  b 3 f z c O l  b 3 f z c 0 2  b 3 c z b l 2  b 3 c z c 0 1  b 3 c z c 0 2  b 3 p z b l 2  b 3 p z c 0 1  b 3 p z c 0 2  B Y  
g r o u p
(1 3)
/ W S F A C T O R S =  s i t e (3) t i m e s (3)
/ C O N T R A S T ( t i m e s ) = p o l y n o m i a l  
/ C O N T R A S T  ( s i t e ) = p o l y n o m i a l
/ C O N T R A S T  ( g r o u p ) = s p e c i a l  ( 1 1 1 1 1 - 2 1 - 1 0 )
/ M E T H O D  U N I Q U E  
/ E R R O R  W I T H I N  
/ P R I N T
S I G N I F ( U N I V  )
/ O M E A N S
/ N O P R I N T  P A R A M ( E S T I M )
S I G N I F ( MULT)
/ d e s i g n = g r o u p (1) g r o u p ( 2 ) .
Manova
* * * * * * A n a f y S f s 0 f V a r i a n c e * * * * * *
36 c a s e s  a c c e p t e d .
0 c a s e s  r e j e c t e d  b e c a u s e  of o u t - o f - r a n g e  f a c t o r  values.
0 c a s e s  r e j e c t e d  b e c a u s e  of m i s s i n g  data.
3 n o n - e m p t y  cells.
1 d e s i g n  w i l l  b e  p r o c e s s e d .
C e l l  M e a n s  a n d  S t a n d a r d  D e v i a t i o n s
V a r i a b l e  .. B 3 F Z B 1 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
For e n t i r e  s a m p l e
V a r i a b l e  .. B 3 F Z C 0 1
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
Fo r  e n t i r e  s a m p l e
M e a n Std. Dev. N
-.228 .748 11
- . 1 3 6 1.323 13
.319 .413 12
-.012 .934 36
M e a n Std. Dev. N
1.291 2.753 11
.170 2.347 13
. 606 1.960 12
.658 2 . 340 36
V a r i a b l e  .. B 3 F Z C 0 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
Fo r  e n t i r e  s a m p l e
M e a n Std. Dev. N
2 . 2 2 9 2 . 7 4 6 11
- . 513 2.247 13
.849 1.677 12
.779 2 . 460 36
V a r i a b l e  .. B 3 C Z B 1 2
F A C T O R  C O D E
G R O U P  1
G R O U P  2
G R O U P  3
F o r  e n t i r e  s a m p l e
M e a n  Std. Dev. N
.237 .973 11
.076 .344 13
.146 .526 12
.149 .634 36
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V a r i a b l e  .. B 3 C Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1.473 2.581 11
G R O U P 2 1.458 1.958 13
G R O U P 3 -.027 2.278 12
Fo r  e n t i r e  s a m p l e .967 2 . 3 1 5 36
V a r i a b l e  .. B 3 C Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1.133 2.062 11
G R O U P 2 .602 .866 13
G R O U P 3 .979 2 . 130 12
For e n t i r e  s a m p l e .890 1.718 36
V a r i a b l e  .. B 3 P Z B 1 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 -.018 .351 11
G R O U P 2 .119 .441 13
G R O U P 3 .044 .408 12
Fo r  e n t i r e  s a m p l e .052 .397 36
V a r i a b l e  .. B 3 P Z C 0 1
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1.891 3.033 11
G R O U P 2 1.490 1.540 13
G R O U P 3 .915 1.666 12
For e n t i r e  s a m p l e 1.421 2 . 115 36
V a r i a b l e  .. B 3 P Z C 0 2
F A C T O R C O D E M e a n Std. Dev. N
G R O U P 1 1.791 2.967 11
G R O U P 2 1.176 1.273 13
G R O U P 3 1.175 1.534 12
For e n t i r e  s a m p l e 1.364 1.973 36
* * * * * * A n a l y s i s  o f V  a r i a n c i0 — — d e s i g n 1 'k -k 'k
T e s t s  of B e t w e e n - S u b j e c t s  Ef f e c t s .
T e s t s  o f  S i g n i f i c a n c e for T1 u s i n g U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F M S F S ig of F
W I T H I N  C E L L S 4 4 5 . 5 9 33 13.50
G R O U P (1) 3.96 1 3.96 .29 .592
G R O U P (2) 19.00 1 19.00 1.41 .244
* * * * * * A n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * 
T e s t s  i n v o l v i n g  ’S I T E ’ W i t h i n - S u b j e c t  E f fect.
M a u c h l y  s p h e r i c i t y  t e s t ,  W = . 8 4 5 8 1
C h i - s q u a r e  a p p r o x .  = 5 . 3 5 8 8 8  w i t h  2 D .  F .
S i g n i f i c a n c e  = . 0 6 9
G r e e n h o u s e - G e i s s e r  E p s i l o n  =
H u y n h - F e l d t  E p s i l o n  =
L o w e r - b o u n d  E p s i l o n  =
.86641
.96557
.50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e s t s  are e q u i v a l e n t  to 
u n i v a r i a t e  o r  s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  MS F Sig. of F
T2
T3
8 . 3 0 4 9 8
3 . 4 6 2 6 6
6 0 . 2 3 3 5 2
3 2 . 5 4 9 3 8
8 . 30498
3 . 4 6 2 6 6
1 . 8 2 5 2 6
.98634
4 . 5 5 0 0 3
3 . 5 1 0 6 0
.040
.070
E F F E C T  .. G R O U P (1) B Y  S I T E
U n i v a r i a t e F - t e s t s  w i t h (1,33) D,. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  MS F Sig. of F
T2
T3
2 . 8 2 1 3 3
1 . 8 8 3 9 5
60 . 2 3 3 5 2
3 2 . 5 4 9 3 8
2 . 8 2 1 3 3
1 . 8 8 3 9 5
1 . 8 2 5 2 6  
.98634
1 . 54571  
1.9 1 0 0 3
.223
.176
E F F E C T  .. S I T E
U n i v a r i a t e F - t e s t s  w i t h (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  MS F Sig. of F
T2 1 0 . 5 8 5 9 9 6 0 . 2 3 3 5 2 1 0 . 5 8 5 9 9 1.8 2 5 2 6 5.7 9 9 7 2 .022
T3 .23036 3 2 . 5 4 9 3 8 .23036 .98634 .23355 . 632
k  k  k  k  k A  n  a 1 y s i s o f V a r i a n e e  — d e s i g n  1 * k  k  k  k  k
T e s t s  i n v o l v i n g  ' S I T E ’ W i t h i n - S u b j e c t  Effect.
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for M E A S . 1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  o f  V a r i a t i o n SS D F M S F Sig of F
W I T H I N  C E L L S 92.IQ 66 1.41
S I T E 10.82 2 5.41 3.85 .026
G R O U P (1) B Y  SITE 4.71 2 2.35 1.67 .195
G R O U P (2) B Y  S I T E 11.77 2 5.88 4.19 .019
k k k k * A  n a 1 y s i s  o f V  a r i a n c e — d e s i g n 1 * * *
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  
C h i - s q u a r e  ap p r o x .  = 
S i g n i f i c a n c e  =
.56770
1 8 . 1 1 7 1 5  w i t h  2 D. F. 
.000
G r e e n h o u s e - G e i s s e r  E p s i l o n  = 
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.69818
.76366
.50000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e sts are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  b e  u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  . .  G R O U P (2) B Y  T IM E S
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U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. M S E r r o r  M S F Sig. of F
T4
T5
1 5 . 5 3 3 0 1
.18305
1 8 7 . 3 0 6 7 8
1 3 0 . 4 6 2 8 7
1 5 . 5 3 3 0 1
.18305
5 . 6 7 5 9 6
3.9 5 3 4 2
2 . 7 3 6 6 3
.04630
.108
.831
E F F E C T  .. 
U n i v a r i a t e
G R O U P (1) B Y  T I MES 
F - t e s t s  w i t h  (1,33) D,. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  M S F Sig. of F
T4
T5
.63190 
1 1 . 3 6 5 4 4
1 8 7 . 3 0 6 7 8
1 3 0 . 4 6 2 8 7
.63190
11.36 5 4 4
5 . 6 7 5 9 6
3 .95342
.11133
2 . 8 7 4 8 4
.741
.099
E F F E C T  .. 
U n i v a r i a t e
T I M E S
F - t e s t s  w i t h  (1,33) D,. F.
V a r i a b l e Hy p o t h .  SS E r r o r  SS Hypoth. MS E r r o r  MS F Sig. of F
T4
T5
5 2 . 1 0 6 0 2
1 6 . 1 8 4 2 7
1 8 7 . 3 0 6 7 8
1 3 0 . 4 6 2 8 7
52 . 1 0 6 0 2
16.18 4 2 7
5 . 6 7 5 9 6
3.95342
9 .18012
4 . 09374
.005
.051
* * * * * * ^ n a l y s i s  o f  V a r i a n c e  —  d e s i g n  1 * * * * *  * 
T e s t s  i n v o l v i n g  'TIMES' W i t h i n - S u b j e c t  Effect.
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E  sums of s quares
S o u r c e  of V a r i a t i o n SS DF MS F Sig of F
W I T H I N  C E L L S 317.77 66 4.81
T I M E S 68.29 2 34.15 7.09 .002
G R O U P (1) B Y  T I M E S 12.00 2 6.00 1.25 .294
G R O U P (2) B Y  T IMES 15.72 2 7.86 1.63 .203
* * * * * A n a l y s i s  o f V a r i a n c e —  d e s i g n 1 'k St *
T e s t s  i n v o l v i n g  'SITE B Y  TIMES' W i t h i n - S u b j e c t  Effect.
M a u c h l y  s p h e r i c i t y  test, W  
C h i - s q u a r e  approx. = 
S i g n i f i c a n c e  =
.32483
3 5 . 3 2 6 6 7  w i t h  9 D. F. 
.000
G r e e n h o u s e - G e i s s e r  E p s i l o n  
H u y n h - F e l d t  E p s i l o n  = 
L o w e r - b o u n d  E p s i l o n  =
.59940 
.68878 
.25000
A V E R A G E D  T e s t s  of S i g n i f i c a n c e  t h a t  f o l l o w  m u l t i v a r i a t e  t e sts are e q u i v a l e n t  to 
u n i v a r i a t e  or s p l i t - p l o t  or m i x e d - m o d e l  a p p r o a c h  to r e p e a t e d  m e a s u r e s .
E p s i l o n s  m a y  be u s e d  to a d j u s t  d.f. for the A V E R A G E D  results.
E F F E C T  .. G R O U P (2) B Y  S I T E  B Y  T I MES
U n i v a r i a t e F - t e s t s  w i t h (1,33) D.. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  M S F Sig. of F
T6 6 . 4 5 6 3 9 2 0 . 5 1 5 9 9 6. 4 5 6 3 9 .62170 1 0 . 38511 .003
T7 .26748 3 6 . 7 4 0 1 4 .26748 1.11334 .24025 .627
T8 4 . 0 1 8 5 0 2 3 . 8 2 0 7 0 4 . 0 1 8 5 0 .72184 5 . 56702 .024
T9 .25328 1 7 . 1 2 2 9 7 .25328 .51888 .48813 .490
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E F F E C T  .. G R O U P (1) B Y  S I T E  B Y  T I M E S  
U n i v a r i a t e  F - t e s t s  w i t h  (1,33) D. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS Hy p o t h .  M S E r r o r  M S F Sig. o f  F
T6 .08601 2 0 . 5 1 5 9 9 .08601 .62170 .13834 .712
T7 .16308 3 6 . 7 4 0 1 4 .16308 1.1 1 3 3 4 .14648 .704
T8 .73962 2 3 . 8 2 0 7 0 .73962 .72184 1 . 0 2 4 6 3 .319
T9 3 . 9 0 6 5 9 1 7 . 1 2 2 9 7 3 . 9 0 6 5 9 .51888 7 . 5 2 8 9 2 .010
E F F E C T  .,. S I T E  B Y  T I M E S
U n i v a r i a t e  F - t e s t s  w i t h (1,33) D,. F.
V a r i a b l e H y p o t h .  SS E r r o r  SS H y poth. MS E r r o r  M S F Sig. of F
T6 1 . 9 1 2 8 0 2 0 . 5 1 5 9 9 1.9 1 2 8 0 .62170 3 . 0 7 6 7 3 .089
T7 2 . 3 9 9 4 0 3 6 . 7 4 0 1 4 2 . 3 9 9 4 0 1 . 11334 2 . 1 5 5 1 4 .152
T8 1 . 4 6 2 0 0 2 3 . 8 2 0 7 0 1. 4 6 2 0 0 .72184 2 . 0 2 5 3 9 .164
T9 .04643 1 7 . 1 2 2 9 7 .04643 .51888 .08947 .767
* * * * * * A  n  a 1 y s i s  o f V a r i a n e e  — d e s i g n  1 * * * + * *
T e s t s  i n v o l v i n g  "SITE BY TIMES' W i t h i n - S u b j e c t E f f e c t .
A V E R A G E D T e s t s  of S i g n i f i c a n c e  for M E A S .1 u s i n g  U N I Q U E sums of s q u a r e s
S o u r c e  of V a r i a t i o n SS D F MS F Sig of F
W I T H I N  C E L L S 98.20 132 .74
S I T E  B Y T I M E S 5.82 4 1.46 1.96 .105
G R O U P (1) B Y  S I T E  BY 4.90 4 1.22 1.65 .167
T I M E S  
G R O U P (2) 
T I M E S
B Y  S I T E  BY 11.00 4 2.75 3.70 .007
Page 5
ALLBOOK
BINDERY
91 RYEDALE ROAD 
WEST RYDE 2114
PHONE: 9807 6026
